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Abstract 
               Prions are highly aggregated infectious proteins that have been identified in 
mammals and in some fungal species. The discovery that prions exist in the yeast 
species S. cerevisiae has enabled researchers to explore the characteristics of these 
unusual proteins and how they propagate within the cell. Heat shock proteins are 
implicated as having a major role in the propagation of prions. The work presented in 
this thesis focuses on the heat shock protein Hsp110. Recent reports have 
demonstrated how the Hsp110 proteins Sse1 and Sse2 are necessary for promoting the 
propagation of the yeast prions [PSI
+
] and [URE3]. A group of Sse1 mutants with 
impaired ability to propagate [PSI
+
] were created. These mutants were characterised 
according to the degree in which they affect [PSI
+
]. Molecular modeling of the 
mutants onto the Sse1 structure allowed us to assess the potential structural affects the 
mutants are having on Sse1. These changes could affect normal Sse1 functions 
necessary for [PSI
+
] propagation such as nucleotide exchange factor function and 
interaction with the molecular chaperone Hsp70. SSE1 and SSE2 are an essential gene 
pair and have been implicated in yeast cellular homeostasis. The Sse1 mutants 
disrupted cellular thermostability at 37
o
C and 39
o
C. Mutant G616D displayed 
osmoremedial temperature sensitivity at 37
o
C. Disruption to cell wall integrity 
signaling was explored as a possible reason for this phenotype but evidence from this 
study suggests that G616D may disrupt PKA signaling. Comparative analysis of Sse1 
and Sse2 reveals that Sse1 is more thermostable than Sse2 and Sse1 propagates [PSI
+
] 
efficiently whereas Sse2 fails to promote [PSI
+
] propagation. Small structural 
differences between the proteins may be responsible for this. However, differentially 
phosphorylating Sse2 may impact its ability to act as a [PSI
+
] promoting factor. 
Overall, this work further highlights the important role Sse1 plays in yeast prion 
propagation and in cellular homeostasis.  
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INTRODUCTION 
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1.1 An introduction to amyloids          
               An amyloid is a filamentous protein aggregate with cross -sheet structure. 
The -strands are stacked perpendicular to the fibril axis (Dobson, 2003). Protein 
amyloid deposition in the central nervous system causes human neurodegenerative 
disorders such as Alzheimer’s, Huntington’s and Parkinson’s disease. Despite much 
research into protein amyloid formation, little is understood about how they cause their 
toxic effects. To date, more than 20 human proteins have been identified which form 
amyloid aggregates, including the protein responsible for a group of diseases termed 
‘prions’ (Caughey and Lansbury, 2003). 
 
1.2 Prion disease in mammalian systems             
               Prions are infectious proteins that cause a group of neurodegenerative diseases 
termed transmissible spongiform encephalopathies (TSEs) (Weissmann and Aguzzi, 
2005). In a review article by Aguzzi (2003) it states that mammalian prion transmission 
is usually taken up orally. Prions enter the GI tract where they travel through the gut 
and invade the peripheral nervous system, finally ascending to the central nervous 
system (CNS) (Aguzzi, 2003). Mammalian prion disease results in spongiform 
degeneration and astrocytic gliosis in the central nervous system of the patient (Zlotnik 
and Stamp, 1961). Mammalian disease caused by prions include Creutzfeldt-Jakob 
disease (CJD), Gerstmann-Straussler-Scheinker syndrome (GSS) and kuru in man; 
chronic wasting disease (CWD) in deer and elk; scrapie in sheep and Bovine 
Spongiform Encephalopathy (BSE) in cattle, as reviewed in Collinge (2001) and 
Collinge (2005). TSEs were first recognised as scrapie of sheep in Western Europe in 
the 1700s but evidence suggests they may have existed much earlier (M’Gowan, 1914; 
Wickner, 2005).  
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1.2.1 Isolation and characterisation of the infectious agent               
                 In 1966 Alper et al. sought to determine the nature of the scrapie infectious 
agent. From inactivation studies using ionizing and UV irradiation they concluded that 
the infectious agent was too small to be a viral particle and it displayed protein-like 
properties. Many questions were left unanswered until the early 1980s when Stanley 
Prusiner performed a number of chemical, physical and enzymatic studies on this 
disease. Once believed to be a viral particle, Prusiner proved that the infectious agent 
was extremely resistant to chemical viral inactivation but sensitive to protein damaging 
agents, suggesting it had a structure completely different from viruses. He hypothesised 
that this enigmatic disease may have a requirement for protein in order to cause 
infectivity. He assigned the name ‘prion’ to the disease, derived from proteinaceous and 
infectious (Prusiner, 1982). He later defined a prion as a ‘proteinaceous infectious agent 
that lacks nucleic acid’ (Prusiner, 1997).  
                In a review article by Riesner (2003) it states that in order to confirm that 
prions were proteinaceous, the protein had to be purified and characterised (Riesner, 
2003). The discovery that PrP protein was associated with prion disease transformed 
prion-related research progress. PrP was first isolated from homogenised animal brain 
tissue purified by precipitation. Prion forms of PrP are resistant to proteinase K 
digestion and this step was crucial in the isolation of the prion protein (Figure 1.1) 
(McKinley et al., 1991; Riesner, 2003).  
                PrP is a highly conserved mammalian glycoprotein essential for prion disease 
infectivity in all TSEs (Weissmann, 1995). PrP is ubiquitously expressed and anchored 
to the surface of cell membranes by a glycosylphosphatidyl inositol (Stahl et al., 1987; 
Prusiner, 2004). Prion disease is composed of a modified PrP
c
 protein called PrP
sc
 
(Prusiner, 1998). PrP
sc
 and PrP
c
 are indistinguishable in their amino acid sequence but 
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differ in conformation (Stahl et al., 1993). Normal cellular protein PrP
c
 is -helical in 
structure. PrP
c
 is converted to the PrP
sc
 infectious form by posttranslational 
modification by which the protein acquires a highly aggregated -sheet rich content 
(Pan et al., 1993; Prusiner, 1997). PrP
sc
 differs from its normal isoform in that it is 
detergent insoluble (Meyer et al., 1986), resistant to proteinase K digestion (McKinley 
et al., 1991) and to inactivation by radiation (Gibbs et al., 1978). They also differ in 
their monomer conformation and state of aggregation (Riesner, 2003; Weissmann, 
2004). 
                 
                           
 
Figure 1.1. Electron micrograph of purified PrP
sc
 amyloid shows the presence of prion 
rods. Prion protein was purified with detergent and proteinase K resulting in insoluble 
aggregates visible by Congo red staining (Riesner, 2003).  
 
              In a review article, by Shorter and Lindquist (2005), it states that prions are 
unusual proteins that can exist in diverse conformations. One of these conformations is 
self-replicating. Prion PrP
sc
 replicates by converting endogenous PrP
c
 into the 
aggregated prion form, therefore infectivity only requires PrP protein templates 
(Shorter and Lindquist, 2005). Prions are an unusual subclass of amyloid protein as 
they replicate their altered conformation by generating infectious prion ‘seeds’, which 
are transmitted to new daughter cells. However, since Prusiner (1982) first proposed the 
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theory that prions are infectious forms of PrP, we are still unclear about the exact 
mechanisms by which a prion is first generated and propagated (Tuite and Koloteva-
Levin, 2004).  
 
1.2.2 Prion disease classification 
               As reviewed in Prusiner (1989) and Collinge (2005), prion disease can be 
divided into inherited, sporadic or acquired forms. The best example of acquired prion 
disease in humans is kuru. In this disease prions were transmitted by ritualistic 
cannibalism in the Fore people of Papau New Guinea (Gajdusek, 1977). The first case 
was recorded in the 1920s and interestingly the disease mainly affected women and 
children with only 2% of cases being in adult men (Alpers, 1987; Collinge et al., 2006). 
Kuru is an inevitably fatal disease but the type of infection and length of incubation 
period is dependent upon a PrP polymorphism, which confers certain people less 
susceptible to the disease (Lee et al., 2001). Collinge et al. (2006) analysed 11 patients 
from New Guinea, who had kuru, and found that men exhibited long prion incubation 
periods, some for up to 56 years. Acquired prion diseases are now rare but the 1990s 
saw a rise in iatrogenic CJD. This was caused by contamination of medical instruments, 
corneal transplantations and pituitary hormone treatment (Brown et al., 1992; Brown et 
al., 2000; Weissmann and Aguzzi, 2005). 
               BSE and CJD are some of the most notable CNS degenerative disorders 
caused by prion disease. It is believed that BSE originated through cannibalism in 
which prion contaminated food was prepared for cattle, as reviewed in Prusiner (1997). 
Sporadic forms of prion disease constitute most human CJD cases. 85% of human prion 
disease is caused by sporadic CJD with a rate of 1-2 cases per million occurring every 
year (Brown et al., 1987; Wadsworth et al., 2003; Collinge, 2005). Variant CJD (vCJD) 
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             Another characteristic of prion disease is that they can exist as different strains. 
Each strain can vary in its incubation time, disease symptoms and its neuropathological 
lesion profile (Bruce et al., 1997). The distinct strains are not due to different PrP 
sequences but differences in amyloid conformations (Wickner et al., 2007a). Amyloid 
plaques are notable in kuru and GSS patients but less notable in sporadic CJD sufferers 
who show a diffuse pattern of PrP deposition (Budka et al., 1995). In a review article 
by Ironside and Head (2004) it discusses how vCJD histopathological features are 
distinguishable from other human prion diseases. vCJD is characterised by having 
abundant florid plaques with the surrounding tissue having a microvacuolated 
appearance (Figure 1.2) (Ironside and Head, 2004). 
                              
 
Figure 1.2. Distinct pattern of PrP deposition in human diseased brain tissue. (a) 
sporadic CJD shows a diffuse, synaptic pattern of PrP deposition (b) kuru shows a 
diffuse pattern of PrP deposition and the formation of amyloid plaques at various 
locations (c) In vCJD PrP plaques are often surrounded by vacuolation designated 
‘florid plaques’. Scale bars a, c 25 m; b 50 m. MV = methionine or valine at PRNP 
codon 129 (Wadsworth and Collinge, 2010). 
 
                The following review articles discuss the nature of mammalian prion disease 
and the importance of understanding their complex molecular composition in order to 
progress prion disease therapeutics. Prion diseases have attracted much research interest 
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for many years because of their unique composition and their impact on public health 
(Collinge, 2001). Understanding the molecular biology behind prion disease processes 
would highlight key aspects of protein misfolding and aggregation and the biological 
entities which regulate them (Wadsworth and Collinge, 2010). Research into prion 
biology is also essential to elucidate a prion curing treatment for patients suffering from 
cerebral degeneration. Early diagnosis is essential as drugs that retard or eliminate the 
prion amyloid will not reverse neuronal loss in the patient. No definite drugs or 
treatments are available as of yet but much research is ongoing into diagnostics and 
therapeutics (Collinge, 2005). Prion research could also prevent the onslaught of 
another BSE endemic. 
 
1.3 Prions exist in yeast S. cerevisiae 
              Saccharomyces cerevisiae is a budding yeast species that has been used for 
decades as a model organism in the study of genetic and biochemical processes 
common to all eukaryotes. It is often referred to as ‘baker’s’ or ‘brewer’s’ yeast as it 
has been used in the food industry as a fermenting agent. It is a single celled eukaryotic 
organism containing approximately 6000 genes and it was the first eukaryote to have its 
genome completely sequenced. Many of its genes have been fully characterised which 
has enabled scientists to investigate fundamental aspects of biology in this simple 
eukaryotic organism (Watson et al., 2008). 
 
1.3.1 The discovery of prions in yeast 
              In 1994 Reed Wickner extended the prion concept to explain how two non-
mendelian elements in yeast S. cerevisiae could propagate without nucleic acid 
(Wickner, 1994). He referred to them as ‘proteins acting like genes’. These prions were 
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is a novel form of human CJD and experimental data has confirmed that vCJD and 
cattle BSE are caused by the same prion strain (Bruce et al., 1997; Hill et al., 1997). In 
1994 the first case of vCJD was identified in young adults in Britain (Will et al., 1996). 
This led to the discovery that prions could be transmitted from cattle to humans through 
the food chain (Prusiner, 2004). The large-scale BSE epidemic affected approximately 
2 million cows (Donnelly et al., 2002) and cases were reported in almost all EU states. 
In the UK approximately 200 cases of vCJD have been identified (Mead, 2009). The 
total vCJD epidemic may be relatively small as the incidence of vCJD has been 
stabilising and gradually falling in the UK since the early 2000s (Valleron et al., 2001; 
Ghani et al., 2003). In the review articles by Collinge (2005) and Mead (2006) they 
discuss how the clinical presentation of human prion diseases tends to vary. The main 
clinical difference between vCJD and CJD is the PrP
sc
 tissue distribution. vCJD 
involves lymphoreticular tissues and most prominently the tonsils (Hill et al., 1999; 
Wadsworth et al., 2001).  
              In review articles by Prusiner (1998) and Collinge (2005) they discuss how 
familial or genetic prion diseases are generally associated with mutations to PrP. 
Approximately 10-15% of human prion diseases are associated with mutations to the 
gene which encodes PrP (PRNP) (Collinge, 2005). A polymorphism at PrP residue 129 
affects susceptibility to human prion disease (Palmer et al., 1991; Lee et al., 2001). All 
cases of vCJD so far have been in individuals homozygous for methionine at position 
129 in PrP (Mead et al., 2009). Humans that are heterozygous for this allele are mostly 
protected from CJD (Mead et al., 2003). This could account for how only a small 
number of people contracted vCJD when it is likely that a lot more were exposed to 
BSE (Mead et al., 2009). To date, over 30 other autosomal dominant mutations have 
been described in PRNP (Collinge, 2005).        
 8 
[PSI
+
] and [URE3], discovered prior to Wickner by Brian Cox in 1965 and Francois 
Lacroute in 1971, respectively. [PSI
+
] was originally discovered by serendipity, as a 
mutant that suppressed nonsense mutations in S. cerevisiae. Cox was monitoring the 
inheritance of a dominant nonsense suppressor called SUQ5, using an ade2-1 allele, at 
the time of the discovery. SUQ5 is a weak tRNA anticodon mutant that inserts serine 
residues at ochre stop codon sites. This enhancement of nonsense suppression produced 
by [PSI
+
] was not restricted to a single tRNA suppressor but was later shown to be an 
‘omnipotent’ suppressor causing readthrough at various nonsense stop codons 
(Liebman and Sherman, 1979). Lacroute was screening for ura2 mutants able to 
incorporate ureidosuccinate when he identified a second class of mutant he termed 
[URE3]. Both Cox and Lacroute demonstrated that [URE3] and [PSI
+
] were dominant 
and demonstrated non-mendelian segregation (4:0) when crossed with another yeast 
strain.  
               These two elements satisfied the criteria to be defined as a fungal prion. 
Wickner (1994) proposed three genetic traits that distinguish prions from nucleic acid 
replicons; (1) if a prion is cured it can arise again as the protein is still present (2) 
overproduction of the protein increases the prion frequency and (3) mutation of the 
gene encoding the protein should have the same phenotype as the prion (Wickner, 
1994).  
 
1.3.2 Linking proteins Ure2 and Sup35 with yeast prion induction 
                 The molecular basis of [URE3] and [PSI
+
] was a long puzzle. [URE3] and 
[PSI
+
] were shown to be prions of Ure2 and Sup35 proteins, respectively (Chernoff et 
al., 1993; Wickner, 1994).  
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                Ure2 is involved in nitrogen catabolite repression. In the presence of rich 
nitrogen sources, such as ammonia, Ure2 mediates the repression of genes that encode 
the enzymes and transporters for poor nitrogen uptake, reviewed in Cooper (2002). 
[URE3] prion is an inactive aggregated amyloid form of Ure2 (Wickner, 1994). [URE3] 
prion disrupts Ure2 function, similarly to ure2 mutants, resulting in the inappropriate 
expression of genes and unnecessary nitrogen uptake (Lacroute, 1971; Brachmann et 
al., 2005). The link between Ure2 and [URE3] prion was confirmed when the over-
expression of Ure2 protein was shown to elevate the frequency of [URE3] appearance 
by 20 to 200 fold (Wickner, 1994).  
                 Sup35 is a protein invoved in stop codon recognition during protein 
synthesis. [PSI
+
] is formed by aggregation of Sup35 monomers resulting in reduced 
termination activity (Wickner et al., 1995). Evidence for the link between Sup35 and 
[PSI
+
] was revealed in independent reports. In 1993 Chernoff et al. demonstrated that 
the over-expression of SUP35 gene resulted in the de novo expression of [PSI
+
], later 
confirmed as the Sup35 protein and not the gene causing the effect (Derkatch et al., 
1996). In 1994 Ter-Avanesyan et al. showed that a deletion to the N-terminus of 
SUP35 resulted in loss of [PSI
+
]. The ‘protein-only’ nature of yeast prions has also 
been demonstrated by groups such as King and Diaz-Avalos (2004) and Tanaka et al. 
(2004). They suggested that [PSI
+
] is ‘infectious’ as in vitro studies demonstrate that 
protein aggregates composed of Sup35 fragments can stimulate de novo [PSI
+
] 
formation and lead to distinct prion strains (King and Diaz-Avalos, 2004; Tanaka et al., 
2004). Since the early 1990s a plethora of biochemical and genetic data substantiates 
[PSI
+
] and [URE3] as yeast prions and the ‘protein-only’ hypothesis is better 
established in yeast than it is in mammals, reviewed in Serio and Lindquist (2000).  
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Figure 1.3. Monitoring Sup35 aggregation in yeast using the red/white assay. Plates a 
and b represent yeast colony colour when cells are (a) [psi
-
] and (b) [PSI
+
]. (c) In [psi
-
] 
cells eRF1 and eRF3 bind and halt translation at the premature stop codon of ADE gene 
(d) In [PSI
+
] cells Sup35 is aggregated and the termination machinery does not form. 
This leads to enhanced readthrough at the premature stop codon and ADE gene is fully 
translated (adapted from Tessier and Lindquist 2009). 
 
 
 
               This red colour screen has been adapted for the [URE3] system whereby an 
ADE2-based reporter system is used. The ADE2 gene is placed under control of the 
DAL5 promoter (Schlumpberger et al., 2001). Ure2 protein negatively regulates the 
transcription of the allantoate permease DAL5. Functional Ure2 prevents the expression 
of DAL5 (Lacroute, 1971; Cooper, 2002). Therefore [ure-o] cells with functional Ure2 
protein fail to induce DAL5 leading to Ade
-
 cells that appear red on limiting adenine 
medium. [URE3] cells fail to halt DAL5 transcription leading to transcription of ADE2 
and colonies appearing white (Schlumpberger et al., 2001; Brachmann et al., 2005). 
The intensity of the red pigment is proportional to the amount of ADE gene expression 
  d 
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and [URE3] strength variants can be distinguished by colour and stability (Brachmann 
et al., 2005). [PSI
+
] variants also exist which are dependent upon efficiency of 
suppression of the ade2/ade1 nonsense codon (Figure 1.4) (Derkatch et al., 1996; 
Halfmann et al., 2010). 
 
                       
Figure 1.4. [PSI
+
] strains differ by their level of nonsense suppression (adapted from 
Halfman et al., 2010). 
 
 
1.3.4 The adenine biosynthesis pathway 
                 In S. cerevisiae the adenine pathway is a seven-step process by which P-
ribosyl-PP (PRPP) is converted into adenine monophosphate. The ADE genes encode 
enzymes which catalyse steps in the conversion from PRPP to adenine. The ADE2 gene 
encodes phosphoribosylaminoimidazole carboxylase which catalyses the sixth step in 
the biosynthesis of the purine nucleotide adenine. Mutations in ADE2 lead to the 
accumulation of purine precursors in the vacuole, causing colonies to be red in colour. 
This pigmentation has been used as a marker for selection and screening of [PSI
+
] and 
[URE3] prions in yeast (Jones and Fink, 1982). ADE2 mutants that turn red are blocked 
in the step forming CAIR and AIR accumulates in the cell. AIR is not red but cells 
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growing aerobically oxidise it to a red pigment. Figure 1.5 illustrates the steps involved 
in the adenine biosynthesis pathway. 
 
 
 
PRPP                  PRA                  GAR   FGAR 
 
                                                                                 FGAM 
                
 
             AIR ACCUMULATES IN                          AIR 
     VACUOLE AND FORMS RED 
                        PIGMENT                                                                
 
                                                                                   CAIR 
                                                                                  
          ADENINE                                              
    MONOPHOSPHATE                                     SAICAIR 
               (AMP)                                     
                                                             
                                                                     
 
Figure 1.5. The adenine biosynthesis pathway in S. cerevisiae (adapted from Jones and 
Fink, 1982 and the Saccharomyces Genome Database (SGD)). 
 
 
               The [PSI
+
] phenotype can also be monitored by means other than the 
red/white colony assay. A more quantitative means of measuring the level of nonsense 
suppression at ade1 or ade2 mutations is by using plasmid-borne gene fusions in which 
two assayable open reading frames are separated by a stop codon. For example the 
PGK-stop-lacZ assay (Firoozan et al., 1991) and the lacZ-stop-luc assay (Namy et al., 
2003). [PSI
+
] can also be monitored by comparing the level of Sup35 degradation when 
cell lysates are treated with proteases such as proteinase K. [PSI
+
] strains are more 
ADE4
E4 
ADE5
E4 
ADE8
E4 
ADE6
E4 
ADE7
E4 
ADE1
E4 
ADE2
E4 
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1.3.3 Monitoring yeast prions 
               It took many years for the ‘protein-only’ mechanism of prion propagation to 
be accepted. The discovery of a similar prion process in yeast allowed scientists to 
study this phenomenon with greater ease, as yeast can be readily manipulated. This was 
an important factor in confirming the ‘protein-only’ hypothesis (Wickner, 1994; Patino 
et al., 1996). In a review article by Osherovich and Weissmann (2002) it states that 
unlike mammalian prions, yeast prions are non-toxic and do not cause cell death, 
therefore there are no obvious ‘sick’ phenotypes like in TSE patients.  
              In a review article by Tuite and Cox (2007) it states that the most 
straightforward measurement of cellular [PSI
+
] is by colony analysis of strains carrying 
a nonsense allele of either ADE1 or ADE2. In S. cerevisiae SUP35 encodes a release 
factor called eRF3. In [psi
-
] (normal) cells eRF3 functions with eRF1 (Sup45) to 
promote protein synthesis termination at in-frame stop codons (Stansfield et al., 1995). 
In [PSI
+
] cells protein synthesis termination machinery is defective due to the 
aggregated nature of Sup35 (Patino et al., 1996; Paushkin et al., 1996) thus preventing 
essential eRF1-eRF3 functional interaction (Tuite and Cox, 2007). Laboratory yeast 
strains can be created with aberrant stop codons in adenine biosynthesis genes ADE1 or 
ADE2. In [psi
-
] cells functional Sup35 promotes translation termination of the gene 
which leads to production of a red pigment due to oxidation of an accumulated 
precursor (Cox, 1965). In contrast, [PSI
+
] cells express Sup35 in a highly aggregated 
insoluble state leading to loss of Sup35 function and enhanced readthrough of nonsense 
mutations (Paushkin et al., 1996). Functional Ade1/Ade2 is produced and cells 
therefore produce white colonies and grow on medium lacking adenine. This red/white 
assay is convenient and widely used in [PSI
+
] research (Figure 1.3), as reviewed in 
Shorter and Lindquist (2005).  
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resistant to protease digestion due to their highly aggregated structure (Paushkin et al., 
1996). [PSI
+
] and [psi
-
] strains also differ in their solubility. Sedimentation assays by 
differential centrifugation analysis can be a useful technique to detect strains with 
insoluble forms of the Sup35 protein. Microscopic localisation of a Sup35-green 
fluorescent protein fusion can also be informative about the cellular location and 
aggregated state of the Sup35 protein (Patino et al., 1996). 
 
1.3.5 Structures of Sup35 and Ure2 and their prion counterparts 
              Sup35 is composed of an N-terminal (N) prion domain (123 residues) which is 
normally involved in mRNA turnover (Hosoda et al., 2003), a 129 residue highly 
charged middle region (M) and a 432 residue C-terminal translation termination domain 
(Ter-Avanesyan et al., 1994). The Ure2 protein is composed of an 80 amino acid N- 
terminal (N) prion domain and a C-terminal domain necessary for nitrogen regulation 
(Figure 1.6) (Coschigano and Magasanik, 1991; Tuite and Cox, 2003). 
              Yeast prion proteins share the same feature of having an abundance of polar 
uncharged residues in their N-terminus prion forming domains. In general less than 
10% of yeast proteins contain glutamine or asparagine residues. In contrast, yeast prion 
proteins, such as Sup35 and Ure2, have regions containing up to 40% glutamine or 
asparagine (Michelitsch and Weissman, 2000; Sondheimer and Lindquist, 2000). In a 
review article by Shorter and Lindquist (2005) it states how Ure2 and Sup35 contain 
these Q/N rich regions in their N-terminus and are referred to as ‘prion forming 
domains’ (PrDs). The PrD of both Ure2 and Sup35 are necessary for prion activity 
(Shorter and Lindquist, 2005). Prion domains are flexible, a characteristic believed to 
be critical in the switch to a prion conformation (Scheibel and Lindquist, 2001). 
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                                           123               253                                                       685 
        Sup35              
                                    N                M                                      C 
                           
            MSDSNQGNNQ QNYQQYSQNG NQQQGNNRYQ GYQAYNAQAQ 
            PAGGYYQNYQ GYSGYQQGGY QQYN   PDAGYQ QQYN  PQGGYQ 
            QYN  PQGGYQQ QFNPQGG 
 
 
                                          80      95                                                        354 
            Ure2                     
                                   N                                                  C 
 
            MMNNNGNQVS NLSNALRQVN IGNRNSNTTT DQSNINFEFS 
            TGVNNNNNNN SSSNNNNVQN NNSGRNGSQN NDNENNIKNT 
            LEQHRQQQQA FSDMS 
 
 
Figure 1.6. The linear structure of yeast prion proteins Sup35 and Ure2. Sup35 has 
three regions, an amino terminal N region, followed by a middle M region and carboxy 
terminal C region. The prion forming domain spans from residue one to 97 in the N- 
terminus and is rich in Q/N residues (highlighted in red). Ure2 consists of an amino 
terminal N domain and a C-terminal carboxy domain. The prion forming domain spans 
the first 65 residues of the N-terminus and like Sup35 is also rich in Q/N residues. The 
Sup35 octapeptide repeats are underlined (adapted from Tuite and Cox, 2003).   
 
 
The Sup35 PrD function is transferable as it can successfully induce prion behaviour 
when fused to other proteins such as GFP, leading to the accumulation of visible prion 
aggregates (Patino et al., 1996; Li and Lindquist, 2000). The prion forming domain is 
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necessary for both induction and propagation of the prion state as prion proteins lacking 
their PrD cannot convert to the prion state spontaneously or when induced by the 
presence of other prions (Ter-Avanesyan et al., 1994; Masison and Wickner, 1995). 
Sup35 N-terminus also contains five imperfect repeats of an octapeptide 
(YQQYNPQGG) with resemblance to an octapeptide repeat found in mammalian PrP 
(PHGGGWGQ) (Figure 1.6). Deletion of these repeats in yeast Sup35 disrupts [PSI
+
] 
propagation (Ter-Avanesyan et al., 1994; Li and Lindquist, 2000). 
 
         
              As reviewed in Lindquist et al. (2001) yeast prions do not cause cell death but 
simply alter the metabolic state of the organism. However, like mammalian prions, the 
protein responsible undergoes changes in conformation which alters its ability to 
function normally (Lindquist et al., 2001). Yeast prions adopt highly aggregated 
conformations with a fibrillar structure and have partial protease resistance (Figure 
1.7.a) (Patino et al., 1996; Paushkin et al., 1996). X-ray diffraction and solid state NMR 
have been extensively used to study their structure. However, there has been much 
controversy over the proposed structure of prion amyloids.  
              The most prominent model for Sup35NM amyloids and the Ure2 prion domain 
is the in-register parallel -sheet conformation. This conformation means that the 
adjacent peptide chains line up in the same orientation with corresponding residues 
opposite one another (Figure 1.7.b) (Kajava et al., 2004; Shewmaker et al, 2006; Baxa 
et al., 2007). Another prominent model for the structure of Sup35NM amyloids is the 
-helix whereby amino acid residues are arranged in a rung with a central pore, thus 
preventing close contact between -sheets (Krishnan and Lindquist, 2005). Resolving 
the controversy surrounding these models will probably depend on new independent 
methods of amyloid structural analysis (Tessier and Lindquist, 2009). 
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                          A                                                      B 
    
 
 
Figure 1.7. Yeast prions have a fibrillar compact structure. 
A. Transmission electron microscopy of the prion conformation. Prions are highly 
ordered amyloids with a fibrillar nature (adapted from Halfmann et al., 2010).  
B. A schematic model of Sup35NM amyloid protein in the in-register parallel -sheet 
conformation. The N domain (blue) is mainly composed of -sheet and the M domain 
(green) is composed of both -sheet and non- -sheet components (adapted from 
Shewmaker et al., 2006). 
 
 
 
 
 
              Loss of the prion conformation results in a return of functional soluble Sup35 
and Ure2 protein (Masison and Wickner, 1995; Patino et al., 1996). These alternating 
states can be tracked by tagging each protein with GFP. Fluorescence of Sup35NM 
GFP is diffusely distributed throughout the cell in a [psi
-
] state (Figure 1.8). In contrast 
[PSI
+
] cells exhibit Sup35NM-GFP fluorescence at specific foci due to the formation of 
aggregates. These aggregates are cytoplasmically transmitted during cell division 
(Figure 1.8) (Patino et al., 1996; Serio and Lindquist, 2000; Halfmann et al., 2010).    
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Figure 1.8. GFP-Sup35 fluorescence in [PSI
+
] and [psi
-
] cells (adapted from Halfmann 
et al., 2010). 
 
1.3.6 Initiation of prion formation and polymerisation 
              What triggers Sup35 and Ure2 to become an amyloid infectious prion is 
complicated and involves a number of cellular and environmental factors. Sup35NM 
converts to amyloid fibres by a nucleated conformational conversion (Scheibel et al., 
2004). Amyloid polymerisation usually starts with the formation of a ‘nucleus’ or a 
‘seed’ of protein with different conformation to the normal soluble form. This nucleus 
promotes the conversion of the rest of the protein monomers to polymerise into the 
prion conformation (Jarrett et al., 1993; Wickner et al., 2000; Tuite, 2000; Scheibel et 
al., 2004). In vitro kinetic models have been established for how Sup35 forms 
amyloids. Collins et al. (2004) determined that de novo amyloid polymerisation occurs 
very slowly by the addition of monomers to the fibre ends of Sup35NM. Once 
established, fibres grow rapidly and efficiently by the addition of Sup35NM monomers 
followed by fibre fragmentation (Collins et al., 2004). The partition of these prion 
‘propagons’ onto daughter cells occurs by passive transfer via cytoplasm distribution. It 
is estimated that approximately 500-1000 propagons can exist per cell (Byrne et al., 
2009). As reviewed in Halfmann et al. (2010), a number of protein remodelling factors 
   [psi
-
]    [PSI
+
] 
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and chaperone proteins interact with prions during the propagation process. Details of 
the role of chaperones in prion propagation will be discussed in section 1.5. 
 
1.3.7 Other fungal prions 
                  A third well documented yeast prion is [PIN
+
], the amyloid form of Rnq1 
protein (Derkatch et al., 2001). [PIN
+] was discovered by Susan Liebman’s laboratory 
in 1997 (Derkatch et al., 1997) and it stands for [PSI
+
] inducibility. The transient over-
expression and subsequent de novo appearance of [PSI
+
] depends upon the presence of 
[PIN
+
] (Derkatch et al., 2001).  
               [Het-s] is a well documented prion form of the protein HET-s found in the 
filamentous fungal species Podospora anserina (Coustou et al., 1997). This prion is 
involved in heterokaryon incompatibility whereby the aggregated prion form [Het-s] 
facilitates programmed cell death when incompatible strain fusions occur (Coustou et 
al., 1997). As discussed in the review article by Benkemoun and Saupe (2006), both 
[Het-s] and [PIN
+
] differ from [PSI
+
] and [URE3] in that their transition to the prion 
state results in no detectable loss of function in the corresponding protein. 
              Until recently the prion field has been confined to this small group of proteins 
but discoveries over the past few years have expanded it. Four additional yeast prions 
[SWI
+
] (Du et al., 2008), [MOT3
+
] (Alberti et al., 2009), [OCT
+
] (Patel et al., 2009) and 
[MCA] (Nemecek et al., 2009) have been reported recently. However, [MCA] was not 
confirmed by Alberti et al. (2009) as a yeast prion and Erhardt et al. (2010) have 
suggested that the prion-like properties of Mca1 protein is dependent upon an N-
terminus peptide stretch, an isoform not consistently expressed. A genome-wide 
analysis of yeast was carried out by Alberti et al. (2009) whereby they discovered many 
potential prions with protein compositions similar to known yeast prions (Q/N rich). 
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But prion proteins may not be restricted to proteins with rich Q/N structure as both PrP 
and HET-s are not rich in glutamine and asparagine residues. It is intriguing to consider 
how many more fungal prions possibly exist (Tessier and Lindquist, 2009). Table 1.1 
summarises the confirmed mammalian and fungal prions, their functions and prion 
manifestations. 
 
1.3.8 Evolutionary significance of yeast prions 
                Research groups have focused much attention on the evolutionary 
significance of yeast prions. Amyloid conformers are disfavoured by natural selection 
and in mammals are usually associated with age-related disorders such as late-onset 
amyloidoses (Alzheimers and Parkinsons disease), as reviewed in Shorter and Lindquist 
(2005). Most groups believe that yeast prions evolved because they are somehow 
beneficial to the cell. True and Lindquist (2000) proposed that [PSI
+
] must affect yeast 
survival and adaptation in the wild as it profoundly affects the relationship between 
genotypes and phenotypes. Many lines of evidence suggest that yeast prions are benign 
and in some cases beneficial. Eaglestone et al., (1999) found that the [PSI
+
] state 
conferred an increased tolerance to heat and ethanol stress possibly due to their 
defective translation termination. Reduced translational fidelity brought about by [PSI
+
] 
could, in the short run, be advantageous by allowing cells to grow in the presence of 
antibiotics and metals or with different carbon and nitrogen sources, depending on the 
strain background, as reviewed in Halfman et al. (2010). True and Lindquist (2000) 
compared various [PSI
+
] and [psi
-
] strains in their preference for certain growth 
conditions. They found that some conditions favoured a [PSI
+
] state whilst others 
favoured [psi
-
]. True and Lindquist (2000) referred to [PSI
+] as an ‘evolutionary 
capacitator’ by facilitating the evolution of new genetic traits. In the review article by 
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Table 1.1. Prions of mammals, yeast and the filamentous fungus Podospora 
anserina  
 
Organism Prion Protein Normal function 
 
Prion manifestation 
 
Mammals TSEs PrP Not known 
Transmissible spongiform 
encephalopathy 
Saccharomyces 
cerevisiae 
[URE3] Ure2 
Nitrogen catabolite 
repression 
Derepression of nitrogen 
catabolism enzymes and 
transporters 
 [PSI
+
] Sup35 
Translation 
termination 
Read-through of stop codons 
 [PIN
+
] Rnq1 Not known 
Rare seeding of [PSI
+
], other 
prions 
 [SWI
+
] Swi1 Chromatin remodeling 
Poor growth on glycerol, 
raffinose, galactose 
 [MCA] Mca1 
Metacaspase 
(suspected function in 
apoptosis) 
Unknown 
 [OCT
+
] Cyc8 
Repression of CYC7 
and other genes 
Derepression of transcription 
 [MOT3
+
] Mot3 Transcription factor Cell-wall changes 
Podospora 
anserina 
[Het-s] HET-s 
Heterokaryon 
incompatibility; 
meiotic drive (as a 
prion) 
Heterokaryon incompatibility; 
meiotic drive (as a prion) 
(Wickner et al., 2009). 
 
 
Shorter and Lindquist (2005) they discuss how [PSI
+
] is perhaps being maintained due 
to the fluctuating environment which yeast are accustomed to. Or, that perhaps the self-
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perpetuating state of modern prions is just a vestige of a once functional mechanism in 
early life forms (Shorter and Lindquist (2005). 
               One group believes that yeast prions are disadvantageous and are actual yeast 
diseases. Wickner believes that yeast prions are non-beneficial and that any prion not 
found in wild yeast strains must be disadvantageous to the host (Nakayashiki et al., 
2005; Wickner et al., 2007b). They analysed 70 wild yeast isolates and failed to find 
[URE3] or [PSI
+
] in any of them (Wickner et al., 2007b). Much of their theory stems 
from the fact that the beneficial prion [Het-s] was found in 80% of P. anserina wild 
isolates (Dalstra et al., 2003). The first description of a yeast prion in a natural isolate 
was [PIN
+
], as reported by Resende et al. (2003). Out of thirteen clinical isolates of S. 
cerevisiae two were [PIN
+
] with none containing either [PSI
+
] or [URE3]. 
             If the [PSI
+
] conformation provided no benefit to the cell then you would 
predict that it would have been lost over time. Even single point mutations to the Sup35 
prion domain dramatically affect [PSI
+
] propagation (Doel et al., 1994; DePace et al., 
1998; Osherovich and Weissman, 2002).  
              
1.4 Structural and functional similarities between yeast and 
mammalian prions  
              There are a number of unifying features of mammalian and fungal prions 
which supports why prion generation and propagation patterns can be modeled in yeast. 
These similar characteristics have been discussed in the following review articles:   
 Mammalian and yeast prions both assemble into self-propagating amyloid 
conformations in vitro (Shorter and Lindquist, 2005). 
 They both form structurally related but distinct prion strains (Tessier and 
Lindquist, 2009). 
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 They both exhibit strong species barriers (Tessier and Lindquist, 2009). 
 Mammalian and yeast prions are composed of tightly packed -sheets which 
are protease resistant and SDS insoluble (Shorter and Lindquist, 2005). 
 They both rely on cellular chaperones to propagate their abnormal 
conformation (Jones and Tuite, 2005). 
               
1.5 Yeast prion propagation and chaperones 
            The generally accepted model for yeast prion propagation is that prions are 
transmitted from mother to daughter cell during cell division. The term ‘propagon’ or 
‘seed’ has been coined for these small transmissible particles (Cox et al., 2003). 
Molecular chaperones have been implicated in playing a major role in the replication of 
these prion particles (Chernoff et al., 1995; Kryndushkin et al., 2003; Allen et al., 
2005; Sadlish et al., 2008). 
 
1.5.1 The role of chaperones in protein folding 
               In order for a protein to reach its final 3D folded form and avoid misfolding, 
many proteins use chaperone proteins to assist them (Walter and Buchner, 2002). In the 
review article by Jones and Tuite (2005) it discusses how proteins are formed in a step-
wise manner with small segments of the protein being produced at a time. This leads to 
many chances of misfolding. Chaperones interact non-covalently with polypeptide 
chains in order to stabilise their folds and prevent them from forming an incorrect 
structure and in doing so they accelerate the folding steps. Chaperones also rescue 
misfolded or highly aggregated proteins by refolding them back into their native active 
state (Jones and Tuite, 2005). Many chaperones are classed as heat shock proteins as 
their expression is up-regulated in response to stress (Perrett and Jones, 2008). In a 
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review article by Parsell and Lindquist (1993) the induction of heat shock protein 
expression is discussed. A mild non-lethal heat shock induces heat shock protein (Hsp) 
synthesis and enhances cell survival to severe heat shock exposure. This is known as 
induced thermotolerance (Parsell and Lindquist, 1993). Most heat shock proteins 
facilitate protein folding, assembly and translocation across intracellular membranes. In 
the past decade heat shock proteins have received much attention in their role in 
maintaining and propagating yeast prions (Rikhvanov et al., 2007). 
 
1.5.2 How Hsps assist prion formation and propagation 
               S. cerevisiae has been widely used to study eukaryotic protein folding 
pathways and all the major chaperones involved in these pathways have been 
extensively characterised in this yeast species. Prion proteins appear to have evolved to 
exploit the molecular chaperone machinery in mammals and fungi. Once proteins have 
established the prion form they use chaperones to remodel their structure in a way that 
can be transmitted and propagated onto daughter cells. Genetic studies have identified a 
number of chaperones which interact with and modulate yeast prions (reviewed in 
Jones and Tuite, 2005). 
              Three classes of chaperone protein (Hsp40, Hsp70 and Hsp100), along with a 
number of co-chaperones, have been extensively analysed in their role in prion 
propagation. Hsp104 is a protein disaggregase responsible for recovering cells from 
environmental stresses, such as extreme heat, by dissolving protein aggregates and with 
help from Hsp70 and Hsp40 it reactivates and refolds them (Parsell et al., 1994b; 
Glover and Lindquist, 1998; True, 2006). Hsp104 plays a dual role in both the 
generation and propagation of yeast prions as it has been implicated in initial Ure2 and 
Sup35 nucleation events and fragmentation of their prion counterparts (Shorter and 
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Lindquist, 2006). In the review article by Perrett and Jones (2008) they suggest that 
Hsp104 can distinguish the difference between heat-denatured and prion substrates and 
can also recognise differences in prion substrates. They based this theory on a study 
done by Doyle et al. (2007) who highlighted that Hsp104 has different requirements for 
ATP hydrolysis depending on the type of protein substrate it is acting on (Doyle et al., 
2007). 
               Hsp104 is a member of the AAA
+
 (ATPases associated with various cellular 
activities) superfamily of proteins (Schirmer et al., 2004) which are characterised by 
assembling into oligomeric ring complexes (usually hexamers) with a central pore, 
when in the presence of ATP (Parsell et al., 1994a). ATP binding results in ATP 
hydrolysis, which possibly leads to release of the substrate from the chaperone (Bosl et 
al., 2005). Hsp104 has two highly conserved nucleotide binding domains 
(NBD1/NBD2) that each display a cooperative kinetics of ATP hydrolysis (Parsell et 
al., 1994a: Hattendorf and Lindquist, 2002). Mutational analysis has shown that the 
structure of the hexamer pore entrance is crucial for Hsp104 function (Lum et al., 
2004). ATP binding to the NBD1 of Hsp104 is essential for the Hsp104 chaperone to 
interact with substrate aggregates as mutations that prevent ATP binding to NBD1 
impair Hsp104-substrate interactions (Bosl et al., 2005). The NBD2 is also important 
for Hsp104 function as mutations to it severely impair Hsp104 hexamerisation 
(Schirmer et al., 1998).  
              There have been two separate models describing how Hsp104 disaggregates 
proteins. The first describes Hsp104 breaking aggregates into smaller fragments in a 
crowbar-like fashion (Glover and Lindquist, 1998). The other, more accepted model, 
suggests an unfolding/threading mechanism whereby individual polypeptide chains are 
removed by passing through the central pore of Hsp104 (Bosl et al., 2006). The 
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mechanism of how this model applies to prion propagation is discussed in the review 
article by Romanova and Chernoff (2009). Hsp104 breaks prion polymers into small 
propagons called ‘seeds’. Prions are propagated from yeast generation to generation by 
the production of these ’seeds’. These are heritable and pass with the cytoplasm from 
mother to daughter cell. The ‘seeds’ initiate protein aggregation in the new cell 
(Romanova and Chernoff, 2009). 
                Hsp104 is conserved in prokaryotes (ClpB) (Squires et al., 1991), fungi and 
plants (Hsp101) (Queitsch et al., 2000) and in animal mitochondria but so far no 
Hsp104 ortholog has been identified in animal cell cytoplasm (Leidhold et al, 2006; 
Romanova and Chernoff, 2009). Induced thermotolerance is evident in mammalian 
cells, indicating that they may have a functional analog of Hsp104 (Romanova and 
Chernoff, 2009). 
                The yeast model provided the first link between chaperones and prions as 
deletion or over-expression of Hsp104 ‘cures’ [PSI+] (Chernoff et al., 1995). Adding 
the agent Guanidine HCl to yeast cures prions, presumably by Hsp104 inhibition 
(Ferreira et al., 2001). Deletion or inhibition of Hsp104 activity results in the 
generation of large prion polymers that are too large to be passed from mother to 
daughter cell, leading to the eventual loss of [PSI
+
] through the cell divisions (Cox et 
al., 2003). When Hsp104 is over-expressed it also results in a loss of [PSI
+
]. It is 
possible that excess Hsp104 eliminates [PSI
+
] by dissolving large polymers into 
monomers that cannot be propagated to daughter cells, but there lacks any direct 
evidence to confirm this. An alternative model proposes that excess Hsp104 cures 
[PSI
+
] by converting polymers into larger structures that are non-transmissible. 
Kryndushkin et al. (2003) showed, by electrophoretic analysis, that cells over-
expressing Hsp104 resulted in Sup35 polymers larger in comparison to extracts from 
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the same strain expressing normal levels of Hsp104 (Kryndushkin et al., 2003). 
Controversies surrounding the mechanism of [PSI
+
] curing by Hsp104 over-expression 
indicate that despite research progress we do not fully understand the role Hsp104 plays 
in prion propagation. 
 
                Although Hsp104 is the primary factor involved in prion replication, Hsp70, 
Hsp70 co-factors and Hsp40 act as components of this machinery and also play critical 
roles in prion propagation (Figure 1.9), as reviewed in Shorter and Lindquist (2008) and 
Guinan and Jones (2009). Hsp70 and Hsp40 bring denatured protein aggregates to 
Hsp104 and themselves refold newly misfolded proteins (Glover and Lindquist, 1998). 
Various studies have shown that shifting the cellular balance of various Hsp70 and 
Hsp40 chaperones can affect the induction and propagation of [PSI
+
] (Chernoff et al., 
1999; Kryndushkin et al., 2002; Allen et al., 2005).  
              Meimaridou et al. (2009) extensively summarised the functions provided by 
Hsp70 proteins in yeast.  Hsp70s are universally conserved chaperones that play a role 
in protein synthesis, translocation across intracellular membranes, sequestration of 
protein aggregates and provide protection from aggregation in times of cellular stress 
(Meimaridou et al., 2009). All Hsp70 proteins share the property of binding to short 
hydrophobic segments of unfolded polypeptides and preventing their aggregation 
(Jones and Tuite, 2005). Hsp70 also interacts directly with Sup35 in vivo as Hsp70s and 
their co-chaperones have been shown to co-purify with [PSI
+
] and [psi
-
] versions of 
Sup35 (Allen et al., 2005; Bagriantsev et al., 2008). Efficient prion propagation is 
dependent on the cytosolic Hsp70 superfamily (Loovers et al., 2007). Mutations in the 
ATPase domain of Hsp70 and residues important for its interaction with Hsp40, impair 
[PSI
+
] propagation. Two mutations have also been isolated in the Hsp70 substrate 
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binding domain (SBD) which impair prion propagation. These mutations highlight the 
importance of Hsp70 ATPase activity and substrate binding efficiency in yeast prion 
propagation (Jung et al., 2000; Jones and Masison, 2003; Loovers et al., 2007). 
 
                
 
Figure 1.9. Chaperones assist yeast prion replication. Prion polymers (rectangles) grow 
by the addition of monomers (ovals) to their ends. Chaperones fragment individual 
polymers into two polymers, each of which can grow and continue the cycle. Hsp70 
and Hsp40 interact directly with the polymer and facilitate Hsp104 interaction. Hsp104 
fragments polymers into monomers by extruding them through its central channel. 
Hsp70/Hsp40 may help in refolding these monomers. Many co-chaperones are involved 
in regulating this process through Hsp70 and thus aid in prion propagation (adapted 
from Guinan and Jones, 2009). 
 
 
 
 
               Hsp70 is a diverse family of proteins 70 kDa in size and in yeast two cytosolic 
Hsp70 subfamilies are involved in [PSI
+
] propagation. The Hsp70 Ssa subfamily 
(stress-seventy subfamily A) are an essential group represented by four proteins (Ssa1-
4), at least one of which must be expressed for viability (Werner-Washburne et al., 
1987). The Hsp70 Ssb subfamily are ribosome-associated proteins and have two 
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members, Ssb1 and Ssb2 (Nelson et al., 1992). The functions of Ssa and Ssb proteins 
has been inferred almost entirely by genetic analysis. These two classes of cytosolic 
Hsp70 are implicated in the de novo formation and propagation of prions but have 
opposing effects. Ssa1 over-expression promotes de novo [PSI
+
] induction even in the 
absence of [PIN
+
] (Allen et al., 2005). Unlike Ssa proteins, the Ssb subfamily has been 
implicated in yeast prion propagation by antagonising [PSI
+
] (Kushnirov et al., 2000). 
Spontaneous [PSI
+
] appearance increases 10-fold when Ssb1 and Ssb2 are deleted 
(Chernoff et al., 1999). Also Ssa1 reduces [PSI
+
] curing when Hsp104 is over-
expressed whereas Ssb1 enhances it (Chernoff et al., 1999). These opposing effects 
may be due to differences in the proteins cellular roles. Ssa1 stabilises misfolded 
proteins for prion conversion whereas Ssb1 may stimulate proteins to fold to their 
native state (Allen et al., 2005).            
              In the review articles by Mayer et al. (2001) and Mayer and Bukau (2005) the 
structure and molecular functions of Hsp70 chaperones are discussed. The structure of 
Hsp70 chaperones are composed of an amino terminal nucleotide/ATP (NBD) binding 
domain, followed by a substrate binding domain (SBD) and a C-terminal variable 
domain. The Hsp70 ATPase cycle regulates the chaperones ability to bind non-
covalently to a substrate. When bound by ATP Hsp70 is in an ‘open’ conformation and 
can rapidly bind and release substrates in the SBD. When ATP is hydrolysed to ADP 
Hsp70 is in a ‘closed’ conformation and substrate is tightly bound to the SBD. 
Nucleotide exchange restores the ‘open’ conformation (Mayer et al., 2001; Mayer and 
Bukau, 2005). It is the fine tuning of this Hsp70 ATPase cycle that proves crucial for 
efficient prion propagation by the Ssa proteins. Evidence suggests that the ATP bound 
‘open’ conformation is necessary for the propagation of yeast prions (Jones and 
Masison, 2003; Jones et al., 2004; Loovers et al., 2007). Hydrolysis of Hsp70 ATP is 
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influenced by the co-chaperones Ydj1, Sti1, Sis1, Cpr7 and Cns1 (reviewed in Jones 
and Tuite, 2005) and nucleotide exchange requires Fes1 and Sse1 (Figure 1.10) (Kabani 
et al., 2002; Dragovic et al., 2006). 
              Hsp70 structural data has helped reveal how interdomain communication 
drives ATP hydrolysis and peptide binding and has allowed other groups to interpret 
Hsp70 mutant data and their effects on prion propagation (Jiang et al., 2005; Loovers et 
al., 2007). Detailed crystallographic data will aid future functional characterisation of 
Hsp70 and other chaperones in their role in yeast prion propagation (Perrett and Jones, 
2008). 
              In a review article by Jones and Tuite (2005), it discusses how a number of co-
chaperones and co-factors have been shown to play a role in yeast prion propagation. 
Hsp40 proteins Ydj1 and Sis1, Hsp70/Hsp90 cofactors Sti1, Cpr7 and Cns1 and Hsp70 
nucleotide exchange factors Sse1 and Fes1 (NEFs) are all implicated in stimulating the 
Hsp70 peptide binding cycle (Figure 1.10) (Jones and Tuite, 2005). It is not fully 
understood as to whether these influence [PSI
+
] propagation solely through Hsp70 or 
independently. It is probable that both scenarios are possible, as reviewed by Perrett 
and Jones (2008). The functions of Hsp104, Hsp70, Hsp40 and their co-chaperones is 
summarised in Table 1.2. 
 
 
1.6 The molecular chaperone Hsp110 
             Hsp110 proteins are a group of eukaryotic proteins that are ubiquitously 
expressed in mammalian tissue, especially at high levels in the brain (Liu and 
Hendrickson, 2007). Several cytosolic Hsp110 proteins have been described in 
eukaryotes, including HSPH1, Apg-1, Apg-2 and Grp170 in mammals (Vos et al., 
2008; Kampinga et al., 2009). Hsp110 is represented by Sse1 and Sse2 in S. cerevisiae. 
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Figure 1.10. Regulation of Ssa peptide binding cycle by co-chaperones. The hydrolysis 
of Ssa ATP to ADP creates a ‘closed’ Ssa conformation and protein substrates are 
tightly bound. Nucleotide exchange by Fes1 and Sse1 promotes an ‘open’ conformation 
and [PSI
+
] is restored (adapted from Jones and Tuite, 2005).     
 
 
 
They constitute an essential gene pair (Trott et al., 2005). They are not individually 
essential but deletion of Sse1 confers a growth defect (Shirayama et al., 1993; Mukai et 
al., 1993; Shaner et al., 2004). Sse1 was first isolated from yeast biochemically as 
acalmodulin-binding protein (Mukai et al., 1993) and genetically as a suppressor of a 
protein kinase A (PKA) mutant (Shirayama et al., 1993). Sse1 and Sse2 share a high 
level of sequence homology (~76%) and also share homology with members of the 
Hsp70 superfamily (Mukai et al., 1993). Sse1 is constitutively expressed in yeast and 
Sse2 is the stress-induced isoform (Polier et al., 2008). Sse1 is expressed at moderately 
high levels under normal growth conditions and is further induced upon heat shock. 
Sse2 transcripts are nearly undetectable at basal temperatures but are increased more 
than 20-fold upon heat shock (Mukai et al., 1993; Shirayama et al., 1993). Little is 
understood about the cellular functions of Sse1 and Sse2 but they have been recently 
Sse1 
ATP ADP 
S 
S 
  Ssa1   Ssa1 
OPEN STATE 
Rapid substrate exchange 
[PSI+] 
CLOSED STATE 
substrate tightly 
bound 
[psi-] Fes1 
Hsp40, Sti1, 
Cns1,Cpr7 
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Table 1.2. Summary of chaperone effects on prion propagation  
 
Chaperone or 
co-chaperone 
Cellular function Effects on prion 
propagation when 
deleted 
Effects on prion 
propagation when 
overexpressed 
Hsp104 
 
 
 
 
Hsp70 (Ssa1-4) 
 
 
 
 
 
 
 
 
   Hsp70 (Ssb1/2) 
 
 
 
 
 
Hsp40 (Ydj1, Sis1, 
Apj1) 
 
 
 
 
 
 
H     Hsp110 (Sse1/2; 
R    related to Hsp70) 
 
 
 
Fes1 
 
 
 
 
Sti1 
Protein 
disaggregation and 
stress tolerance. 
 
 
Protein folding, 
stress tolerance, 
binds denatured 
proteins and prevents 
aggregation. Protein 
translocation 
and translation. 
 
 
Ribosome 
associated. 
Aid in folding of 
newly 
synthesised proteins. 
 
Deliver peptide 
substrates. 
Stimulate ATPase 
activity of Hsp70 
partner. Sis1 is 
involved in 
translation initiation. 
 
Nucleotide exchange 
factor for Hsp70 (Ssa 
and Ssb). 
 
 
Nucleotide exchange 
factor for Hsp70 
(Ssa). 
 
 
Aids in the Hsp70-
Hsp90 protein 
folding cycle. 
Regulates ATPase 
activity of both 
Hsp70 and Hsp90. 
Cures all known 
naturally 
occurring yeast 
prions. 
 
Deletion of all 4 Ssa 
members is lethal, 
constitutes an 
essential gene 
family. 
 
 
 
 
10-fold increase in 
spontaneous 
appearance of 
[PSI
+
] in a [PIN
+
] 
background. 
 
No effects of 
YDJ1 or APJ1 
deletion. 
SIS1 is essential. 
 
 
 
 
Reduced efficiency 
of propagation for 
some [PSI
+
] variants. 
Cures [URE3]. 
 
Reduced efficiency 
of propagation for 
some [PSI
+
] variants. 
Cures [URE3]. 
 
Reduced stability of 
[URE3]. 
Efficiently cures 
[PSI
+
] but not 
[URE3] or 
[PIN
+
]/[RNQ
+
]. 
 
Can counteract the 
[PSI
+
] curing effect 
of Hsp104 
overexpression. Can 
cure some variants of 
[PSI
+
]. Ssa1 can cure 
[URE3] while Ssa2 
cannot. 
 
Can cure some weak 
variants of [PSI
+
]. 
 
 
 
 
Ydj1 efficiently 
cures [URE3] but not 
[PSI
+
]. All three can 
cure artificial [PSI
+
] 
variants. 
 
 
 
Efficiently cures 
[URE3]. 
 
 
 
Weakens [PSI
+
]. 
 
 
 
 
Cures artificial 
[PSI
+
] and weakens 
wild type variant. 
 
(adapted from Perrett and Jones, 2008). 
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implicated in playing a role in yeast prion propagation (Fan et al., 2007; Kryndushkin 
and Wickner, 2007; Sadlish et al., 2008).  
 
1.6.1 Hsp110 is a divergent member of the Hsp70 superfamily 
              The Sse1 protein was crystalised by Liu and Hendrickson (2007). They 
established that Sse1 is modular and built-up from Hsp70-like subdomains. Even 
though Sse1 and Hsp70 functions have diverged, certain structural vestiges in Hsp70 
have been conserved in Sse1. Mutational analysis revealed that certain mutant variants 
in Sse1 and Ssa1 resulted in similar phenotypic defects, supporting the hypothesis that 
Sse1 is an evolutionary vestige of Hsp70 (Liu and Hendrickson, 2007). Recent 
structural analysis studies of complexes formed by Hsp70 and Hsp110 has revealed that 
residues important for Hsp70 binding and initiation of nucleotide exchange, are almost 
invariant in the Sse1 protein (Polier et al., 2008). A recent report suggests that Sse1, 
like Ssa1, can recognise and bind hydrophobic peptide sequences with high affinity 
(Goeckeler et al., 2008) and can exhibit ATPase activity (Raviol et al., 2006a; Raviol et 
al., 2006b). However the functional similarities end there, as Sse1 cannot functionally 
refold denatured proteins but instead acts as a ‘holdase’ by binding denatured proteins 
and preventing their aggregation (Oh et al., 1999). This ‘holdase’ function may serve a 
function in the peptide refolding pathway carried out by other chaperones. SSE1 has 
been shown to accelerate the refolding of luciferase by Hsp70/Hsp40 machinery 
(Brodsky et al., 1999; Goeckeler et al., 2002). Sse1 is the only nucleotide exchange 
factor (NEF) with a substrate binding domain containing a peptide binding site (Cyr, 
2008). 
              The general domain organisation of Sse1 does reflect that of Hsp70. Sse1 
consists of an N-terminal nucleotide binding domain (NBD), a sandwich domain 
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(SBD- ) and a three helical bundle domain (3HBD or SBD- ) in the C-terminus. The 
Sse1 protein has a compact structure with tight interactions between the NBD and SBD 
(substrate binding domain). Unlike Hsp70, the Sse1 SBD does not form a lid over its 
binding pocket but instead interacts with the flank of the Sse1 NBD (Polier et al., 
2008). Sse1 is larger than Hsp70 due to insertions at its SBD and C-terminus extensions 
(Figure 1.11) (Easton et al., 2000; Liu and Hendrickson, 2007). Sse1 shares ~30% 
sequence identity with Ssa1 (Yam et al., 2005; Shaner et al., 2005). Like other Hsp70-
Hsp110 interacting components the sequence similarity between Sse1 and Ssa1 is 
largely confined to the NBD (Goeckeler et al., 2008).  
               
Figure 1.11.  The domain organisation of Sse1 is similar to Hsp70. Schematic diagram 
of h (human)/b (bovine) Hsp70 and y (yeast) Hsp110. Both structures are similar except 
Hsp110 contains an insertion in the SBD  and an extended C-terminus (adapted from 
Liu and Hendrickson, 2007).  
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                Sse1 preferentially associates with Ssa1 in vivo (Shaner et al., 2005). The 
Hsp70 NBD is embraced by the NBD and 3HBD (SBD- of Sse1 leading to the 
opening of the Hsp70 nucleotide binding cleft. The Sse1 -sandwich domain of the 
substrate binding cleft (SBD- ) alternates away from the Sse1-Ssa1 complex (Polier et 
al., 2010). It appears that almost the entire length of Sse1 is required for complex 
formation with Hsp70 (Shaner et al., 2004; Dragovic et al., 2006; Polier et al., 2008). 
Complex formation also requires Sse1 to be ATP bound as this alters the NBD in a way 
that stabilises Sse1 and allows it to bind Hsp70 (Shaner et al., 2006; Polier et al., 2008). 
Yeast Sse1 can also form a functional complex with human Hsp70 which reflects a 
high degree of conservation in the Hsp70 structure (Shaner et al., 2006).               
               The multidomain architecture of Sse1 suggests that it may play a role as a 
chaperone similar to Hsp70. However, the protein folding ability of Hsp70 relies 
heavily on the conformational structural changes between the NBD and SBD upon 
ATP/ADP binding. This allostery is not present in Sse1. The Sse1 substrate binding 
pocket remains closed upon ATP binding suggesting that any potential substrate-
binding or chaperone activity expressed by Sse1 will potentially function differently to 
Hsp70 (Andreasson et al., 2008).  
 
1.6.2 The nucleotide exchange function of Sse1 
              Defective regulation of the Hsp70 peptide binding and nucleotide exchange 
cycle is lethal to S. cerevisiae (Raviol et al., 2006b). Prion propagation can also become 
impaired by altering this peptide binding cycle (Jones and Tuite, 2005). Peptide binding 
and release by Hsp70 is controlled by an ATP hydrolytic cycle (Cyr, 2008). ATP binds 
tightly to the Hsp70 NBD. In this state, peptides are bound with low affinity to the SBD 
due to the extensive contacts made between the NBD and SBD (Liu and Hendrickson, 
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and the Hsp70 NBD is thought to stimulate the release of ADP nucleotide. It has been 
suggested that when the Sse1 NBD and its SBD-  contact lobes I and II of Hsp70 NBD 
this leads to the opening of the Hsp70 SBD and subsequent nucleotide release (Figure 
1.12) (Cyr, 2008). Mutational analysis supports this and reveals that the Sse1 ATPase 
domain and C-terminus are important for its NEF function and that complex formation 
requires ATP binding by Sse1 (Dragovic et al., 2006; Shaner et al., 2006). Many 
questions remain unanswered about how this heterodimer functions in vivo and whether 
it is involved in protein folding or if it has specific cellular targets.  
 
 
 
Figure 1.12. Schematic model for Hsp110 (dark grey) and Hsp70 (light grey) 
interaction and the mechanism of catalysed nucleotide release. The lobes of each NBD 
are indicated as I and II and subdomains of the SBD are indicates as  and . The 
arrows indicate the the outward rotation of Hsp70 NBD lobe II and the triggered release 
of ADP. Points of interaction are noted as the striped areas. The main contact between 
the two molecules is via their NBDs which orientate towards one another. The  
subdomain in Hsp110 protrudes outwards perhaps to embrace the upper periphery of 
the Hsp70 SBD (adapted from Andreasson et al., 2008). 
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1.6.3 How the expression of Sse1 affects yeast prion propagation 
             The initiation and propagation of yeast prions are constituted by folding and 
remodelling events that require the action of chaperones. Many reports have confirmed 
that Sse1 is required for the de novo formation and the propagation of [PSI
+
] 
(Kryndushkin and Wickner, 2007; Fan et al., 2007; Sadlish et al., 2008). Sse1 mainly 
functions in prion propagation due to its NEF activity for Hsp70. However, Sse1 has 
been suggested to bind to early intermediates in Sup35 prion conversion and thus 
facilitate prion seed conversion independently of its NEF function. The exact 
mechanism as to how this occurs is still undiscovered (Sadlish et al., 2008). Fan et al. 
(2007) over-expressed Sse1 and observed an increase in the rate of de novo [PSI
+
] 
formation compared to a control (Figure 1.13). They also tested the effects of deleting 
SSE1 on [PSI
+
] de novo formation and found a reduction in prion formation. It is 
possible that when Sse1 is over-produced it forms increased heterodimer complexes 
with Ssa promoting nucleotide exchange of Ssa (Fan et al., 2007). However, the over-
production of Sse1 has no effect on pre-existing [PSI
+
] (Kryndushkin and Wickner, 
2007; Fan et al., 2007).  
               In contrast, the over-production and deletion of SSE1 has a curing effect on 
the [URE3] prion (Figure 1.14). Mutant analysis indicates that this function depends 
upon ATP binding and interaction with Hsp70. Deletion of SSE1 may promote tight 
binding of Ure2 protein to Hsp70 which could block the addition of monomers to the 
fibril. Sse1 up-regulation could stimulate an Hsp70 disaggregating activity that shears 
Ure2 prion polymers or perhaps stabilises Ure2 monomers (Kryndushkin and Wickner, 
2007). Sse1 expression does affect yeast prion propagation but the resulting phenotype 
depends on a number of parameters. It is still unclear as to whether Sse1 has an 
influence on prion propagation directly or indirectly through Hsp70 but evidence to  
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date suggests that it mainly functions through its NEF activity. 
 
 
 
Figure 1.13. Overproduction of Sse1 promotes Sup35 aggregation. Cells either 
expressed an extra copy of SSE1 on plasmid DNA or an empty vector control. GFP-
Sup35NM is visible evenly distributed under normal conditions (vector) but aggregates 
into defined foci when Sse1 is over-expressed (SSE1) (Fan et al., 2007). 
 
 
          
 
Figure 1.14. BY241 [URE3] expressing a control empty vector or a copy of SSE1 gene. 
Overproduced Sse1 results in the loss of [URE3] (Kryndushkin and Wickner, 2007). 
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2007). ATP hydrolysis results in ADP-bound Hsp70 leading to the -SBD closing over 
the -SBD and the peptide tightly binding to the complex. Substrate release is then 
stimulated by nucleotide exchange (Cyr, 2008).  
              Genetic studies carried out by Jones and Masison (2003) and Jones et al. 
(2004) suggested that promoting the ADP bound form of Hsp70 leads to impaired prion 
propagation. It is possible that when substrates, such as Sup35, are tightly bound by 
Hsp70 in its closed state they are unable to be released and converted into the prion 
state (Loovers et al., 2007). Loovers et al. (2007) also found that altering the interaction 
between Hsp70 and its NEFs can affect ATPase cycle regulation and inhibit prion 
propagation. 
               Functions of Hsp110 proteins are poorly characterised but it has been recently 
suggested that they may act as the principal nucleotide exchange factor (NEF) for 
Hsp70. It has been shown that Sse1 acts as a potent NEF for yeast Hsp70 proteins Ssa1 
and Ssa2 (Dragovic et al., 2006; Raviol et al., 2006b). This discovery followed soon 
after the discovery that Hsp110 proteins interact physically and functionally with their 
Hsp70 counterparts (Yamagishi et al., 2004; Shaner et al., 2005; Yam et al., 2005). 
Previous to these findings Fes1 was the only known Ssa1 NEF (Kabani et al., 2002).  
              The NEF function of Sse1 is to catalyse the exchange of nucleotides on Hsp70, 
thereby increasing the rate of Hsp70-dependent processes (Polier et al., 2008). 
Therefore Sse1 may indirectly stimulate the release of Sup35 from Hsp70 and in this 
way promote prion conversion of Sup35. sse1 strains have a decreased ability to 
propagate [PSI
+], possibly by limiting the amount of free ‘open’ Hsp70 with the 
capacity to bind and release aggregates (Sadlish et al., 2008). 
              The process by which this nucleotide exchange occurs is reliant on the stable 
Hsp70:Sse1 heterodimeric complex (Shaner et al., 2006). The contact between Sse1 
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1.6.4 Other cellular functions of Sse1 
             Before Sse1 was ever defined as a NEF and linked with prion propagation it 
was known as an Hsp90 co-chaperone. Hsp90 is a molecular chaperone that plays a role 
in protein folding and activation but unlike other chaperones its client proteins are 
typically transcription factors and kinases that rely on Hsp90 for proper signaling (Pearl 
and Prodromou, 2001). Sse1 has been physically and genetically linked with Hsp90 and 
is implicated in the maturation and client fate of Hsp90 substrates, which is possibly 
dependent on its NEF function (Liu et al., 1999; Lee et al., 2004; Shaner et al., 2008; 
Mandal et al., 2010). Completely separate from its function in protein folding and as a 
co-chaperone, Sse1 has been implicated in cell wall signaling pathways. In partnership 
with Hsp90, Sse1 has been suggested as playing a role in the MAP kinase cell integrity 
signaling pathway. This pathway is responsible for regulating genes involved in cell 
wall repair and morphogenesis. Evidence suggests that Sse1 may signal in this pathway 
as a member of a multichaperone complex that supports cell integrity (Shaner et al., 
2008). Sse1 has also been implicated in the protein kinase A (PKA) pathway, a 
pathway that responds to alterations in environmental glucose concentrations by 
changing the magnitude and direction of gene transcription (Broach and Deschenes, 
1990; Wang et al., 2004; Zaman et al., 2009). Sse1 has been linked with PKA signaling 
and it has been shown that the temperature sensitive effects of sse1 can be suppressed 
by decreasing PKA signaling (Trott et al., 2005). Trott et al. (2005) demonstrated that 
sse1 temperature sensitivity can be alleviated by growth on non-fermentable carbon 
sources suggesting that Sse1 is a negative regulator of PKA signaling.  
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1.6.5 The relevance of studying Sse1 as a modulator of prion propagation 
               Despite recent advances in our knowledge of Sse1 and the role it plays in 
prion propagation it still remains an enigmatic protein. Much is to be discovered about 
how exactly it interacts with other chaperones, whether it interacts with prion 
aggregates and how it drives prion propagation. How Hsp110 chaperones regulate prion 
propagation in yeast can be used as a model for how its mammalian counterparts 
function in prion disease progression. The fact that yeast Sse1 can functionally interact 
with mammalian Hsp70 suggests that both mammalian and yeast Hsp110 proteins have 
conserved functions. Human and yeast Sse1 are 41% identical but share higher 
homology in their regions forming the protein:protein interface (61%) (Schuermann et 
al., 2008; Polier et al., 2008). Human and yeast Hsp110 both function as NEFs for 
Hsp70 and this function in yeast appears essential for prion propagation (Dragovic et 
al., 2006). Understanding the mechanisms that promote yeast prion propagation could 
help us determine the underlying features of mammalian prion disease generation. 
 
1.7 Objectives of this study 
              The primary objective of this study was to investigate the role that Hsp110 
plays in yeast prion propagation. The first step undertaken was to create a group of 
Sse1 mutants with altered ability to propagate [PSI
+
] and to express them in an 
appropriate sse1 knockout strain. Once these mutants were created we could test what 
effects they have on prion propagation by using a number of phenotypic and growth 
tests. Previously within our laboratory, such an approach has been successfully 
undertaken to isolate Ssa1 mutants that disrupt prion propagation.  
              From here we could model the mutants on the 3D structure of Sse1 and 
decipher possible disruptions the mutations cause to protein stability and protein 
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interaction. Such work could help pinpoint whether Sse1 mutants affecting prion 
propagation are working directly through Sse1 or indirectly through its function as a 
NEF. 
              As Sse1 is an important cellular protein and also plays a role in cell signaling 
processes we wanted to determine if any of the mutants have effects on normal cellular 
homeostasis such as thermostability. It was also an objective to investigate the role of 
Sse1 in activities such as cell wall integrity signaling, Hsp90 signaling and in PKA 
signaling.  
              Another objective of this project was to draw a comparative analysis of Sse1 
and Sse2. Sse2 is a more enigmatic protein than Sse1 and seems to play a less important 
role in yeast prion propagation. Little research has been published on the comparative 
differences in their ability to propagate prions and in their ability to provide cellular 
homeostasis.  
              An area we wished to explore was the role phosphorylation plays in the ability 
of molecular chaperones to function as prion propagators. Differentially inducing and 
preventing phosphorylation of Sse1 and Sse2 may impact their ability to propagate 
[PSI
+
]. This is a totally new theory that hasn’t been investigated in detail by other 
groups. As Hsp110 has only been recently implicated as a modulator of prion 
propagation there is much that needs to be determined to further our understanding of 
the nature of the chaperone and the complexity involved in prion propagation. 
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2.1 S. cerevisiae strains and plasmids used in this study 
2.1.1 S. cerevisiae strains 
              All [PSI
+
] strains used in this study are derivatives of strain G600. This strain 
was originally constructed in the laboratory of Daniel Masison and is a descendent of 
BSC strains isolated and characterised by Brian Cox. 
 
Table 2.1.  S. cerevisiae strains used in this study      
 
Strain name 
 
Genotype 
 
Source 
 
G600 
 
MATa/MAT ade2.1 SUQ5 kar1-1 his3 leu2 trp1 
ura3 
 
Jones et al. (2004) 
 
MYS101 
 
G600 MATa sse1::kanMX 
 
Harriet Loovers 
Yeast Genetics Lab 
 
MYS105 
 
G601 MAT sse2::kanMX 
 
Harriet Loovers 
Yeast Genetics Lab 
 
CMK1 
 
G600 MATa akl1::kanMX 
 
This study 
 
CMK2 
 
G600 MAT kin2::kanMX 
 
This study 
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CMK3 G600 MAT hsl1::kanMX This study 
 
CMK4 
 
G600 hsl1::kanMX akl1::kanMX 
 
This study 
 
CMK5 
 
                   G600 kin2::kanMX hsl1::kanMX 
 
This study 
 
CM01 
 
G600 MATa sse1::kanMX 
G601 MAT sse2::kanMX mated diploid transformed 
with pRS316SSE1 
 
This study 
 
CM02 
 
sse1::kanMX  sse2::kanMX  pRS316SSE1, isolated as 
haploid segregant following sporulation of CM01 
 
This study 
 
CM02-SSE1 
 
sse1::kanMX sse2::kanMX  pRS315SSE1 
 
This study 
 
CM02-SSE2 
 
sse1::kanMX sse2::kanMX  pRS315SSE2 
 
This study 
 
CM02-315 
 
sse1::kanMX sse2::kanMX  pRS315 
 
This study 
 
CM02-(SMP3-
SMG6) 
 
sse1::kanMX sse2::kanMX pRS315SSE1mutant 
(fourteen sse1 mutants- plasmid mutants listed in 
Table 2.2) 
 
This study 
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CM02-FES1 
 
sse1::kanMX sse2::kanMX pRS423FES1 
      
This study 
 
CM02-423 
 
sse1::kanMX sse2::kanMX pRS423 
 
This study 
 
CM02-HSPH1 
 
sse1::kanMX sse2::kanMX pC210HSPH1 
 
This study 
 
CM02-Q458trunc 
 
sse1::kanMX sse2::kanMX pC210SSE1 truncated at 
position 458 
 
This study 
 
CM02F-SM1 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
P37L
 
 
This study 
 
CM02F-SM2 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
G41D
 
 
This study 
 
CM02F-SM3 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
G50D
 
 
This study 
 
CM02F-SM4 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
C211Y
 
 
This study 
 
CM02F-SM5 
sse1::kanMX sse2::kanMX pRS423FES1  
pRS315SSE1
D236N
 
 
This study 
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CM02F-SM6 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
G342D
 
 
This study 
 
CM02F-SM7 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
G343D
 
 
This study 
 
CM02F-SM8 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
T365I
 
 
This study 
 
CM02F-SM9 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
E370K
 
 
This study 
 
CM02F-SM11 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
S440L
 
 
This study 
 
CM02F-SM12 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
E504K
 
 
This study 
 
CM02F-SM13 
 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
E554K
 
 
This study 
 
CM02F-SM14 
sse1::kanMX sse2::kanMX pRS423FES1 
pRS315SSE1
G616D
 
 
This study 
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CM02F-SSE1 
 
sse1::kanMX sse2::kanMX 
pRS423FES1pRS315SSE1 
 
This study 
 
CM02423-SM1 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
P37L
 
 
This study 
 
CM02423-SM2 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
G41D
 
 
This study 
 
CM02423-SM3 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
G50D
 
 
This study 
 
CM02423-SM4 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
C211Y
 
 
This study 
 
CM02423-SM5 
 
sse1::kanMX sse2::kanMX pRS423 
pRS315SSE1
D236N
 
 
This study 
 
CM02423-SM6 
 
sse1::kanMX sse2::kanMX pRS423 
pRS315SSE1
G342D
 
 
This study 
 
CM02423-SM7 
 
sse1::kanMX sse2::kanMX pRS423 
pRS315SSE1
G343D
 
 
This study 
 
CM02423-SM8 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
T365I
 
 
This study 
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CM02423-SM9 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
E370K
 
 
This study 
 
CM02423-SM11 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
S440L
 
 
This study 
 
CM02423-SM12 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
E504K
 
 
This study 
 
CM02423-SM13 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1
E554K
 
 
This study 
 
CM02423-SM14 
 
sse1::kanMX sse2::kanMX pRS423 
pRS315SSE1
G616D
 
 
This study 
 
CM02423-SSE1 
 
sse1::kanMX sse2::kanMX pRS423 pRS315SSE1 
 
This study 
 
CM02-S-PKC1 
 
sse1::kanMX sse2::kanMX pRS315SSE1 p241PKC1 
 
This study 
 
CM02-G3-PKC1 
 
sse1::kanMX sse2::kanMX pRS315SSE1
G342D
 
p241PKC1 
 
This study 
 
CM02-G6-PKC1 
 
sse1::kanMX sse2::kanMX pRS315SSE1
G616D
 
p241PKC1 
 
This study 
 
CM02-S-BCK1 
 
sse1::kanMX sse2::kanMX pRS315SSE1 p636BCK1 
 
This study 
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CM02-G3-BCK1 
 
 
sse1::kanMX sse2::kanMX pRS315SSE1
 G342D
 
p636BCK1 
 
This study 
 
CM02-G6-BCK1 
 
sse1::kanMX sse2::kanMX pRS315SSE1
G616D 
p636BCK1 
  
This study 
 
 
CM02-S-316 
 
sse1::kanMX sse2::kanMX pRS315SSE1
 
pRS316 
 
This study 
 
CM02-G3-316 
 
 
sse1::kanMX sse2::kanMX pRS315SSE1
 G342D 
pRS316 
 
This study 
 
CM02-G6-316 
 
 
sse1::kanMX sse2::kanMX pRS315SSE1
 G616D 
pRS316 
 
This study 
 
CM02-SSE1-SSS 
 
sse1::kanMX sse2::kanMX pRS315SSE1
G342D T100I
 
 
This study 
 
CM02-SSE1SDMA 
 
sse1::kanMX sse2::kanMX  pRS315SSE1
S85A
 
 
This study 
 
CM02-SSE1SDMB 
 
sse1::kanMX sse2::kanMX  pRS315SSE1
S85E
 
 
This study 
 
CM02-SSE1SDMC 
 
sse1::kanMX sse2::kanMX pRS315SSE1
S384A
 
 
This study 
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CM02-SSE1SDMD 
 
sse1::kanMX sse2::kanMX pRS315SSE1
S384E
 
 
This study 
 
CM02-SSE2SDMA 
 
sse1::kanMX sse2::kanMX pRS315SSE2
S384A
 
 
This study 
 
CM02-SSE2SDMB 
 
sse1::kanMX sse2::kanMX pRS315SSE2
S384E
 
 
This study 
 
CM02-SSE2SDMC 
 
sse1::kanMX sse2::kanMX pRS315SSE2
S679A
 
 
This study 
 
CM02-SSE2SDMD 
 
sse1::kanMX sse2::kanMX pRS315SSE2
S679E
 
 
This study 
 
CM02-SSE2SDME 
 
sse1::kanMX sse2::kanMX pRS315SSE2
S682A
 
 
This study 
 
CM02-SSE2SDMF 
 
sse1::kanMX sse2::kanMX pRS315SSE2
S682E
 
 
This study 
 
CM02-SSE2
Q504E
 
 
sse1::kanMX sse2::kanMX pRS315SSE2
Q504E
 
 
This study 
 
CM02-SSE2
G616D
 
 
sse1::kanMX sse2::kanMX pRS315SSE2
G616D
 
 
This study 
 
Y02146 
 
MATa his3leu2met15ura3 sse1::kanMX 
 
EUROSCARF 
 
Y17167 
 
MAT his3leu2lys2ura3 sse2::kanMX 
 
EUROSCARF 
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CMY01 
MATa/his3/his3leu2leu2lys2
met15ura3+/sse1::kanMX  sse2::kanMX+ 
pRS316SSE1 (constructed by mating Y02146 and 
Y17167 and transforming with pRS316SSE1) 
 
 
This study 
 
CM03 
        MATa his3 leu2 ura3 sse1::kanMX 
sse2::kanMX pRS316SSE1 (isolated as haploid 
following sporulation of CMY101) 
 
This study 
 
CM03-SSE1 
 
sse1::kanMX sse2::kanMX pRS316SSE1 
 
This study 
 
CM03-SSE2 
 
sse1::kanMX sse2::kanMX pRS315SSE2 
 
This study 
 
CM03-315 
 
sse1::kanMX sse2::kanMX pRS315 
 
This study 
 
CM03-(SMP3-
SMG6) 
 
sse1::kanMX sse2::kanMX pRS315SSE1mutant (14 
sse1 mutants listed in Table 2.2) 
 
This study 
 
CM03-FES1 
 
sse1::kanMX sse2::kanMX pRS423FES1 
 
This study 
 
CM03-FES1P315 
 
sse1::kanMX sse2::kanMX pRS423FES1, pRS315 
 
This study 
 
CM03-HSPH1 
 
sse1::kanMX sse2::kanMX pC210HSPH1 
 
This study 
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CM03-Q458trunc 
 
sse1::kanMX sse2::kanMX pC210Q458trunc 
 
This study 
 
CM03-Q458* 
 
sse1::kanMX sse2::kanMX pRS315SSE1
Q458*
 
 
This study 
 
Cswi6sse2 
 
CM03 sse1::kanMX sse2::kanMX swi6::HIS5 
pRS315SSE1 
 
This study 
 
BY4741swi6 
 
BY4741swi6:: kanMX 
 
EUROSCARF 
 
Cswi6sse1 
 
CM03 sse1::kanMX sse2::kanMX swi6::HIS5 
pRS315SSE2 
 
This study 

Cswi6sse2+
G41D  
 
CM03 sse1::kanMX sse2::kanMX swi6::HIS5 
pRS315SSE1
G41D
 
 
This study 

Cswi6sse2+
G50D  
 
CM03 sse1::kanMX sse2::kanMX swi6::HIS5 
pRS315SSE1
G50D
 
 
This study 

Cswi6sse2+
G342D  
 
CM03 sse1::kanMX sse2::kanMX swi6::HIS5 
pRS315SSE1
G342D
 
 
This study 
   
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Cswi6sse2+
T365I 
 
CM03 sse1::kanMX sse2::kanMX swi6::HIS5 
pRS315SSE1
T365I
 
 
This study 
 
G600 ( 
YBRO74W
 
G600 () pYCGYBRO74W 
 
This study 
 
G600 ( 
pRS316
 
G600 () pRS316 
 
This study 
 
G600 ( + 
YBRO74W 
 
G600 () pYCGYBRO74W 
 
This study 
 
G600 ( 
pRS316 
 
G600 () pRS316 
 
This study 
 
SB34 
 
MATa, trp1-1, ade2-1, leu2-3, 112, his3-11, 15, 
URA2::HIS3, erg6::TRP1, dal5::ADE2[URE3] 
 
Bach et al. (2003) 
 
SB34-SSE1 
 
SB34 pRS315SSE1 
 
This study 
 
SB34-pRS315 
 
SB34 pRS315 
 
This study 
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SB34-(SMP3-
SMG6) 
 
SB34 pRS315SSE1mutant (SB34 expressing 1 of 14 
sse1 mutants SMP3-SMG6-mutants listed in Table 
2.2) 
 
This study 
 
slt2 
 
BY4741slt2 
 
EUROSCARF 
 
 
2.1.2 Plasmid vectors  
 
Table 2.2. Plasmid vectors used in this study 
 
Plasmid Name 
 
Description 
 
Source 
 
pRS315 
 
Centromeric Saccharomyces cerevisiae shuttle 
vector- LEU2 marker 
 
Sikorshi and Hieter 
(1989) 
 
pRS316 
 
Centromeric Saccharomyces cerevisiae shuttle 
vector- URA3 marker 
 
Sikorski and Hieter 
(1989) 
 
pC210 
 
SSA1 under control of SSA2 promoter-LEU2 marker 
 
Schwimmer and 
Masison (2002) 
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pRS315-SSE1 
 
SSE1+/-500bp cloned into pRS315, LEU2 marker 
 
Harriett Loovers 
 
pRS315-SSE2 
 
SSE2 + promoter cloned into pRS315, LEU2 marker 
 
This study 
 
pRS316-SSE1 
 
SSE1+/-500bp cloned into pRS316, URA3 marker 
 
Harriett Loovers 
 
SMP3 
 
Mutation P37L in pRS315SSE1 
 
This study 
 
SMG4 
 
Mutation G41D in pRS315SSE1 
 
This study 
 
SMG5 
 
Mutation G50D in pRS315SSE1 
 
This study 
 
SMC2 
 
Mutation C211Y in pRS315SSE1 
 
This study 
 
SMD2 
 
Mutation D236N in pRS315SSE1 
 
This study 
 
SMG311 
 
Mutation G342D in pRS315SSE1 
 
This study 
 
SMG312 
 
Mutation G343D in pRS315SSE1 
 
This study 
 
SMT3 
 
Mutation T365I in pRS315SSE1 
 
This study 
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SME3 
 
Mutation E370K in pRS315SSE1 
 
This study 
 
SMS4 
 
Mutation S440L in pRS315SSE1 
 
This study 
 
SMQ4 
 
Mutation Q458* in pRS315SSE1 
 
This study 
 
SME511 
 
Mutation E504K in pRS315SSE1 
 
This study 
 
SME512 
 
Mutation E554K in pRS315SSE1 
 
This study 
 
SMG6 
 
Mutation G616D in pRS315SSE1 
 
This study 
 
SMG3-T1 
 
Mutation G342D and T100I in pRS315SSE1 
 
This study 
 
pRS315-SSE2
G616D
 
 
Site directed mutagenesis of pRS315SSE2 to produce 
G616D 
 
This study 
 
pRS315-SSE2
Q504E
 
 
Site directed mutagenesis of pRS315SSE2 to produce 
Q504E 
 
This study 
 
pC210-HSPH1 
 
HSPH1 under control of SSA2 promoter-LEU2 
marker 
 
This study 
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pRS423-FES1 
 
FES1+/-500bp cloned into pRS423, HIS3 marker 
 
Jones et al. (2004) 
 
pRS423 
 
pRS423, HIS3 marker 
 
Addgene 
 
pC210-
SSE1Q458TRUNC 
 
pRS315SSE1 truncated at position 458 
 
This study 
 
pUG27 
 
 
Plasmid expresses HIS5 gene and loxP flanking 
regions 
 
EUROSCARF 
 
pSH47 
 
Plasmid expresses cre recombinase gene under 
control of GAL promoter 
 
EUROSCARF 
 
p241PKC1 
 
Constitutively activated PKC1 gene  - URA3 marker 
Gift from Andy 
Truman (University 
of Chicago) 
 
p636BCK1 
 
Constitutively activated BCK1 gene - URA3 marker 
Gift from Andy 
Truman (University 
of Chicago) 
 
EP10,11,21,22 
 
pRS315SSE1 mutagenesis resulting in four ts 
plasmid mutants-all sequenced as mutant G616D 
 
This study 
   
 58 
 
p20632 
 
YBR074W gene cloned into  pYCG vector 
 
EUROSCARF 
 
SSE1SDMA 
 
pRS315-SSE1
S85A
 
 
This study 
 
SSE1SDMB 
 
pRS315-SSE1
S85E
 
 
This study 
 
SSE1SDMC 
 
pRS315-SSE1
S384A
 
 
This study 
 
SSE1SDMD 
 
pRS315-SSE1
S384E
 
 
This study 
 
SSE2SDMA 
 
pRS315-SSE2
S384A
 
 
This study 
 
SSE2SDMB 
 
pRS315-SSE2
S384E
 
 
This study 
 
SSE2SDMC 
 
pRS315-SSE2
S679A
 
 
This study 
 
SSE2SDMD 
 
pRS315-SSE2
S679E
 
 
This study 
 
SSE2SDME 
 
pRS315-SSE2
S682A
 
 
This study 
 
SSE2SDMF 
 
pRS315-SSE2
S682E
 
 
This study 
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2.2 Sterilisation techniques 
              Sterilisation of growth media and materials required for aseptic techniques was 
achieved by autoclaving at 121
o
C for 15 minutes. Any solutions that were susceptible to 
decomposition during autoclaving were filter sterilised using 0.22 m Millipore 
membrane filters. All worktops and benches were washed with 70% (v/v) ethanol prior to 
carrying out experiments. 
 
2.3 Yeast and bacterial growth media 
2.3.1 Media for culturing yeast 
             All media was adjusted to a final volume of 1000 ml using dH2O prior to 
autoclaving, unless otherwise stated. All liquid media was autoclaved and stored at room 
temperature unless otherwise stated. All agar plates were poured into sterile Petri dishes, 
allowed to cool and stored at 4
o
C. 
 
 
Complete Media (YPD) 
10 g Bacteriological yeast extract ((Becton, Dickinson and Company, Le Point de Claix, 
France) (BD)) 
20 g Bacteriological peptone (BD) 
20 g D-glucose (Sigma Aldrich Chemical Company, St. Louis, USA) 
20 g Bacteriological agar (BD) (can be added to the growth media to solidify it) 
adjusted to 1000 ml with dH2O 
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Dropout Media  
6.7 g Bacteriological yeast nitrogen base without amino acids and ammonium sulphate 
(BD) 
20 g D-glucose  
2 g Dropout mix (mix of 15 amino acids, the contents of which are described in Table 
2.3) 
20 g Bacteriological agar (can be added to media to solidify it)     
adjusted to 1000 ml with dH2O 
 
 
                             Table 2.3. Amino acid composition of dropout mix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dropout mix contains 2 g of each of the amino acid components. Each amino acid was 
mixed together in a pestle and mortar and the mixture was stored at room temperature. 
 
 
 
                               
 
           Alanine                          Inositol 
         Isoleucine             Arginine 
           Lysine                       Asparagine 
        Methionine                  Aspartic acid 
  Aminobenzoic acid         Phenylalanine 
           Proline                           Serine 
         Threonine            Cysteine 
         Glutamine              Valine 
      Glutamic acid             Tyrosine 
           Glycine 
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Synthetic Complete Medium (SC)               
                Dropout media can be supplemented with one or more additional amino acids 
to become Synthetic Complete (SC) media. The media is supplemented depending upon 
the growth requirements of the strain. Amino acids L-Leucine, Adenine sulphate, L-
Tryptophan, L-Histidine and Uracil were purchased from Sigma. Stock concentrations of 
each amino acid were made by adding the appropriate amount indicated in Table 2.4 into 
100 ml dH2O. The stocks were vortexed until the amino acids were completely dissolved 
and subsequently filter sterilised using 0.22 m Millipore membrane filters. Adenine and 
Uracil stocks were stored at room temperature. Tryptophan, Histidine and Leucine stocks 
were stored at 4
o
C. The volume of amino acid stock added to 1 Litre of SC medium is 
indicated in Table 2.4 along with the final concentrations of the amino acid. 
 
 
Table 2.4. Amino acid stock concentrations and final concentration of amino acids 
supplemented into SC media (Synthetic Complete) 
 
 
 
 
AMINO  
ACID 
 
 
AMINO ACID 
CONCENTRATION 
ADDED TO 100 ML 
H2O TO MAKE 
STOCK SOLUTIONS 
(G) 
VOLUME OF 
STOCK ADDED TO 
1 LITRE SC MEDIA  
(ML) 
 
 
FINAL AMINO 
ACID 
CONCENTRATION 
IN 1 LITRE SC 
MEDIA 
(G/ML) 
       
Leucine 
Adenine 
Histidine 
Tryptophan 
Uracil 
 
1 g 
0.2 g 
1 g 
1 g 
0.2 g 
 
10 ml 
10 ml 
2 ml 
2 ml 
10 ml 
 
100 g/ml 
20 g/ml 
20 g/ml 
20 g/ml 
20 g/ml 
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Synthetic Dextrose Media (SD) 
6.7 g Bacteriological yeast extract  
20 g D-glucose  
20 g Bacteriological agar (can be added to media to solidify it)  
adjusted to 1000 ml with dH2O 
                    
Supplemented Minimal Media (SMM) 
SMM is SD to which various growth supplements have been added. 
 
Sporulation Medium 
10 g Potassium acetate (Sigma) 
1 g Bacteriological yeast extract  
0.5 g D-glucose 
20 g Bacteriological agar  
adjusted to 1000 ml with dH2O 
 
Minimal Sporulation Medium 
10 g Potassium acetate  
20 g Bacteriological agar  
Amino acid stocks (Table 2.4) were supplemented prior to autoclaving, depending upon 
strain requirements.  
adjusted to 1000 ml with dH2O 
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Yeast Peptone Glycerol Medium (YPG) 
10 g Bacteriological yeast extract 
20 g Bacteriological peptone 
20 ml Glycerol (Sigma) 
20 g Bacteriological agar 
adjusted to 1000 ml with dH2O 
 
Yeast Peptone Ethanol Medium 
10 g Bacteriological yeast extract 
20 g Bacteriological peptone 
20 ml Ethanol (Sigma) 
20 g Bacteriological agar 
adjusted to 1000 ml with dH2O 
 
Yeast Peptone Galactose Medium (YPGal) 
10 g Bacteriological yeast extract 
20 g Bacteriological peptone 
20 g Galactose (Sigma) 
20 g Bacteriological agar 
adjusted to 1000 ml with dH2O 
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5-fluoro-orotic acid Medium (5-FOA) 
           Amino acid stocks of Leucine (10 ml), Adenine (10 ml), Tryptophan (2 ml) and 
Histidine (2 ml) were added to 400 ml dH2O along with 50 mg of Uracil (Sigma). 
Glucose (20 g), dropout mix (2 g), Bacteriological yeast nitrogen base without amino 
acids or ammonium sulphate (6.7 g) and 5-FOA (1 g) (Sigma) were also added. The 
mixture was brought to a final volume of 500 ml with dH2O and filter sterilised. 20 g of 
Bacteriological agar was added, in a separate flask, to 500 ml dH2O and autoclaved. This 
was allowed to cool and the components of both flasks were combined and mixed before 
pouring into sterile Petri dishes. The final concentration of 5-FOA was 1 mg/ml. 
 
 
Guanidine-HCl Medium 
10 g Bacteriological yeast extract 
20 g Bacteriological peptone 
20 g D-glucose 
20 g Bacteriological agar 
adjusted to 990 ml with dH2O 
             The media was cooled to approximately 60
o
C prior to adding Guanidine HCl. 
Stock solutions of Guanidine HCl were made by adding 2.9 g of Guanidine HCl (Sigma) 
to 100 ml of dH2O (0.029 g/ml stock) followed by filter sterilisation. This made a 300 
mM stock. 10 ml of Guanidine HCl stock solution was added to the 990 ml media to 
make a final concentration of 3 mM. 
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YPD-Geneticin Medium (G418) 
10 g Bacteriological yeast extract 
20 g Bacteriological peptone 
20 g D-glucose 
20 g Bacto agar 
adjusted to 1000 ml with dH2O 
         The solution was autoclaved and allowed cool to approximately 60
o
C. 200 mg of 
Geneticin (Sigma) was added to the media to make a final concentration of 200 g/ml.  
 
Geldanamycin Medium 
10 g Bacteriological yeast extract 
20 g Bacteriological peptone 
20 g D-glucose 
20 g Bacto agar 
adjusted to 1000 ml with dH2O 
          Geldanamycin (Sigma) was added to flasks of cooled media, making a final 
concentration of 80 M or 160 M. This medium was made by members of Dr 
Panaratou’s laboratory, Kings College London. 
 
YPD-Sorbitol 
5 g Bacteriological yeast extract 
10 g Bacteriological peptone 
10 g D-glucose 
 66 
10 g Bacto agar 
            The components of YPD medium listed above were added to a 500 ml flask. In a 
separate flask 91 g of sorbitol (Sigma) was mixed with 200 ml of warm dH2O and stirred 
until the sorbitol dissolved. The sorbitol-dH2O mix was added to the dry YPD 
components and the mixture was adjusted to 500 ml with dH2O. The final sorbitol 
concentration was 1 M.  
 
Cell wall damaging Medium 
           All cell wall damaging media was made using YPD with the addition of the 
following chemicals when media reached approximately 60
o
C after autoclaving. Stock 
solution concentrations and final concentrations are listed in Tables 2.5-2.8. 
          (a) Caffeine (Sigma): 100 mM caffeine stock was prepared by dissolving 9.6 g 
caffeine in 500 ml dH2O. From this a 10 mM stock was made by mixing 10 ml of the 100 
mM stock with 90 ml dH2O. This stock was filter sterilised before adding appropriate 
volumes to cooled YPD media. The final caffeine concentrations used were 4 M, 6 M, 
8 M and 10 M. Dilutions and concentrations are indicated in Table 2.5. 
         (b) SDS (Sigma): A 1% SDS stock was made by dissolving 1 g of SDS in a final 
volume of 100 ml dH2O. The stock was filter sterilised prior to adding to the media. 
YPD-SDS plates were made to a final concentration of 0.005%, 0.01% and 0.02%. 
Dilutions and concentrations are indicated in Table 2.6. 
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   Table 2.5. Concentrations of YPD-caffeine medium for cell wall damage analysis 
 
VOLUME OF YPD  
MEDIA 
(ML) 
 
VOLUME OF 10 
mM CAFFEINE 
STOCK ADDED 
TO YPD MEDIA 
(L) 
 
FINAL CONCENTRATION 
OF CAFFEINE ADDED TO 
YPD (M) 
 
 
499.8 ml 200 l (1/2500 
dilution) 
4 M 
499.7 ml 300 l (1/1666 
dilution) 
6 M 
499.6 ml 400 l (1/1250 
dilution) 
8 M 
499.5 ml 500 l (1/1000 
dilution) 
10 M 
 
 
   Table 2.6. Concentrations of YPD-SDS medium for cell wall damage analysis 
 
VOLUME OF YPD  
MEDIA 
(ML) 
 
VOLUME OF 
1% SDS STOCK 
ADDED TO YPD 
MEDIA (ML) 
 
FINAL CONCENTRATION 
OF SDS ADDED TO YPD 
(%) 
 
 
497.5 ml 2.5 ml (1/200 
dilution) 
0.005% 
495 ml 5 ml (1/100 
dilution) 
0.01% 
490 ml 10 ml (1/50 
dilution) 
0.02% 
 
 
 68 
           (c) Congo red (Sigma): 1000X congo red stocks were made by making four 
separate stocks to a final volume of 100 ml with dH2O (Table 2.7). 1000X stocks were 
filter sterilised and diluted 1/10 in fresh sterile dH2O to make 100X stocks. YPD-congo 
red medium was made to a final concentration of 5 g/ml, 10 g/ml, 25 g/ml and 35 
g/ml. Stock concentrations and dilutions made are indicated in Table 2.7.          
           (d) Calcofluor white (Sigma): 1000X calcofluor white stocks were made by 
making four separate stocks to a final volume of 100 ml with dH2O (Table 2.8). 1000X 
stocks were filter sterilised and diluted 1/10 in fresh sterile dH2O to make 100X stocks. 
YPD-calcofluor white medium was made to a final concentration of 5 g/ml, 10 g/ml, 
15 g/ml and 25 g/ml. Stock concentrations and dilutions made are indicated in Table 
2.8. 
 
Table 2.7. Concentrations of YPD-congo red medium for cell wall damage analysis 
 
1000X CONGO  
RED STOCK  
SOLUTION 
CONCENTRATIONS  
IN 100 ML OF dH2O 
 
 
100X CONGO RED 
STOCK 
SOLUTION 
CONCENTRATIONS 
 
 
VOLUME OF 
100X CONGO 
RED STOCK 
ADDED TO 495 
ML OF YPD 
MEDIA (ML) 
 
FINAL 
CONCENTRATION  
OF CONGO RED IN 
YPD  
(G/ML) 
 
 
0.5 g (0.005 g/ml) 0.0005 g/ml 5 ml 5 g/ml 
1.5 g (0.015 g/ml) 0.0015 g/ml 5 ml 15 g/ml 
2.5 g (0.025 g/ml) 0.0025 g/ml 5 ml 25 g/ml 
3.5 g (0.035 g/ml) 0.0035 g/ml 5 ml 35 g/ml 
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Table 2.8. Concentrations of YPD-calcofluor white medium for cell wall damage 
analysis 
 
 
1000X CALCOFLUOR  
WHITE STOCK  
SOLUTION 
CONCENTRATIONS  
IN 100 ML OF dH2O 
 
 
100X 
CALCOFLUOR 
WHITE STOCK 
SOLUTION 
CONCENTRATIONS 
 
 
VOLUME OF 
100X STOCK 
ADDED TO 495 
ML OF YPD 
MEDIA (ML) 
 
FINAL 
CONCENTRATION  
OF CALCOFLUOR 
WHITE IN YPD 
(G/ML) 
 
0.5 g (0.005 g/ml) 0.0005 g/ml 5 ml 5 g/ml 
1.0 g (0.010 g/ml) 0.0010 g/ml 5 ml 10 g/ml 
1.5 g (0.015 g/ml) 0.0015 g/ml 5 ml 15 g/ml 
2.5 g (0.025 g/ml) 0.0025 g/ml 5 ml 25 g/ml 
 
          
             (e) H2O2 (Sigma): 30% liquid H2O2 with a molar concentration of 12 M was used 
to make a stock solution. 300 mM H2O2 stocks were made by adding 1 ml of H2O2 to 39 
ml of H2O (1/40 dilution). The stock was filter sterilised and 5 ml was added to 495 ml of 
sterile YPD media to give a final concentration of 3 mM H2O2. 
 
 
2.3.2 Media for culturing E. coli 
 
Luria Broth (LB) Media 
25 g Luria bertani broth (BD) 
Media was supplemented with 20 g (w/v) Bacto agar to solidify it. 
adjusted to 1000 ml with dH2O 
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LB-ampicillin         
               LB liquid or solid media was supplemented with ampicillin to make LB-amp. 
This ensures the selection of ampicillin resistant plasmids incorporated into the cell. 
Stock solutions of the antibiotic ampicillin (Sigma) were made by adding 5 g of 
ampicillin into 100 ml dH2O to give a 50 mg/ml concentration. The stock was filter 
sterilised, separated into 100 x 1 ml volumes and stored at -20
o
C until needed. 1 ml of 
ampicillin stock was thawed and added to 999 ml of LB media after it was autoclaved 
and cooled to approximately 60
o
C. This gave a final ampicillin concentration of 50 
g/ml. 
 
2.4 Yeast and bacterial culture conditions 
2.4.1 Yeast culture conditions 
              All parent yeast stocks were stored at -80
o
C in a sterile mixture of 15% (v/v) 
glycerol to 85% (v/v) liquid YPD. Yeast strains were grown on YPD or synthetic 
selective media at 30
o
C static (BD series, Binder incubator, Mason Technology) for 48 
hours and kept at 4
o
C for short-term storage. Working stocks of yeast strains were 
maintained on YPD plates at 4
o
C and were routinely sub-cultured every 2-4 weeks. 
              For liquid culturing, yeast were grown overnight in 14 ml round bottom falcon 
tubes (BD). Yeast cultures were grown in an orbital shaker (Innova 4000, New 
Brunswick Scientific, UK) at 30
o
C and 200rpm using either YPD or synthetic selective 
liquid medium. 
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2.4.2 Bacterial culture conditions 
              E. coli strain DH5was stored at -70oC in dH2O or in 20% (v/v) glycerol to 
80% (v/v) liquid LB. Strains were cultured overnight on LB-amp plates at 37
o
C (B series, 
Binder incubator, Mason Technology). Liquid culturing involved inoculating a single E. 
coli colony in 5 ml of LB + 5 l ampicillin stock (final concentration of 50 g/ml) , in a 
round bottom falcon (BD), and cultured overnight in an orbital shaker (Innova 44, New 
Brunswick Scientific) at 37
o
C and 200rpm.  
 
2.4.3 Harvesting yeast and bacterial liquid cultures 
              Both yeast and bacterial cultures were harvested by centrifugation (Centrifuge 
5810R, Eppendorf) for 5 minutes at 2000rpm (yeast) or 4000rpm (bacteria). 
 
2.5 Determination of yeast and bacterial cell density 
2.5.1 Determination of yeast cell density 
              Yeast overnight cultures were diluted 1/100 with sterile dH2O and added to a 
haemocytometer (Bright Line, Hausser Scientific). The cells were counted using a light 
microscope (INGENIUS, Bio imaging Syngene) at a magnification of X 100. Other 
experiments required O.D values of yeast growth over a certain time period. In this case 
cell concentration was determined using a spectrophotometer (Eppendorf) at OD600nm. 
 
2.5.2 Determination of bacterial cell density 
The OD600nm of bacterial cultures was determined using a spectrophotometer. 
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2.6 Comparative growth analysis 
            Yeast were grown overnight at 30oC shaking in 5 ml selective media. The 
following morning the cultures were diluted back to OD600nm= 0.1 in 5 ml of fresh media 
and incubated at 30
o
C shaking until the cells reached a concentration of 3x10
6
 cells/ml. 
The cells were harvested by centrifugation and resuspended in selective media to a final 
concentration of 5x10
6
 cells/ml. 100 l of culture was placed in well A1 in a 96 well 
plate (Starstedt) and 80 l of media added to wells A2-A6. A 1/5 serial dilution was 
performed on the cells using a multichannel pipette by removing and adding 20 l of 
culture from well A1 through to A6. Using a 96 well metal replicator (Sigma) cells were 
transferred as spots onto appropriate agar plates and left to dry on the bench. The plates 
were incubated at 30
o
C and in the case of temperature-sensitive tests plates were also 
incubated at 37
o
C and 39
o
C. The plates were incubated for 48 hours and growth was 
monitored over that time. 
 
2.7 Yeast growth curve 
              Yeast strains were inoculated overnight in 5 ml YPD at 30
o
C shaking. The 
following morning each cultures concentration was measured at OD600nm and diluted back 
to an OD600nm of 0.1 (t=0) in 10 ml selective media. The 10 ml cultures were placed in 
fresh falcons and incubated at 30
o
C and 37
o
C shaking. Cell growth was measured at 
OD600nm at t= 2 h, 4 h, 6 h, 8 h. Each strain was measured in duplicate and the experiment 
was repeated in triplicate. The data was entered into excel and compiled into linear 
graphs. The linear graphs were achieved by plotting the log values for the OD values 
obtained against time. The time points which gave the most linear point on the graph 
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were used in the following formula to calculate the mean generation time (GT) for each 
yeast strain;  
                                              ((t1-t0)/(logx1-logx0))/log2 
 
2.8 Cell morphology analysis       
             Cellular morphology was analysed on a Cell^M imaging station using an 
Olympus IX microscope at 40X magnification. Yeast were prepared by growing fresh 
cells on selective medium at 30
o
C for 2 days and spreading on glass slides with dH2O. 
 
2.9 Transformation of yeast with plasmid DNA 
Materials 
(a) 1 M Lithium acetate (Sigma) was prepared by dissolving 10.2 g of Lithium acetate in 
100 ml of dH2O, followed by autoclaving the mixture. 100 mM Lithium acetate was 
prepared by mixing 10 ml of 1 M Lithium acetate with 90 ml of sterile dH2O. Stocks 
were stored at room temperature. 
(b) 50% polyethylene glycol (PEG) (Sigma) stock solutions were prepared by mixing 50 
g PEG in 50 ml of dH2O and adjusting it to a final volume of 100 ml with dH2O, 
followed by autoclaving. PEG Stocks were stored at room temperature. 
(c) Carrier DNA was prepared by adding 200 mg of single stranded DNA (Sigma) into 
100 ml of 10 mM Tris (Sigma)/1 mM EDTA (Sigma) solution. This gave a final carrier 
DNA concentration of 2 mg/ml. The 100 ml stocks were separated into 1 ml volumes in 
fresh 1.5 ml microfuge tubes (Eppendorf) and boiled at 100
o
C for 5 minutes on a digital 
dry bath. After boiling, the tubes were cooled on ice and stored at -20
o
C.  
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(d) The plasmid DNA to be transformed into the yeast cells is prepared by methods 
described in sections 2.10.4 and 2.12. DNA concentrations were determined on a 
Nanodrop Spectrophotometer and 50 l volumes of DNA/dH2O were prepared by 
resuspending plasmid DNA in dH2O to give a final concentration of approximately 0.1-
1.0 ng of DNA. The amount of DNA used depended on the numbers of colonies desired 
on the transformation plate. 
(e) The 10 mM Tris/1 mM EDTA solutions used in (c) were prepared by making a 100X 
stock concentration. 12.14 g Tris and 2.92 g EDTA were added together and adjusted to 
100 ml with dH2O. The pH was adjusted to 7.5. The solution was autoclaved and 1 ml 
was removed and added to 99 ml sterile dH2O to give a final concentration of 10 
mMTris/1 mM EDTA.  
 
Method 
              Yeast strains were inoculated and harvested as previously described in sections 
2.4.1 and 2.4.3. Following centrifugation, the cells were counted and resuspended in 50 
ml of appropriate media to a cell density of 5x10
6
 cells/ml. Yeast cultures were incubated 
at 30
o
C shaking for a further 3-5 h until cell concentrations reached 1-2 x 10
7
cells/ml. 
The cells were harvested by centrifugation at 2000rpm, washed in 25 ml of sterile dH2O 
and centrifuged again. The supernatants were disposed of and pellets resuspended in 1 ml 
100 mM Lithium acetate. The cells were transferred to 1.5 ml microfuge tubes and cell 
pellets were harvested in a table top centrifuge (Centrifuge 5415D, Eppendorf AG, 
Hamburg) at 13000rpm for 5 sec and resuspended in 500 l of 100 mM Lithium acetate. 
50 l aliquots of the cell suspensions were added to fresh 1.5 ml microfuge tubes and 
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centrifuged again for 5 sec to remove any residual Lithium acetate. Add this stage the 
cells could be stored at 4
o
C for 1-2 weeks or used immediately for transformation. The 
following components were added to each microfuge tube in the order listed: 
        240 l 50% (w/v) PEG  
        36 l 1 M Lithium acetate 
        25 l single stranded carrier DNA (taken from 2 mg/ml stock)  
        50 l mix of dH2O and plasmid DNA  
               Cell suspensions were mixed and incubated at 30
o
C for 30 minutes. The 
mixtures were heat shocked at 42
o
C in an Accublock Digital Dry Bath (Labnet 
International.Inc) for 20-25 minutes. The microfuge tubes were centrifuged at 13000rpm 
for 15 sec and the pellets were resuspended in 200 l of dH2O. Aliquots from each 
microfuge tube were plated onto separate selective agar plates and the plates were 
incubated at 30
o
C for 2-3 days. 
 
2.10 Preparation and transformation of E. coli 
2.10.1 Procedure for the preparation of electro-competent E. coli DH5
             E. coli DH5 were inoculated in 20 ml of LB media and incubated overnight at 
200rpm at 37
o
C. The following morning the 20 ml cell culture was resuspended in 1 Litre 
LB media and incubated at 37
o
C shaking until OD600nm = 0.6-1.0. The cell culture was 
then separated into 4 x 250 ml volumes, centrifuged in a GSA rotor at 6000rpm for 10 
minutes at 4
o
C (Sorvall centrifuge). The pellets were resuspended in 1 Litre of ice cold 
water and were kept on ice from now on in between each centrifugation. Cell cultures 
were centrifuged for 10 minutes at 6000rpm and the pellets resuspended in 500 ml cold 
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dH2O. The cells were centrifuged at 6000rpm for 10 minutes and the pellets were 
resuspended 250 ml cold dH2O then centrifuged again and resuspended in 100 ml cold 
dH2O. The cells were centrifuged for a fifth time at 6000rpm for 10 minutes and 
resuspended in 10 ml of 10% (v/v) glycerol to 90% (v/v) cold dH2O. The cells were 
centrifuged at 6000rpm for 10 minutes for the last time and the pellets were pooled and 
resuspended in 1 ml of 10% (v/v) glycerol to 90% (v/v) cold dH2O. The cells were then 
aliquoted into 1.5 ml microfuge tubes in 100 l suspensions and frozen in liquid nitrogen 
before storing E. coli stocks at -70
o
C. Care was taken when using liquid nitrogen, by 
wearing thermal protective gloves and goggles. 
 
2.10.2 Procedure for the preparation of competent E. coli DH5
              E. coli DH5 were inoculated in 10 ml of LB media and incubated overnight at 
37
o
C 200rpm. The 10 ml culture was added to 1 L of LB media and incubated for 2 hours 
at 37
o
C shaking. The E. coli culture was split into 4 x 250 ml centrifugation tubes and 
cooled on ice for 10 minutes. The cells were centrifuged at 5000rpm for 10 minutes at 
4
o
C. The pellets were resuspended in 10 ml RFI Buffer and kept on ice for 30 minutes. 
The cells were centrifuged at 5000rpm for 10 minutes at 4
o
C and each pellet was 
resuspended in 3.2 ml RF2 Buffer. The tubes were kept on ice for 15 minutes. 100 l 
aliquots were transferred to pre-cooled 1.5 ml microfuge tubes and the cells were stored 
at -70
o
C. The components of Buffer RF1 and RF2 are listed in Table 2.9. 
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Table 2.9. Components of buffers used in the preparation of competent E. coli. 
 
All chemicals and solutions were added in consecutive order from top to bottom, as 
illustrated in the table. Both RF1 and RF2 buffers were filter sterilised and stored at 4
o
C 
prior to use. All chemicals were purchased from Sigma.  
 
 
 
 
          
BUFFER 
 
 
COMPONENT 
 
CONCENTRATION/ 
VOLUME  
ADDED 
 
FINAL 
CONCENTRATION/
VOLUME 
 
 
       RF1 
 
 
 
 
 
 
 
 
          
K-Acetate 
 
CaCl2.2H2O (dihydrate) 
 
Glycerol 
 
dH2O 
 
 
Adjusted to pH 5.92 with 
0.2 M acetic acid (Sigma). 
(0.2 M = 3 g in 250 ml 
dH2O) 
 
 
RbCl 
 
MnCl2.4H2O (tetrahydrate) 
 
dH2O 
 
1.47 g 
 
     5 ml of a 1 M stock  
 
7.5 ml 
 
 
 
 
 
 
 
 
 
 
                   6 g 
 
4.95 g 
 
30 mM 
 
10 mM 
 
15% 
 
Adjusted to 450 ml 
 
 
 
 
 
 
 
 
100 mM 
 
50 mM 
 
Adjusted to 500 ml 
 
 
 
       RF2 
 
RbCl 
 
CaCl2.2H2O 
 
H2O 
 
5 ml of a 1 M stock 
 
     5.5 g 
 
 
 
10 mM 
 
     75 mM 
 
Adjusted to 500 ml 
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2.10.3 Transformation of plasmid DNA into E. coli (long method) 
              1-20 l (approximately 1 g DNA) of plasmid DNA was mixed into 100 l 
competent E. coli on ice and left to incubate for 30 minutes. The cells were subjected to 
42
o
C for 1 minute on a digital dry bath. The cells were recovered immediately by adding 
1 ml of liquid LB to each 1.5 ml microfuge tube. Each tube was incubated at 37
o
C 
shaking for 1 hour and plated onto LB-amp agar. The plates were incubated overnight at 
37
o
C. 
 
2.10.4 Transformation of plasmid DNA into E. coli (5 minute method) 
              LB-amp plates were pre-heated to 37ºC in an incubator for approximately 1 
hour.  50 l of competent E. coli were defrosted on ice. 1 l of plasmid DNA was added 
to 50 l E. coli immediately after defrosting. The cells were kept on ice for 5 minutes and 
selected onto warm LB-amp plates and incubated overnight at 37ºC. 
 
2.10.5 Transformation of plasmid DNA into E. coli by electroporation 
              Mixtures of DNA and water (30 l total volume) were prepared and transferred 
into pre-chilled polystyrol cuvettes (Starstedt, Numbrecht, Germany). The plasmid DNA 
was often too concentrated and had to be diluted with water to allow electroporation to 
work. The volumes of DNA to water in the mixtures depended upon the exact plasmid 
DNA concentration being used. The cuvettes were placed on ice and 20 l of defrosted 
electro-competent E. coli were added and mixed with the DNA. The mixtures were 
incubated on ice for 10-20 minutes and then electroporated (0.9ms) in a Micropulser 
electroporator (BIORAD). The cells were recovered by adding 1 ml of LB to each 
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cuvette and transferring to sterile 1.5 ml microfuge tubes. The microfuge tubes were 
incubated for 1 h shaking at 37C and the cells were selected on LB-amp plates to 
incubate overnight at 37
o
C. 
 
2.11 Yeast DNA isolation 
2.11.1 Yeast genomic DNA isolation 
Materials 
(a) 1 M sorbitol/100 mM EDTA (Sigma) solutions were prepared by dissolving 18.2 g of 
sorbitol in 20 ml warm dH2O and adding 2.92 g of EDTA. The solutions were adjusted to 
100 ml with dH2O, autoclaved and stored at room temperature. 
(b) Zymolase stocks were prepared by adding 500 mg of zymolase (Sigma) to 100 ml 
dH2O and filter sterilising. The stocks were aliquoted into 1 ml volumes and stored at -
20
o
C. 
(c) 1 M Tris/100 mM EDTA solutions were prepared by dissolving 2.92 g of EDTA and 
12.1 g Tris in 20 ml dH2O and adjusting the final volume to 100 ml with dH2O. The 
solutions were autoclaved and stored at room temperature. 
(d) 10% SDS solutions were prepared by dissolving 10 g SDS in 20 ml dH2O and 
adjusting the final volume to 100 ml with dH2O. The solutions were autoclaved and 
stored at room temperature. 
(e) 5 M potassium acetate (KAc) solutions were prepared by dissolving 49 g KAc in 20 
ml dH2O and adjusting the final volume to 100 ml with dH2O. The solutions were 
autoclaved and stored at room temperature. 
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Method 
              To isolate genomic DNA from a desired strain, yeast were inoculated in 1.5 ml 
YPD and incubated overnight shaking at 30C. The cells were centrifuged at 2000rpm for 
5 minutes and the pellets were resuspended in 150 l of 1 M sorbitol/100 mM EDTA in 
1.5 ml microfuge tubes. 12 l of 5 mg/ml zymolase was added to each set of cells and the 
tubes were incubated for 1 hour at 37C. The mixtures were centrifuged at 13000rpm for 
5 seconds and pellets resupended in 150 l of 1 M Tris/100 mM EDTA. 15 l of 10% 
SDS was mixed with the cell suspensions and incubated at 65C for 30 minutes. 60 l of 
5 M KAc was added to each tube and left on ice for 1 hour. The resulting mixtures were 
centrifuged at 13000rpm for 5 minutes and the supernatants were retained. 195 l of 
Isopropanol (Sigma) was added to each supernatant and allowed to sit for 5 minutes at 
room temperature. The DNA pellets were centrifuged at 13000rpm for ten seconds and 
allowed to air dry. The DNA was dissolved in 45 l dH2O and stored at -20C. 
 
2.11.2 Yeast plasmid DNA isolation 
              To isolate plasmid DNA from yeast, cells were inoculated overnight in 5 ml 
selective media at 30
o
C 200rpm. The cells were harvested by centrifugation at 2000rpm 
for 5 minutes. All buffers used in this procedure were purchased in a plasmid miniprep 
kit from QIAGEN. The cell pellets were resuspended in 250 l Resuspension Buffer in 
1.5 ml microfuge tubes and approximately 200 l of 0.5 mm soda lime glass beads 
(Biospec products Inc.) were added to the cell suspensions. The cells were vortexed 
(Vortex-2 Gene, Scientific Industries) for 5 minutes at maximum speed. At this stage the 
glass beads were at the bottom of the microfuge tubes and the liquid cell mixtures were 
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carefully removed. 250 l of Lysis Buffer followed by 350 l of Neutralising Buffer 
were added to the cells, mixed well and centrifuged for 10 minutes at 13000rpm. The 
supernatants were then removed and transferred to DNA binding columns (QIAGEN) 
where they were centrifuged for 1 minute at 13000rpm. Flow-through into the catchment 
tubes were discarded and 750 l of Wash Buffer was added to each column, this was 
followed by centrifugation for 1 minute at 13000rpm. Flow-through was discarded and 
columns were centrifuged for an additional 1 minute to remove any residual buffer from 
the binding column. DNA was eluted by adding 50 l of Elution Buffer directly into the 
binding columns and allowing them to sit for 1-2 minutes. The binding columns were 
transferred to fresh 1.5 ml microfuge tubes and plasmid DNA was isolated by a final 1 
minute centrifugation at 13000rpm. 
              To ensure plasmid DNA was at an ideal concentration for further 
experimentation (ideal amount is 100-500 ng/l), 17 l of each DNA elution was 
transformed into E. coli by the ‘long’ method of transformation (section 2.10.3). Plasmid 
DNA was finally isolated by additional steps that will be discussed in section 2.12. 
 
2.12 Isolation of plasmid DNA from E. coli 
               Following transformation of plasmid DNA into E. coli, individual bacterial 
colonies were isolated from the LB-amp plates. Each bacterial colony should contain 
hundreds-thousands of copies of the same plasmid. To isolate this DNA, a single colony 
was inoculated in 5 ml of LB-amp liquid and grown overnight at 37C 200rpm. The cells 
were harvested by centrifugation for 5 minutes at 4000rpm. All buffers used in this 
procedure were purchased in a plasmid miniprep kit from QIAGEN. The cell pellets were 
 82 
resuspended in 250 l Resuspension Buffer. 250 l of Lysis Buffer followed by 350 l of 
Neutralising Buffer were added to the cells, mixed well and centrifuged for 10 minutes at 
13000rpm. The supernatants were then removed and transferred to DNA binding columns 
where they were centrifuged for 1 minute at 13000rpm. Flow-through in catchment tubes 
was discarded and 750 l of Wash Buffer was added to each column, this was followed 
by centrifugation for 1 minute at 13000rpm. Flow-through was discarded and columns 
were centrifuged for an additional 1 minute to remove any residual buffer from the 
binding column. DNA was eluted by adding 50 l of Elution Buffer directly into the 
binding columns and allowing it sit for 1-2 minutes. The binding columns were 
transferred to fresh 1.5 ml microfuge tubes and plasmid DNA was isolated by a 1 minute 
centrifugation at 13000rpm. Plasmid DNA was stored at -20C.  
 
2.13 Measuring [PSI
+
] propagation in yeast 
              The presence of [PSI
+
] can be monitored in yeast strains by a colour assay 
(Figure 2.1). Sup35 is an S. cerevisiae protein involved in translation termination. When 
Sup35 aggregates into a non-functional form it is called [PSI
+
]. Laboratory yeast strains 
have an ochre mutation (ade2.1) in a gene responsible for adenine biosynthesis. When 
Sup35 is in its normal unaggregated state it halts translation at this premature stop codon 
which leads to the build-up of a red pigment in the cells. Cells which are [psi
-
] are red 
when grown on limiting amounts of adenine. When Sup35 is in its aggregated [PSI
+
] 
form, there is reduced translation termination of the ade2 gene and cells appear white on 
limiting adenine media (Figure 2.1 and 2.2). A second way of monitoring the presence of 
[PSI
+
] is by growth of yeast cells on medium lacking adenine. [PSI
+
] cells grow on 
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medium lacking adenine whereas [psi
-
] cells do not. This is because [PSI
+
] cells produce 
a fully functional Ade2 protein which is involved in the adenine biosynthesis pathway. 
[psi
-
] cells disrupt this pathway and require supplemented adenine for normal growth. 
 
                           
   Figure 2.1. The presence of [PSI+] is easily monitored by a colour assay. 
 
 
2.14 Monitoring [URE3] propagation 
               [URE3] is the prion form of protein Ure2. Its activity was monitored by ADE2 
gene, under control of the DAL5 promoter, in strain SB34. When Ure2 protein is active 
the ADE2 gene is not translated and cells are red on media with limiting adenine. When 
Ure2 is in the aggregated [URE3] state ADE2 is fully translated and colonies appear 
white or pink on media with limiting adenine (Schlumpberger et al., 2001). [URE3] 
propagation is a lot more unstable than [PSI
+
] propagation. Colonies often appear 
sectored after a few generations as the cell starts to lose [URE3]. In this study the effect 
of Sse1 mutants on the rate of [URE3] propagation was monitored. SB34 was prepared 
for transformation and WT Sse1 and thirteen Sse1 mutants were transformed into the 
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cells and selected on SC - leucine. The plates were incubated for 2 days at 30
o
C and 
colonies were marked as being red, white or sectored. The experiment was repeated in 
triplicate and [URE3] was measured as the average percentage of red, white and sectored 
colonies. 
 
 
 
 
 
 
Figure 2.2. Sup35 translation termination efficiency when cells are [PSI
+
] and [psi
-
]. 
Laboratory yeast strains have an aberrant stop codon in ade2-1 gene. [psi-] cells halt 
translation due to functional Sup35 and cells appear red. [PSI
+
] cells allow readthrough of 
the stop codon and cells appear white. 
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2.15 Random mutagenesis of plasmid DNA using hydroxylamine 
            The method for random mutagenesis of plasmid DNA is derived from a protocol 
by Schatz et al. (1988). Hydroxylamine (Sigma) is the mutagen used but is made into a 
solution prior to mutagenesis (Table 2.10). Desired plasmid DNA was transformed into 
E. coli and extracted as described in sections 2.10.4 and 2.12. A DNA concentration of 5 
g was needed for this experiment. An accurate measurement of this was made on a 
Nanodrop 1000 Spectrophotometer (Mason Technology). 250 l of hydroxylamine 
solution (Table 2.10) was added to 5 g of DNA and incubated at 70oC for 60 minutes. 
DNA was purified using a PCR purification kit (QIAGEN) and eluted in 50 l Elution 
Buffer. Approximately 10 1.5 ml microfuge tubes were set-up, each containing 5 l of 
the mutated DNA mixed with 25 l of dH2O. The DNA-dH2O mixes were transformed 
into E. coli by electroporation (section 2.10.5). E. coli colonies were counted on LB-amp 
plates the following day. For DNA to be completely saturated with all possible mutations 
approximately 10,000 colonies were needed (1,000 colonies per plate). E. coli colonies 
were pooled together in 5 ml of LB-amp and incubated at 37
o
C for 1 hour 200rpm. 
Plasmid DNA (mutant library) was extracted using methods in section 2.12. The mutant 
library DNA was stored at -20
o
C until further use.      
 
2.16 Isolating mutants by the plasmid shuffle technique 
               The mutant library was transformed into a desired yeast strain as described in 
section 2.9. 100 ng (0.2-1 l) of mutant library was transformed into each set of yeast 
cells. Colonies were selected on SC – leucine, using sterile glass beads for an even 
spread, and subsequently replicated onto 5-FOA. 5-FOA plates were incubated for 2 days 
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                     Table 2.10. Components in hydroxylamine solution. 
           
 
 
 
 
 
 
 
 
  
                      All components were purchased from Sigma. 
 
 
at 30
o
C. 5-FOA selects colonies that only contain a LEU2 marker plasmid from the 
mutant library. Wild type gene is on a URA3 marker plasmid which is toxic in the 
presence of 5-FOA. Colonies that appeared pink or red were selected and cultured onto 
fresh SC - leucine medium. The absence of URA3 plasmid pRS316SSE1 was re-
confirmed by replicating colonies onto SC - uracil medium (no growth). The 
transformation was repeated if any mutant library DNA was still available. Plasmid DNA 
from each colony was extracted via methods described in section 2.11.2 and 
retransformed back into yeast to reconfirm the phenotype. Colonies that appeared 
red/pink were sent for sequencing as described in section 2.21. 
              When screening for new temperature-sensitive sse1 mutants the same procedure 
was carried out with the exception that CM03 was used and the 5-FOA replicated plates 
were incubated at 37
o
C. Any colonies that failed to grow at 37
o
C were picked off from 
their corresponding SC - leucine plate. Secondary screening of potential mutants involved 
 
COMPONENT                                  AMOUNT 
 
         200 mM EDTA                                           20 l 
             1 M NaCl                                                200 l 
         Hydroxylamine                                      138.98 mg 
    Sodium Pyrophosphate                                 44.6 mg 
                dH2O                                                 1.78 ml 
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extracting the plasmid DNA, retransforming it back into yeast and performing a 
comparative growth assay at 37
o
C. 
 
2.17 Isolating second-site suppressor mutants 
            Plasmid mutants Sse1G342D and Sse1G616D were used in this study to screen for 
second-site mutations that suppress their original temperature-sensitive (ts) and [psi
-
] 
phenotypes. Plasmid DNA was prepared and mutagenised as described in section 2.15. 
DNA mutant libraries of G342D and G616D were transformed into CM02 along with 
WT Sse1, pRS315, Sse1
G342D
 and Sse1
G616D
.
 
The transformants were selected on SC - 
leucine medium, using glass beads to get an even lawn of cells, and incubated for 2 days 
at 30
o
C. There were approximately twenty mutant library plates and one for each control. 
The plates were subsequently left at room temperature for a day before replicating them 
onto 5-FOA. The 5-FOA plates were incubated overnight at 37
o
C or for 2 days at 30
o
C. 
For ts reverting mutant analysis WT Sse1 was the only plate with complete cell growth as 
pRS315 control and ts mutants G342D and G616D were non-viable. Colonies were 
screened for potential growth at 37
o
C and individual colonies were picked (primary 
screen). Plasmid DNA from each isolate was extracted and re-transformed into CM02. 
Comparative growth analysis at 37
o
C confirmed which isolates were potential second-site 
suppressors (sss) (secondary screen). Any G342D/G616D mutant isolates that survived at 
37
o
C were sent for DNA sequencing.  
               Analysing potential sss for reverting mutant [psi
-
] phenotype involved screening 
the 5-FOA plates for any colonies that looked white at 30
o
C. These colonies were 
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selected and plasmids retransformed back into CM02. Potential sss were analysed by 
streaking onto YPD medium alongside the Sse1 mutant of interest and WT Sse1.  
 
2.18 Site-directed mutagenesis of plasmid DNA 
              Site-directed mutagenesis is an effective tool for generating mutants of interest 
at specific amino acid residues. The technique of inducing mutations using 
oligonucleotides was first described by Hutchison et al. (1978). Complementary primer 
pairs were designed to anneal to approximately 40-50 bp of SSE1 or SSE2 DNA with one 
or more of the base pairs being mismatched to the WT sequence. This resulted in a single 
amino acid change in the protein sequence. Plasmid DNA was prepared and PCRs were 
setup as described in Table 2.11 using primers listed in Table 2.12.c. The PCR product 
was treated with 1 l Dpn1 (New England Biolabs) and incubated for 1 hour at 37oC. 
This digested away any methylated parental plasmid DNA. Approximately 8 l of each 
PCR product was transformed into competent E. coli using the long transformation 
method as decribed in section 2.10.3. Approximately four E. coli colonies from each 
transformation were isolated and the plasmid DNA extracted as described in section 2.12. 
The plasmid DNA was sent for sequencing as described in section 2.21 using primers 
listed in Table 2.13. If sequence analysis confirmed the presence of the desired mutation, 
the plasmid was transformed into yeast to observe any phenotypic changes. 
  
2.19 Genomic DNA knockout by homologous recombination 
               Certain yeast knockout strains used in this study were purchased from 
EUROSCARF. All other strains were made in the laboratory. Yeast knockout strains 
 89 
were made by applying a technique called homologous recombination. This involves 
creating a gene disruption cassette that encodes a selectable marker. Located at either side 
of the selectable marker are segments of DNA homologous to the gene being knocked 
out. The knockout cassette incorporates itself into the genome at the corresponding 
chromosomal locus by homologous recombination. 
              Genomic knockouts were created using either the selectable marker kanMX 
(kanamycin resistance gene) or HIS5. kanMX knockout constructs were available in 
EUROSCARF strain BY4741 for AKL1, HSL1, KIN2 and SSE2. These knockouts were 
transferred into G600 yeast strains by homologous recombination (Figure 2.3). Genomic 
DNA was isolated from the purchased BY4741 strains and primers were designed to 
anneal ~ 250 bp upstream and downstream of the gene being knocked out. Table 2.12.d 
lists all primers used for creating knockout strains. The PCR resulted in the amplification 
of the kanMX gene with overhangs homologous to the gene of interest (Figure 2.3). 
              The SWI6 gene was knocked out with HIS5. Primers were designed to anneal to 
vector pUG27 at regions upstream and downstream of HIS5. The primers also included 
~50 base pairs homologous to SWI6 which acted as overhangs in the resulting knockout 
construct. 
               Following PCR, the desired yeast strains were prepared for transformation as 
described in section 2.9. Four transformations took place for each knockout, one was a 
water control and the others had varying concentrations of PCR product (10 l, 30 l and 
60 l). Transformed yeast were incubated overnight in 1 ml YPD media at 30oC shaking 
and selected on G418 or SC - histidine plates the following morning (section 2.3.1). The  
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(a) Primers were designed to anneal upstream and downstream of kanMX gene 
 
 
            
                                      
                  PCR 5’- 3’ - - - - - - - ATG                              TAA- - - - - - - -  PCR 3’- 5’ 
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(b) DNA knockout cassette: primers amplify kanMX gene with the addition of 
overhangs that are homologous to the gene of interest. 
 
                                                                                                                           
   
         
 
 
 
 
(c) Homologous recombination: knockout cassette was transformed into yeast and 
homologous overhangs enable kanMX to incorporate into genome at the desired site. 
 
 
    DNA KNOCKOUT 
    CASSETTE   
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Figure 2.3. Creating kanMX DNA knockouts by homologous recombination. The 
kanamycin resistance gene replaces the gene of interest by homologous recombination. 
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plates were incubated for 2-3 days at 30
o
C and colonies were tested for positive 
knockouts by diagnostic PCR. Diagnostic PCRs involved extracting genomic DNA 
(section 2.11.1) from each isolate and a WT control strain and performing the following 
PCR reactions on them; 
(a) Forward and reverse primers that anneal outside the start and stop codon of the 
knocked out gene. If the gene was successfully knocked out the PCR product 
would correspond to the size of the kanMX/HIS5 gene instead of wild type gene.    
(b) Forward primer used in (a) with a reverse primer that anneals to the coding region 
of kanMX/HIS5. This PCR confirmed the gene was knocked out and the PCR 
product reflected the left flanking region of the knockout cassette. 
(c) Reverse primer used in (a) with a forward primer that anneals internally in the 
coding region of kanMX/HIS5. This PCR confirmed the gene was knocked out 
and the PCR product reflected the right flanking region of the knockout cassette. 
 
2.20 PCR analysis 
2.20.1 PCR amplification 
              All primers were purchased from Sigma in the de-salted powder form. They 
were dissolved in molecular grade sterile water (Sigma) to produce 100 M stock 
solutions. The volume of water added was indicated on the specific primer sticker, as 
provided by Sigma. They were further diluted 1/10 to produce 10 M working samples. 
Stock and working primers were stored at -20
o
C. PCRs were carried out using a Peltier 
Thermal cycler (MJ Research) in sterile PCR tubes (Starstedt). The dNTP mix was made 
using 2.5 mM each of dATP, dGTP, dTTP and dCTP (Sigma). Table 2.11 lists the 
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specific PCR reaction mixtures and cycles for the appropriate product. Table 2.12a-d lists 
the primers used for PCR. 
 
2.20.2 Agarose gel electrophoresis 
              PCR products were resolved on 0.8% agarose gel at 90V for 45 minutes in a 
Biorad electrophoresis power-pack. 0.4 g agarose (Sigma) was dissolved in 50 ml of 1X 
TAE Buffer (Millipore), boiled and allowed to cool. Once cooled, 1 l of a 10 mg/ml 
ethidium bromide solution (Sigma) was added to make a final concentration of 0.2 g/ml. 
Care was taken when handling the carcinogen ethidium bromide. All materials that were 
in contact with the agent were disposed of in a separate ethidium bromide waste 
container. The molten agarose was poured into a casting rig and allowed to set. PCR 
products (3 l) were mixed with 1 l of 6X Blue Loading Dye (NEB) and 2 l of dH2O. 
The gel was submerged in 1X TAE Buffer and the PCR products were added to the wells 
alongside a 1kb molecular grade marker (NEB). 
 
Table 2.11. PCR reaction mixtures and PCR cycles. 
 
          PCR 
 
         PCR MIXTURE (25 l) 
 
PCR CYCLE           
(TIME IN MINUTES) 
 
1. PCR FOR 
GENOMIC 
KNOCKOUTS 
& 
DIAGNOSTIC 
TESTS 
 
2.5 l Taq Buffer (New England 
Biolabs, (NEB)) 
1 l dNTP mix (Sigma) 
0.5 l forward primer (Sigma) 
0.5 l reverse primer (Sigma) 
 
95
o
C 5:00 
95
o
C 0:30 
55
o
C 0:30 
72
o
C 1:00 per kb 
Go to 2 30 times 
72
o
C 6:00 
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2. PCR OF 
TEMPLATE DNA 
FOR CLONING 
 
 
 
 
 
 
 
 
 
 
3. SITE-
DIRECTED 
MUTAGENESIS 
 
 
1 l MgCl2 (NEB) 
0.5 l template DNA 
0.5 l Taq Polymerase (NEB) 
18.5 l molecular grade water  
 
 
 
2.5 l High Fidelity (HF) Taq Buffer 
(Invitrogen) 
0.5 l dNTP mix 
0.5 l forward primer 
0.5 l reverse primer 
1 l MgSO4 (Invitrogen) 
0.5 l template DNA 
0.2 l HF Taq Polymerase (Invitrogen) 
19.3 l molecular grade water 
 
 
 
2.5 l PFU ULTRA Buffer (Starstedt) 
0.5 l dNTP mix 
1 l forward primer 
1 l reverse primer 
0.5 l template DNA 
0.5 l HF PFU ULTRA (Starstedt) 
19 l molecular grade water 
 
 
 
4
o
C overnight 
 
 
 
 
 
 
 
94
o
C 2:00 
94
o
C 0:30 
62
o
C 0:30 
62
o
C 1:00 per kb 
Go to 2 30 times 
72
o
C 6:00 
4
o
C overnight 
 
 
 
 
 
          95
o
C 1:00 
95
o
C 0:30 
55
o
C 1:00 
62
o
C 2:00 per kb 
Go to 2 12 times 
68
o
C 7:00 
4
o
C overnight 
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Table 2.12.a PCR primers used to confirm knockout strains CM02 and CM03. 
 
Primers were used to perform diagnostic tests on CM02 and CM03 strains. 
*Primers sse04, sse03, sse05 and sse06 all sequence regions of SSE1 and SSE2 genes. 
When SSE1 and SSE2 were genomically replaced by kanMX the primers amplified the 
knockout construct which resulted in a different size DNA band. 
 
 
 
 
 
 
      PRIMER 
 
                OLIGONUCLEOTIDE 
 
FRAGMENT 
SIZE (BP) 
 
     SSE04F 
     SSE03R 
 
     KAN02F 
     SSE03R 
 
     SSE04F 
     KAN01R 
 
     SSE05F 
     SSE06R 
 
     KAN02F 
     SSE06R 
 
     SSE05F 
     KAN01R 
 
 
         ACGAAGATGATTCTAGAAG 
           TTAGGAGACTAATGCGTG 
 
          TTGATGACGAGCGTAATGG 
           TTAGGAGACTAATGCGTG 
 
         ACGAAGATGATTCTAGAAG 
         TGCGCACGTCAAGACTGTC 
 
           ATCACATCATACGAGGAG 
           TACTTTGAAACATAGGAC 
 
          TTGATGACGAGCGTAATGG 
            TACTTTGAAACATAGGAC 
             
           ATCACATCATACGAGGAG 
          TGCGCACGTCAAGACTGTC 
 
2496 (WT SSE1) 
1943 (kanMX KO) 
 
 
772 
 
 
277 
 
2519 (WT SSE2) 
1948 (kanMX KO) 
 
 
861 
 
 
                 293 
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Table 2.12.b PCR primers used to clone segments of DNA into a vector. 
 
 
 
      PRIMER 
 
                 OLIGONUCLEOTIDE 
 
 
FRAGMENT  
   SIZE (BP) 
 
     HSPH1F 
 
 
     HSPH1R 
 
     
 
SSE2CLONEF 
     
 
 
SSE2CLONER 
 
     
 
Q458pC210F 
     
 
Q458pC210R 
 
 
 
CAAGCAGATTTTATACAGAAATATTTATACA 
TATGTCGGTGGTGGGGTTGGACGTGGC 
 
CTTCCTGATTAAACAGGAAGACAAAGCATG 
CCTAGTCCAAGTCCATATTAACAGAA 
 
 
ACCGCGGTGGCGGCCGCTCTAGAACTAGTG 
GATCCAATCACATCATACGAGGAGTTTTAAGG 
 
 
AAGCTTGATATCGAATTCCTGCAGCCCGGG 
GGATCCTTAATCAAGGTCCATGTTTTCATCAT 
TGT 
 
CAAGCAGATTTTATACAGAAATATTTATACA 
TATG ATGAGTACTCCATTTGGTTT 
 
GCGACTTCCTGATTAAACAGGAAGACAAA 
GCATGC TTATTCTGGAGTGTTTGGTG 
 
 
 
2640 
 
 
 
 
 
 
2365 
 
 
 
 
 
 
1445 
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Table 2.12.c PCR primers used to amplify DNA for site-directed mutagenesis. 
 
 
PRIMER 
  
OLIGONUCLEOTIDE 
 
SSE2G616DF 
SSE2G616DR 
 
SSE2Q504EF 
SSE2Q504ER 
 
SSE2S384AF 
SSE2S384AR 
 
SSE2S384EF 
SSE2S384ER 
 
SSE2S679AF 
SSE2S679AR 
 
SSE2S679EF 
SSE2S679ER 
 
SSE2S682AF 
SSE2S682AR 
 
SSE2S682EF 
SSE2S682ER 
 
 
              
               GTGGTTATACGATGAAGATTTCGATTCCATCAAAG 
CTTTGATGGAATCGAAATCTTCATCGTATAACCAC 
 
CGGAAGATATTACGGTTGAAGAGCCAGTGCCTTTAC 
GTAAAGGCACTGGCTCTTCAACCGTAATATCTTCCG 
 
GCTTTCATATGTGCCATTCACGCTCCAACTTTAAGGGTCAGG 
CCTGACCCTTAAAGTTGGAGCGTGAATGGCACATATGAAAGC 
 
GCTTTCATATGTGCCATTCACGAACCAACTTTAAGGGTCAGG 
CCTGACCCTTAAAGTTGGTTCGTGAATGGCACATATGAAAGC 
 
CAAAGAAGGGCACGCGCTGCAGCTGATGATAGCGATGACAACAA 
TTGTTGTCATCGCTATCATCAGCTGCAGCGCGTGCCCTTCTTTG 
 
CAAAGAAGGGCACGCGCTGCAGAAGATGATAGCGATGACAACAA 
TTGTTGTCATCGCTATCATCTTCTGCAGCGCGTGCCCTTCTTTG 
 
GCACGCGCTGCAAGTGATGATGCCGATGACAACAATGATGAAAAC 
GTTTTCATCATTGTTGTCATCGGCATCATCACTTGCAGCGCGTGC 
 
GCACGCGCTGCAAGTGATGATGAGGATGACAACAATGATGAAAAC 
GTTTTCATCATTGTTGTCATCCTCATCATCACTTGCAGCGCGTGC 
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Table 2.12.d. PCR primers used to create genomic DNA knockouts. 
 
 
     PRIMER 
 
 
OLIGONUCLEOTIDE 
 
   FRAGMENT 
     SIZE (BP) 
 
AKL1F 
AKL1R 
 
AKL1F 
KAN01R 
 
AKL1R 
KAN02F 
 
HSL1F 
HSL1R 
 
GGTGAACCCCGCCATTCTG 
CTGTCAAATTGCGAGCAC 
 
GGTGAACCCCGCCATTCTG 
TGCGCACGTCAAGACTGTC 
 
CTGTCAAATTGCGAGCAC 
TTGATGACGAGCGTAATGG 
 
CGTAAATTGGACAGCGAGAGG 
GGATGACGAATCTTCTTGAGC 
 
3809 (WT AKL1) 
1989 (kanMX KO) 
 
 
353 
 
 
742 
 
5045 (WT HSL1) 
1995 (kanMX KO) 
SSE1S85AF 
SSE1S85AR 
 
SSE1S85EF 
SSE1S85ER 
 
SSE1S384AF 
SSE1S384AR 
 
SSE1S384EF 
SSE1S384ER 
CCAGATTTCGAGCAAGAAGCTAAGCACTTCACCTCTAAGTTG 
CAACTTAGAGGTGAAGTGCTTAGCTTCTTGCTCGAAATCTGG 
 
CCAGATTTCGAGCAAGAAGAAAAGCACTTCACCTCTAAGTTG 
CAACTTAGAGGTGAAGTGCTTTTCTTCTTGCTCGAAATCTGG 
 
CTTTATTTGCGCCATTCACGCTCCAACTCTAAGAGTTAG 
CTAACTCTTAGAGTTGGAGCGTGAATGGCGCAAATAAAG 
 
CTTTATTTGCGCCATTCACGAACCAACTCTAAGAGTTAG 
          CTAACTCTTAGAGTTGGTTCGTGAATGGCGCAAATAAAG 
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HSL1F 
KAN01R 
 
HSL1R 
KAN02F 
 
KIN2F 
KIN2R 
 
KIN2F 
KAN01R 
 
KIN2R 
KAN02F 
 
SWI6KOF 
 
     
SWI6KOR 
 
 
 
SWI6F 
SWI6R 
 
HIS5F 
HIS5R 
 
SWI6F 
HIS5R 
 
CGTAAATTGGACAGCGAGAGG 
TGCGCACGTCAAGACTGTC 
 
             GGATGACGAATCTTCTTGAGC 
TTGATGACGAGCGTAATGG 
 
GACCTAGAAGTCCTGCTTTGC 
GGGAATGCATCTAACTGTTCG 
 
GACCTAGAAGTCCTGCTTTGC 
TGCGCACGTCAAGACTGTC 
 
GGGAATGCATCTAACTGTTCG 
TTGATGACGAGCGTAATGG 
 
GCTAAAAAAAAAAGAATAATAAAGGGGAA 
CACAGTATAATTCTCGAGAGGATGCAGCTG 
AAGCTTCG 
TAACTTCAAATAAAGTCATAAAAGTTAATG 
CAATGAAATCACATGCCCTCAGCATAGGCC 
ACTAGTGGATCTG 
 
          CCTTGCAGCGTTACTAGCCATAG 
GGCAAACCATTGGACGAAGAG 
 
GAGGGTATATTGCTAGACGCC 
CCGGAACAGCCTAATTCGTTAC 
 
CCTTGCAGCGTTACTAGCCATAG 
           CCGGAACAGCCTAATTCGTTAC 
 
331 
 
 
770 
 
 
   3949 (WT KIN2) 
2012 (kanMX KO) 
 
 
317 
 
 
801 
 
 
 
1562 
 
 
   3048 (WT SWI6) 
2167 (HIS5 KO) 
 
971 
 
1741 
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SWI6R 
HIS5F 
 
GGCAAACCATTGGACGAAGAG 
GAGGGTATATTGCTAGACGCC 
 
1684 
 
 
2.21 DNA sequence analysis 
            Yeast genomic or plasmid DNA was prepared as described in section 2.11. 
Approximately 1 g of DNA was mixed in 1.5 ml microfuge tubes with 20 pmol of an 
appropriate primer to a final volume of 14 l. Microfuge tubes were tagged with a 
prepaid barcode and samples were sent to Agowa Sequencing Services Berlin, Germany. 
DNA was sequenced by dye-terminator sequencing and results were available on the 
Agowa website. Sequencing results were compared to the gene of interest by BLAST 
analysis on NCBI. A list of the sequencing primers used to screen for sse1 and sse2 
mutants are listed in Table 2.13. These primers were also used in addition to those listed 
in Tables 2.12a,b and d to confirm knockouts and clones.  
 
Table 2.13. DNA sequencing primers. 
 
 
PRIMER 
 
OLIGONUCLEOTIDE 
 
SSE04F 
SSE07F 
SSE08F 
 
ACGAAGATGATTCTAGAAG 
TACACCGAAGAACAACG 
ACCAAGATGAAGCCATCG 
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2.22 Mating yeast strains to select for specific genotypes 
              The mating type of a haploid strain is determined by the MAT locus whereby 
yeast are either MATa or MAT. Haploid cells mate with other haploid cells of the 
opposite mating type to produce a diploid. By a process called sporulation, diploids 
undergo a single meiotic event whereby they produce an ascus containing four haploid 
spores. Subsequent random spore analysis is useful for constructing strains necessary for 
genetic experiments. 
 
SSE03R 
SSE07R 
SSE08R 
TTAGGAGACTAATGCGTG 
CGTTGTTCTTCGGTGTA 
CGATGGCTTCATCTTGGTTC 
 
           SSE05F 
SSE2AF 
SSE2BF 
SSE2CF 
SSE2DF 
SSE06R 
SSE2AR 
SSE2BR 
SSE2CR 
ATCACATCATACGAGGAG 
CAGCTACTCAACTGACTGC 
CCGTGAAGAGCTGGAAG 
GATGCGATCCTTCCGGCTTG 
GGCACGCGCTGCAAGTGATGATAG 
TACTTTGAAACATAGGAC 
GCAGTCAGTTGAGTAGCTG 
CTTCCAGCTCTTCACGG 
CAAGCCGGAAGGATCGCATC 
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2.22.1 Mating haploid yeast strains 
              Two yeast haploid strains containing desired genotypes were grown on selective 
nutrient media for two days at 30
o
C. Using a wooden dowel, one strain was streaked 
through the other on a separate agar plate and incubated at 30
o
C for two days. Mating 
occured where the two strains meet. The plates were replicated onto SD agar that was 
also supplemented with one or more amino acids. This supplementation depended upon 
the genotype of both strains as the agar was made specifically so that only diploids would 
survive. For example Y02146 (MATa his3leu2met15ura3 sse1::kanMX) 
was mated with Y17167 (MAT his3leu2lys2ura3 sse2::kanMX) to create 
strain CM03. They were replicated onto medium whereby the haploid parents died and 
the diploids survived. The medium was supplemented with histidine, leucine and uracil as 
the absence of lysine and methionine is lethal to haploids. The replicated SD plates were 
incubated for 2 days at 30
o
C.  
 
2.22.2 Sporulation and random spore analysis 
               Diploid strains were patched onto sporulation medium and minimal sporulation 
medium (+ amino acids) using a wooden dowel. The components of sporulation media is 
outlined in section 2.3.1. The plates were incubated at 30
o
C for 2 days and then left at 
room temperature for 2-5 days. Diploids undergo meiosis and sporulate into asci after 4-7 
days due to the limited carbon source in the growth medium. The presence of asci or 
tetrads can be observed by light microscopy.  
              The cells were mixed with 200 l of dH2O in 1.5 ml sterile microfuge tubes. 5 l 
-glucuronidase (500 units) (Sigma) was added to cells and incubated on a rotor for 1 h at 
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room temperature. 100 l of 0.5 mm glass beads were added to the cells and incubated on 
a rotor at room temperature for an additional 1 hour. 1 ml of dH2O was added and the 
mixtures were vortexed for 2-3 minutes to disrupt the asci. The cell mixtures were 
centrifuged for 10 seconds at 13000rpm and the supernatants removed and placed into 15 
ml falcon tubes. 4 ml of dH2O was added to the cells and a serial dilution of 10
-1
 to 10
-4
 
was made in fresh 1.5 ml microfuge tubes. 200 l of each serial dilution was plated onto 
selective medium and incubated at 30
o
C for 2 days.  
              Individual colonies on each plate represented a single spore segregated from the 
tetrad, or in some cases an unsporulated diploid. These colonies were analysed to see if 
they had the desired genotype (Figure 2.4.). For example, in the case of making CM03 
the serial dilution was performed on SC - uracil as a pRS316SSE1 plasmid was 
transformed in at the diploid stage. Plates were subsequently replicated onto 5-FOA and 
any colonies that died were taken as potential sse1sse2 haploids. After phenotypic 
analysis, the DNA was extracted from individual colonies using methods described in 
section 2.11.1 and diagnostic PCRs were performed using PCR cycles in Table 2.11 and 
primers listed in Table 2.12 a and d. 
 
2.23 Cloning DNA into plasmid vector by homologous recombination 
2.23.1 Creating DNA fragment for cloning 
              In this study three plasmid clones were created by homologous recombination. 
These were pC210HSPH1, pC210Q458trunc and pRS315SSE2. The first step was to 
PCR template DNA using specifically designed primers listed in Table 2.12.b. These 
primers annealed to approximately 30 bp of the gene of interests coding region but also 
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incorporated approximately 30-40bp of DNA sequence from the plasmid vector as 
overhangs. The PCR cycle used is described in Table 2.11. HF Taq has better proof-
reading than Taq so was used for cloning. The PCR product size was confirmed by gel 
electrophoresis. 
 
 
 
 
 
                Y02146                                                                                           Y17167 
              HAPLOID HAPLOID 
 
                                  
 
 
                  MATED 
 
                                           
                                                SPORULATED 
 
 
POSSIBLE  
SPORES 
 
 
 
 
Figure 2.4. Creating yeast strain CM03 by mating and random spore analysis. 
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2.23.2 PCR purification of DNA fragment 
               100 l PCR products were purified using a QIAGEN PCR purification kit. 500 
l of Buffer PB was added to each PCR product and transferred to QIAquick columns. 
The columns were centrifuged at 13000rpm for 1 minute, flow-through discarded and the 
columns were subsequently washed with 750 l Buffer PE. The columns were 
centrifuged for 1 minute, flow-through discarded and centrifuged again for 1 minute to 
remove residual buffer. The binding columns were placed in fresh 1.5 ml microfuge tubes 
and DNA was eluted by adding 50 l Buffer EB. The microfuge tubes were left to stand 
for 1 minute followed by centrifugation for 1 minute. 
 
2.23.3 Restriction digest of plasmid DNA 
               Plasmid DNA pRS315 or pC210 was prepared as described in sections 2.10.4 
and 2.12. pC210 vector DNA was digested with enzymes Nde1 and Sph1 in order to 
linearise the DNA and remove the SSA1 gene. The reactions were as follows: 4 g 
plasmid DNA, 5 l Buffer 4 (NEB), 2U Nde1 (NEB), 2U Sph1 (NEB) and adjusted to 50 
l with molecular grade water. pRS315 vector DNA was digested with BamH1 and the 
reactions were as follows: 4 g plasmid DNA, 5 l Buffer 2 (NEB), 2U BamH1 (NEB) 
and adjusted to 50 l with molecular grade water. The reactions were mixed in 1.5 ml 
microfuge tubes and incubated at 37
o
C for 1 hour to allow digestion to occur. Following 
incubation, the mixtures were treated with 10U of Cip (NEB) per 1 mg of DNA and 
Buffer 3 (NEB) at a 10X concentration. The tubes were then incubated at 37
o
C for 1 
hour. Cip removes the phosphate groups at the ends of linear DNA. This prevents the 
plasmids from re-annealing. 
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2.23.4 Gel extraction and purification of plasmid DNA 
              Digested and Cip-treated vectors were analysed by agarose gel electrophoresis. 
This confirmed the size of the linearised vector and, in the case of pC210, that SSA1 had 
been removed. The plasmids were excised from the gel under UV light using a clean 
scalpel. The pieces of gel were added to 1.5 ml microfuge tubes and weighed on a fine 
balance. If the agarose gel weighed more than 400 mg then it was split into two 1.5 ml 
microfuge tubes. Using a QIAGEN gel extraction kit, QG Buffer was added to the gels at 
a concentration of 100 l per 100 mg of gel. The gels were then dissolved in the QG 
Buffer at 50
o
C for 10 minutes. The dissolved samples were applied to QIAquick spin 
columns and centrifuged for 1 minute at 13000rpm. The flow-through was discarded and 
750 l Buffer PE was added to each column. The columns were centrifuged for 1 minute, 
flow-through discarded and centrifuged for an additional 1 minute. 50 l of Buffer EB 
was added to the columns and left to stand for 1 minute. DNA was eluted by 
centrifugation for 1 minute. 3 l of sample was analysed by agarose gel electrophoresis to 
confirm the presence of DNA. 
 
2.23.5 Homologous recombination of vector and DNA fragment. 
               Prior to cloning, the exact DNA concentration of both vector and insert was 
calculated on a Nanodrop Spectrophotometer. Yeast cells were prepared for 
transformation as described in section 2.9. The cells acted as carriers for the cloning to 
occur. Four DNA samples were prepared as follows: (a) 700 ng insert/500 ng digested 
vector (b) 700 ng insert/500 ng undigested vector (c) 700 ng insert/H2O (d) H2O/500 ng 
digested vector. Each DNA mix was transformed into separate yeast cells as described in 
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section 2.9. The cells were selected on SC - leucine. Any colonies that grew on SC - 
leucine should have had an intact plasmid being expressed. For transformant (c) there 
were no colonies as it had no intact vector. Colony numbers were counted on 
transformants (a), (b) and (d). Sample (d) had digested vector so colonies were noted as 
being the amount of digested plasmids that had re-annealed. Sample (b) represented the 
number of colonies when 500 ng of intact vector was expressed. Colonies from cloning 
plate (a) were selected and plasmids extracted as described in section 2.11.2. Each 
plasmid was enzyme digested as described in section 2.23.3 and examined by agarose gel 
electrophoresis. Potential clones should have at least two DNA bands, one corresponding 
to the linearised vector and the other the size of the gene cloned. This depends on where 
and how often the enzyme cuts. Plasmids were sent to Agowa for sequencing to confirm 
the presence of the gene of interest. Figure 2.5 illustrates the methodology behind cloning 
by homologous recombination. 
 
2.24 Western blot analysis 
2.24.1 Preparing protein lysates 
              Yeast strains were grown overnight in 5 ml YPD at 30
o
C shaking. They were 
diluted to an equal concentration of OD600nm 0.1-0.2 in 25 ml YPD the following 
morning. The yeast cultures were incubated at 30
o
C shaking until OD = 0.5-0.6 and 
centrifuged for 5 minutes at 2000rpm. 2 ml screw cap tubes (Starstedt) were ¾ filled with 
0.5 mm glass beads and put on ice to chill. Each cell pellet was resuspended in 500 l of 
Cell Lysis Buffer (Sigma) and transferred to the 2 ml tubes. The tubes were inverted to 
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            HOMOLOGOUS                                                                   HOMOLOGOUS 
                                                           OVERHANG                                                                             OVERHANG 
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     DIGESTED VECTOR 
 
 
 
 
 
 
 
 
 
Figure 2.5. Schematic diagram of steps involved in cloning plasmid DNA by 
homologous recombination. DNA insert is created by PCR and contains overhangs 
homologous to plasmid vector DNA. Recombination occurs at the homologous regions 
and gene of interest is now expressed by the plasmid vector. 
 
 
remove air bubbles and extra lysis buffer was added to fill the tubes. The cells were 
vortexed using a mini-bead beater for 20 seconds and incubated on ice for thirty seconds. 
This was repeated twice more to ensure that the cells were disrupted. The cells were 
centrifuged for 5 minutes at 7000rpm and the supernatants were transferred to sterile 1.5 
ml microfuge tubes. The samples were either stored at -20
o
C until further use or prepared 
       GENE 
RESTRICTION 
     DIGEST 
       
GE
NE 
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for gel electrophoresis. For running samples on polyacrylamide gels 60 l of sample was 
mixed with 20 l 4X Sample Buffer (Table 2.14) and incubated at 100oC for 5 minutes. 
 
2.24.2 Protein concentration determination  
              Protein concentration standard curves were prepared on a Nanodrop 
Spectrophotometer (nanodrop 1000, Mason) at OD595nm by using several dilutions (0.125 
µg-4000 µg/ml) of BSA (New England Biolabs). The BSA standard curves were saved 
and used to determine the protein concentration of various cell lysates. 
            The protein concentrations of cell lysates were quantified using the Bradford 
assay. This assay was originally developed by Marion Bradford (Bradford, 1976). 
Quickstart Bradford dye solution (Biorad) was allowed to warm at room temperature for 
15 minutes and 1 ml was added to 1.5 ml microfuge tubes. 10 l of lysate samples were 
added to Bradford reagent mixed well and incubated at room temperature for 5-30 
minutes. Protein concentrations were read on the Nanodrop Spectrophotometer at 
OD595nm. Bradford protein concentrations were determined against the BSA standard 
graphs. 
 
 
 
2.24.3 Gel electrophoresis 
              Acrylamide gels were prepared using 1 mm BioRad glass plates with 15 well 
combs and 20 l sample capacity. The components of the running gel and stacking gel 
are listed in Tables 2.15 and 2.16. The running gels were prepared first by mixing all the 
components in 15 ml falcon tubes. Polyacrylamide is a neurotoxin and was handled with 
care. While still liquid they were gently pipetted between two clean glass plates to 
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roughly a 70% capacity. The glass plates were sealed in a Biorad Gel Cassette and a 
Casting Frame. A few drops of 100% Isopropanol (Sigma) were added on top of the gels 
to allow them set smoothly. After 20-30 minutes the Isopropanol was removed, washed 
away with distilled water and the stacking gels were added between the two plates to 
100% capacity. A comb was inserted between the glass plates and the gels were left to set 
for 30 minutes. The casting frames were assembled so that the short plates faced inward 
into the gel box and the clamping frames were sealed. The samples for electrophoresis 
were prepared by mixing the lysates with the Sample Buffer as described in section 
2.24.1 and loaded directly into the gel at a concentration of 10 g protein. 5 l of 
prestained protein marker (NEB) was added alongside the samples. The gels were 
resolved in 1X Protein Gel Buffer (Table 2.19) at 100V per gel for 1.5 hours in a Biorad 
Mini-Protean3 Electrophoresis Module. 
 
 
              Table 2.14. Components in 4X Sample Buffer for Western blot analysis.  
 
Buffer components Final 
concentration/volume 
 
Tris pH6.8 
DTT 
SDS 
Glycerol 
Bromophenol Blue 
Deionised water 
 
 
0.25 M 
0.755 g 
10% 
50% 
5 mg 
adjusted to 10 ml 
 
                               All components were purchased from Sigma. 
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      Table 2.15. Volume of Buffers required for creation of one Resolving Gel. 
 
Buffer components 12.75% Gel 
 
Polyacrylamide (Invitrogen) 
10% Ammonium persulphate (Sigma) 
4X Gel Running Buffer 
TEMED (Sigma) (added last) 
Deionised water 
 
4.15 ml 
      100 l 
2.5 ml 
10 l 
3.3 ml 
 
              10% = 10 g Ammonium persulphate in final volume of 100 ml dH2O. 
              Polyacrylamide is a carcinogen and needs to be handled with care. 
 
 
 
 
 
       Table 2.16. Volume of Buffers required for creation of one Stacking Gel. 
 
Buffer components 12.75% 
                        
                           Polyacrylamide  
10% Ammonium persulphate 
2X Stacking Buffer 
TEMED (added last) 
Deionised water 
 
 
0.4 ml 
25 l 
1.25 ml 
2.5 l 
0.825 ml 
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                     Table 2.17. Components of 10X Gel Running Buffer. 
 
Buffer components concentration 
 
                       Tris 
Glycine 
SDS 
Deionised water 
 
15 g 
72 g 
5 g 
adjusted to 500 ml 
 
 
 
 
                     Table 2.18. Components of 2X Stacking Gel Buffer. 
 
Buffer components concentration 
 
Tris 
SDS 
Deionised water 
pH 6.8 
 
15 g 
0.2 g 
adjusted to 500 ml 
 
 
 
 
 
                          Table 2.19. Components of 10X Protein Gel Buffer. 
 
Buffer components concentration 
 
Tris 
Glycine 
10% SDS 
Deionised water 
 
 
30.2 g 
18.8 g 
100 ml 
adjusted to 1000 ml 
 
                    A 1X dilution of Protein Gel Buffer was made for resolving gels. 
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2.24.4 Gel transfer and blotting 
              After gel electrophoresis the plates were separated and the stacking gels 
removed. The gels were equilibrated in Transfer Buffer for 15 minutes (Transfer Buffer 
components in Table 2.20). PVDF transfer membrane paper (PerkinElmer) was cut at 
approximately the size of the gel (8cm x 5cm) and soaked in 100% Methanol (Sigma) for 
5 seconds. The membranes were washed for 1 minute in water and 5 minutes in Transfer 
Buffer (Table 2.20). Whatmann paper (Schleicher and Schuell) was cut into 4 pieces 
approximately the same size as the gels and then soaked along with transfer sponges in 
Transfer Buffer. The Biorad gel Transfer system was assembled with sponges on the 
outside, two pieces of Whatmann paper either side, PVDF membrane on clear side of 
cassette (positive pole) and gel on top (negative pole). The system was locked, air 
bubbles removed and inserted into the blot chamber. The proteins that were separated in 
electrophoresis were transferred onto PVDF in Transfer Buffer at 100V for one hour. 
               PVDF blots were washed twice with TBS-t (Table 2.21) and ‘blocked’ in 
blocking solution (40 ml TBS-t with 2 g Marvel) for 1-2 hours at room temperature. The 
primary antibody was added to the blots in 5 ml TBS-t at a dilution of 1/2,000 for Hsp110 
(Jeff Brodsky, University of Pittsburgh, USA) and Hsp70 (SPA-822) (Stressgen, 
Victoria, BC, Canada) antibodies and 1/150,000 for Hsp104 antibody (John Glover, 
University of Toronto). The blots were incubated with the primary antibody on a rocker 
(MSC) at room temperature overnight. The primary antibodies were washed off 3 times 
with TBS-t and the blots were incubated with a secondary antibody for 2 hours. The 
secondary antibodies were both alkaline phosphatase-conjugated and purchased from 
Sigma. They were goat anti-rabbit (Hsp104/Hsp110) or goat anti-mouse (Hsp70). They 
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were added to the blot in 5 ml of TBS-t at a 1/2000 dilution. The blots were washed 3 
times with TBS-t prior to development. 
 
 
                         Table 2.20. Components of 1X Transfer Buffer.  
Buffer components concentration 
                     
                     Tris 
Glycine 
Methanol 
            Deionised water 
 
 
3.03 g (25 mM) 
14.4 g (192 mM) 
200 ml 
adjusted to 1 litre 
 
 
 
                    Table 2.21. Components of 10X TBS Buffer and 1X TBS-t. 
Buffer components concentration 
 
10X TBS stock: 
Tris pH 7.5 
NaCl 
Deionised water 
 
 
      12.14 g (100 mM) 
58.44 g (1 M) 
adjusted to 1 litre 
 
TBS-t : 
10X TBS Buffer 
Tween (Sigma) 
Deionised water 
 
 
100 ml 
1 ml 
899 ml 
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2.24.5 Chemiluminescence and Western blot development 
              PVDF membranes were incubated with 2 ml CDP-Star Chemiluminescence 
reagent (Perkin Elmer) for 5 minutes. The membranes were transferred onto plastic 
overhead film and a piece of overhead was placed on top of each blot and bubbles or 
grooves were smoothed out. In a dark room the membranes were exposed to X-ray film 
(Kodak Biomax Ms) in an X-ray cassette for 30-60 seconds depending on the antibody 
used. The films were placed in 1/5 diluted Kodak Developer solution (Sigma) for 10 
seconds, washed shortly with water and put in 1/5 diluted Kodak Fixer solution (Sigma) 
for 30 seconds. The films were washed thoroughly with water and allowed to dry. 
 
2.24.6 Stripping membrane 
              Used PVDF membranes can be stripped of their antibodies and blotted again. 
This was performed if the development did not work sufficiently or if the same blot 
needed to be probed with a different antibody. The membranes were washed in water for 
5 minutes and incubated in 200 mM NaOH (4 g NaOH in 500 ml dH2O) (Sigma) for 5 
minutes. The membranes were washed in water for 5 minutes and in TBS-t for 5 minutes. 
They were then blocked in blocking solution for 1 hour before incubating with primary 
antibody and following steps in section 2.24.4. 
 
2.24.7 Staining membrane 
               To check for even protein loading the membranes were stained for 1 minute 
with amido black (0.1% naphthol blue black in 2% acetic acid and 45% MeOH) and 
destained for 1 hour in 2% acetic acid with 45% MeOH. 
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2.24.8 Staining gel 
              A gel replicate of each Western blot was stained after gel electrophoresis to 
show an even loading of protein. The staining solution was 0.1% Coomassie Brilliant 
Blue R250 in 25% EtOH /10% acetic acid and was left on the gels for 30-60 minutes. The 
gels were destained with 25% EtOH/10% acetic acid. 
 
2.25 Sse1 3D crystal structure analysis 
              The Sse1 mutants were modeled onto the 3D crystal structure using the 
programme iMOL. Changing amino acid residues to examine their structural implications 
was done using MOE-Homology. MOE-Homology creates full-atom, energy-minimised 
3D models of amino acid sequences. The underlying methodology is based on a 
combination of the segment-matching procedure of Levitt (1992) and an approach on the 
modeling of indels based on that of Fechteler et al. (1995). 
 
2.26 G600 genome sequencing 
2.26.1 Illumina library construction and sequencing 
              Genomic DNA was isolated from strain G600 using the standard protocol 
described in section 2.11.1. DNA libraries were generated using 1.5 g of genomic DNA 
following the Illumina Genomic DNA sample preparation protocol with the exception 
that the samples were sheared using a bioruptor (Diagenode) instead of nebulisation. The 
samples were sonicated on high for 30 seconds and off for 30 seconds for a total 30 
minutes with addition of ice after every 10 minutes to keep the samples cool. 16 pM of 
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the sequencing library was loaded onto a flowcell and single reads of 40 bases were 
generated using an Illumina GAII.  
  The images were processed into sequence data and aligned to the S. cerevisiae 
genome using the Illumina GA Pipeline v1.4. SNP detection and the generation of data to 
determine sequence coverage across the genome was performed with MAQ using the 
default settings. The Illumina quality scores were converted to the standard phred scores 
required by MAQ by using a modified version of the fq_all2std.pl script supplied with 
MAQ. 
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3.0 Introduction 
             The aim of this Chapter was to gain insight into Hsp110’s role in yeast prion 
propagation. A group of Hsp110 mutants were created, which were impaired in [PSI
+
] 
propagation. 
               Yeast prions exploit cellular chaperones in order to maintain and replicate 
their aggregated state (Perrett and Jones, 2008). Heat shock proteins (Hsps) are a 
class of chaperones that are induced in response to cellular stress. Their normal 
function is in protein folding and disaggregation. However, prions like [PSI
+
] are not 
refolded into their correct conformation but instead use Hsps to aid their propagation 
(Jones and Tuite, 2005). 
                Hsp110 is represented by the proteins Sse1 and Sse2 in yeast. The Sse1 
protein is constitutively expressed whereas Sse2 is stress induced (Polier et al., 2008). 
The Hsp110 chaperone plays a critical role in yeast cellular physiology. Deletion of 
Sse1 results in slow-growing, temperature-sensitive cells and deletion of both Sse1 
and Sse2 is lethal (Mukai et al., 1993; Shiryama et al., 1993; Shaner et al., 2006). 
Recent studies have shown that Hsp110 plays a role in yeast prion propagation (Fan 
et al., 2007; Kryndushkin and Wickner, 2007; Sadlish et al., 2008). Sadlish et al. 
(2008) demonstrated that deletion of Sse1 results in an increased amount of soluble 
Sup35 and that the presence of cytosolic Sse1 stimulates initial nucleation of Sup35 
fibers. Sse1 interacts with the aggregated [PSI
+
] form of Sup35 to a much greater 
extent than the [psi
-
] version (Bagriantsev et al., 2008). These findings suggest that 
Sse1 plays an active role in [PSI
+
] propagation.  
              Sse1 acts as a ‘holdase’ by binding denatured proteins (Oh et al., 1999). It 
has also been suggested that Sse1 binds aggregated polypeptides in order to present 
them to Hsp70 (Dragovic et al., 2006). Sse1 is a divergent member of the Hsp70 
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superfamily and it physically associates with the Hsp70 protein Ssa1 in vivo. 
Together Hsp110 and Hsp70 play a major role in the peptide binding cycle (Fan et 
al., 2007). The ATPase activity of Ssa1 (Hsp70) governs the binding and release of 
misfolded proteins. Sse1 acts as a nucleotide exchange factor (NEF) by removing 
ADP from Ssa1. This results in an ‘open’ Ssa1 conformation that rapidly binds and 
releases aggregated substrates and promotes [PSI
+
] propagation (Shaner et al., 2006).  
Crystal structure studies and mutational analysis indicate that Hsp70 and Sse1 interact 
mainly at the nucleotide binding domains, but the whole length of the Sse1 protein 
structure is required for complex formation (Shaner et al., 2004; Dragovic et al., 
2006). Polier et al. (2008) demonstrated the importance of Sse1 NEF activity by 
creating mutations at known Hsp70 binding sites. Mutants with severe reduction in 
NEF activity could not complement a sse1 sse2 deleted strain, while other mutants 
displayed temperature-sensitive phenotypes.  
              The main objective was to isolate a group of Sse1 mutants that are impaired 
in their ability to propagate [PSI
+
] prion. Once Sse1 mutants were identified they 
were characterised according to their effects on [PSI
+
]. This study helped in 
understanding the complexity of Sse1 and its role in prion propagation. It also 
revealed the importance of particular amino acid residues and how altering them can 
have negative effects on the function of Sse1. 
                        
   3.1 Strategy used to isolate sse1 mutants that impair [PSI
+
] 
propagation 
              The plasmid shuffle technique was used to isolate sse1 mutants (Figure 3.1). 
This strategy was previously used by Loovers et al. (2007) and Jones and Masison 
(2003) in isolating ssa1 mutants that affect [PSI
+
] propagation. The method, 
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described in section 2.16, involves mutating SSE1 plasmid DNA with hydroxylamine 
and screening for mutants in an appropriate sse1 sse2 strain. Impairment to [PSI
+
] 
propagation was measured subjectively, by the red/white colour assay, on medium 
with limiting adenine. The method for this measurement is described in section 2.13. 
The mutant [PSI
+
] phenotypes were subsequently confirmed by growth on medium 
lacking adenine and mating with a [psi
-
] strain. 
URA3
SSE1
sse1,2
ade2-1 
[PSI+]
LEU2SSE1*
LEU2
SSE1*
5-FOA 
selection
sse1,2 
ade2-1 
= hydroxylamine mutagenised
gene (library)
LEU2
5-FOA plate
SC-leucine
selection
Figure 3.1. Proposed plasmid shuffle strategy to isolate sse1 mutants that impair [PSI
+
] 
propagation. pRS315SSE1 was mutated with hydroxylamine and transformed into a 
sse1 sse2 strain. Medium containing 5-FOA selected for yeast with a LEU2 marker 
plasmid and those with URA3 plasmids were non-viable. sse1 mutants were selected on 
rich medium with limiting adenine on the basis of their [PSI
+
] colour phenotype. 
 120 
3.2 Creating sse1 sse2 yeast strain CM02 for isolation of sse1 
mutants     
               Laboratory haploid yeast strains MYS101 ( sse1, MATa) and MYS105 
( sse2, MAT ) were mated on appropriate SD medium (strain genotypes available in 
Table 2.1). A copy of plasmid pRS316SSE1 was transformed into the diploid strain. 
This enabled the selection of haploid sse1 sse2 cells after sporulation. The diploid 
cells were sporulated on minimal sporulation medium and random spore analysis was 
performed. Colonies were picked off and streaked onto SC - uracil medium (Figure 
3.2.a) and replicated onto 5-FOA medium to select against any cells expressing 
pRS316SSE1. The colonies that were non-viable without pRS316SSE1 were selected 
as potential sse1 sse2 haploid cells (Figure 3.2.b). Six potential sse1 sse2 strains 
were selected and their DNA isolated as described in section 2.11.1.  
               Diagnostic PCRs were performed using primers sse03, sse04, sse05, sse06, 
kan01 and kan02 (Table 2.12.a). The PCR cycles are described in Table 2.11. The 
PCR band sizes are annotated for the knockout constructs in Figure 3.3 for sse1 and 
in Figure 3.5 for sse2. Figures 3.4 and 3.6 illustrate the diagnostic PCRs ran on 0.8% 
agarose gels. They represent PCRs performed on one isolated DNA sample GP2. The 
diagnostic gels illustrate that isolate GP2 had DNA bands equal in size to the 
kanamycin resistance gene, when primers that anneal upstream and downstream of 
SSE1 and SSE2 were used. The sse1 and sse2 knockouts were confirmed by PCR 
using primers that anneal internally to the kanMX gene and externally to the 
SSE1/SSE2 gene. This strain was confirmed as haploid sse1 sse2 and designated 
CM02. 
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                                                       SC- uracil 
 
                                           
 
 
Figure 3.2.a. Growth of potential sse1 sse2 knockouts on SC - uracil. Random 
spore analysis results in haploid yeast cells with potential sse1 sse2 genotype. 
Colonies from random spore analysis were selected on SC - uracil medium, to 
maintain pRS316SSE1 plasmid, and incubated at 30
o
C for 2 days. 
 
 
 
 
                                               5-FOA 
 
                                           
                                      
 
Figure 3.2.b. Replication onto 5-FOA resulted in colony lethality. Colonies from SC 
- uracil plate in Figure 3.2.a were replicated onto 5-FOA to select against 
pRS316SSE1 plasmid. The plates were incubated at 30
o
C for 2 days and colonies 
failed to grow. All four colonies were potential sse1 sse2 knockouts.  
 
 
 
 
 
 122 
 
(1) Wild type 
 
                                  --------------------------------------------------------- 
  
 
                                       
 
 
 
(2) sse1 
                                                                  1943 bp 
                                     ------------------------------------------------------- 
 
                                       277 bp                                                       772 bp  
                                     ----------        ------------------- 
 
 
 
 
 
 
 
Figure 3.3. Illustration shows the expected wild type SSE1 and sse1 PCR fragment 
sizes. (1) SSE1 wild type DNA coding sequence is 2082 bp. Primers sse03R and 
sse04F are located upstream and downstream of the SSE1 coding sequence. PCR 
using these primers should result in a DNA band of approximately 2496 bp. (2) 
illustrates an sse1 knockout construct with kanMX gene replacing the coding 
sequence of SSE1. PCR using primers sse03R and sse04F should result in a band 
approximately 1943 bp in size. Internal kan01R and kan02F primers used with 
external sse03R and sse04F primers should result in two bands of 277 bp and 772 bp 
and confirms SSE1 is replaced with kanMX. 
 
 
 
 
 
 
 
 
 
 
 
5’   3’           SSE1  
sse04 sse03 2496 bp 
5’   3’ 
   sse04 
           kanMX  
sse03 
   kan01 
kan02    sse04 
sse03 
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             Kilobases       A             B            C            D           E 
                        
                          
                       
 
Figure 3.4. PCR confirmation of sse1 knockout in strain CM02 by agarose gel 
electrophoresis. PCR represents DNA from sample GP2. 
 
Lane A: 1kb molecular weight marker. 
Lane B: G600 genomic DNA amplified with primers sse03 and sse04 results in a 
2496 bp band for wild type SSE1. 
Lane C: GP2 genomic DNA amplified with primers sse03 and sse04 results in two 
DNA bands. The 2496 bp band is wild type SSE1 on pRS316 plasmid. The 1943 bp 
band is kanMX DNA replacing genomic SSE1. 
Lane D: GP2 genomic DNA amplified with primers kan01 and sse04. The 277 bp 
band represents the left flanking region of kanMX knockout construct. 
Lane E: GP2 genomic DNA amplified with primers kan02 and sse03. The 772 bp 
band represents the right flanking region of kanMX knockout construct. 
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(1) Wild type 
 
                                  --------------------------------------------------------- 
  
 
                                       
 
 
 
(2) sse2 
                                                                                1948 bp 
                                     ------------------------------------------------------- 
 
                                        293 bp                                                     861 bp  
                                     ----------        ------------------- 
 
 
 
 
 
 
 
Figure 3.5. Illustration shows the expected wild type SSE2 and sse2 PCR fragment 
sizes. (1) SSE2 wild type DNA coding sequence is 2082 bp. Primers sse05F and 
sse06R are located upstream and downstream of the SSE2 coding sequence. PCR 
using these primers should result in a DNA band of approximately 2519 bp. (2) 
illustrates an sse2 knockout construct with kanMX gene replacing the coding 
sequence of SSE2. PCR using primers sse05F and sse06R should result in a band 
approximately 1948 bp in size. Internal kan01R and kan02F primers used with 
external sse05F and sse06R primers should result in two bands of 293 bp and 861 bp 
and confirms SSE2 is replaced with kanMX. 
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                                          A              B            C            D            E 
         Kilobases 
                              
                             
 
Figure 3.6. PCR confirmation of sse2 knockout in strain CM02 by agarose gel 
electrophoresis. PCR represents DNA from sample GP2. 
 
Lane A: 1kb molecular weight marker. 
Lane B: G600 genomic DNA amplified with primers sseo5 and sse06 results in a 
2519 bp band for wild type SSE2. Band is very faint but is there. 
Lane C: GP2 genomic DNA amplified with primers sse05 and sse06 results in a 1948 
bp band which is kanMX DNA replacing genomic SSE2. 
Lane D: GP2 genomic DNA amplified with primers kan01 and sse05. The 293 bp 
band represents the left flanking region of kanMX knockout construct. 
Lane E: GP2 genomic DNA amplified with primers kan02 and sse06. The 861 bp 
band represents the right flanking region of kanMX knockout construct. 
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3.3 Isolating sse1 mutants with impaired [PSI
+
] propagation 
          An sse1 mutant library was created and transformed into CM02, along with 
positive and negative controls, as described in sections 2.15 and 2.16. Colonies that 
appeared dark pink or red on 5-FOA plates were selected as potential sse1 mutants 
impaired in [PSI
+
] propagation. From this primary screen eighty seven colonies were 
chosen (EP1-87). Subsequent plasmid isolation and transformation back into CM02 
resulted in 30 plasmids exhibiting a reproducible phenotype. An example of this is in 
Figure 3.7. 
 
 
3.4 Identifying amino acid changes in potential sse1 mutants 
            Twenty nine potential sse1 mutants were sent for sequencing after the 
secondary screen. SSE1 sequencing primers used are listed in Table 2.13. The DNA 
sequencing results were compared to wild type SSE1 DNA by BLAST analysis on 
NCBI. Seventeen SSE1 plasmids had single amino acid changes and six plasmids had 
two amino acid changes. One SSE1 plasmid came back having more than two 
mutations and five came back as wild type SSE1. Plasmids that were identified as WT 
SSE1 but appeared [psi
-
] may have mutations in the promoter or terminator sequence, 
but these plasmids were not analysed any further. The fact that some single mutations 
were isolated more than once suggests the screen was approaching saturation (Table 
3.1 and 3.2). Figure 3.8 illustrates the position of thirteen single amino acid change 
mutants on the linear structure of Sse1.          
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                           CM02 +  SSE1                                       CM02 + pRS315 
 
                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                           
 
 
 
                           CM02 +  EP56                                          CM02 +  EP57 
         
                                                
                                  
                            
 
 
Figure 3.7. 5-FOA selection of sse1 mutants in the secondary screen. Individual 
plasmids were isolated from selected colonies (EP1-87) in the primary screen and 
transformed back into CM02. Colony EP56 was picked in the first screen as [psi
-
] 
however it appears [PSI
+
] in the secondary screen. Colonies such as EP57 remained 
dark pink and were selected as potential [psi
-
] mutants. 
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Table 3.1. SSE1 plasmids isolated with single mutations. 
 
       
PLASMID NAME 
SSE1 
NUCLEOTIDE 
CHANGE 
 
AMINO ACID 
CHANGE 
 
TIMES 
ISOLATED 
             
             EP14 
EP25 
EP26 
EP33 
EP39 
EP42 
EP46 
EP49 
EP50 
EP51 
EP55 
EP59 
EP61 
EP62 
EP65 
EP68 
             EP77 
        
       1028. G – A 
1025. G – A 
1108. G – A 
706. G – A 
1319. C – T 
1372. C – T 
1094. C – T 
122. G – A 
122. G – A 
110. C – T 
1510. G – A 
149. G – A 
122. G – A 
149. G – A 
1660. G – A 
1847. G – A 
632. G - A 
           
           G343D 
G342D 
E370K 
D236N 
S440L 
Q458* 
T365I 
G41D 
G41D 
P37L 
E504K 
G50D 
G41D 
G50D 
E554K 
G616D 
           C211Y 
              
                1 
1 
1 
1 
1 
1 
1 
3 
3 
1 
1 
2 
3 
2 
1 
1 
    1 
 
This table illustrates their nucleotide change and corresponding amino acid change. 
Some mutants have appeared more than once indicating that the screen is approaching 
saturation. 
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  Table 3.2. SSE1 plasmids isolated with multiple mutations. 
                 
 
PLASMID NAME 
 
 
SSE1 
NUCLEOTIDE 
CHANGE 
 
 
AMINO ACID 
CHANGE 
 
TIMES 
ISOLATED 
 
EP3 
 
EP54 
 
EP60 
 
EP66 
 
EP67 
 
EP70 
 
EP72 
 
 
 
88. G – A 
1310. G – A 
 
 
149. G – A   
151. G – A 
 
 
1025. G – A 
1409. C – T 
 
 
       809. G – T  
      1024. G – C  
 
 
      1025. G – A   
      1411. G – A  
      1415. G – T  
 
       809. G – T  
      1024. G – C  
 
 
      1372. C – T  
      1707. C – G  
 
 
E30K  G437D 
 
 
 
G50D  E51K 
 
 
 
G342D P470L 
 
 
 
A270V G342R 
 
 
 
G342D E471K 
G472D 
 
 
A270V G342R 
 
 
Q458* D569E 
 
 
1 
 
 
 
1 
 
 
 
1 
 
 
 
2 
 
 
  
   1 
 
 
 
   2 
 
 
 
   1 
  
This table illustrates their nucleotide changes and corresponding amino acid changes. 
Some mutations from Table 3.1 appear in these isolates e.g. G50D, G342D and 
Q458*. It is difficult to determine which mutation is causing the [psi
-
] phenotype 
when there is more than one present. Mutants found in this table were not included in 
any subsequent work. 
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1                                                             385    396                        540                         657    693
NBD                                  L           SBD SBD E
P37L G41D  G50D   C211Y  D236N T365I    E370K
G342D
G343D
S440L                     E504K   E554K                         G616D
 
 
 
Figure 3.8. Thirteen single amino acid change mutants were identified in the screen. 
These mutants are located in various domains of Sse1. Sse1 is composed of a 
nucleotide binding domain (NBD), substrate binding domain (SBD), a linker (L) and 
a C-terminus extension (E). 
 
 
 
3.5 Phenotypic analysis of Sse1 mutants 
                 [PSI
+
] phenotypes were assessed in each Sse1 mutant by their colour on 
limiting adenine medium and ability to grow on medium lacking adenine (as 
described in section 2.13). In Figure 3.9 the varying [PSI
+
] phenotypes were observed 
after 2 days incubation at 30
o
C, followed by 2 days at room temperature. WT Sse1 
did appear [PSI
+
] but had small hints of pink. However, all mutants had a weaker 
[PSI
+
] phenotype than wild type as they were pink/red in colour. Mutants such as 
P37L and C211Y were pink on YPD so have some degree of [PSI
+
] present. 
However, mutants G342D, D236N and G616D were completely [psi
-
]. The position 
of the mutation and the specific amino acid change seems to have different effects on 
the ability of [PSI
+
] to propagate. 
               In Figure 3.10 wild type Sse1 grows well on SC - adenine. However all the 
mutants struggled to grow after two days incubation at 30
o
C. When mutants P37L, 
C211Y, G343D, and E504K were subsequently left at room temperature for 5 days 
they showed a small amount of growth. It was expected to see growth on SC – 
adenine for [PSI
+
] weak mutants such as P37L and C211Y as they may contain some 
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non-functional Sup35 that allows readthrough of ade2.1. To further test their [PSI
+
] 
phenotype the Sse1 mutants were mated with [psi
-
] G621 and mutants P37L, C211Y, 
G343D, E504K and E554K all had some [PSI
+
] present as the diploids demonstrated 
a white/pink colour (data not shown).  
      
                    SSE1                  P37L               G41D              G50D 
              
 
 
                     C211Y            D236N              G342D            G343D          
              
                     
                     
                    T365I            E370K             S440L             E504K 
              
 
 
                               E554K              G616D 
              
                                 
 
Figure 3.9. [PSI
+
] colour phenotype of Sse1 mutants on YPD. 10 l spots were 
placed onto YPD and incubated at 30
o
C for 2 days. This was followed by an 
additional 2 days at room temperature. 
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                  SSE1                  P37L                G41D                G50D 
             
 
              
                C211Y               D236N              G342D            G343D   
             
 
 
                T365I                E370K               S440L               E504K              
              
                  
                               
                             E554K                G616D 
                    
 
              
                                   
Figure 3.10. Growth of Sse1 mutants on medium lacking adenine. 10 l spots of each 
mutant was placed onto SC - adenine medium and incubated at 30
o
C for 2 days. WT 
Sse1 grew well however the mutants struggled to grow. The plates were left at room 
temperature for another 5 days and some growth was visible for mutants P37L, 
C211Y, G343D, E504K and E554K. 
 
 
 
 
               In order to further characterise the Sse1 mutants they were subjectively 
scored by their red/white colours. This method has been used by others (Jones and 
Masison 2003; Loovers et al., 2007) and involves assigning each mutant a colour 
score according to a weak or strong [PSI
+
] phenotype. All thirteen mutants were 
assessed in the presence of wild type SSE1 (pre-FOA) and their expression alone in 
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the cell (post-FOA). This also helped confirm whether any of the mutants had a 
dominant effect over wild type SSE1. [PSI
+
] (white) cells were scored as 0. Cells that 
were completely [psi
-
] (dark red) were scored as 10. Any colour between white and 
red was scored subjectively between 0 and 10. Table 3.3 summarises the results of 
this assessment. The sse1 mutants showed varying degrees of dominance as they all 
scored above 0 in pre-FOA analysis indicating that they have some ability to weaken 
[PSI
+
] propagation in the presence of WT SSE1. The mutants which scored as 7-9 in 
post-FOA analysis were also considered [psi
-
] as there were variations in the degree 
of shading. 
 
 
3.6 Analysis of the effects of Sse1 mutants on [URE3] propagation 
             [URE3] is another well characterised yeast prion. It is the amyloid form of 
the Ure2 protein. Ure2 plays a role in regulating nitrogen metabolism (Lian et al., 
2006). Like [PSI
+
], the propagation of [URE3] is highly dependent on molecular 
chaperones. Recently, it was discovered that both over-expression and deletion of 
SSE1 disrupts [URE3] propagation (Kryndushkin and Wickner, 2007). 
               In order to investigate whether the sse1 mutants could alter the propagation 
of [URE3] the yeast strain SB34 (Bach et al., 2003) was transformed with each 
mutant, WT Sse1 and a negative control. At least 100 colonies were scored for each 
mutant as being white, red or sectored (Figure 3.11.a/b.). SB34 contains wild type 
Sse1 and Sse2 so any changes to [URE3] propagation came from a dominant effect 
exerted by the mutant (Loovers et al., 2007).  
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Table 3.3.  Colour score for Sse1 mutants, according to their [PSI
+
] phenotype. 
 
 
Assessment was carried out of mutants both in the presence of WT SSE1 (pre-FOA) 
and mutants alone (post-FOA). Mutants G342D, E370K and G616D were scored as 
completely [psi
-
]. Although WT Sse1 has shadings of pink it was assigned a 0 for 
comparative purposes. 
 
Scale:   0 = white ([PSI
+
])   
             10 = dark red ([psi
-
]) 
 
 
 
SSE1 mutation 
 
Times isolated 
 
Colour pre-FOA 
 
Colour post-FOA 
 
None 
 
- 
 
0 
 
0 
P37L 1 3 5 
G41D 3 4 8 
G50D 3 5 8 
C211Y 1 4 5 
D236N 1 6 10 
G342D 3 4 10 
G343D 1 4 6 
T365I 1 4 7 
E370K 1 3 9 
S440L 1 3 10 
E504K 1 3 6 
E554K 2 3 5 
G616D 1 3 10 
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                             (i) pRS315 
 
                              
                            
 
 
                              (ii) pRS315SSE1 
  
                              
                             
                              
 
Figure 3.11.a. SB34 transformed with (i) pRS315 and (ii) pRS315SSE1. 
Transformants were selected on SC - leucine medium and incubated for 2 days at 
30
o
C. Each transformation was done in triplicate. The colonies were counted and 
scored as red, white or sectored. The presence of an extra copy of SSE1 (ii) greatly 
inhibits [URE3] propagation compared to (i) SB34 with an empty vector.  
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                            (i) pRS315SSE1 
                          
 
 
 
 
 
 
 
 
 
        
                               
 
                       (ii) pRS315SSE1E370K 
                            
                           
                        (iii) pRS315SSE1G616D 
                            
                               
 
Figure 3.11.b. SB34 transformed with (i) pRS315SSE1 (ii) pRS315SSE1
E370K
 and 
(iii) pRS315SSE1
G616D
. Transformants were selected on SC - leucine medium and 
incubated at 30
o
C for 2 days. Each transformation was repeated in triplicate. The 
colonies were counted and scored as red, white or sectored. Wild type SSE1 over-
expression inhibits [URE3] propagation greater than any of the mutants. The 
experiment was repeated for all thirteen mutants. 
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               It was hypothesised that if the Sse1 mutants were fully functional, they 
would disrupt [URE3] propagation in a similar manner to wild type Sse1. However, 
in contrast to wild type Sse1 the mutants had no major effect on [URE3] stability 
(Table 3.4.). The Sse1 mutants with the least effect on [URE3] propagation were 
G41D, D236N and G342D. The Sse1 mutants were demonstrating a dominant 
negative expression over WT Sse1. They showed phenotypes similar to SB34 
transformed with an empty vector control. [URE3] propagation is more unstable than 
[PSI
+
] and wild type colonies tend to spontaneously lose [URE3] at a greater 
frequency.  
               
3.7 Can over-expression of the protein Fes1 compensate for loss of 
Sse1 function in sse1 sse2 cells or sse1 mutants? 
             Fes1 is a yeast cytosolic protein that shares functional similarity with Sse1. 
Fes1 was first characterised by Kabani et al. (2002). They discovered that Fes1 
associates with the ADP-bound form of Ssa1 protein and promotes nucleotide release. 
Like Sse1, deletion of Fes1 weakens [PSI
+
] propagation and the over-expression of 
Fes1 promotes [PSI
+
] (Jones et al., 2004). Fes1 may also play a role in cellular 
thermostability as fes1 results in cells that are sensitive to high temperatures (Kabani 
et al., 2002). However differences do exist between these two nucleotide exchange 
factors (NEFs). In a genome-wide screen, Sse1 was found associated with many 
Hsp70-Hsp90-substrate complexes whereas Fes1 was notably absent (Zhao et al., 
2005). Sse1 is more potent than Fes1 as a NEF as Sse1 accelerates ADP release from 
Ssa1 by 81 fold compared to only 8 fold by Fes1 (Raviol et al., 2006b; Sadlish et al., 
2008). Since Fes1 and Sse1 share some functional characteristics it was aimed to see 
what influence Fes1 would have on growth and [PSI
+
] propagation in the Sse1 strains. 
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Table 3.4.  The relative effects of sse1 mutants on [URE3] propagation. 
 
 
       MUTATION 
 
    % WHITE  
    COLONIES     
 
      % RED    
   COLONIES 
 
% SECTORED
a
 
    
 WT 
EMPTY VECTOR 
P37L 
G41D 
G50D 
C211Y 
D236N 
G342D 
G343D 
T365I 
E370K 
S440L 
E504K 
E554K 
G616D 
 
48 
96 
90 
96 
94 
92 
98 
95 
84 
84 
94 
87 
87 
86 
83 
 
 
           13 
2 
3 
1 
4 
3 
1 
2 
7 
           11 
2 
5 
4 
4 
4 
 
           39 
2 
7 
3 
2 
5 
1 
3 
9 
5 
4 
8 
9 
           10 
           13 
 
At least 100 colonies were counted and scored as red, white or sectored* for each 
mutant.  
a
 Sectored colonies are colonies loosing [URE3] at various stages of development. 
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3.7.1 Fes1 overproduction cannot recover the sse1 sse2 non-viable phenotype 
in CM02 
             The deletion of both sse1 and sse2 renders cells non-viable and it is the loss 
of NEF activity responsible for this phenotype (Shaner et al., 2006; Polier et al., 
2008). There is conflicting evidence as to whether Fes1 overproduction can 
compensate for the loss of both sse1 and sse2 (Raviol et al., 2006b; Sadlish et al., 
2008). Raviol et al. (2006b) concluded that Fes1 only provides ‘partial recovery’ for 
sse1 sse2 cells, while Sadlish et al. (2008) found that incorporating an extra copy 
of FES1 into the cell completely restores cell viability. This hypothesis was tested and 
resulted in no growth in strain CM02 sse1 sse2 transformed with plasmid 
pRS423FES1 (Figure 3.12). Fes1 complementation is analysed further in Chapter 4 
where it is over-expressed in a BY4741 background. 
 
 
                            (a) pRS423                                         (b) pRS423FES1 
 
                             
 
                                                  
Figure 3.12. Analysis of sse1 sse2 growth recovery when FES1 is over-expressed. 
Strain CM02 was transformed with (a) pRS423 and (b) pRS423FES1. The cells were 
selected on 5-FOA, to remove WT SSE1, and incubated at 30
o
C for 2 days. (b) Over-
expression of Fes1 does not recover a sse1 sse2 lethal phenotype in CM02. 
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3.7.2 Assessment of the effects of Fes1 over-expression on Sse1 mutant [PSI
+
] 
phenotypes 
            It is unclear how the Sse1 mutants isolated in this screen are affecting [PSI+] 
propagation. There is a possibility that some impair Sse1 NEF activity. Studies by 
Jones et al. (2004) showed that an Ssa1-21 mutant strain propagated [PSI
+
] better 
when Fes1 protein was overproduced. The aim of this section was to investigate 
whether Fes1 could improve [PSI
+
] in any of the Sse1 mutant strains.  
              CM02 was transformed with both pRS423 and pRS423FES1 high copy 
plasmids, and selected on SC - histidine medium. Both strains were then transformed 
with WT SSE1 and each of the thirteen sse1 mutants and selected on SC - leucine - 
histidine medium. The cells were replicated onto 5-FOA to select against 
pRS316SSE1. Figure 3.13.a/b illustrates the phenotypic results of this test. The only 
Sse1 mutant with an improved [PSI
+
] phenotype was G616D, as assessed by colour. 
There is a possibility that this mutant could disrupt Sse1 NEF activity, a function 
shared by both Sse1 and Fes1. The overall [PSI
+
] phenotype of all the mutants 
appeared stronger in this experiment compared to in Figure 3.9.  
              Each strain was also grown on medium lacking adenine to determine if 
[PSI
+
] was present (Figure 3.14). Sse1 mutant G616D showed only slight improved 
growth in the presence of pRS423FES1 and some mutants seemed to grow better in 
the presence of control plasmid pRS423. The overall growth of the mutants on 
medium lacking adenine seemed greater than those observed in Figure 3.10.  
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                                   SSE1              P37L             G41D            G50D 
                          
                         
                                   SSE1              P37L             G41D            G50D 
                         
                                     
 
 
                                           
                                C211Y          D236N           G342D          G343D                            
                         
 
 
                                 C211Y           D236N             G342D          G343D                            
                         
                                  
 
 
Figure 3.13.a. Analysis of sse1 mutant [PSI
+
] phenotypes when FES1 is over-
expressed. CM02 was first transformed with pRS423 and pRS423FES1 followed by 
transformation of sse1 mutants. Transformants were selected on SC - leucine - 
histidine medium and selected on 5-FOA to remove WT SSE1. 10 l spots of each 
strain was placed onto YPD followed by 2 days incubation at 30
o
C and 2 days at 
room temperature.  
                                  
 
 
 
 
 
pRS423FES1 
 
 
 
 
 
 
 
 
pRS423 
pRS423FES1 
 
 
 
 
 
 
 
 
pRS423 
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                                T365I           E370K            S440L              E504K 
                         
                                  
 
                                 T365I            E370K            S440L            E504K                                  
                         
                                  
  
 
 
                        
 
                                E554K              G616D 
                          
                                 
 
                                 E554K              G616D 
                          
                                 
 
Figure 3.13.b. Analysis of sse1 mutant [PSI
+
] phenotypes when FES1 is over-
expressed. CM02 was first transformed with pRS423 and pRS423FES1 followed by 
transformation of sse1 mutants. Transformants were selected on SC - leucine - 
histidine medium and selected on 5-FOA to remove WT SSE1. 10 l spots of each 
strain was placed onto YPD followed by 2 days incubation at 30
o
C and 2 days at 
room temperature. Mutant G616D shows an improved [PSI
+
] status in the presence of 
pRS423FES1. 
 
 
 
                
pRS423FES1 
 
 
 
 
 
 
 
pRS423 
pRS423FES1 
 
 
 
 
 
 
 
pRS423 
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                  SSE1          P37L           G41D      G50D        C211Y      D236N 
               
 
               
                      
         
 
            
                 G342D     G343D      T365I          E370K          S440L      E504K 
                
 
                
                 
 
 
                 
                 E554K        G616D 
                
 
                
                    
 
Figure 3.14. Analysis of sse1 mutant growth on SC - adenine medium when FES1 is 
over-expressed. Strains from Figure 3.13 were spotted (in 10 l dH2O) onto SC - 
adenine - histidine and incubated at 30
o
C for 2 days. There was no great improvement 
in mutant [PSI
+
] phenotypes in the presence of pRS423FES1. Slight improvement 
was seen for G343D and G616D. 
 
 
pRS423FES1 
 
 
 
 
pRS423 
pRS423FES1 
 
 
 
 
pRS423 
pRS423FES1 
 
 
 
 
pRS423 
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3.8 Can a human Sse1 homolog complement deletion in a yeast 
strain? 
 
               The human genome contains four Hsp110 stress responsive genes 
designated HSPH1 (Hsp110), HSPH2 (APG-2), HSPH3 (APG-1) and HSPH4 
(Grp170) (Vos et al., 2008; Kampinga et al., 2009). Mammalian HSPH1 and yeast 
Sse1 share general structural similarity and are both divergent members of the Hsp70 
superfamily (Easton et al., 2000; Raviol et al., 2006a). 
              HSPH1, also known as Hsp110, has nucleotide exchange factor (NEF) 
function for mammalian Hsp70 and it is distantly related to yeast Sse1. NEF activity 
seems to be a conserved function amongst all Hsp110 homologs (Dragovic et al., 
2006). 
                   Studies by Oh et al. (1997) showed that the over-expression of mammalian 
Hsp110 in mammalian cell lines provided significant protection from heat stress. 
Hsp110 may also function as a protein disaggregase in mammals either by directly 
interacting with aggregates or indirectly through Hsp70 activity (Yamagishi et al., 
2003). In vitro studies have shown that Hsp110 is very efficient at recognising and 
maintaining heat denatured proteins such as luciferase and presenting them to Hsp70 
(Oh et al., 1997; Oh et al., 1999). This is why mammalian and yeast Hsp110 are often 
referred to as ‘holdases’ (Shaner et al., 2005). 
                   Hsp110 is quite a heterogenous family of proteins since mammalian Hsp110 
cannot compensate for Sse1 function in vivo (Shaner et al., 2004). Since HSPH1 and 
Sse1 share functional similarities it was aimed to see whether HSPH1 could 
compensate for loss of Sse1 and Sse2 in yeast strain CM02. 
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3.8.1 Cloning human HSPH1 into vector pC210  
              HSPH1 (Hsp110) cDNA was purchased from ORIGENE and the coding 
sequence was amplified by PCR using primers HSPH1F/R listed in Table 2.12.b and 
PCR cycle 2 in Table 2.11. The PCR product was cloned into vector pC210, under the 
SSA2 promoter, as described in section 2.23. Four potential clones were isolated for 
further analysis. A diagnostic digest using restriction enzyme Nde1 confirmed that 
one isolate was pC210HSPH1 (Figure 3.15). The plasmid DNA was sent for sequence 
analysis to further verify that HSPH1 was successfully cloned. Figure 3.16 illustrates 
the protein sequence similarities between yeast Sse1 and mammalian HSPH1 and 
Figure 3.17 illustrates the plasmid construct of pC210HSPH1.  
 
 
3.8.2 Complementing CM02 sse1 sse2 with pC210HSPH1 
             HSPH1 did not complement sse1 sse2 in CM02 (Figure 3.18). This result 
concurs with Shaner et al. (2004) who stated that the mammalian Hsp110 isoform 
HSPH1 can not complement the deletion of both sse1 and sse2 in yeast. It can be 
speculated as to why it did not complement the loss of yeast Hsp110. Perhaps it can 
not provide yeast with essential Sse1 functions or HSPH1 may be too divergent to 
function in a yeast system. In Chapter 4 this plasmid construct is tested in a different 
strain background.  
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                                         Nde1                                                Nde1    Nde1 
 
 
pC210                                                                                                                                               pC210 
                                                       ----------------------------------------- 
                                                               1957 bp                               
                                                                                              -------- 
 <<-------------------------------                                                105 bp 
 
 
                         
 
                                            A             B             C           D            E 
  kilobases 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15.  Diagnostic restriction digests of potential pC210-HSPH1 constructs. 
 
(i) pC210-HSPH1 construct with expected base pair sizes after restriction digest with 
Nde1. Nde1 cuts HSPH1 internally twice at position 1956 and 2061. Nde1 also cuts 
plasmid pC210 at end of the promoter region. These three cuts should result in three 
bands at 7233 bp, 1957 bp and 105 bp. 
 
(ii) Agarose gel shows diagnostic restriction digest of four potential HSPH1 clones. 
Lane A: 1kb molecular weight marker. 
Lane B-D: Potential clones 1-3 were digested with Nde1. Gel electrophoresis shows 
DNA bands that do not correspond to a HSPH1 clone. 
Lane E: Three DNA bands were visible for clone 4 that equate to the expected sizes. 
The extra band visible at approximately 2500 bp is unknown, it is possibly un-ligated 
vector. Clone 4 was sent for sequencing and confirmed that HSPH1 was cloned in.  
  
 10.0 - 
 
 
  3.0 - 
 
  2.0 - 
 
  
   
  1.0 - 
 
 
   
  0.5 - 
 
 
7233 bp 
1957 bp 
105 bp 
SSA2 
PROMOTER 
 
HSPH1 (2577 bp) 
(i) pC210-HSPH1 construct digested with Nde1 enzyme 
(ii) Agarose gel electrophoresis of digested vectors 
Rest of plasmid = 7233 bp 
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     1   MSTPFGLDLGNNNSVLAVARNRGIDIVVNEVSNRSTPSVVGFGPKNRYLG   
         ||. .|||:|:.:..:||||..||:.:.||.|:|.||||:.||.|||.:| 
     1   MSV-VGLDVGSQSCYIAVARAGGIETIANEFSDRCTPSVISFGSKNRTIG   
 
 
     51  ETGKNKQTSNIKNTVANLKRIIGLDYHHPDFEQESKHFTSKLVELDDKKT  
         ...||:|.::..|||:|.||..|..::.|..::|.::.:..||.|.:... 
     50  VAAKNQQITHANNTVSNFKRFHGRAFNDPFIQKEKENLSYDLVPLKNGGV   
 
 
     101 GAEVRFAGEKHVFSATQLAAMFIDKVKDTVKQDTKANITDVCIAVPPWYT  
         |.:|.:.||:|:||..|:.||.:.|:|:|.:...|..:||..|:||.::| 
     100 GIKVMYMGEEHLFSVEQITAMLLTKLKETAENSLKKPVTDCVISVPSFFT  
 
 
     151 EEQRYNIADAARIAGLNPVRIVNDVTAAGVSYGIFKTDLPEGEEKPRIVA  
         :.:|.::.|||:|.|||.:|::||:||..::|||:|.|||..:||||||. 
     150 DAERRSVLDAAQIVGLNCLRLMNDMTAVALNYGIYKQDLPSLDEKPRIVV  
 
 
     201 FVDIGHSSYTCSIMAFKKGQLKVLGTACDKHFGGRDFDLAITEHFADEFK  
         |||:|||::..|..||.||:|||||||.|...||::||..:.|||..||| 
     200 FVDMGHSAFQVSACAFNKGKLKVLGTAFDPFLGGKNFDEKLVEHFCAEFK  
 
 
     251 TKYKIDIRENPKAYNRILTAAEKLKKVLSAN-TNAPFSVESVMNDVDVSS  
         ||||:|.:...:|..|:....|||||::|:| |:.|.::|..|||.|||. 
     250 TKYKLDAKSKIRALLRLYQECEKLKKLMSSNSTDLPLNIECFMNDKDVSG  
 
 
     300 QLSREELEELVKPLLERVTEPVTKALAQAKLSAEEVDFVEIIGGTTRIPT  
         :::|.:.|||...||:::..|:...|.|..|..|:|..|||:||.||||. 
     300 KMNRSQFEELCAELLQKIEVPLYSLLEQTHLKVEDVSAVEIVGGATRIPA  
 
 
     350 LKQSISEAFGKPLSTTLNQDEAIAKGAAFICAIHSPTLRVRPFKFEDIHP  
         :|:.|::.|||.:|||||.|||:|:|.|..|||.||..:||.|...|..| 
     350 VKERIAKFFGKDISTTLNADEAVARGCALQCAILSPAFKVREFSVTDAVP  
 
 
     400 YSVSYSWDKQVEDEDHM-EVFPAGSSFPSTKLITLNRTGDFSMAASYTDI  
         :.:|..|:...||.:.: |||....:.|.:|::|..|.|.|.:.|.|:|. 
     400 FPISLIWNHDSEDTEGVHEVFSRNHAAPFSKVLTFLRRGPFELEAFYSDP  
 
 
     449 TQLPPNTPE-QIANWEITGVQLPEGQDSVPVKLKLRCDPSGLHTIEEAYT  
         ..:|  .|| :|..:.:..|...:..:...||:|:|.:..|:.||..|.. 
     450 QGVP--YPEAKIGRFVVQNVSAQKDGEKSRVKVKVRVNTHGIFTISTASM  
 
 
     498 IEDIEVEE------------------------------------------  
         :|.:..||  
     498 VEKVPTEENEMSSEADMECLNQRPPENPDTDKNVQQDNSEAGTQPQVQTD  
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     506 -------PIPLPE---------DAPE------DAEQEFKKVTKTVKKDDL  
                | |.||         ||.:      |...|.||....|...:| 
     548 AQQTSQSP-PSPELTSEENKIPDADKANEKKVDQPPEAKKPKIKVVNVEL  
 
   
     534 TIVAH-TFGLDAKKLNELIEKENEMLAQDKLVAETEDRKNTLEEYIYTLR  
         .|.|: .:.|....||..||.|.:|:.||||..|..|.||.:|||:|..| 
     597 PIEANLVWQLGKDLLNMYIETEGKMIMQDKLEKERNDAKNAVEEYVYEFR  
 
 
     583 GKLEEEYAPFASDAEKTKLQGMLNKAEEWLYDEGFDSIKAKYIAKYEELA  
         .||...|..|..:.:......:|.:.|:|||:||.|..|..|:.|.|||. 
     647 DKLCGPYEKFICEQDHQNFLRLLTETEDWLYEEGEDQAKQAYVDKLEELM  
 
 
     633 SLGNIIRGRYLAKEEEKKQAIRSKQEASQMAAMAEKLAAQRKAEAEK---  
         .:|..::.|:...||..|.. :|..|......|:||..:.:.||    
     697 KIGTPVKVRFQEAEERPKMF----EELGQRLQHYAKIAADFRNKDEKYNH  
 
 
     680 --KEEKKDTEGDVD--MD--------------------------------  
           :.|.|..|..|:  |:     
     743 IDESEMKKVEKSVNEVMEWMNNVMNAQAKKSLDQDPVVRAQEIKTKIKEL  
 
    
     693 --------------------------------------------------  
      
     793 NNTCEPVVTQPKPKIESPKLERTPNGPNIDKKEEDLEDKNNFGAEPPHQN  
 
 
     693 ---------------- 693 
 
     843 GECYPNEKNSVNMDLD 858 
 
 
 
 = conserved 
          . .      = similar 
           .       = dissimilar 
 
 
 
Figure 3.16. Protein alignment of Sse1 with HSPH1. Sse1 is the top sequence. The 
proteins are approximately 33% identical and 48% similar. The most highly 
conserved regions are in the ATPase domain. Nine out of the thirteen Sse1p residues 
identified as being important in prion propagation are conserved (mutant residues are 
in red). 
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Figure 3.17. Construct of plasmid pC210 with cloned HSPH1. 
 
 
 
  
 
 
           
 
Figure 3.18. HSPH1 does not restore viability in CM02 sse1 sse2. CM02 was 
transformed with pC210HSPH1, pRS315 and pRS315SSE1 and selected on SC - 
leucine plates. Transformants were replicated onto 5- FOA and incubated at 30
o
C for 
2 days. 
pRS315SSE1 
pRS315 
pC210HSPH1 
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3.9 Analysis of Sse1 mutant growth and rate of cell division 
            Hsp110 chaperones play a major role in cellular physiology. Deletion of 
Sse1 renders cells slow-growing (Shaner et al., 2006) and Sse1 is also involved in cell 
wall integrity signaling (Shaner et al., 2008). The aim in this section was to see 
whether any of the Sse1 mutants influence the rate of cell division at 30
o
C. Cell 
doubling times were determined from growth curves which were carried out as 
described in section 2.7. Growth curves were repeated in triplicate. Generation Time 
(GT) is the amount of time it takes the parent yeast cell to replicate. Cell GT for each 
mutant was worked out as a percentage of wild type Sse1 GT (Table 3.5). The results 
from this experiment indicated that there were no major alterations in the rate of cell 
division for any of the strains carrying a mutant Sse1. Mutants D236N, G342D, 
E504K and G616D had the slowest generation time when compared to wild type 
Sse1. 
 
3.10 Western blot analysis of chaperone protein abundance 
              Mutations to sse1 may have an effect on the production of subsequent Sse1 
protein or on other chaperone protein levels. [PSI+] propagation can be influenced by 
the expression levels of molecular chaperones (Chernoff et al., 1995; Kushnirov et 
al., 2000).  
              Western blot analysis was performed to assess chaperone levels in yeast that 
harboured mutant alleles of sse1. Each of the thirteen mutants represented the sole 
Sse1 protein in the cell. 10 g of each protein was loaded onto a polyacrylamide gel 
as described in section 2.24.3. The Sse1 mutants were probed with antibodies for 
Hsp110, Hsp104 and Hsp70. There was no considerable difference in the abundance 
of Hsp110, Hsp70 or Hsp104. This suggests that the effects of Sse1 mutants on [PSI
+
] 
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propagation are not due to alterations in cellular chaperone levels. Figure 3.19 
represents a Western blot with some alterations in the amount of protein. This 
Western blot was repeated on at least two more occasions and protein levels were 
consistent for all the Sse1 mutants. 
          
 
                        Table 3.5. Generation Time (GT) of Sse1 mutants. 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Generation times are represented as a percentage of wild type Sse1 GT. WT Sse1 had 
an average GT of 125 minutes. Some mutants were slightly faster at replicating than 
WT Sse1 i.e P37L, C211Y and S440L. The mutants with the slowest GT were 
G342D, E504K and G616D. 
 
                   
 
SSE1 
 
Generation Time 
(minutes) 
 
WT 
 
P37L 
 
G41D 
 
G50D 
 
C211Y 
 
D236N 
 
G342D 
 
G343D 
 
T365I 
 
E370K 
 
S440L 
 
E504K 
 
E554K 
 
G616D 
 
 
                 100 
 
                   96 
                 
                 100 
                 101 
                   93 
                 110 
                 114 
                 104 
                 104 
 
                 107 
 
                   97 
 
                 118 
 
                 101 
 
                 113 
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                    WT      P37L    G41D    G50D   C211Y   D236N   G342D   G343D  T365I  E370K  S440L  E504K  E554K  G616D 
 
KDa   
          
                
          (i) Hsp110                     
             
            
   
            (ii) Hsp104 
                            
 
            (iii) Hsp70 
  (iii) 
 
                          
               (iv) Coomassie blue 
                
 
 
 
 
 
            (v) Amido black 
    
 
 
Figure 3.19. Protein abundance of (i) Hsp110 (ii) Hsp104 and (iii) Hsp70. Western 
blot shows chaperone levels in yeast with Sse1 mutations as indicated. 10 g of 
protein from each mutant was loaded onto four gels. Three gels were probed with 
Hsp110, Hsp70 and Hsp104 antibodies and (iv) the fourth gel was stained with 
coomassie to show equal loading of samples. (v) Each blot was stained with amido 
black to show equal protein transfer. This Western blot reveals small chaperone 
alterations in Hsp70 for mutant G616D and Hsp110 for S440L/E504K. However this 
Western blot was repeated twice which confirmed that there were no changes to 
chaperone abundance.  
 
 
175 – 
 
  
  80 –  
 
175 – 
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3.11 Molecular modeling of Sse1 mutants 
              The crystal structure of Sse1 was determined by Liu and Hendrickson 
(2007). They hypothesised that although Hsp70 and Hsp110 are functionally 
divergent, Sse1 may retain some structural vestiges of Hsp70. The general structural 
organisation of Sse1 does reflect that of Hsp70, consisting of an N-terminal 
nucleotide binding domain (NBD), a sandwhich domain (SBD- ) and a three 
helical bundle domain (3HBD or SBD- ) in the C-terminus (Polier et al., 2008). Sse1 
is larger than Hsp70 due to insertions in its substrate binding domain (SBD) and C-
terminus extensions (Easton et al., 2000; Liu and Hendrickson, 2007). Sse1 interacts 
with Hsp70 (Yam et al., 2005; Shaner et al., 2005). The Hsp70 NBD co-elutes with 
the Sse1 protein in the presence of ATP (Andreasson et al., 2008). This binding 
characteristic is essential for Sse1 nucleotide exchange factor function. Sse1 crystal 
structure analysis and mutational analysis revealed that the NBD of Hsp70 embraces 
the NBD and 3HBD of Sse1. This leads to the opening of the Hsp70 binding cleft and 
subsequent nucleotide release. Almost the entire length of Sse1 is required for 
Sse1:Hsp70 complex formation (Shaner et al., 2004; Dragovic et al., 2006; Polier et 
al., 2008). 
               All thirteen Sse1 mutants have been modeled onto the Sse1 3D structure. 
The predicted structural implications of these amino acid changes on Sse1 have been 
examined. This analysis determined that certain mutants may be located at important 
Hsp70 interaction points and at sites of Sse1 interdomain communication. Other 
mutants had no obvious structural or functional implications. Gemma Kinsella from 
the Membrane Protein Lab in NUIM performed the molecular modeling of the Sse1 
mutants. 
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3.11.1 The locations of the Sse1 mutants mapped onto the 3D crystal structure 
              The Sse1 mutants are dispersed across the structure of the Sse1 protein 
(Figure 3.20). Nine mutants are located in the NBD, three in the SBD-  and two in 
the SBD- . In Figure 3.21 each Sse1 protein domain is highlighted and Hsp70 is 
bound to the NBD and 3HBD of Sse1.  
                The binding interface of Sse1:Hsp70 is mainly composed of hydrogen 
bonded water molecules that interact with both proteins. The most potent interaction 
is between the 3HBD of Sse1 and the helix9 of Hsp70 NBD (Polier et al., 2008). 
The extension region of Sse1 has not been fully crystalised. A 2D prediction of the 
extension region was performed using Jnet (Cuff and Barton, 2000) and it was 
predicted as being largely -helical. 
 
3.11.2 Possible structural implications of Sse1 mutants 
             The movement of proteins or ‘protein dynamics’ is important for protein 
function. Single amino acid substitutions can affect the dynamics of a protein (Wales 
and Engen, 2006). Possible structural changes caused by the mutations were analysed 
using MOE-Homology. MOE-Homology creates full-atom, energy-minimised 3D 
models of amino acid sequences. The underlying methodology is based on a 
combination of the segment-matching procedure of Levitt (1992) and an approach on 
the modeling of indels based on that of Fechteler et al. (1995). All thirteen mutants 
were analysed using this method but the figures only illustrate the results for five 
mutants (Figure 3.22.a-f).               
               Mutations can cause alterations to a protein by disrupting intramolecular 
interactions. Mutants can lose intramolecular bonds and interactions formed normally 
in wild type Sse1. Mutations can also disrupt amino acid polarity, charge and 
 155 
hydrophobicity, which may ultimately lead to a loss of function. A summary of all the 
possible structural and interaction changes in each mutant is in Table 3.6. 
 
 
 
 
 
Figure 3.20. Sse1 crystal structure with mutant locations marked in pink and ATP in 
purple. 
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Figure 3.21. Sse1 crystal structure in complex with Hsp70. NBD is in blue, SBD-  in 
brown and 3HBD in green. Hsp70 (orange) physically interacts with the NBD and 
3HBD of Sse1. 
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                        (i) G41 
                                 
                                
                         (ii) D41  
              
                                  
Figure 3.22.a. Amino acid alterations to Sse1 residue 41, from (i) glycine (G) to (ii) 
aspartic acid (D). This residue is on a -strand in the NBD of Sse1. Change from a 
G41 to D41 makes a non-polar neutral residue polar acidic and it also introduces a 
new hydrogen bond with T64. This mutation could affect -strand packing and 
perhaps affect a nearby helix that is involved in the Hp110:Hsp70 interface (A47). 
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                        (i) G50 
 
 
              
                 
                       
                     
                
                                
                                  
   
 
                                               
                            
                           
                                                       
                           
                        (ii) D50 
                     
Figure 3.22.b. Amino acid alterations to Sse1 residue 50, from (i) glycine (G) to (ii) 
aspartic acid (D). This residue is at the start of a -helix in the NBD of Sse1. Change 
from G50 to D50 makes a non-polar neutral residue polar acidic. D50 hydrogen 
bonds (HBs) with Sse1 K54 and forms water mediated interactions with T36 and 
T129. G50 HBs with V39. This mutation could affect -strand packing and perhaps 
affect a nearby helix that is involved in the Hp110:Hsp70 interface. 
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                       (i) D236 
 
 
             
 
 
 
 
 
 
 
 
 
 
 
 
                            
                          
                        (ii) N236 
                    
                             
Figure 3.22.c. Amino acid alterations to Sse1 residue 236, from (i) aspartic acid (D) 
to (ii) asparagine (N). Change from D236 to N236 makes a polar acidic residue polar 
uncharged. (i) D236 forms water-mediated reactions with R235 and S207, Sse1 
residues which interact with ATP. (ii) Mutation N236 loses interaction with S207 and 
forms HBs with K86 and A240. 
 160 
                            
                                                                       
 
 
 
 
 
 
 
Figure 3.22.d. Schematic 2D diagram of Sse1 ATP binding pocket. Residues G342 
and G343 are located in this binding cleft. A single mutation to a residue in the ATP 
binding pocket can affect its function and the orientation of other amino acids 
important for binding (MOE Chemical Computing Group, 2008). 
 
ATP 
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Figure 3.22.e. Schematic 2D diagram of Sse1 ATP binding pocket with residue G342 
(glycine) changed to D342 (aspartic acid). In this mutation a non-polar neutral residue 
becomes polar acidic. G342 and D342 both HB with T345 and Q368 in Sse1. 
However D342 forms a water-mediated Mg bond. This mutation is likely to affect 
ATP binding. 
 
 
 
ATP 
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Figure 3.22.f. Schematic 2D diagram of Sse1 ATP binding pocket with residue G343 
(glycine) changed to D343 (aspartic acid). In this mutation a non-polar neutral residue 
becomes polar acidic. G343 interacts with ATP but forms no other HBs. D343 HBs 
with T344 and R346 in Sse1. D343 also forms a water-mediated interaction to ATP 
instead of a hydrogen bond seen in G343. This mutation is likely to affect ATP 
binding. 
 
ATP 
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Table 3.6. Summary of Sse1 mutants structural effects on the Sse1 3D model.    
         
                                                                                                                     LIKELY 
   MUTATION                   AMINO ACID AND                                STRUCTURAL 
                                      INTERACTION CHANGES                            EFFECTS 
 
P37L 
 
 
G41D 
 
 
G50D 
 
 
 
C211Y 
 
 
D236N 
 
 
 
G342D 
 
 
 
G343D 
 
 
T365I 
 
 
E370K 
 
 
 
S440L 
 
 
E504K 
 
 
E554K 
 
 
G616D 
 
 
 
 
                                        
 
  Both WT and mutant non-polar hydrophobic.           Unclear. May disrupt ATP binding 
                                                                                   through different amino acid residue.                                 
 
  Non-polar neutral to polar acidic.                              May impact Hsp70 binding site or 
  HB with T64 introduced.                                           -strand packing                                                                                                                                                                                                                                                                      
 
  Non-polar neutral to polar acidic. HBs &                  Unclear. May impact Hsp70:Hsp110 
  water mediated bonds with K54, T36                        interface by disrupting a different                                                                                                                                                                       
  and T129 introduced.                                                 amino acid residue  
 
  Both WT and mutant polar uncharged                       Unclear              
  residues. Both HB with A227.                         
.                                                                                                                                                         
  Polar acidic to polar uncharged. Loss of                    Unclear 
  interaction with S207. Loss of S207                           Loss of ATP binding? 
  ATP binding. 
 
  Non-polar neutral to polar acidic. Magnesium           ATP binding 
  bond introduced. Both HB with T345 and 
  Q368. 
 
  Non-polar neutral to polar acidic. Mutant HBs          ATP binding 
  with T344 and R346.      
 
  Polar uncharged to non-polar hydrophobic.               Hsp70 binding 
  Residue 365 HBs to Hsp70.     
                                                                                   
  Polar acidic to polar basic. Mutant forms HBs           Hsp70 binding 
  with different region to WT interactions. 
  E370 HBs to two Hsp70 residues. 
 
  Polar uncharged to non-polar hydrophobic.                Unclear 
  S440 has no HBs. L440 HBs to D407.                                                                                                     
                                                                                        
  Polar acidic to polar basic. Loss of                             Unclear 
  interaction with residue G505.                                     
 
  Polar acidic to polar basic. Mutant loss of 
  interaction with R47 but gains L550 and I551.          Hsp70 binding 
                                     
  Non-polar neutral to polar acidic. Mutant and  
  WT Hsp70 surrounded by similar residues but          Hsp70 binding 
  HB different.  
  Nearby residues contact Hsp70. 
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                From here some of the mutants were characterised according to their 
potential change of function. Residues 364-367 in Sse1 tightly contact the Hsp70 
backbone. Thr365 in Sse1 shapes the Sse1 surface into a conformation that cradles 
Hsp70 residue Tyr134 (Polier et al., 2008). One of the mutants isolated in this screen 
was located at T365 (T365I). 
               Glu554 in Sse1 is found in a buried polar interaction with Arg47 of Sse1. 
This interaction is located at the core of the interface between Sse1 3HBD and NBD. 
This ensures correct positioning of the 3HBD and is probably critical for complex 
formation with Hsp70 (Polier et al., 2008). One of the mutants was located at this 
point (E554K). However, E554K did not cause severe disruption to [PSI
+
], compared 
to the other mutants. Polier et al. (2008) created E554A which showed significantly 
diminished complex formation with Hsp70. E554A also showed a growth defect at 
37
o
C by strongly impairing nucleotide exchange. However they discovered that it 
requires multiple mutations at the binding interface to completely disrupt the 
interaction. In this study the Sse1 mutants believed to affect Hsp70 binding include 
G41D, T365I, E370K, E554K and G616D. 
              Binding of ATP to Sse1 at the NBD is essential for Hsp70:Sse1 complex 
formation (Shaner et al., 2006). Two of the mutations are located in the nucleotide 
binding cleft (G342D and G343D). G343 was seen to make hydrogen bonds with 
ATP.  Mutant G342D is [psi
-
] and G343D is [PSI
+
] weak, phenotypes which may be 
due to effects on ATP binding. Other mutants that may affect the ATP binding site 
include P37L and E370K. 
 
3.12 Chapter discussion 
            Thirteen new mutations within the yeast molecular chaperone Sse1 have 
been generated. In order to study the effects the mutants have on [PSI
+
], an 
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appropriate sse1 sse2 yeast strain CM02 was made. The thirteen mutants were 
characterised according to their [PSI
+
] phenotypic effects. Mutant Q458* appeared 
[psi
-
] in the initial screen but expressed a nonsense stop codon mutation (TAA), 
potentially creating a truncated protein. Mutant Q458* was not included in the 
phenotypic analysis and its possible disruption to [PSI
+
] propagation is discussed in 
Chapter 4. All thirteen mutants demonstrated a weak [PSI
+
] phenotype when 
compared with wild type Sse1. The mutants with the most severe loss of [PSI
+
] were 
D236N, G342D, S440L and G616D (Table 3.3). The results presented in this Chapter 
suggest that the efficient propagation of [PSI
+
] is dependent upon the chaperone Sse1. 
Although Sse1 binds aggregated proteins and acts as a ‘holdase’ (Oh et al., 1999), it 
can be speculated that the Sse1 mutants may affect [PSI
+
] indirectly through its 
influence on Ssa function (Fan et al., 2007; Kryndushkina and Wickner, 2007). Both 
Fan et al. (2007) and Kryndushkin and Wickner (2007) performed tests on Sse1 
mutants K69Q and G233D concluding that Ssa1 binding and ATP hydrolysis is 
necessary for efficient Sse1 function in prion propagation. It is also possible that Sse1 
directly affects [PSI
+
] propagation through interaction with Sup35 aggregates. 
                Sse1 mutants P37L, C211Y, G343D, E504K and E554K all appeared to 
retain some [PSI
+
] but they failed to grow on SC – adenine after two days incubation 
(Figure 3.10). These results were surprising. Mutants such as P37L and C211Y 
scored low in their effects on [PSI
+
] propagation and were expected to show partial 
growth on SC - adenine medium. Perhaps these [PSI
+
] weak mutants were failing to 
grow on SC – adenine because they affect cellular processes other than [PSI+] 
propagation? Or perhaps they need longer incubation times at 30
o
C as they have less 
[PSI
+
] present than WT Sse1? When mated with a [psi
-
] strain, the [PSI
+
] weak 
mutants did demonstrate [PSI
+
] dominance confirming that the mutants do possess 
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some [PSI
+
]. However, when the spot test was repeated on SC - adenine - histidine in 
the presence of pRS423 in Figure 3.14, [PSI
+
] weak mutants such as C211Y did show 
some growth. The only difference in the two experiments was the presence of a 
histidine marker plasmid and that histidine was lacking from the medium. The overall 
[PSI
+
] phenotype of the mutants also seemed improved on YPD in Figure 3.13. These 
results were unclear and suggested that perhaps something else is occurring and is 
affecting the results.                                
              The Sse1 mutants were further characterised by whether or not they impaired 
[URE3] propagation. Previous studies have shown that the overproduction of Sse1 
cures [URE3]. All thirteen Sse1 mutants failed to cure [URE3] to the same extent as 
wild type Sse1 (Table 3.4). The Sse1 mutants were exerting a dominant negative 
effect over WT Sse1, by disrupting Sse1’s normal [URE3] curing ability. 
Kryndushkin and Wickner (2007) isolated two Sse1 mutants with different effects on 
[URE3] propagation. They isolated an Sse1
G233D
 mutant known to disrupt ATP 
binding and hydrolysis. This mutant was incapable of Ssa1 binding, lost its NEF 
function and when over-expressed it failed to cure [URE3]. In contrast Sse1
K69M 
binds 
ATP and retains Ssa1 binding and NEF activity. Overproduction of Sse1
K69M
 cured 
[URE3] which suggests that Sse1 may be affecting [URE3] indirectly through its 
Hsp70-related functions.
  
This suggests that a combination of ATP binding, Ssa1 
interaction and NEF activity are essential for Sse1 to efficiently cure [URE3]. 
However, NEF activity alone is not sufficient to inhibit propagation as Fes1 fails to 
cure [URE3] when overproduced (Kryndushkin and Wickner, 2007). One interesting 
observation was that the mutants with the least curing effect all lie in the nucleotide 
binding domain (NBD). The NBD is essential for binding of nucleotides such as ATP 
and in turn drives Ssa1 ATP hydrolysis. As all the Sse1 mutants failed to carry out 
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[URE3] curing functions to the same magnitude as WT Sse1 it can be speculated that 
the mutants affect either, or a combination of, ATP binding, substrate binding, Hsp70 
interaction and NEF activity (section 3.11.2 for Sse1 mutant structural effects). All of 
the mutants had a collective response indicating that [URE3] function is lost through 
many Sse1 processes. It is unclear as to whether this is occurring directly through 
Sse1 or indirectly through interaction with other chaperones.  
               The Fes1 protein associates with ADP-bound Hsp70 and promotes 
nucleotide release in a similar manner to Sse1 (Kabani et al., 2002). There is 
conflicting evidence as to whether Fes1 overproduction can compensate for loss of 
Sse1 and Sse2. This theory was investigated and found that Fes1 could not support 
growth in sse1 sse2. This suggested that Sse1 has critical cellular functions other 
than NEF activity. Both Sadlish et al. (2008) and Raviol et al. (2006b) found either 
full or partial recovery of cell viability when Fes1 was over-expressed. The reasons 
for differences in these results could be due to the varying strain backgrounds and 
expression vectors used by each group. Raviol et al. (2006b) and our experiment used 
pRS423FES1 whereas Sadlish et al. (2008) used p425-GPD-FES1. All three 
background strains were also different which could account for the different results 
observed. This is examined further in Chapter 4 where Fes1 is over-expressed in a 
different (BY4741) background strain.  
               Investigations into the Sse1 mutant [PSI
+
] phenotypes, in the presence of an 
extra copy of FES1, revealed that it only improved propagation in one mutant. Sse1 
mutant G616D showed an improved [PSI
+
] phenotype when FES1 was over-
expressed (Figure 3.13.b). This result suggested that G616D potentially disrupts the 
ability of Sse1 to function as a NEF. G616D is in the SBD and could impair Sse1-
Hsp70 interaction and subsequent Hsp70 nucleotide exchange. The other Sse1 
 168 
mutants showed no improvement in [PSI
+
] in the presence of pRS423FES1. Perhaps 
the mutants affect other functions such as ATP or peptide binding. The overall [PSI
+
] 
phenotype of the mutants appeared stronger in this experiment compared to in Figure 
3.9. Perhaps the additional plasmid is having an effect on the colony colours? Each 
Fes1 + Sse1 mutant strain was also grown on medium lacking adenine (Figure 3.14). 
Mutant G616D showed only slight improved growth in the presence of pRS423FES1 
and mutant G343D also displayed growth, indicating that Fes1 over-expression had 
no great effect on the mutant’s ability to propagate [PSI+]. The overall growth pattern 
in Figure 3.14 was surprising and unclear. Certain mutants grew well in the presence 
of the control plasmid but not in the presence of FES1 and the mutant growth patterns 
did not always reflect their [PSI
+
] phenotype observed in Figure 3.13. The only 
difference between this growth analysis and that observed in Figure 3.9 was the 
presence of control plasmid pRS423 and the absence of histidine in the medium. The 
small alterations in nutrient growth medium or the presence of pRS423 could result in 
different cell growth abilities. These results may be highlighting the complexity of the 
adenine biosynthesis pathway and how it can be influenced by cross-talk from other 
metabolic activities. SC medium is quite nutrient deficient compared to YPD rich 
medium, this could affect the up-regulation or activation of cellular pathways which 
in turn could interfere with growth patterns.    
              Human Sse1 homolog HSPH1 could not recover cell viability in sse1 sse2. 
This result is supported by Shaner et al. (2004) and Raviol et al. (2006a) who stated 
that mammalian Hsp110 cannot functionally compensate for yeast Sse1. Yeast and 
mammalian Hsp70 are structurally conserved and yeast Sse1 can form complexes 
with bovine and human Ssa1. 90% of the residues that form the Hsp70 interface are 
conserved between mammals and yeast. In comparison the human and yeast Hsp110 
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binding interface only share 61% identity (Polier et al., 2008; Schuermann et al., 
2008). Perhaps Sse1 residues critical for interaction with Hsp70 are not conserved in 
human HSPH1. This is examined further in Chapter 4 by expressing HSPH1 in a 
different (BY4741) background strain. 
              Investigations into the growth rates of yeast harbouring mutant Sse1’s 
revealed that the mutants had only small differences in cell generation time (GT), 
when compared to WT Sse1. These small alterations in growth rates may not be 
severe enough to disrupt [PSI
+
]. Mutant S440L was [psi
-
] but it grew at a slightly 
faster rate than WT. Western blot analysis suggested that the effects of Sse1 mutants 
on [PSI
+
] propagation are not influenced by changes in chaperone abundance. All 
thirteen mutants had normal growth rates and protein chaperone levels irrespective of 
their effects on [PSI
+
] propagation. 
               Finally, 3D crystal structure studies revealed possible structural and 
functional disruptions caused by the Sse1 mutations. Changes to amino acid residues 
caused by these mutations potentially alter the dynamics of Sse1 and possibly the 
subsequent function of the protein. ATP binding, Hsp70 binding and interdomain 
communication appears to be the main functions which the mutant Sse1’s are 
disrupting. Mutants with potentially the most severe structural effects are those 
located at known intramolecular interaction sites e.g G343D, T365I, E370K and 
E554K. However, these structural disruptions are not reflected in all the mutants 
[PSI
+
] phenotypes. T365I and E370K were considered [psi
-
] but mutants G343D and 
E554K were only considered [PSI
+
] weak with respect to their effects on [PSI
+
] 
(Table 3.3). Perhaps the amino acid changes in these mutants were not severe enough 
to completely disrupt [PSI
+
] propagation. Mutants predicted as having the least 
structural effects were P37L (both residues nonpolar hydrophobic) and C211Y (both 
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residues polar uncharged). Their lack of structural disruption is reflected by their 
[PSI
+
] phenotype as they both scored quite low for their loss of [PSI
+
], compared to 
other mutants (Table 3.3). Differences in the severity of structural effects caused by 
each mutant may account for the differences in [PSI
+
] phenotypes observed in section 
3.5.  
              From the results in this Chapter thirteen Sse1 mutants have been identified 
that impair S. cerevisiae prion propagation. Phenotypic analysis and structural 
modeling suggests that Sse1 plays an integral role in prion propagation in yeast. 
 
 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER 4 
INVESTIGATION INTO THE                  
TEMPERATURE-SENSITIVE 
EFFECTS OF sse1 MUTANTS 
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4.0 Introduction  
              The aim of this Chapter was to investigate why certain Sse1 mutants 
displayed temperature-sensitive phenotypes. The initiative behind this Chapter was to 
see if the Sse1 mutants had any influence on cellular processes other than prion 
propagation. 
               The non-viable sse1 sse2 phenotype indicates that Hsp110 plays an 
important role in normal cellular homeostasis. It has been suggested that Sse1 plays a 
role in providing cellular thermostability, Hsp90 signaling and in cell wall integrity 
(CWI) signaling (Lee-Yoon et al., 1995; Liu et al., 1999; Shaner et al., 2008).  
               Changing environmental temperature is the most predominant stress that all 
organisms have to cope with. Microbes such as yeast have evolved mechanisms that 
allow them to adapt to temperature alterations (Strassburg et al., 2010). Hsp110 has 
been identified as a heat stress-induced protein in yeast and in a number of eukaryotes 
including Arabidopsis thaliana, Caenorhabditis elegans and mammals (Lee-Yoon et 
al., 1995). As well as having an abundance of heat shock proteins to protect the cell 
from the onslaught of protein denaturation, yeast also contain a resilient cell wall 
composed of thick polysaccharide layers (Parsell and Lindquist, 1993; Cabib et al., 
1998).  
              Cell wall damage caused by heat stress results in the activation of the cell 
wall signaling pathways (Kamada et al., 1995). This involves signaling through 
kinase cascades resulting in the activation of transcription factors for genes involved 
in protection against temperature stress (Torres et al., 1991; Paravicini et al., 1992). 
Loss of function of any protein kinase in the signal cascade results in cell temperature 
sensitivity (ts) and cell lysis that can be recovered by support on highly osmotic 
substances such as 1 M Sorbitol (Levin, 2005). 
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             Sse1 has been shown to physically interact with the molecular chaperone 
Hsp90 and is required for Hsp90-mediated signaling (Liu et al., 1999; Mandal et al., 
2010). Client proteins such as transcription factors and protein kinases depend upon 
Hsp90 for effective signaling (Mayer and Bukau, 1999). Hsp90 has been implicated 
in playing a major role in the cell wall signaling pathway. Mutants defective in Hsp90 
function are temperature-sensitive and remediated by osmotic support. The cell wall 
integrity (CWI) signaling kinase Slt2 is a client protein of Hsp90 and it requires 
proper Hsp90 chaperone functioning in order to be an active kinase protein (Millson 
et al., 2005; Piper et al., 2006; Truman et al., 2007).  
               Shaner et al. (2008) proposed that Sse1 signals through the CWI pathway in 
conjunction with Slt2. They discovered that deletion of Sse1 results in osmoremedial 
temperature sensitivity and sensitivity to cell wall antagonists, characteristics shared 
by mutants of the CWI pathway. Temperature-sensitive phenotypes caused by sse1 
or sse1 mutants may not be solely due to cellular protein aggregation (Truman et al., 
2007; Wright et al., 2007) but caused by weakened cell walls as a result of improper 
CWI signaling (Shaner et al., 2008).  
                Sse1 has also been linked with PKA signaling and it has been shown that 
the temperature-sensitive effects of sse1 can be suppressed by decreasing PKA 
signaling (Trott et al., 2005). Trott et al. (2005) demonstrated that sse1 temperature 
sensitivity was alleviated by growth on non-fermentable carbon sources suggesting 
that Sse1 is a negative regulator of PKA signaling. 
             The work presented in this Chapter identified temperature-sensitive Sse1 
mutants and the main objective was to investigate whether they are affecting CWI 
signaling, Hsp90 signaling, PKA signaling or another cellular process. Results from 
this investigation led to the generation of a new sse1 sse2 strain in a BY4741 
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background and subsequent analysis of Sse1 mutant characteristics in this new strain. 
This allowed a comparative analysis of G600 and BY4741 background strains to be 
carried out, concentrating on areas such as strain sensitivity and growth when 
expressing Sse1 and Sse1 mutants.  
         
4.1 Sse1 mutants have increased temperature sensitivity 
4.1.1 Temperature sensitivity testing of Sse1 mutants by comparative growth 
analysis 
               In Chapter 3 it was established that particular mutations in Sse1 affect the 
propagation of yeast prions [PSI
+
] and [URE3]. As Sse1 is a heat shock protein and 
an important cellular chaperone one of the objectives was to assess whether the 
mutants have any effects on cellular thermostability. Comparative growth analysis 
was carried out on each mutant in strain CM02. The plates were incubated at 30
o
C, 
37
o
C and 39
o
C and growth was monitored over 2 days. After 48 hours it was evident 
that mutants G342D and G616D were temperature-sensitive (ts) at 37
o
C and that all 
the remaining mutants grew relatively well at this temperature (Figure 4.1.a-e). At 
39
o
C treatment varying degrees of growth was seen for all thirteen mutants. Most 
mutants were growth deficient but some grew as well as WT Sse1 (P37L, E504K). 
Table 4.1 summarises a subjective analysis of mutant growth at 39
o
C in comparison 
to WT Sse1 after 2 days. 
              As wild type (WT) Sse1 cells did not display complete growth at 39
o
C after 
2 days, the plates were incubated for an additional 24 hours. This resulted in 
improved growth for WT Sse1 but mutants G342D and G616D were still non-viable 
(data not shown). Mutants G41D, G50D, C211Y and D236N displayed partial growth  
after 3 days incubation at 39
o
C but were still inhibited in comparison to WT Sse1  
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(Figure 4.2).          
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Figure 4.1.a. Comparative growth assay of Sse1 mutants P37L-G50D. The assay was 
performed as described in section 2.6 and selected on YPD plates. The plates were 
incubated at 30
o
C, 37
o
C and 39
o
C for 48 h. P37L grew as well as WT Sse1 at 39
o
C. 
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Figure 4.1.b. Comparative growth assay of Sse1 mutants C211Y-D236N. The assay 
was performed as described in section 2.6 and selected on YPD plates. The plates 
were incubated at 30
o
C, 37
o
C and 39
o
C for 48 h. 
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Figure 4.1.c. Comparative growth assay of Sse1 mutants G342D-T365I. The assay 
was performed as described in section 2.6 and selected on YPD plates. The plates 
were incubated at 30
o
C, 37
o
C and 39
o
C for 48 h. Mutant G342D was completely ts at 
37
o
C and 39
o
C. 
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Figure 4.1.d. Comparative growth assay of Sse1 mutants E370K-E504K. The assay 
was performed as described in section 2.6 and selected on YPD plates. The plates 
were incubated at 30
o
C, 37
o
C and 39
o
C for 48 h. E504K grew as well as Sse1 at 39
o
C. 
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Figure 4.1.e. Comparative growth assay of Sse1 mutants E554K-G616D. The assay 
was performed as described in section 2.6 and selected on YPD plates. The plates 
were incubated at 30
o
C, 37
o
C and 39
o
C for 48 h. Mutant G616D was ts at 37
o
C and 
39
o
C. 
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Table 4.1. Subjective growth score for mutants incubated at 39
o
C for 2 days.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutants were compared to the WT Sse1 cell growth that was on the same plate. WT 
Sse1 did not demonstrate complete growth after 2 days but was given a score of 10 
for comparative purposes. 
Mutants G342D and G616D were completely non-viable and mutants P37L and 
E504K grew nearly as well as or as well as WT Sse1. 
 
 
 
MUTATION 
 
GROWTH SCORE 
 
WT 
P37L 
G41D 
G50D 
C211Y 
D236N 
G342D 
G343D 
T365I 
E370K 
S440L 
E504K 
E554K 
G616D 
 
10 
9 
1 
1 
4 
2 
0 
3 
4 
1 
3 
10 
6 
0 
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Figure 4.2. Comparative growth analysis of Sse1 temperature-sensitive mutants after 
3 days incubation. The plates were incubated at 39
o
C for 3 days. WT had complete 
growth after 3 days and Sse1 mutants G41D, G50D, C211Y and D236N were slow-
growing.  
 
 
               The results from these experiments indicated that normal Sse1 function is 
required for protecting the cell against extreme environmental temperatures. 39
o
C is 
an extreme temperature to which WT Sse1 is slightly sensitive after 2 days growth 
(possibly due to lack of Sse2) (Figure 4.1a-e). However, most of the mutants were 
very sensitive after 2 and 3 days growth. 39
o
C sensitive mutants could affect the 
stability and folding of Sse1 under extreme heat shock. If this temperature makes the 
mutant protein non-functional then the cell would ultimately be sse1 sse2. Given 
the structural analysis data from Chapter 3, it was speculated that perhaps mutants 
G342D and G616D are affecting the protein dissagregation system. This could occur 
directly through Sse1 or indirectly through Hsp70 interaction. 
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4.1.2 Growth on high osmotic medium recovers temperature sensitivity in 
G342D and G616D 
              Mutants that cause cell lysis at increased temperatures are often located in 
genes involved in cell wall maintenance (Paravicini et al., 1992). G342D and G616D 
temperature sensitivity was suppressed by increasing the osmolarity of the growth 
medium with 1 M sorbitol (Figure 4.3). Paravicini et al. (1992) previously isolated 
121 random temperature-sensitive mutants of which 12 were osmotically stabilised.  
Paravicini et al. (1992) and Shaner et al. (2008) both tested temperature-sensitive 
mutants for cell permeability and lysis at increased temperatures in a method first 
used in yeast by Cabib and Duran (1975). They found that certain osmoremedial 
temperature-sensitive mutants had substantial levels of ‘leakage’ (cellular contents 
leaking into external environment) indicating some sort of disruption to cell wall 
integrity (Paravicini et al., 1992; Shaner et al., 2008).  
              In yeast, environmental osmotic changes often initiate the cell wall integrity 
(CWI) pathway and HOG response pathway (Fuchs and Mylonakis, 2009). When 
yeast grow on hypoosmotic solutes such as YPD the MAP kinase CWI pathway is 
activated. Mutants which prevent MAP kinase signaling lyse in the absence of 
osmotic stabilisers such as 1 M sorbitol (Lee and Levin, 1992; Davenport et al., 
1995). 
               It is possible that Sse1 mutants G342D and G616D have become more 
permeable at increased temperatures, due to alterations to MAP kinase signaling or 
some other signaling pathway, making growth on hypotonic medium (YPD) lethal 
compared to the support provided by 1 M sorbitol. This test was repeated on YPD 
medium containing 0.4 M NaCl and the results were similar confirming that it is an 
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increased osmolarity effect rather than a sorbitol-specific effect that was recovering 
cell growth (data not shown).  
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Figure 4.3. Comparative growth analysis performed on WT Sse1 and mutants 
G342D, G343D and G616D in strain CM02. The cells were serial diluted onto YPD 
and YPD + 1 M sorbitol and incubated at 30
o
C and 37
o
C for 2 days. 1 M sorbitol 
recovered normal growth in Sse1 mutants G342D and G616D. 
 
 
4.2 Investigations into the role of Sse1 in cell wall integrity signaling 
              Exposure of S. cerevisiae to environmental stress such as heat and oxidative 
shock results in the activation of five separate mitogen-activated protein kinase 
(MAPK) cascades (Chen and Thorner, 2007). The cell wall integrity (CWI) signaling 
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pathway uses one of these MAP kinase cascades to mediate cell wall biosynthesis and 
maintenance (Levin, 2005). This cascade is initiated by cell wall stress sensors Mid2 
and Wsc1 (Verna et al., 1997; Ketela et al., 1999) which ultimately leads to the 
activation of the kinase Pkc1 (Nonaka et al., 1995). Pkc1 activates a cascade of 
phosphorylation through MAP kinases which results in the activation of two 
transcription factors Rlm1 and SBF (Swi4/Swi6). These transcription factors trigger 
the expression of genes involved in cell wall synthesis (Madden et al., 1997; Jung et 
al., 2002). Figure 4.4 illustrates this cascade and the biological factors involved in its 
signaling. 
              Loss of function of any kinase or transcription factor in this cascade can lead 
to temperature-sensitive cell lysis that is remediated by osmotic support (Lee and 
Levin, 1992). Levin (2005) discusses in the review paper that other phenotypes seen 
by mutants of CWI signaling include sensitivity to cell wall damaging agents such as 
caffeine, calcofluor white and congo red (Martin et al., 2000; Errede et al., 1995).  
               A number of reports have linked protein chaperone function with CWI 
signaling (Millson et al., 2005; Piper et al., 2006). Shaner et al. (2008) proposed that 
Sse1 may be involved in CWI signaling. They performed co-immunoprecipitation 
assays and found that Sse1 co-purifies with the CWI signaling kinase Slt2. They also 
found that deletion of Sse1 results in osmoremedial temperature sensitivity and 
sensitivity to cell wall damaging agents, atypical characteristics of CWI signaling 
mutants. In this section the aim was to determine whether the temperature-sensitive 
(ts) mutants G342D and G616D were affecting this signaling cascade by performing a 
number of cell wall sensitivity tests. 
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Figure 4.4. Cell wall integrity signaling pathway. The interaction of chaperones 
Hsp90, Sse1 and Sti1 with the terminal Slt2 Map kinase is believed to help signal 
through to transcription factors SBF and Rlm1. Chaperones may also play a role in 
the functions of MBF, a transcription factor that works alongside SBF in initiating 
cell morphogenesis. This figure is adapted from Shaner et al. (2008) and they also 
suggest a role for Ssa1 in this pathway. 
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4.2.1 Temperature-sensitive Sse1 mutants show sensitivity to cell wall damaging 
agents 
              Mutants of the MAP kinase cascade often display sensitivity to cell wall 
damaging agents. For example, deletion of the Rlm1 transcription factor renders cells 
caffeine sensitive (Watanabe et al., 1997). Shaner et al. (2008) showed that sse1 
cells are sensitive to congo red and caffeine when compared to WT cells. Exposure of 
yeast cells to agents such as calcofluor white, caffeine and congo red leads to the 
disruption of the cell wall network and subsequent activation of the MAP kinase 
pathway (Ketela et al., 1999; De Nobel et al., 2000).  
               If the Sse1 temperature-sensitive mutants are defective in the CWI signaling 
pathway then they should show sensitivity to cell wall damaging agents. Comparative 
growth analysis was performed on CM02 with WT Sse1, Sse1
G342D
 and Sse1
G616D
. In 
some cases G600 WT strain and mutant Sse1
G343D
 were also included as controls. The 
cells were selected on medium with varying concentrations of congo red, calcafluor 
white, caffeine and SDS and grown at 30
o
C for 2 days (Figure 4.5 and 4.6). 
Interestingly, WT G600 was more resistant to chemical stress than CM02. This 
difference may be due to the absence of Sse2 in CM02. Mutants G342D and G616D 
were very sensitive to the chemical agents and looked slightly more sensitive than 
WT Sse1 when grown on SDS and calcafluor white. However, due to the varying 
degrees of sensitivity seen in all strains an accurate comparison could not be made. 
The temperature-sensitive mutants were sensitive to the cell wall damaging agents but 
strain CM02 also showed sensitivity. These results were suggestive but not 
conclusive that the Sse1 mutants may be affecting CWI signaling. 
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Figure 4.5. Comparative growth analysis of Sse1 mutants on cell wall damaging 
agents. Initial tests included WT G600 and mutant G343D as controls. The cells were 
spotted onto YPD plates that had varying concentrations of chemicals and incubated 
at 30
o
C for 2 days. CM02 with WT Sse1 appears, in most cases, just as sensitive as all 
three Sse1 mutants.  
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Figure 4.6. Comparative growth analysis of Sse1 mutants on cell wall damaging 
agents. The cells were spotted onto YPD medium that had varying concentrations of 
chemicals and incubated at 30
o
C for 2 days. Strain CM02 was very sensitive to cell 
wall damaging agents even in the presence of WT Sse1. The lack of growth of 
mutants on SDS and calcafluor white suggests they could be affecting CWI but it is 
inconclusive due to strain sensitivity. 
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4.2.2 Can inducers of cell wall signaling recover growth in G342D and G616D? 
              Pkc1 and Bck1 are essential components of the CWI signaling pathway. 
Pkc1 (protein kinase C) transmits the first signal through the cascade in response to 
cell wall damage (Levin and Bartlett-Heukusch, 1992). Pkc1 phosphorylates Bck1 at 
several different sites (Levin et al., 1994). Bck1 (bypass of C kinase) phosphorylates 
Mkk1/2 which ultimately leads to the up-regulation of cell wall repair genes (Irie et 
al., 1993). Bck1 was first isolated as a suppressor of Pkc1 deletion (Lee and Levin, 
1992).  
              The deletion of the PKC1 gene results in the most severe growth defect 
shown by deletion of any of the members of the MAP kinase pathway. It is believed 
that Pkc1 regulates a multitude of biological pathways as it is the only protein kinase 
C isoform found in S. cerevisiae (Levin et al., 1990; Lee and Levin, 1992) compared 
to at least ten isoforms found in mammals (Mellor and Parker, 1998). Deletion of the 
BCK1 gene also affects the growth and proliferation of yeast as it results in 
temperature-sensitive growth that is remediated by osmotically stabilising agents (Lee 
and Levin, 1992).  
              As Pkc1 and Bck1 are involved in the stimulation of cell wall repair the 
constitutively active forms of these proteins were expressed in the Sse1 temperature- 
sensitive mutants. This helped clarify whether or not the mutants were affecting the 
CWI pathway. Phosphorylated activated forms of Pkc1 and Bck1 were expressed on 
plasmids p241 and p636, respectively, and transformed into CM02 that expressed 
Sse1, G342D or G616D. Comparative growth analysis was performed and cells were 
incubated on SC - uracil medium for 2 days at 30
o
C and 37
o
C. PKC1 and BCK1 did 
appear to improve temperature-sensitive growth in mutants G342D and G616D at 
37
o
C, particularly in cells with p241PKC1 (Figure 4.7.a/b).  
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Figure 4.7.a. Comparative growth analysis of CM02 with WT Sse1 and temperature- 
sensitive mutants in the presence of pRS316 empty vector. The cells were selected on 
SC - uracil and incubated for 2 days at 30
o
C and 37
o
C. Mutants Sse1
G342D 
and 
Sse1
G616D
 both failed to grow at 37
o
C. 
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Figure 4.7.b. Comparative growth analysis of CM02 with WT Sse1 and temperature- 
sensitive mutants in the presence of plasmid p241PKC1. The cells were selected on 
SC - uracil and incubated for 2 days at 30
o
C and 37
o
C. Mutants Sse1
G342D 
and 
Sse1
G616D
 showed slightly enhanced growth at 37
o
C when p241PKC1was expressed. 
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Figure 4.7.c. Comparative growth analysis of CM02 with WT Sse1 and temperature- 
sensitive mutants in the presence of plasmid p636BCK1. The cells were selected on 
SC - uracil and incubated for 2 days at 30
o
C and 37
o
C. Mutant Sse1
G342D
 showed 
slightly enhanced growth at 37
o
C when p636BCK1 was expressed. 
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4.3 Isolation of second-site suppressor mutants that recover G342D 
and G616D temperature-sensitive phenotypes 
              Previous work in the laboratory has shown that the effects of a chaperone 
mutant on [PSI
+
] propagation can be reversed by the addition of a second mutation to 
the protein structure (unpublished data). Isolating such mutants can help gain insight 
into the structural organisation of the protein and how altering particular residues 
affects intramolecular interactions. The aim was to isolate second-site suppressors 
(sss) of mutant G342D and G616D to restore Sse1 wild type phenotypes. The fact 
that G616D and G342D were ts and [psi
-
] provided an opportunity to alter both these 
functions.  
               Second-site suppressors of a particular mutation can be isolated by treating 
the plasmid DNA with hydroxylamine as described in section 2.15. Once the mutant 
library was created it was transformed into CM02 along with WT Sse1, pRS315 and 
Sse1
G342D 
or Sse1
G616D
 and selected on SC - leucine medium. Approximately 4,000 
colonies were screened for each library by replicating the plates onto 5-FOA. Two 
screens were carried out for each mutant library. One set of 5-FOA plates were 
incubated at 37
o
C overnight and the other at 30
o
C for 2 days. This enabled the 
isolation of ts revertants and [psi
-
] revertants separately for both G342D and G616D.    
Isolation of potential sss is fully described in section 2.17.  
              The screen for sss which affect the mutant [PSI
+
] phenotypes resulted in the 
isolation of pink colonies that, when restreaked, appeared [psi
-
]. No white/[PSI
+
] sss 
were isolated in this screen. No sss for G616D temperature sensitivity were isolated 
either, but potential G342D temperature-sensitive sss were isolated. Five potential 
G342D temperature-sensitive sss were isolated in the primary screen. These plasmids 
were isolated and transformed back into CM02 for further phenotypic analysis 
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(secondary screen). The potential sss were subsequently analysed by comparative 
growth analysis in order to assess whether they fully recovered temperature 
sensitivity at 37
o
C (Figure 4.8). In the comparative growth analysis, isolate P9, P11 
and P13 all showed a reproducible phenotype and were sent for sequencing. P9 
returned as Sse1
G342D T100I
 but P11 and P13 sequenced as WT Sse1 so perhaps 
hydroxylamine reverted them back to WT and they got through the screen as potential 
sss. Mutant T100I is located in the nucleotide binding domain of Sse1 and somehow 
altered Sse1
G342D 
in a way that modifies its temperature-sensitive phenotype. T100I 
also improved mutant G342D [PSI
+
] phenotype slightly as it appeared pink on YPD 
at 30
o
C. This means that this mutation may not be specific in its effects as it can 
improve G342D temperature-sensitive growth and possibly [PSI
+
] propagation. This 
screen was not saturated as mutant T100I was only isolated once.  
             The difficulty in isolating Sse1 mutant sss could have been due to the low 
number of colonies screened. When transformed into yeast, the mutant library 
resulted in approximately 4,000 colonies per screen. Based on similar mutational 
studies on SSA1 and Hsp104 plasmid DNA the rate of mutant generation is 
approximately 8%. The low number of colonies that went through the screen in this 
experiment would have only produced 320 mutants. It was disappointing that T100I 
was the only mutant to produce a desirable phenotype and this did not indicate much 
about the Sse1 structure. The fact that 2 mutants were WT reverts suggested that the 
screen was not worth pursuing. 
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Figure 4.8. Recovery of Sse1
G342D 
mutant temperature sensitivity by second-site 
suppressor T100I. Comparative growth analysis was performed on YPD medium and 
grown for 3 days at 30
o
C and 37
o
C. Cells were grown for 3 days to allow colony 
colour to develop and to confirm definite ts recovery phenotypes. Plasmid P9, P11 
and P13 all recovered growth at 37
o
C. Each plasmid was sent to Agowa for sequence 
analysis.     
                      
4.4 Creating a BY4741 sse1 sse2 strain to compare growth and 
sensitivity with CM02 
4.4.1 Reasoning behind making BY4741 sse1 sse2 
              The results from tests carried out in section 4.2.1 prompted the creation of a 
new Hsp110 deletion strain. CM02 with WT Sse1 was non-viable on YPD containing 
5 g/ml of congo red, 10 g/ml calcofluor white and non-viable on high 
concentrations of caffeine. These results can be compared to those found by Shaner et 
al. (2008). They expressed Sse1 in a BY4741 sse1 sse2 strain and found that cells 
were sensitive but survived on media containing up to 30 g/ml calcofluor white and 
10 M caffeine.        
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             CM02 appeared to have strain background effects which disrupted sensitivity 
tests. Strain BY4741 is more widely used for CWI signaling analysis so a new strain 
was generated. This would help to compare our results to those from other studies. 
Euroscarf strains Y02146 (MATahis3 leu2 met15 ura3  sse1::kanMX) and 
Y17167 (MAT  his3 leu2 lys2 ura3  sse2::kanMX) were purchased, in order 
to create BY4741 sse1 sse2 double knockout. BY4741 has no ade2.1 ochre 
mutation so [PSI
+
] phenotypes could not be monitored. 
 
4.4.2 Confirmation of BY4741 sse1 sse2 knockout strain 
             Euroscarf strains Y02146 and Y17167 were mated on SD + histidine, leucine 
and uracil medium. The diploids were selected as being able to grow without 
supplemented methionine or lysine. A copy of plasmid pRS316SSE1 was transformed 
into the diploid strain. This enabled the selection of haploid sse1 sse2 cells after 
sporulation. Diploid cells were sporulated on minimal sporulation medium and 
random spore analysis was performed. The cells were selected on SC - uracil medium 
and colonies were replicated onto 5-FOA medium (Figure 4.9) to select against any 
cells expressing pRS316SSE1. Colonies that were non-viable without pRS316SSE1 
were selected as potential sse1 sse2 haploid cells. Figure 4.10 represents the test 
carried out to determine the genotype of the knockout strains. Single BY4741 sse1 
and sse2 mutants had either a lys2 or met15 mutation but each of the four potential 
double knockouts had wild type genomic variants of these mutations. This was 
proven by strain growth on medium lacking lysine or methionine (Figure 4.10). 
               Four potential sse1 sse2 strains were selected and their DNA isolated as 
described in section 2.11.1. Diagnostic PCRs were performed using primers sse03, 
sse04, sse05, sse06, kan01 and kan02 (Table 2.12.a). PCR cycles are described in  
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Figure 4.9. Confirming sse1 and sse2 knockout in BY4741. After diagnostic PCR 
analysis four haploid BY4741 yeast strains had a sse1 sse2 genotype. (a) They 
were selected on SC - uracil and (b) replicated onto 5-FOA to confirm that the 
removal of pRS316SSE1 results in cell death. 
 
 
 
 
               
 
 
Figure 4.10. Determining the lys2/met15 genotype of BY4741 sse1 sse2. Euroscarf 
strains YBR169C (his3 leu2 met15 ura3  sse1::kanMX) and YPL106C 
(his3 leu2 lys2 ura3  sse2::kanMX) were selected on SD + histidine + 
leucine alongside four double knockouts of sse1 sse2. Each double mutant survived 
in the absence of methionine and lysine. CM03 isolate 1 genotype is MATa his3  
leu2  ura3  sse1::kanMX sse2::kanMX pRS316SSE1. 
 
 
 
Table 2.11. Figures 4.12 and 4.14 illustrate the diagnostic PCRs ran on 0.8% agarose 
gels and Figures 4.11 and 4.13 annotate these band fragment sizes. Figures 4.12 and 
4.14 represent PCRs performed on isolated DNA samples GP1-4. All four strains 
 
met15 
lys2 
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were confirmed as sse1 sse2 haploid cells but the gels illustrate the presence of 
knockout construct flanking regions for GP1 only (Figure 4.12 and 4.14). The strain 
was designated CM03 and had the following genotype; MATa his3 leu2  
ura3 sse1::kanMX sse2::kanMX pRS316SSE1.              
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(2) sse1 
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Figure 4.11. Illustration shows the expected wild type SSE1 and sse1 PCR fragment 
sizes. (1) SSE1 wild type DNA coding sequence is 2082 bp. Primers sse03R and 
sse04F are located upstream and downstream of the SSE1 coding sequence. PCR 
using these primers should result in a DNA band of approximately 2496 bp. (2) 
illustrates an sse1 knockout construct with kanMX gene replacing the coding 
sequence of SSE1. PCR using primers sse03R and sse04F should result in a band 
approximately 1943 bp in size. Internal kan01R and kan02F primers used with 
external sse03R and sse04F primers should result in two bands of 277 bp and 772 bp 
and confirms SSE1 is replaced with kanMX. 
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Figure 4.12. PCR confirmation of sse1 knockout in strain CM03 by agarose gel 
electrophoresis. PCR is represented by GP1 DNA isolate. 
 
Lane A: 1kb molecular weight marker 
Lane B: G600 genomic DNA amplified with primers sse03 and sse04 results in a 
2496 bp band for wild type SSE1. 
Lane C-F: Four potential sse1 knockouts (GP1-4). Genomic DNA amplified with 
primers sse03 and sse04 results in two DNA bands. The 2496 bp band is wild type 
SSE1 on pRS316 plasmid. The 1943 bp band is kanMX DNA replacing genomic 
SSE1. 
Lane H:  GP1 genomic DNA amplified with primers kan02 and sse03. The 772 bp 
band represents the right flanking region of kanMX knockout construct. 
Lane I:  GP1 genomic DNA amplified with primers kan01 and sse04. The 277 bp 
band represents the left flanking region of kanMX knockout construct. 
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Figure 4.13. Illustration shows the expected wild type SSE2 and sse2 PCR fragment 
sizes. (1) SSE2 wild type DNA coding sequence is 2082 bp. Primers sse05F and 
sse06R are located upstream and downstream of the SSE2 coding sequence. PCR 
using these primers should result in a DNA band of approximately 2519 bp. (2) 
illustrates an sse2 knockout construct with kanMX gene replacing the coding 
sequence of SSE2. PCR using primers sse05F and sse06R should result in a band 
approximately 1948 bp in size. Internal kan01R and kan02F primers used with 
external sse05F and sse06R primers should result in two bands of 293 bp and 861 bp 
and confirms SSE2 is replaced with kanMX. 
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Figure 4.14. PCR confirmation of sse2 knockout in strain CM03 by agarose gel 
electrophoresis.  
 
Lane A: 1kb molecular weight marker. 
Lane B: G600 genomic DNA amplified with primers sseo5 and sse06 results in a 
2519 bp band for wild type SSE2. 
Lane C-E: GP1-3 genomic DNA amplified with primers sse05 and sse06 results in a 
1948 bp band which is kanMX DNA replacing genomic SSE2. 
Lane G: 1kb molecular weight marker. 
Lane H: GP1 genomic DNA amplified with primers sse05 and sse06 results in a 
1948 bp band. 
Lane I: GP1 genomic DNA amplified with primers kan02 and sse06. The 861 bp 
band represents the right flanking region of kanMX knockout construct. 
Lane J: GP1 genomic DNA amplified with primers kan01 and sse05. The 293 bp 
band represents the left flanking region of kanMX knockout construct. 
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4.5 Testing temperature sensitivity of Sse1
G342D
 and Sse1
G616D
 in 
strain CM03 
              Sse1 mutants G342D and G616D displayed temperature-sensitive growth in 
strain CM02 at 37
o
C. In order to confirm their temperature-sensitive phenotype they 
were expressed in the new BY4741 strain CM03. Mutants were transformed into 
CM03 and replicated onto 5-FOA to remove pRS316SSE1 (Figure 4.15). 
Comparative growth analysis was performed on YPD, including wild type Sse1 and 
Sse1
G343D
 as controls, and plates were incubated at 30
o
C and 37
o
C for 2 days. The 
results from this experiment suggested that G616D is a temperature-sensitive mutant 
and that G342D is only slightly sensitive at 37
o
C (Figure 4.16). Growth at 37
o
C on 1 
M sorbitol also fully restored the growth of both ts mutants (Figure 4.16). Plasmids 
p241PKC1, p636BCK1 and pRS316 control were transformed into each strain and 
comparative growth analysis was performed on SC - uracil medium. The plates were 
incubated at 37
o
C for 2 days and the results confirmed that G342D is not a non-viable 
mutant in CM03 but slow-growing and that the activation of Pkc1 or Bck1 cannot 
recover growth in mutant G616D (Figure 4.17). This suggested that the Pkc1 and 
Bck1 recovery phenotype observed in CM02 was strain specific and that these 
mutants may not be disrupting CWI signaling. 
      (a)                                                          (b) 
               
 
Figure 4.15. Transformation of Sse1 mutants into strain CM03. (a) Each transformant 
was selected on SC - leucine followed by (b) replication onto 5-FOA to select against 
pRS316SSE1. 
CM03+ Sse1 
CM03 + pRS315 
CM03 + Sse1
G342D
 
CM03 + Sse1
G616D
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(a) YPD 30oC 
                            
                            
 
(b) YPD 37oC 
                            
 
 
                           (c) YPD + 1 M sorbitol 37
o
C 
                            
 
                            
                             
Figure 4.16. Analysis of temperature-sensitive status of Sse1 mutants in CM03. 
Mutants G342D, G343D and G616D were subjected to comparative growth analysis 
on YPD medium and YPD + 1 M sorbitol medium and incubated at 30
o
C and 37
o
C. 
(b) This confirmed that G616D is a ts mutant as it was non-viable at 37
o
C, however 
G342D did show some growth at 37
o
C. (c) 1 M sorbitol fully recovered G616D at 
37
o
C. This suggested that G616D may still impair CWI signaling. 
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                          (a) 37
o
C 
                            
                             
 
(b) 37oC 
                            
 
                           (c) 37
o
C 
                            
                             
 
 
Figure 4.17. Analysis of the effects of Pkc1 and Bck1 over-expression in CM03. 
CM03 + Sse1, Sse1
G342D
 and Sse1
G616D
 were transformed with p241PKC1, 
p636BCK1 and pRS316. Comparative growth analysis was performed on SC - uracil 
medium and plates were incubated for 2 days at 37
o
C. (c) Pkc1 and Bck1 activation 
failed to recover G616D ts in strain CM03. (b) G342D control did not show any 
temperature sensitivity. 
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4.6 Analysis of CM03 sensitivity to cell wall damaging agents in the 
presence of WT Sse1 and Sse1 mutants 
                Sse1 temperature-sensitive mutants were transformed into strain CM03 for 
comparative growth analysis on YPD, caffeine, congo red, calcofluor white and SDS. 
A BY4741 slt2 strain was used as a control as it represents a mutant of CWI 
signaling. 
              Slt2 (Mpk1) is activated in response to cell wall perturbations. Treatment of 
WT cells with congo red and calcofluor white has been shown to strongly induce Slt2 
phosphorylation (De Nobel et al., 2000). Stimulation of Slt2/Mpk1 results in 
phosphorylation of Rlm1 and SBF, transcription factors that induce the expression of 
cell wall synthesis genes (Madden et al., 1997; Dodou and Treisman, 1997). A slt2 
strain was included in this study as a control that should show sensitivity to cell wall 
damaging agents. 
              The first thing noticed from the results of this experiment was that CM03 
grew better on the chemical agents than CM02 did (Figure 4.18.a/b). However there 
was no difference in sensitivity between WT Sse1 and Sse1 mutants which indicated 
that the ts mutants may not affect CWI signaling after all. slt2 was selective in the 
agents it was sensitive to. It showed no sensitivity to SDS and grew relatively well on 
low concentrations of caffeine. slt2 was particularly sensitive to congo red even at 
concentrations of only 5 g/ml which is substantial when the Sse1 ts mutants 
survived on concentrations up to 25 g/ml. slt2 and CM03 were both very sensitive 
to calcofluor white but Sse1 did grow better as slt2 was non-viable at concentrations 
of 30 g/ml (Figure 4.18.a/b).  
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Figure 4.18.a. Testing the sensitivity of strain CM03 to SDS and calcofluor white. 
Comparative growth analysis was performed on WT Sse1, Sse1
G342D
, Sse1
G343D
, 
Sse1
G616D
 and BY4741 slt2. The cells were selected on YPD or YPD with varying 
concentrations of cell wall damaging agents. CM03 was sensitive to calcofluor white 
and all strains were non-viable at concentrations above 30 g/ml. For SDS, strains 
grew relatively well with G616D being slightly more sensitive. slt2 grew well on 
SDS but failed to grow on calcofluor white. 
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   4 M caffeine                                       6 M caffeine 
      
       
    8 M caffeine                                         5 g/ml congo red            
       
    
       
    10 g/ml congo red                               25 g/ml congo red 
       
    
 
 
 
Figure 4.18.b. Testing the sensitivity of strain CM03 to caffeine and congo red. 
Comparative growth analysis was performed on WT Sse1, Sse1
G342D
, Sse1
G343D
, 
Sse1
G616D
 and BY4741 slt2. The cells were selected on YPD or YPD with varying 
concentrations of cell wall damaging agents. CM03 was sensitive to high 
concentrations of caffeine but there was no distinguishable difference between WT 
and mutant growth. slt2 was non-viable even at 5 g/ml congo red but was not 
sensitive to low concentrations of caffeine. 
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4.7 Analysis of the effects of Sse1 temperature-sensitive mutants on 
Hsp90 signaling 
               Hsp90 is an essential cytosolic yeast chaperone that was first isolated as a 
regulator of steroid hormone receptors (Pratt, 1998). Hsp90 is one of the most 
abundant eukaryotic cytosol proteins which has stress-related and cellular house- 
keeping functions (Mayer and Bukau, 1999). It has since been elucidated that Hsp90 
forms the core of a large macromolecular complex that includes other co-chaperones, 
co-factors and substrates (Zhao et al., 2005). It plays a central role in cell signaling by 
maintaining the activity of protein kinases and it is also functionally required at a 
higher level in response to cell thermal stress (Nathan et al., 1997; Zhao et al., 2005). 
                Sse1 interacts with the Hsp90 complex (Liu et al., 1999). Sse1 has been 
shown to be involved in the development and activity of Hsp90 substrates by 
regulating the transfer of client proteins to and from Hsp90, in the early stages of the 
chaperone cycle (Liu et al., 1999; Goeckeler et al., 2002; Lee et al., 2004). Like Sse1, 
Hsp90 mutants exhibit osmoremedial temperature sensitivity (Piper et al., 2006; 
Truman et al., 2007). Given that Sse1 is required for Hsp90 signaling and chaperone 
activity it was an objective to determine if the Sse1 temperature-sensitive mutants 
affected Hsp90 signaling. sse1 strains are known to be hypersensitive to Hsp90 
inhibitors (Liu et al., 1999).  
              Figure 4.19 illustrates the results of Sse1 mutant comparative growth 
analysis on medium containing geldanamycin, which at 80 M normally inhibits the 
growth of Hsp90 mutants and Hsp90 co-chaperone mutants. If Sse1 mutants are 
affecting Hsp90 signaling then they should show sensitivity to geldanamycin. This 
inhibitor targets Hsp90 by binding to its ATP binding domain, a region essential for 
client protein activation (Pearl and Prodromou, 2000). The result of this experiment 
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was that the Sse1 mutants showed no sensitivity to geldanamycin therefore they are 
not disrupting Hsp90 signaling (Figure 4.19). 
 
       YPD 
        
         
        YPD + DMSO                                         YPD + 80 M geldanamycin 
            
         
 
       YPD + DMSO                                YPD + 160 M geldanamycin 
            
         
 
Figure 4.19. Comparative growth analysis of Sse1 mutant sensitivity to 
geldanamycin. CM03 + Sse1, Sse1
G342D
, Sse1
G343D 
and Sse1
G616D
 were serial diluted 
onto YPD medium containing 80/160 M geldanamycin or DMSO control. The 
plates were incubated at 30
o
C for 2 days and analysed for differences in growth. 
Hsp90 and Hsp90 co-chaperone mutants are usually sensitive to 80 M 
geldanamycin. Hsp90 signaling appeared normal in these Sse1 mutants. Zhai Chao 
from Dr Panaratou’s laboratory Kings College London carried out these experiments. 
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              A v-src assay was also performed. Sse1 mutant strains were transformed 
with a plasmid containing v-src under the control of a GAL promoter. V-src (viral 
sarcoma) is a non-receptor tyrosine kinase protein and Hsp90 plays a major role in 
tyrosine phosphorylation mediated by v-src (Xu and Lindquist, 1993). Xu and 
Lindquist (1993) found that a reduction in cellular Hsp90 levels has a major impact 
on v-src activity and that v-src regulates the phosphorylation activity and cellular 
localisation of Hsp90.  
              The theory behind this experiment was that if the Sse1 mutants affect Hsp90 
signaling then v-src levels would also diminish and the cells would be viable and 
grow better than WT Sse1. V-src is toxic to yeast and its activity can be monitored by 
cell viability. This occurs in a cell cycle dependent manner (in M phase). However 
the plates were monitored over 24 h and all strains grew at the same rate (Figure 
4.20). These results led to the conclusion that Sse1 temperature-sensitive mutants are 
not affecting Hsp90 activity. 
 
4.8 Analysis of the effects of Sse1 temperature-sensitive mutants on 
protein kinase (PKA) signaling 
              Yeast readily ferment glucose and fructose in order to generate energy and 
cellular carbon metabolites (Johnston and Carlson, 1992). Glucose is detected by 
signal transduction components that transfer the signal into the cell nucleus where 
adjustments to gene expression are made (Santangelo, 2006). Glucose stimulates the 
cAMP/PKA signaling pathway by activating GTPase or G protein-coupled receptors 
on the cell surface. Efficient PKA signaling promotes protein synthesis, cell division 
and down-regulates stress response genes (Schneper et al., 2004; Santangelo, 2006). 
PKA signaling is responsible for inducing >90% of all genes regulated by glucose  
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Figure 4.20. V-src assay on Sse1 mutants by comparative growth analysis. Strain 
CM03 was transformed with WT Sse1, Sse1
G342D
 Sse1
G343D
 and Sse1
G616D
 and strains 
were transformed with plasmid vector containing v-src DNA. Strains were 
maintained on YPD-glucose before comparative growth analysis on YP-gal medium. 
The plates were incubated at 30
o
C for 2 days and monitored over this period. No 
difference in growth pattern was observed between WT Sse1 and Sse1 mutants. Zhai 
Chao from Dr Panaratou’s laboratory Kings College London carried out these 
experiments. 
 
 
and it responds to changes in glucose concentration by changing the magnitude and 
direction of gene transcription (Broach and Deschenes, 1990; Wang et al., 2004; 
Zaman et al., 2009). The external carbon supply available to yeast affects cell 
division and morphology. Yeast cells grown on glucose are larger than those grown 
on a non-fermentable carbon source such as ethanol (Johnston et al., 1979). Cells 
starved of adequate fermentable carbon depend on signaling through both a MAP 
kinase cascade and a cAMP dependent PKA (Lengeler et al., 2000; Pan et al., 2000; 
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Truckses et al., 2004). PKA deleted strains are non-viable (Zaman et al., 2009) and 
mutants that affect PKA signaling are sensitive to growth on non-fermentable carbon. 
              It has been suggested that the cAMP/PKA signaling cascade may also play a 
role in thermotolerance (Zhu et al., 2000). Sse1 has been linked with PKA signaling 
and it has been shown that the temperature-sensitive effects of sse1 can be 
suppressed by decreasing PKA signaling (Trott et al., 2005). Growth on ethanol and 
glycerol decreases PKA signaling (Thevelein and De Winde, 1999). Trott et al. 
(2005) demonstrated that sse1 temperature sensitivity was alleviated by growth on 
non-fermentable carbon sources suggesting that Sse1 is a negative regulator of PKA 
signaling.  
              As the growth of Sse1 mutants Sse1
G342D
 and Sse1
G616D
 was sensitive at 37
o
C 
(both in CM02), they may be mimicking a sse1 loss of function effect and could be 
alleviated by decreasing PKA activity. The theory was that if they are affecting the 
role of Sse1 in regulating PKA activity then they should show growth at 37
o
C on non-
fermentable carbon sources. Mutant G342D was included in this analysis before it 
was confirmed non-ts. 
              Yeast strains CM02 and CM03 were transformed with ts mutants and 
analysed by comparative growth analysis on YP-ethanol and YP-glycerol. After 2 
days growth at 30
o
C and 37
o
C the plates were analysed. It appeared that CM02 and 
CM03 with Sse1 mutants were very sensitive to ethanol even at 30
o
C and no growth 
recovery was observed at 37
o
C for either mutant (Figure 4.21). CM02 + Sse1
G616D 
did 
appear a lot more sensitive to ethanol than WT Sse1 at 30
o
C and 37
o
C but this result 
was not reflected in CM03. Interestingly Sse1 mutants G342D and G616D grew as 
well as WT Sse1 at 37
o
C when spotted onto YP-glycerol (Figure 4.21). This indicated 
that perhaps the ts Sse1 mutants are not functioning properly as PKA regulators and  
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Figure 4.21. Analysis of Sse1 mutant growth on non-fermentable carbon sources. 
CM02 and CM03 were transformed with WT Sse1, Sse1
G342D
 and Sse1
G616D
. 
Comparative growth analysis was performed on YP-glycerol and YP-ethanol and 
plates were incubated at 30
o
C and 37
o
C. Yeast were sensitive to growth on ethanol, 
particularly in CM03. Ts mutant Sse1
G616D
 is normally non-viable at 37
o
C on glucose 
medium however its growth was restored on YP-glycerol. This indicates that Sse1 is a 
negative regulator of PKA signaling and perhaps G616D is affecting this function. 
Mutant G342D showed similar growth but as it is not a definite ts mutant a 
conclusion could not be made. 
 30
o
C YP-ethanol                             30
o
C YP-ethanol 
Sse1 
Sse1
G342D
 
Sse1
G616D
 
 
Sse1 
Sse1
G342D
 
Sse1
G616D
 
 
Sse1 
Sse1
G342D
 
Sse1
G616D
 
 
    37
o
C YP-ethanol                             37
o
C YP-ethanol 
Sse1 
Sse1
G342D
 
Sse1
G616D
 
 
 30
o
C YP-glycerol   
 37
o
C YP-glycerol    37
o
C YP-glycerol
 212 
down-regulation of this pathway can completely restore a wild type phenotype. 
 
4.9 A phenotypic and genetic comparison of strains CM02 and CM03 
4.9.1 Comparing growth and sensitivity to chemicals reveals that these strains 
are very different 
              Because of the differences observed between CM02 and CM03 a 
comparative analysis study was performed on the two strains. Figure 4.22 is a 
summary of CM02 and CM03 growth on a variety of cell wall damaging agents. 
These comparative growth assays were performed previously and are comprised in 
this figure in way that emphasises the differences in sensitivity between the strains. 
CM02 is clearly more sensitive to cell wall damage than CM03 indicating a possible 
strain background difference (Figure 4.22). This strain sensitivity difference appears 
to be specific for these chemical agents as CM02 grew better on non-fermentable 
carbon in Figure 4.21.  
               Both strains were transformed with mutant G342D, which appeared non-
viable in CM02 but only slow-growing in CM03 (Figure 4.23). It appears that the 
effects of mutant G342D are over-emphasised in CM02, possibly due to strain 
background differences.     
 
4.9.2 Fes1 complements a sse1 sse2 deletion in strain CM03                             
               As discussed previously in Chapter 3, Fes1 is a nucleotide exchange factor 
that works alongside Sse1 in the Hsp70 peptide binding cycle (Kabani et al., 2002). 
As it shares functional similarity with Sse1 it was an aim to see if it could compensate 
yeast for the loss of Sse1 and Sse2. In Chapter 3 it was concluded that pRS423FES1 
could not compensate for CM02 sse1 sse2 non-viable phenotype. In contrast,  
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                      CM02 + Sse1                                        CM03 + Sse1             
 
                    
 
 
                     
 
 
                     
 
 
                    
 
 
                                                                       
 
 
Figure 4.22. A summary of CM02 and CM03 growth and their sensitivity to cell wall 
damaging agents. Comparative growth analysis was performed on CM02 sse1 sse2 
+ pRS315SSE1 and CM03 sse1 sse2 + pRS315SSE1 in previous sections. This 
summary illustrates how CM02 is more sensitive than CM03 to cell wall damaging 
agents. 
 
 
 
 
 
  CM02 + Sse1
G342D
                                CM03 + Sse1
G342D
 
 
                  
 
 
Figure 4.23. Comparative growth analysis of CM02 + Sse1
G342D
 and CM03 + 
Sse1
G342D 
at 37
o
C. Sse1 mutant G342D was temperature-sensitive at 37
o
C in CM02 
but not in CM03. 
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previous work by Raviol et al. (2006b) and Sadlish et al. (2008) suggested that Fes1 
could partially/fully complement sse1 sse2. Therefore pRS423FES1 was 
transformed into CM03 to see if the previous result may be due to CM02 strain 
background effects.    
                Figure 4.24 illustrates the result of transforming pRS423FES1 and pRS423 
into both CM02 and CM03. WT Sse1 was removed from each strain by replication 
onto 5-FOA. Surprisingly Fes1 did compensate for loss of Sse1 and Sse2 in strain 
CM03 but not in CM02. In conclusion, Fes1 can complement sse1 sse2 and 
previous negative results in CM02 could be related to strain background differences.  
 
 
 
 
                                  
 
 
 
 
 
Figure 4.24. Fes1 complementation in CM02 and CM03. pRS423 and pRS423FES1 
were transformed into CM02 and CM03, selected on SC - histidine and incubated for 
2 days at 30
o
C. Colonies were patched onto fresh SC - histidine medium and 
replicated onto 5-FOA to select against pRS316SSE1. 5-FOA plates were incubated 
for 2 days at 30
o
C. Cell growth for CM03 + pRS423FES1 was slow on 5-FOA but the 
strain grew well when restreaked onto fresh SC – histidine medium. 
 
CM02 + 
pRS423FES1 
CM03 + 
pRS423FES1 
CM02 + 
pRS423 
CM03 + 
pRS423 
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4.9.3 HSPH1 complements a sse1 sse2 deletion in strain CM03 
              As discussed previously in Chapter 3, HSPH1 is the yeast Hsp110 human 
homolog. It functions as a nucleotide exchange factor for mammalian Hsp70 and is 
distantly related to yeast Sse1 (Dragovic et al., 2006). HSPH1 has functional and 
general structural similarities to yeast Sse1 which prompted us to see if HSPH1 could 
compensate for loss of Hsp110 in yeast. HSPH1 was cloned under control of the 
SSA2 promoter into pC210 vector as described in section 2.23. To test whether 
pC210HSPH1 could complement sse1 sse2 the plasmid was transformed it into 
CM02 and CM03 along with positive and negative controls. Following 5-FOA 
selection HSPH1 was able to provide essential function in CM03 but not CM02 
(Figure 4.25). From this figure it is clear that the results are comparable to those 
found in Figure 4.24 where Fes1 could also complement sse1 sse2 in CM03. This 
highlights again the possible genotypic differences between the strain backgrounds. 
 
4.9.4 Analysis of the Sse1 mutant Q458* in CM02 and CM03 
              Sse1 mutant Q458* was isolated as a [psi
-
] mutant, as described in Chapter 
3. The amino acid change is from a glutamine (Q) to a TAA stop codon. It was 
unclear whether this mutation created a truncated Sse1 protein and for this reason it 
was not included in the Sse1 mutant phenotypic analysis in Chapter 3. The fact that 
Sse1
Q458*
 point mutation allowed for the growth of a fully functional yeast strain led 
to the speculation that this premature stop codon may be subjected to a high level of 
readthrough. To investigate this theory further truncated Sse1 was cloned, under the 
control of the SSA2 promoter, into pC210. Primers were designed to anneal to the 
ATG start codon of Sse1 and the reverse primer annealed to amino acid position 458. 
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Figure 4.25. HSPH1 complementation in CM02 and CM03. pRS315, pRS315SSE1 
and pC210HSPH1 were transformed into CM02 and CM03, selected on SC - leucine 
and incubated for 2 days at 30
o
C. Transformants were patched onto fresh SC - leucine 
medium and replicated onto 5-FOA to select against pRS316SSE1. 5-FOA plates 
were incubated for 2 days at 30
o
C. Cell growth for CM03 + pC210HSPH1 was 
slower than growth for pRS315SSE1 on 5-FOA but the strain grew well when 
restreaked onto fresh SC - leucine. 
 
 
The PCR product contained overhangs homologous to pC210 and it was cloned as 
described in section 2.23 using primers and PCR cycles described in Table 2.11 and 
2.12.b. Four potential clones were tested by diagnostic PCR (Figure 4.26) and one 
isolate was sent for sequence analysis. The confirmed pC210SSE1Q458 vector 
(Figure 4.27) was transformed into both CM02 and CM03 along with 
pRS315SSE1
Q458*
 point mutation vector and positive/negative controls.    
              Interestingly, the Sse1 truncated protein could not support growth in either 
CM02 or CM03 (Figure 4.28 and 4.29) indicating that Sse1 may not be able to form a 
fully functional protein when truncated by over 200 amino acids. However, the point 
mutation mutant SSE1
Q458*
 did support growth in CM02 but not in CM03. It seems 
that there may be a high level of readthrough in CM02 compared to CM03. 
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CM03 + 
pRS315 
CM02 + 
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pRS315SSE1 
CM02 + 
pC210HSPH1 
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Figure 4.26. Diagnostic restriction digest of potential pC210-Q458trunc clones. 
 
(i)  pC210-SSE1Q458trunc construct with expected bp sizes after restriction digest 
with Nde1 and Sph1. Nde1 cuts plasmid pC210 at end of the promoter region and 
Sph1 cuts at the end of the cloned SSE1Q458 sequence. This should result in two 
bands of 6715 bp and 1374 bp. 
(ii) Agarose gel electrophoresis of four potential Q458trunc plasmid clones. Each 
isolate was digested with restriction enzymes Nde1 and Sph1.  
Lane A: Molecular weight marker 
Lane B-C: Potential pC210-Q458trunc clones. DNA bands did not correspond to a 
successful clone. 
Lane D: Potential pC210-Q458trunc clone 3. The large top band was very 
concentrated and hard to determine exact size. The smaller band was approximately 
1374 bp. This clone was sent for sequencing and confirmed as a pC210-Q458trunc 
clone. 
Lane E: Potential pC210-Q458trunc clone 4. DNA bands did not correspond to a 
successful clone. 
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Figure 4.27. Construct of plasmid pC210 with Sse1 protein truncation at position 
458.  
                           
 
                                                                5-FOA 
                                    
 
Figure 4.28. Growth status of CM02 cells expressing the Sse1 point mutation Q458* 
and Sse1 Q458 truncation protein. WT Sse1, pRS315, Sse1
Q458*
 and Sse1Q458 
truncation protein were transformed into CM02, selected on SC - leucine and 
incubated for 2 days at 30
o
C. All strains grew on SC - leucine and were replicated 
onto 5-FOA to select against pRS316SSE1. This figure illustrates how Q458* can 
support growth and the Q458 truncated protein cannot.    
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Figure 4.29. Growth status of CM03 cells expressing the Sse1 point mutation Q458* 
and Sse1 Q458 truncation protein. WT Sse1, pRS315, Sse1
Q458*
 and Sse1Q458 
truncation protein were transformed into CM03, selected on SC - leucine and 
incubated for 2 days at 30
o
C. All strains grew on SC - leucine and were replicated 
onto 5-FOA to select against pRS316SSE1. This figure illustrates how both Q458* or 
the Q458 truncated protein cannot support growth. 
 
 
4.10 Yeast strain G600 genome sequencing      
4.10.1 Identification of SNPs in G600 strain 
              To further investigate the differences between CM02 and CM03 next 
generation sequencing was used to analyse G600 genomic DNA. This resulted in the 
identification of approximately 6,500 high quality SNPs (Single Nucleotide 
Polymorphisms) in G600 genomic DNA compared to reference strain S288C 
(BY4741). Using an Illumina GAII approximately 40X genome coverage was 
obtained. Isolated SNPs equated to approximately 1,500 non-synonymous amino acid 
changes. DNA sequencing was carried out in St James hospital in conjunction with 
Trinity College. A summary of the SNP data is presented in Table 4.2. Detailed  
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Table 4.2. SNPs present in G600 compared to reference strain S288C.  
 
 
Chromosome 
 
Size(bp)
a
 
 
ORFs
a
 
 
Total 
number of 
SNPs 
 
SNPs in  
ORFs 
Non- 
synonymous 
amino acid 
changes 
 
I 
 
230,208 
 
117 
 
157 
 
126 
 
59 
II 813,178 456 885 516 211 
III 316,616 183 228 157 65 
IV 1,531,919 836 38 28 22 
V 576,869 324 47 34 23 
VI 270,148 141 32 14 7 
VII 1,090,947 583 625 340 120 
VIII 562,643 321 10 5 2 
IX 439,885 241 505 304 98 
X 745,741 398 380 270 94 
XI 666,454 348 515 312 117 
XII 1,078,175 578 652 461 150 
XIII 924,429 505 655 380 138 
XIV 784,333 435 673 396 177 
XV 1,091,289 598 983 618 228 
XVI 948,062 511 79 54 34 
mito 85,779 19 87 62 4 
Totals 12,070,898 6,602 6,551 4,077 1,549 
 
a
The information was obtained from the Saccharomyces Genome Database. 
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sequence analysis data is supplemented as a hard copy (CD) and located in Tables S3 
and S4. 
               SNPs were located in three kinase proteins known to interact and 
phosphorylate Sse1 and Sse2. They are Hsl1, Kin2 and Akl1. These SNPs equated to 
five non-synonymous amino acid changes in Hsl1 (P1136R, V1308I, V1400I, 
N1439D and S1482T) and four in Akl1 (S176P, F812L, S997P, S1090G) 
(supplemented Tables S3/S4). Such changes could affect Sse1 and Sse2 protein 
phosphorylation and subsequent functions. Four non-synonymous amino acid 
changes were identified in the protein Pkc1 (supplemented Table X). This protein 
kinase is the first signaling kinase in CWI pathway and perhaps these mutations in 
G600 are responsible for the strains sensitivity to chemical compounds. A single non-
synonymous change (P2005L) was identified in G600 Ira2 protein. This protein plays 
a role in PKA signaling which could impact the sensitivity of strain CM02 or the 
functionality of Sse1.  
              Some ORFs had altered natural stop codons. Nat4 is an acetyltransferase 
protein responsible for acetylation of histones H4 and H2A (Song et al., 2003). In 
G600 a Nat4 stop codon, at 286aa, was identified as an arginine (R) mutation 
resulting in the addition of 53 amino acids to the C-terminus of the protein 
(supplemented Tables S3/S4). This could potentially alter yeast molecular and 
biological processes. However Song et al. (2003) also concluded that nat4 delete 
mutants displayed no obvious phenotypes. Other ORFs with altered natural stop 
codons included MFT1 (involved in transcription elongation and telomere 
maintenance), YNR066C, CRS5 (copper resistantance gene) and YGR067C 
(supplemented Tables S3/S4).  
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4.10.2 Analysis of G600 ISCMs 
              In addition to non-synonymous amino acid changes ISCMs (Inactivating 
Stop Codon Mutations) were also identified in a variety of genes (Table 4.3). The fact 
that the sequence data correctly identified the ade2 nonsense mutation in strain G600 
(Table 4.3) provided confidence that the other identified ISCMs would also be 
correct. The presence of ISCMs and SNPs in G600 could have major implications on 
the interpretation of [PSI
+
] associated phenotypes. Increased translation read-through 
of aberrant stop codons in a [PSI
+
] expressing strain may lead to accumulation of 
ISCMs as there is less selective pressure against them.  
              Figure 4.30 illustrates the phylogenetic distribution of yeast strains that have 
been generated by the Saccharomyces Genome Resequencing project. Analysis of 
this phylogeny was carried out by Dr David Fitzpatrick (NUI Maynooth). This shows 
that strain G600 is more related to the reference strain S288c. 
            Figure 4.31 illustrates sequencing chromatogram results for chromosome V 
and XII. The large peaks in the graph represent repetitive sequences that appear more 
than once in the chromosome e.g. origins of replication (ORFs) or transposable 
elements. Ribosomal DNA copies also come off as large broad peaks. A copy of all 
chromosomal sequencing chromatograms is available in supplementary Figure Y. 
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Table 4.3. ORFs in G600 containing single internal nonsense mutations. 
 
 
Systematic 
name
a
 
 
Gene 
name
a
 
 
Biological function
a
 
 
Chromosomal 
SNP position 
Nonsense 
change and 
consequence 
 
YBR074W 
 
- 
 
Putative metalloprotease 
 
387,247 
 
Q323TAA 
653 amino acid 
truncation 
YNL106C INP52 Polyphosphatidylinositol 
phosphatase, 
dephosphorylates a number 
of phosphatidylinositols 
(PIs) to PI 
422,546 W651TAG 
532 amino acid 
truncation 
YOR128C ADE2 Adenine biosynthesis 566,003 E64TAA 
507 amino acid 
truncation 
YOR129C AFI1 Arf3p polarisation-specific 
docking factor, required for 
polarised distribution of the 
ADP-ribosylation factor 
Arf3p 
566,901 E887TAA 
6 amino acid 
truncation 
 
a
Information obtained from the Saccharomyces Genome Database. 
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Figure 4.30. Phylogenetic distribution of yeast species. 74D is another commonly 
used yeast strain in prion research laboratories. This phylogeny was generated by Liti 
et al. (2009).  
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Figure 4.31.  Chromatogram showing chromosomal coverage from DNA sequencing. 
Graphs represent full 40X coverage of chromosome V and XII. Chromosome XII has 
more repetitive sequence and more ribosomal DNA copies than chromosome V. 
Repetitive sequence and ribosomal DNA have a higher coverage as they overlap and 
map onto each other, resulting in larger peaks. 
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4.10.3 Analysis of G600 sensitivity to cell wall damaging agents in the presence of 
a plasmid expressing gene YBR074W  
              The identification of nonsense mutations in YBR074W, YOR129C and 
YNL106C in G600 may have implications for cellular homeostasis in this strain. As 
seen in section 4.9 G600 strain CM02 showed a higher level of sensitivity to cell wall 
damaging agents than BY4741 strain CM03. CM03 was also able to complement 
sse1 sse2 growth by the over-expression of Fes1 and HSPH1 and CM02 was not. 
Of the three identified ISCMs YBR074W and YNL106C were concentrated on as 
YOR129C only had a 6 amino acid truncation. 
              YNL106C or INP52 is a member of a conserved family of phosphoinositide 
phosphatases. It is a 136 kDa membrane protein and its deletion is viable (Stolz et al., 
1998). The phosphoinositides are regulators of the actin cytoskeleton and membrane 
trafficking (Corvera et al., 1999) and it has been suggested that YNL106C (INP52) 
may play a role in actin cytoskeleton re-organisation following osmotic stress (Ooms 
et al., 2000). YBR074W is a less well characterised gene but it does form a putative 
protease which may act as a vacuolar proteolytic enzyme (Wiederhold et al., 2009). 
             YBR074W ISCM creates a 653 amino acid truncated protein at Q323 and 
YNL106C ISCM creates a 532 amino acid truncated protein at W651. To determine 
whether ISCMs to genes YBR074W and YNL106C were causing strain sensitivity 
plasmid vectors containing these genes were purchased from Euroscarf. At the time 
only plasmid pYCGYBR074W was available from Euroscarf and an attempt to clone 
YNL106C into a vector was unsuccessful. Plasmids pRS316 and pYCGYBR074W 
were transformed into G600 [PSI
+
] and G600 [psi
-
] (previously cured on 3 mM 
GdnHCl). Yeast were cultured in SC - uracil media to maintain plasmid expression 
and comparative growth analysis was performed on YPD and YPD supplemented 
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with cell stress chemicals. The plates were incubated for 2 days at 30
o
C. Interestingly, 
[psi
-
] versions of G600 were more sensitive to chemical cell wall stress than [PSI
+
] 
strains (Figure 4.32. a-c). When G600 [psi
-
] yeast were exposed to 0.005% SDS, 
0.01% SDS and 10 g/ml congo red the expression of pYCGYBR074W did improve 
cell growth compared to the control. This suggests that the incomplete translation of 
YBR074W in G600 [psi
-
] may affect the cells ability to withstand chemical stress. 
This result was significant as Inactivating Stop Codon Mutations (ISCMs), such as 
the one identified in YBR074W, may be responsible for G600 strain sensitivity. 
 
4.11 Random mutagenesis screen for the isolation of new Sse1 
temperature-sensitive mutants 
             The rationale behind this screen was to isolate ts mutants that affect Sse1 
residues important for cell wall signaling through PKA or CWI. This could help gain 
insight into important amino acid residues that are structurally and functionally 
involved in Sse1 interactions and signaling processes. pRS315SSE1 mutant library 
was created as described in section 2.15 and transformed into CM03 along with WT 
pRS315SSE1 and pRS315. Plasmid shuffle was performed on transformants by 
selecting colonies on 5-FOA and incubating plates at 37
o
C for two days (Figure 4.33). 
Approximately 10,000 colonies went through the primary screen. Twenty five 
potential temperature-sensitive mutants were isolated from 5-FOA and the 
corresponding colonies were picked from SC - leucine replication plates. The 
secondary screen involved isolating these plasmids as described in section 2.11.2 and 
transforming them back into CM03. Each potential ts mutant was analysed by  
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Figure 4.32.a. Comparative growth analysis of G600 sensitivity to cell wall 
damaging agents. G600 [PSI
+
] and [psi
-
] were transformed with pRS316 and 
pYCGYBR074W. Transformants were grown in SC - uracil media before being serial 
diluted onto YPD and medium containing varying concentrations of SDS. The plates 
were incubated for 2 days at 30
o
C. G600 [psi
-
] control was non-viable on SDS 
medium, however the expression of pYCGYBR074W restored some cellular growth. 
G600 [psi
-
] appeared more sensitive to the cell wall damaging agent SDS than G600 
[PSI
+
]. 
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Figure 4.32.b. Comparative growth analysis of G600 sensitivity to cell wall 
damaging agents. G600 [PSI
+
] and [psi
-
] were transformed with pRS316 and 
pYCGYBR074W. Transformants were grown in SC - uracil media before being serial 
diluted onto YPD medium containing varying concentrations of chemical agents. The 
plates were incubated for 2 days at 30
o
C. G600 [psi
-
] control was non-viable on 
congo red medium, however the expression of pYCGYBR074W restored some 
cellular growth. 3 mM H2O2 and caffeine treatment had no effect on any of the 
strains. G600 [psi
-
] appeared more sensitive to cell wall damaging agent congo red 
than G600 [PSI
+
].                           
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Figure 4.32.c. Comparative growth analysis of G600 sensitivity to cell wall 
damaging agents. G600 [PSI
+
] and [psi
-
] were transformed with pRS316 and 
pYCGYBR074W. Transformants were grown in SC - uracil media before being serial 
diluted onto YPD medium containing varying concentrations of calcofluor white. The 
plates were incubated for 2 days at 30
o
C. G600 [psi
-
] and [PSI
+
] were sensitive to 
calcoflour white medium, however the expression of pYCGYBR074W did restore 
some growth in G600 [psi
-
]. G600 [psi
-
] appeared more sensitive to cell wall 
damaging agent calcofluor white than G600 [PSI
+
]. 
 
 
 
comparative growth at 30
o
C and 37
o
C which led to four isolates (EP10, 11, 21, 22) 
having a reproducible ts phenotype (Figure 4.34). Each isolate was sent for sequence 
analysis and they all returned as Sse1
G616D
. This mutant was isolated in previous 
screens as a ts mutant in CM02. Given that this was the only mutant obtained and was 
isolated four times suggests that the screen was saturated. The results from this screen 
G600 pRS316 
G600  pYCGYBR074W 
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indicate that it may be difficult to isolate 37
o
C ts mutants in Sse1. Perhaps more 
mutants could have been isolated if the screen was performed at 39
o
C. The reason 
why the screen was carried out at 37
o
C rather than 39
o
C was to identify specific cell 
wall signaling mutants rather than general ts mutants. 
 
  
                   pRS315 control                                 SSE1 control 
            
                  
                                                                                                             
                                           SSE1 mutant library 
                            
          
 
Figure 4.33. Primary screen for the isolation of Sse1 temperature-sensitive mutants. 
Strain CM03 was transformed with SSE1 mutant library, WT SSE1 and empty vector 
controls. 5-FOA replication and 24 hour incubation at 37
o
C resulted in a number of 
potential temperature-sensitive plasmids. Examples of colonies that were selected as 
potential ts mutants are highlighted (red circles). 
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Figure 4.34. Secondary screen for the isolation of potential Sse1 temperature- 
sensitive mutants. Comparative growth analysis was performed on twenty five 
potential ts mutants. Yeast were serial diluted onto YPD and incubated at 30
o
C and 
37
o
C for 2 days. Four isolates were confirmed as ts. Sequence analysis revealed that 
they were all Sse1
G616D
. 
 
 
 
4.12 Investigation into the effects of SWI6 deletion on Sse1 mutant 
growth and cellular morphology 
              SBF and MBF are transcription factors which mediate transcription in late 
G1 phase of cell cycle progression (Koch and Nasmyth, 1994; Breeden, 1996). They 
function as heterodimers composed of the regulatory protein Swi6 (Breeden and 
Nasmyth, 1987) and DNA binding protein Swi4 or Mbp1 (Andrews and Herskowitz, 
1989; Koch et al., 1993). SBF (Swi6-Swi4) plays a role in CWI signaling as a Mpk1 
target. swi4 and swi6 mutants are sensitive to calcofluor white and Swi6 is 
Sse1 
EP10 
EP11 
EP21 
EP22 
Sse1 
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EP11 
EP21 
EP22 
 37
o
C-YPD 
 37
o
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 233 
phosphorylated by Mpk1 (Slt2) in response to cell wall stress (Igual et al., 1996; 
Madden et al., 1997). 
               It has been suggested that Sse1 may genetically interact with the 
transcription factor SBF in a manner that supports cell growth and proliferation 
(Shaner et al., 2008). In this investigation a combination of Swi6 and Hsp110 mutant 
strains were generated that have abnormal growth and cell morphology indicating that 
these components do interplay in similar cellular mechanisms.  
 
 
4.12.1 Knocking out SWI genes in CM03 
               SWI6 was replaced by a HIS5 marker in strain CM03. This was performed 
by knockout by homologous recombination using methods described in section 2.19. 
A PCR product of the SWI6 knockout cassette (Figure 4.35) was transformed into 
CM03 and colonies were replicated onto SC - histidine. Colonies were picked off to 
confirm the presence of a knockout. Diagnostic PCRs were carried out on 
approximately six potential knockouts using primers listed in Table 2.12.d and PCR 
cycle listed in Table 2.11. The expected PCR product sizes are annotated in Figure 
4.36. Three isolates were confirmed as swi6 and Figure 4.37 illustrates the PCR 
results for one of these strains.  
               Shaner et al. (2008) successfully created a BY4741 swi6 swi4 strain, a 
combination of deletions previously believed to be non-viable. One of the aims in this 
study was to make this double deletion in CM03. In order to knockout SWI4 with the 
same HIS5 gene HIS5 was successfully removed from CM03 swi6 by a method 
known as ‘Cre lox’. This was performed by transforming vector pSH47 into 
CM03 swi6. This vector expresses a cre-recombinase that recognises loxP sites. The 
HIS5 knockout construct from vector pUG27 contains loxP sites which have been 
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incorporated into CM03 swi6 either side of the HIS5 gene. The cre-recombinase 
loops out the internal HIS5 gene and the strands recombine. SWI4 deletions were 
attempted on three separate occasions and were unsuccessful each time.  
 
                                 
 
                                                                                     
     pUG27                                                                                                            pUG27 
   
                                                               
      ------------------------------------------------------------------------------------------------- 
  
                                                                 1562 bp 
     
 
 
(ii) Agarose gel electrophoresis of PCR product 
 
                           kilobases                 A                   B 
                                         
 
Figure 4.35. PCR product of swi6 HIS5 knockout cassette.  
(i) Illustration of the expected band size for the swi6 HIS5 knockout cassette. 
Primers SWI6KO F/R were designed with sequence overhangs homologous to 
upstream and downstream of SWI6 coding sequence. The primers also annealed to 
DNA upstream and downstream of the HIS5 promoter and terminator sequence, in 
plasmid pUG27. The total PCR product was expected to be approximately 1562 bp. 
(ii) Primers SWI6KO F/R were used on plasmid pUG27 which resulted in a product 
size of 1562 bp. This PCR product was used to knockout SWI6 in CM03 by 
homologous recombination. Lane A illustrates 1kb DNA ladder and lane B is the 
knockout cassette PCR product. 
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(1) wild type SWI6 
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Figure 4.36. Illustration shows the expected wild type SWI6 and swi6 constructs 
and PCR fragment sizes. (1) SWI6 wild type DNA coding sequence is 2412 bp. 
Primers SWI6F and SWI6R are located upstream and downstream of SWI6 coding 
sequence. PCR using these primers should result in a DNA band of approximately 
3048 bp for wild type SWI6. (2) illustrates a swi6 knockout construct with HIS5 gene 
replacing the coding sequence of SWI6. The HIS5 DNA used was from vector 
pUG27. PCR of the knockout construct, using primers SWI6F and SWI6R, should 
result in a band approximately 2167 bp in size. HIS5 F/R primers anneal internally to 
the HIS5 DNA sequence and should result in a DNA band of 971 bp. PCR of the 
knockout construct, using primers SWI6R and HIS5F, should result in a DNA band 
approximately 1684 bp in size and corresponds to the right flanking region of the 
swi6 knockout construct. 
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Figure 4.37. Diagnostic PCR of swi6 knockout in strain CM03. 
 
Lane A: 1kb molecular weight marker. 
Lane B: PCR product from potential swi6 genomic DNA using primers SWI6F/R. 
This resulted in a DNA band approximately 2167 bp in size and corresponds to HIS5 
gene replacement. WT SWI6 would result in a 3048 bp band. 
Lane C: PCR product from potential swi6 genomic DNA using primers SWI6R and 
HIS5F. This resulted in a DNA band approximately 1684 bp in size and corresponds 
to the right flanking region of the CM03 swi6 knockout construct. 
Lane D: PCR product from potential swi6 genomic DNA using primers HIS5F/R. 
This resulted in a DNA band approximately 971 bp in size and confirms that HIS5 
gene has been successfully incorporated into the CM03 genome. All primers are 
listed in Table 2.12.d. 
 
 
 
4.12.2 Comparative growth analysis of CM03 swi6 expressing WT Sse1, Sse2 
and Sse1 mutants 
               To further investigate the relationship between Sse1 and SBF components 
strains were constructed with various mutations and deletions in Sse1, Sse2 and Swi6. 
The aim was to see what effect a Swi6 deletion would have on Sse mutant growth at 
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restrictive temperatures. In section 4.1 the temperature-sensitive effects of Sse1 
mutants in strain CM02 were tested. This led to the conclusion that particular Sse1 
mutants are ts to varying degrees at 39
o
C. These mutants may have similar effects in 
CM03 and CM03 swi6. [psi
-
] mutants were used in this study because they may have 
the biggest phenotypic and functional alterations although [PSI
+
] phenotypic effects 
could not be analysed in CM03.  
              Sse1 mutants G41D, G50D, G342D and T365I were selected and their 
growth compared to WT Sse1 and Sse2 by comparative growth analysis (Figure 
4.38). One major difference observed was that G41D, G50D and T365I grew well at 
39
o
C when these mutants were nearly completely non-viable in CM02 at this 
temperature. In CM03 mutant G342D was non-viable at 39
o
C but grew well at 37
o
C 
(Figure 4.38) suggesting that this mutant is ts but at a higher temperature of 39
o
C. 
                swi6 sse1 sse2 + Sse1 grew relatively well and was the only strain to 
survive at 39
o
C (Figure 4.39). However, in agreement with observations made by 
Shaner et al. (2008), swi6 sse1 sse2 + Sse2 growth was sensitive even at 30
o
C 
(Figure 4.39). They tested swi6 growth alone at 30
o
C and 37
o
C and found that it 
grew normally and sse1 alone was slightly slow-growing, so it must be the 
combined effect of Sse1 and Swi6 deletion making the strain sick. Shaner et al. 
(2008) concluded that this phenotype may be caused by disruption to CWI pathway.  
              Four Sse1 mutants G41D, G50D, G342D and T365I were also expressed in 
CM03 sse1 sse2 swi6 and analysed by comparative growth analysis. All Sse1 
mutants were non-viable at 39
o
C indicating that their particular mutation to Sse1 was 
incapable of providing a function to keep the cell alive in the presence of sse2 and 
swi6 (Figure 4.39). However the mutations to Sse1 did not have as severe of an 
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Figure 4.38. Comparative growth analysis of CM03 expressing Sse1 and Sse2 
mutants. CM03 sse1 sse2 was transformed with either Sse1, Sse2 or a selection of 
Sse1 mutants. Cells were selected on SC - leucine, incubated at 30
o
C for 2 days and 
replicated onto 5-FOA. Comparative growth analysis was performed on YPD and 
plates were incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. All strains grew well at 
30
o
C and 37
o
C however mutant G342D was completely non-viable at 39
o
C. All 
mutants grew much better at 39
o
C in strain CM03 compared to strain CM02. 
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Figure 4.39. Comparative growth analysis of CM03 swi6 expressing Sse1 and Sse2 
mutants. CM03 sse1 sse2 swi6 was transformed with either Sse1, Sse2 or a 
selection of Sse1 mutants. Cells were selected on SC - leucine, incubated for 2 days at 
30
o
C and replicated onto 5-FOA. Comparative growth analysis was performed on 
YPD and plates were incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. 
CM03 swi6 sse1 sse2 + Sse2 struggled to grow even at 30
o
C. These results can be 
compared to the mutants in Figure 4.38 where they were in the presence of WT Swi6. 
The deletion of Swi6 made sse1 and Sse1 mutant strains non-viable at 39
o
C. 
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effect as complete deletion of Sse1, which when combined with swi6  demonstrated 
incomplete growth even at 30
o
C. These results can also be compared to those found 
in Figure 4.38 when Sse1 and mutants were expressed alone. It appears that the 
deletion of SWI6 does impair the ability of Sse1 and Sse1 mutants to grow at normal 
and restrictive temperatures. 
 
 
 
4.12.3 Analysis of the effect of swi6 deletion on cellular morphology 
              Yeast strains from section 4.12.2 were further classified according to their 
cellular morphology. Cell morphology is a good indicator for how ‘healthy’ a 
particular yeast strain is. Yeast normally have a small oblong shape which results 
from maintenance through cell cycle control, gene expression, cell wall synthesis and 
various signaling interactions (Blacketer et al., 1995). Swi4 and Swi6 transcription 
factors are known to control the expression of many cell cycle regulating proteins and 
their deletion has been implicated in abnormal bud elongation morphology (Nasmyth 
and Dirick, 1991; Andrews and Moore, 1992; Blacketer et al., 1995). 
              As Swi6 and Sse1 play a role in CWI signaling, and deletion of both genes 
has an effect on yeast growth (as seen in section 4.12.2), the next step taken was to 
determine whether a combination of these mutations disrupts cell structure. Cell 
morphology was examined by light microscopy at 40X magnification. Cells in 
swi6 sse1 sse2 + Sse2, swi6 sse1 sse2 + Sse1 and swi6 sse1 sse2 + Sse1 
mutants were large, elongated and amorphous and were similar to those found by 
Shaner et al. (2008). In comparison, Sse1/2 deletion or Sse1 mutants alone produced 
circular shaped budding cells and seemed to have little obvious impact to cell 
morphology (Figure 4.40.a/b). However, Shaner et al. (2008) also discovered that 
swi6 alone results in approximately 30% of cells being elongated and the rest 
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normal so Swi6 deletion alone has some impact on cellular morphology. However, 
when BY4741 swi6 cells were observed by light microscopy there was no alteration 
to cell morphology (Figure 4.40.c). 
          The additional deletion of swi6 in Sse1 mutants had a huge impact on cell 
structure resulting in cells with disrupted structure, size and bud formation. The most 
severe abnormalities was seen for swi6 sse1 sse2 + Sse2, swi6 sse1 sse2 + 
Sse1
G50D
 and swi6 sse1 sse2 + Sse1
T365I
 where approximately 80% of cells were 
amorphous or elongated, indicative of defects to cell cycle regulation (Shaner et al., 
2008). The least effect observed was for swi6 sse1 sse2 + Sse1 and 
swi6 sse1 sse2 + Sse1
G342D
 which only produced approximately 30-40% elongated 
cells and the rest appeared normal. This was interesting since Sse1
G342D
 alone is ts at 
39
o
C and was expected to have quite a severe affect on cellular homeostasis. 
Somehow the functions for Sse1 in temperature stability and cell morphology must be 
distinct and unrelated. It was not surprising that swi6 sse1 sse2 + Sse1 had one of 
the least effects as it still expressed WT Sse1 which probably plays a bigger role than 
Sse2 in cellular homeostasis. 
 
4.13 Chapter discussion 
              This Chapter further classified thirteen Sse1 mutants according to their 
growth, sensitivity and involvement in cellular signaling processes. The 
understanding of Sse1 as a molecular chaperone and as a regulator of cell signaling 
and thermostability has been extended. Analysis of the strain CM02 led to the 
creation of a new background strain in BY4741 (CM03) in which the Sse1 mutant 
phenotypes could be compared. This allowed the creation of a comparative profile of 
these two yeast strains on a genetic and phenotypic level.  
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    (a) CM03 sse1 sse2 Sse1                      (b) CM03 sse1 sse2 swi6 Sse1 
        
     
    (c) CM03 sse1 sse2 Sse2                      (d) CM03 sse1 sse2 swi6 Sse2 
        
     
    (e) CM03 sse1 sse2 Sse1
G41D
               (f) CM03 sse1 sse2 swi6 Sse1
G41D
 
        
     
 
40X magnification 
 
Figure 4.40.a. Analysis of yeast cellular morphology changes when swi6 is deleted. 
CM03 sse1 sse2 and CM03 sse1 sse2 swi6 were transformed with Sse1, Sse2 and 
four Sse1 mutants. Cells were selected on SC - leucine, incubated at 30
o
C for 2 days 
and replicated onto 5-FOA. Strains were maintained on SC-leucine and prepared by 
streaking on glass slides with 20 l dH2O. Cells were analysed at 40X under light 
microscopy. 
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    (g) CM03 sse1 sse2 Sse1
G50D
               (h) CM03 sse1 sse2 swi6 Sse1
G50D
 
        
     
    (i) CM03 sse1 sse2 Sse1
G342D
               (j) CM03 sse1 sse2 swi6 Sse1
G342D
 
        
     
    (k) CM03 sse1 sse2 Sse1
T365I
               (l) CM03 sse1 sse2 swi6 Sse1
T365I
 
        
     
40X magnification                         
 
 
Figure 4.40.b. Analysis of yeast cellular morphology changes when swi6 is deleted. 
CM03 sse1 sse2 and CM03 sse1 sse2 swi6 were transformed with Sse1, Sse2 and 
four Sse1 mutants. Cells were selected on SC - leucine, incubated at 30
o
C for 2 days 
and replicated onto 5-FOA. Strains were maintained on SC - leucine and prepared by 
streaking on glass slides with 20 l dH2O. Cells were analysed at 40X under light 
microscopy. 
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40X magnification 
 
Figure 4.36.c. Analysis of BY4741 strain when swi6 is knocked-out. Cells were 
prepared by streaking on glass slides with 20 l dH2O and analysed at 40X under 
light microscopy.  
 
 
              The Hsp110 group of molecular chaperones serve as heat-induced stress 
factors in many eukaryotic species including mammals (Lee-Yoon et al., 1995). In 
yeast, SSE1 gene is moderately expressed at normal growth temperatures and induced 
at higher levels upon heat shock. SSE2 is virtually undetectable until it is induced 20-
fold upon heat stress (Mukai et al., 1993; Shirayama et al., 1993). Deletion of SSE1 
leads to slow-growing temperature-sensitive cells (Mukai et al., 1993). Due to the 
nature of Sse1 the initial aim was to test if any of the Sse1 mutants were incapable at 
providing cellular thermostability. Results from 37
o
C comparative growth analysis 
revealed that the mutants Sse1
G342D
 and Sse1
G616D
 were ts. Comparative growth 
analysis at 39
o
C allowed us to further classify all the mutants as they all displayed 
varying degrees of sensitivity at this temperature with Sse1
G41D
, Sse1
G50D
, Sse1
G342D
 
and Sse1
G616D
 completely non-viable. These results confirmed a role of Sse1 in 
cellular thermotolerance and it is interesting how each Sse1 mutant showed thermal 
stress at different magnitudes. Sensitivity to thermal stress could be due to disruption 
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to Sse1 protein stability and interaction with other molecular chaperones due to heat 
denaturation. Sse1
G342D
 and Sse1
G616D
 were both temperature-sensitive at 37
o
C in 
CM02. These non-viable phenotypes could result from improper Sse1 heat shock 
protein function. It was later investigated whether these mutants were ts in CM03 
BY4741 background and Sse1
G342D
 was not ts but only slightly slow-growing at 37
o
C. 
The differences in growth of mutant G342D in two strains could be due to strain 
background differences but how exactly is unknown. The next step involved 
investigating whether these mutants cause any other cell sensitivity in CM02.  
               Yeast cope well with environmental stress such as heat and osmotic shock 
by activating MAP kinase cascades (Chen and Thorner, 2007). When yeast grow on 
hypoosmotic medium such as YPD, the MAP kinase CWI signaling pathway is 
activated. CWI signaling mediates cell wall biosynthesis and repair (Levin, 2005). 
Mutants which disrupt this pathway need osmotic stabilisers such as 1 M sorbitol in 
order to grow (Davenport et al., 1995). Mutants G342D and G616D were 
osmoremedial at 37
o
C when grown on YPD with 1 M sorbitol. This result indicated 
that the Sse1 protein may play a role in cell wall integrity. Other groups have found 
that mutants causing cell lysis at increased temperatures are often located in genes 
involved in cell wall maintenance (Paravicini et al., 1992). This theory was 
investigated further by testing the ts mutants sensitivity to cell wall damaging agents. 
Exposure of yeast to chemical agents such as congo red initiates CWI signaling and 
mutants of this cascade often display sensitivity to these agents (Levin, 2005). The 
results from this experiment were inconclusive as CM02 expressing WT Sse1 was 
sensitive to the chemicals and an accurate comparison between WT and mutant 
growth could not be made. The chemical concentrations used were lower than those 
used by other groups and the strain background was different to those used by others. 
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CM02 observed a general strain sensitivity, particularly to congo red and calcofluor 
white. This could be due to a background sensitivity in CM02 making it particularly 
sensitive to cell wall stress. Further on in this Chapter a number of SNPs were 
identified in the G600 genome which could be accountable for this strain sensitivity. 
                It was also investigated whether high copy inducers of CWI signaling could 
restore growth in temperature-sensitive Sse1 mutants. Pkc1 and Bck1 are essential 
components of CWI signaling and their constitutive expression on plasmid DNA did 
partially recover G342D and G616D growth at 37
o
C. This indicated that these 
mutants could be affecting CWI signaling, through the MAP kinase pathway, as 
activation of Pkc1 and Bck1 leads to the up-regulation of genes involved in cell wall 
repair (Irie et al., 1993). However, the constitutive expression of Pkc1 seemed to have 
a greater effect on mutant growth at 37
o
C than Bck1. Perhaps this was due to the fact 
that Pkc1 fulfills more than one role in cellular homeostasis and its activation 
stimulates the up-regulation of a multitude of genes through many signaling 
pathways. Despite these positive results no accurate conclusion could be made. The 
sensitivity of G600 and CM02 to the chemical agents was concerning and suggested 
an underlying genetic problem with this strain. The recovery of Sse1 mutant ts by 
Pkc1 and Bck1 was not reproduced in CM03. 
                These results prompted the creation of a new BY4741 sse1 sse2 strain for 
testing Sse1 mutant phenotypes. Shaner et al. (2008) also used a BY4741 background 
strain for testing Sse1 mutant sensitivity to congo red and calcofluor white. They 
found a comparable difference in sensitivity between WT Sse1 and sse1/sse1 mutant 
strains when grown on these agents. All previous tests performed in CM02 were 
repeated in BY4741 sse1/sse2 strain (CM03). The first difference observed was that 
the Sse1 mutant G342D was not fully ts but only slightly slow-growing. Sse1
G342D
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and Sse1
G616D
 temperature-sensitive growth was fully recovered on 1 M sorbitol but 
the activation of Bck1 and Pkc1 resulted in no growth recovery at 37
o
C. When tested 
on chemical cell wall perturbing agents CM03 grew substantially better than CM02 
although its response to each individual chemical was not uniform. There were no 
obvious differences in growth between WT Sse1 and Sse1 mutants on chemical 
agents. BY4741 slt2 was used as a control and it was non-viable on 5 g/ml congo 
red. CM03 survived on congo red at concentrations up to 25 g/ml. The stability of 
Sse1 mutants on congo red compared to slt2 suggested that the Sse1 mutants are not 
affecting CWI signaling at all, or that their effects are not easily detectable, as they 
should have displayed similar phenotypes to slt2. However slt2 was selective in 
what it was sensitive to as it only showed sensitivity to congo red and calcofluor 
white. It was clear from these results that different chemical stresses do not have a 
uniform response in CWI signaling mutants such as slt2 (Fuchs and Mylonakis, 
2009). The recovery of Pkc1 and Bck1 in CM02 did hint at CWI signaling but this 
may have been due to a strain background issue and not the mutants alone. A number 
of SNPs were identified in G600 with one located in Pkc1. This could possibly 
account for growth recovery in the presence of activated Pkc1 and Bck1. 
               CWI signaling is known to cross-talk with other cellular pathways in 
response to stress such as protein kinase A, TOR and HOG signaling (Fuchs and 
Mylonakis, 2009). It has also been suggested that Slt2 activation is independent of 
Pkc1 and Bck1. Harrison and collegues tested Pkc1 and Bck1 mutant strains and 
found Slt2 induction and phosphorylation in response to heat shock (Harrison et al., 
2004). Perhaps CWI signaling is dispensable and allows lateral influences to activate 
Slt2? (Fuchs and Mylonakis, 2009). The activation of CWI signaling also depends on 
the type of stress that initiates the response. Osmotic stress and exposure to zymolase 
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involves both HOG and CWI signaling whereas caffeine stress induces a CWI 
response through Slt2 phosphorylation in a TOR dependent manner (Fuchs and 
Mylonakis, 2009). The lack of sensitivity of CM03 to caffeine re-emphasised no role 
in CWI signaling. The complexity of the CWI signaling network and numerous 
interacting components makes it difficult to pinpoint exactly how and why the Sse1 
mutants may be affecting signaling. Perhaps Sse1 mutants are not affecting a single 
stress pathway in a specific manner but causing a more complicated effect through 
multiple interacting pathways? 
               The Sse1 mutants were further assessed to determine if they affect other cell 
signaling pathways. Hsp90 is a cellular chaperone that plays a central role in cell 
signaling and in providing cell thermostability (Nathan et al., 1997; Zhao et al., 
2005). Sse1 has been physically and genetically linked with Hsp90 and is implicated 
in the maturation and client fate of Hsp90 substrates (Liu et al., 1999; Lee et al., 
2004; Shaner et al., 2008; Mandal et al., 2010). Like Sse1 mutants, Hsp90 mutants 
exhibit osmoremedial temperature-sensitive growth (Piper et al., 2006; Truman et al., 
2007). A number of tests were carried out to assess whether Sse1 mutants affect 
Hsp90 signaling and the results suggested that they do not interfere with Hsp90 
signaling. Whether the mutants were disrupting PKA signaling was also tested. Yeast 
cell growth on glucose medium results in the hyperactivation of the PKA pathway 
which is ultimately associated with decreased tolerance to thermal stress. Sse1 and 
Sse2 may decrease PKA activity in times of heat shock when chaperone levels are 
highly induced. Sse1 has been linked with PKA signaling, as a negative regulator, and 
the ts effects of sse1 can be suppressed by decreasing PKA signaling (Trott et al., 
2005). Sse1 mutants G342D and G616D growth was improved at 37
o
C and they grew 
as well as WT Sse1 when selected on YP-glycerol. YP-glycerol down-regulates 
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normal PKA signaling and it is perhaps suppressing a ts phenotype exerted by Sse1 
mutants on YP-glucose. So mutations to Sse1 such as G616D may be preventing Sse1 
from regulating PKA thus leading to a ts phenotype.  
            The availability of two sse1 sse2 strains allowed a comparative analysis to 
be carried out between both CM02 and CM03. Firstly, strain temperature sensitivity 
and sensitivity to cell wall damaging agents was looked at. Mutant Sse1
G342D
 was 
non-viable in CM02 at 37
o
C but only slightly slow-growing in CM03. This indicates 
that Sse1
G342D 
is having an enhanced effect when expressed in CM02. CM03 + Sse1 
grew on cell wall perturbing agents at a much greater rate than CM02 + Sse1. CM02 
was unstable on relatively low concentrations of congo red and SDS (Figure 4.22). 
These differences in environmental stress coping mechanisms are indicative of 
genetic mutations to cell wall stress signaling. Differences were also observed in the 
strains ability to complement different proteins with similar NEF function. In Chapter 
3 it was concluded that Fes1 and HSPH1 could not support non-viable growth in 
CM02 sse1 sse2. The tests were repeated in CM03 and found that both proteins 
could support deletion of sse1/sse2. As previous work has shown that Fes1 could 
partially/fully complement Sse deletion it was concluded that Fes1 over-expression 
can complement deletion of sse1 and sse2. HSPH1 is the human homolog of yeast 
Sse1 and they share functional characteristics so it does seem plausible that it can 
compensate for loss of Sse1 in yeast as it was expressed on a high copy plasmid 
vector. These results confirmed the previous belief that CM02 has a background 
strain weakness making it highly sensitive. An additional comparative observation 
was made with the Sse1 mutant Q458*. This was analysed as a difference in the level 
of nonsense suppression between the two strains. Truncated protein Sse1
Q458trunc
 was 
created and expressed in CM02 and CM03 and it could not support growth. This was 
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not surprising as Sse1 could not form a fully functional protein with such a huge 
truncation. However, the Sse1
Q458*
 stop codon mutant could support growth in CM02 
but not in CM03. It can be speculated that perhaps the premature stop codon was 
subjected to a relatively high level of readthrough in CM02. Highly efficient 
nonsense suppression in an ade2.1 strain means that the cell is [PSI
+
] caused by 
aggregation of Sup35 (Tuite and Cox, 2007). However, Sse1 mutant Q458* was 
originally isolated as a [psi
-
] mutant therefore there is still a certain level of functional 
Sup35 in the cell. A number of factors could enhance readthrough in strain CM02 
including the presence of SUQ5 mutation. CM02 contains SUQ5 and CM03 does not.  
SUQ5 is a serine tRNA nonsense suppressor resulting in the incorporation of a serine 
residue at certain stop codons. Therefore, there is the possibility that Q458* is 
actually translated as Q458S in CM02. This would account for the readthrough and 
possible [psi
-
] phenotype of this mutant. To confirm this theory a Q458S mutant 
could be induced into WT SSE1 DNA by site-directed mutagenesis to assess whether 
the mutant has a [psi
-
] phenotype. The Sse1
Q458trunc 
DNA was cloned into the plasmid 
pC210 at Nde1 and Sph1 sites. The C-terminal sequence of this truncated form of 
SSE1 is composed of approximately 175 bp of SSA1 terminator sequence which then 
leads onto pC210 plasmid sequence after a HindIII site. The next in-frame stop codon 
is approximately 100 bp after the Sse1 truncated protein. If this nonsense Q458-TAA 
stop codon was subjected to readthrough then the Sse1 protein would possibly have a 
100 bp C-terminal extension composed of Ssa1 protein. This could also impact the 
Q458* truncated protein phenotype in CM02 and CM03. 
              Using next generation sequencing approximately 6,500 SNPs were identified 
in G600 compared reference strain S288C (BY4741 is directly related to this strain). 
This translated into approximately 1,500 non-synonymous amino acid changes 
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distributed across G600 coding DNA. A number of plausible hypotheses for 
mutations that could change the sensitivity to cell wall damaging agents can be made. 
Five changes were identified in the protein kinases Akl1 and Hsl1, kinases that 
phosphorylate Sse1 and Sse2. Changes to Sse phosphorylation could alter the proteins 
stability, location and function. Four mutations were also identified in protein kinase 
Pkc1. This protein initiates cell stress signals from the cell wall and through the the 
CWI pathway, leading to the up-regulation of stress response genes. SNPs in Pkc1 
could potentially explain why CM02 was so sensitive to cell wall damaging agents. 
No SNPs were identified in heat shock proteins. A single mutation was also identified 
in Ira2 protein. This protein plays a role in cAMP/PKA signaling and a mutation to it 
may affect CM02 thermotolerance and sensitivity. CM02 grew better than CM03 on 
non-fermentable carbon which reduces PKA activity. Perhaps this mutation is 
affecting CM02 in a way that makes it better able to grow in the absence of glucose.  
                G600 also contains a number of Inactivating Stop Codon Mutations 
(ISCMs) which can have major implications on mRNA translation and function. Four 
ORFS in G600 contained single internal nonsense mutations, one of them being 
ade2.1. Two of these genes were YNL106C and YBR074W. Both were severely 
truncated by 532 and 653 amino acids respectively. If YNL106C and YBR074W play 
a role in cell wall signaling then their truncation could affect one of these pathways 
and thus lead to strain sensitivity. Whether or not YBR074W expression could 
suppress G600 sensitivity to cell wall damaging agents was tested. G600 PSI
+
] grew 
relatively the same whether YBR074W was over-expressed or not. However G600 
psi
-
] was non-viable on small quantities of congo red, SDS and calcofluor white. 
This sensitivity was partially recovered by the over-expression of YBR074W. This 
provided a new perspective on G600 sensitivity. It appears that some of G600 
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sensitivity is related to the cellular levels of [PSI
+
]. When Sup35 is nonfunctional and 
G600 is [PSI
+
] perhaps there is decreased translation termination at the ISCMs 
leading to some functional YBR074W protein available in the cell. This could have 
an impact on phenotypic results for Sse1 [psi
-
] mutants in CM02 as their growth and 
sensitivity could be affected by the level of nonsense suppression at ISCMs. 
However, there must be something else affecting G600 sensitivity as it is not just a 
[psi
-
] phenotype making the strains more sensitive. Sse1 [psi
-
] mutant G616D was ts 
and recovered by sorbitol in both CM02 and CM03 showing no difference in growth 
or recovery in both strains so sensitivity of strain G600 is not just [PSI
+
] related.  
                As Sse1
G616D
 was confirmed temperature-sensitive in CM03 it was an 
objective to screen for other possible sse1 ts mutants. The screen was carried out 
meticulously and all the controls behaved as predicted. The secondary screen 
confirmed that four isolates were ts and each was sequenced as Sse1
G616D
. It seemed 
unusual that only one mutation was isolated that could cause Sse1 to be 
thermosensitive, but the screen was approaching saturation as Sse1
G616D
 was isolated 
more than once. Perhaps the screen could have been performed at a higher 
temperature in order to isolate more ts mutants. However, this could have resulted in 
many ts mutants with unknown structural problems so it was carried out at 37
o
C to 
isolate specific cell wall signaling mutants. This result confirmed that mutant G616D 
is altering the Sse1 chaperones ability to deal with the consequence of thermal stress 
either directly or indirectly through interaction with other chaperones. In Chapter 3, 
G616D was suggested to disrupt Hsp70 interaction perhaps indicating that its 
temperature sensitivity is due to a loss of Hsp70 interaction. 
              The growth and morphological effects that swi6 has on yeast expressing 
Sse1 mutants was also investigated. Swi6 is a component of the SBF and MBF 
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transcription factors that activate gene expression in the late G1 phase of cell cycle 
progression (Breeden, 1996). Swi6 is also involved in CWI signaling and is activated 
by Mpk1 in response to cellular stress (Madden et al., 1997). swi6 was successfully 
knocked out in CM03 but attempts at creating CM03 swi6 swi4 was unsuccessful. 
Shaner et al. (2008) successfully created swi6 swi4 but the difference between this 
strain and Shaner et al. (2008) was that the CM03 strain was deleted for SSE2. The 
CM03 strain used to knock out SWI4 in was BY4741 sse1 sse2 swi6 + 
pRS316SSE1 compared to BY4741 swi6 used by Shaner et al. (2008). It may have 
been the absence of SSE2 that prevented the viability of this deletion therefore 
sse2 swi6 swi4 is a lethal knockout.  
               Swi6 deletion had major growth effects on CM03 sse1 ( sse1 sse2 + Sse2) 
at basal temperatures and disrupted Sse1 mutant growth at 37
o
C and 39
o
C. Shaner et 
al. (2008) also observed this phenotype but in their strain background swi6 sse1 
grew poorer than the CM03 strain at 30
o
C and 37
o
C. The only difference between the 
two strains was that CM03 had SSE2 expressed on a plasmid vector, under its own 
promoter, and Shaner et al. (2008) had genomic SSE2. This could account for the 
small differences in growth. Sse1 mutants G41D, G50D and T365I could support 
growth at 39
o
C when expressed alone but were completely non-viable when swi6 was 
deleted. As both Swi6 and Sse1 are involved in cell wall signaling perhaps their 
combined deletion/mutation is affecting signaling through this pathway. However, the 
mutants must be affecting some other biological process as a non-stress temperature 
of 30
o
C resulted in poor growth for CM03 sse1 swi6 ( sse1 sse2 swi6 + Sse2). 
These results concur with Shaner et al. (2008).  
               Swi6 is known to control the expression of many cell cycle regulating 
proteins and its deletion has been implicated in abnormal bud elongation morphology 
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(Nasmyth and Dirick, 1991; Andrews and Moore, 1992; Blacketer et al., 1995).  
Changes in yeast morphology is indicative of alterations to cell cycle control and cell 
signaling activity (Blacketer et al., 1995). CM03 with mutations to sse1 and sse2 
alone produced normal circular budding cells and seemed to have little obvious 
impact on normal cell morphology. However, the additional deletion of swi6 had a 
huge impact resulting in cells with disrupted structure, size and bud formation (Figure 
4.40). The combination of swi6 and sse mutants/deletions created amorphous 
elongated yeast cells. The most severe abnormalities was seen for sse1 sse2 swi6 + 
Sse2, swi6 sse1 sse2 + Sse1
G50D
 and swi6 sse1 sse2 + Sse1
T365I
 where 
approximately 80% of cells were amorphous or elongated, indicative of defects to cell 
cycle regulation  (Shaner et al., 2008). Shaner et al. (2008) found that reintroducing 
WT Sse1 into sse1 swi6 restored normal cell morphology by approximately 90% 
indicating that it is a combination of the two mutations creating the abnormalities but 
that swi6 alone does impact cell structure. They also found that the over-expression 
of Fes1 restored a normal phenotype in approximately 90% of sse1 swi6 cells 
indicating a possible role for NEF activity in regulating cell morphology. Shaner et 
al. (2008) expressed mutant Sse1
G233D 
in sse1 swi6 and found that cells still 
suffered severe morphological defects. This mutant is known to disrupt NEF activity. 
The Sse1 mutant T365I exhibited the most severe morphological defects in 
sse1 sse2 swi6 and in Chapter 3 it was hypothesised that this mutant disrupts 
Hsp70 interaction and NEF activity. This supports Shaner et al. (2008) suggestion 
that NEF activity is important for normal cell morphology. However, mutant G50D 
also exhibited severe amorphous elongated cells and it is not believed to disrupt NEF 
activity.  
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               Recently, using a variety of genetic, bioinformatic and biochemical 
techniques Alberti et al. (2009) identified a number of novel yeast prion proteins. 
This involved isolating proteins with prion-like Q/N-rich domains. These prion 
forming domains (PrDs) are rich in Q/N residues and can be transferred to other 
proteins to create new prions (Li and Linquist, 2000; Alberti et al., 2009). Alberti et 
al. (2009) found that Slt2 and Rlm1 have the potential to form prion proteins. If they 
are true prions then Sse1 mutant chaperones could have unknown effects on their 
stability and possible cell phenotypes. If they are true prions then that could suggest 
why there was sensitivity in CWI signaling.           
              In this Chapter the temperature-sensitive effects of Sse1 mutants on the cell 
were assessed. It was investigated whether the mutants were disrupting MAP kinase 
signaling, Hsp90 signaling and PKA signaling. This led to the conclusion that yeast 
cell wall signaling processes are complicated and influenced by numerous factors 
making it hard to pinpoint and exact mechanism of disruption. Therefore mutations to 
Sse1 which make the cell ts could be affecting a multitude of factors which all 
accumulate to create the resulting sensitive phenotype. This Chapter helped reveal the 
major differences in the laboratory strain G600 compared to commonly used 
BY4741. This prompted the sequence analysis of the G600 genome leading to genetic 
analysis which is still ongoing. It provided possible answers to questions as to 
potentially why this strain has different characteristics to BY4741 and why [PSI
+
] 
may have an effect on strain sensitivity.  
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5.0 Introduction 
            The main objective of the experiments described in this Chapter was to carry 
out a comparative analysis of Sse1 and Sse2 by assessing their role in prion 
propagation and the role protein phosphorylation plays in their cellular functions. 
Posttranslational modifications such as phosphorylation have the potential to impact 
how these chaperones function in prion propagation and in providing cellular 
thermostability.  
               In yeast, Hsp110 is represented by Sse1 and Sse2 molecular chaperones 
(Polier et al., 2008). SSE1 and SSE2 work together to create an essential gene pair 
(Trott et al., 2005) that respond to heat stress and function as NEFs (Mukai et al., 
1993; Sadlish et al., 2008). Sse1 is the more well-studied protein of the two and it 
appears to play a more dominant role in cellular activity (Mukai et al., 1993). Few 
groups have compared Sse1 and Sse2 in their ability to propagate yeast prions or in 
their role as heat shock activated proteins. Mukai et al. (1993) were one of the first 
groups to study Hsp110 in yeast. They discovered that the deletion of SSE1 resulted in 
temperature sensitivity. Mukai et al. (1993) also investigated the response of Sse1 and 
Sse2 to cellular heat shock. They concluded that SSE1 is constitutively expressed at 
basal temperatures and SSE2 mRNA was hardly detectable at 30
o
C. However, both 
Hsp110 isoforms are up-regulated in response to thermal stress. Since then other 
groups have confirmed these observations and research into Hsp110 molecular 
chaperones has revealed that they are vital proteins, playing roles in many cellular 
pathways. The significance of these chaperones in yeast cell viability is emphasised 
by the fact that deletion of both proteins results in cell lethality (Shaner et al., 2004; 
Raviol et al., 2006b).  
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               Sse2 does function as a NEF alongside Sse1, however it stimulates 
nucleotide release ~50% less than Sse1 (Dragovic et al., 2006; Sadlish et al., 2008). It 
has also been suggested that up-regulated Sse2 may be sufficient to refold firefly 
luciferase in the absence of Sse1 (Raviol et al., 2006b). However, Polier et al. (2010) 
concluded that Sse2 fails to stabilise the luciferase substrate under heat stress, 
possibly due to small structural differences between the proteins. The proteins are 
structurally similar but somehow Sse2 has a smaller role when it comes to Hsp110 
activity. In the absence of Sse1 the level of [PSI
+
] propagons diminishes with soluble 
Sup35 levels rising. This indicates that Sse2 is incapable at propagating [PSI
+
] at an 
equal rate to Sse1 (Sadlish et al., 2008).  
              The differences in the Sse1 and Sse2 proteins ability to propagate [PSI
+
] and 
support growth may also be due to the amount of molecular interactions they make 
within the cell. It has been confirmed that Sse1 does interact with more biological 
entities than Sse2 (Gong et al., 2009). The small differences in protein structure could 
also account for functional differences. As Sse2 is only stress induced, it may have 
originally evolved as a ‘backup’ chaperone for Sse1 by helping out in times of stress. 
It is presumed that the SSE genes resulted from gene-duplication in the 
Saccharomyces progenitor species (Polier et al., 2010). 
               In this study, the abilities of Sse1 and Sse2 to propagate [PSI
+
], provide 
growth and withstand thermal stress were compared. It was also aimed to investigate 
the response of Sse2 to mutations, originally isolated in Sse1, and how mutations 
which make Sse2 more structurally similar to Sse1 affect its phenotype. Another 
objective was to investigate how phosphorylation affects the ability of chaperones to 
propagate [PSI
+
]. In this Chapter, kinases which phosphorylate Hsp110 proteins were 
analysed and how posttranslational modification of Hsp110 may affect prion 
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propagation was also examined. The objective was to gain insight into this 
phenomenom by mutating particular kinases and phosphorylation sites and observing 
the responding phenotypes. 
 
5.1 A comparative analysis of Sse1 and Sse2’s influence on growth 
and [PSI
+
]  
              The function of Sse2 in prion biology is less understood than Sse1 (Fan et 
al., 2007). Sse1 remains the main Hsp110 chaperone in yeast as its deletion results in 
slow-growing temperature sensitivity whereas deletion of Sse2 has no obvious growth 
defects (Mukai et al., 1993). Few groups have looked at the comparative differences 
between yeast expressing either Sse1 or Sse2. In this section the two proteins were 
compared in their ability to provide cellular growth, at normal and adverse 
temperatures, and in their ability to promote [PSI
+
] propagation as the only Hsp110 
isoform.   
 
 
5.1.1 Cloning SSE2 into pRS315 
 
              SSE2 was cloned into plasmid vector pRS315 using homologous 
recombination methods described in section 2.23. G600 genomic DNA was isolated 
and SSE2 promoter and coding sequence were amplified by PCR using primers listed 
in Table 2.12.b and PCR cycle 2 in Table 2.11. The PCR product was 2365 bp with 60 
bp overhangs homologous to pRS315 sequence. pRS315 plasmid DNA was prepared 
as described in sections 2.23.3 and 2.23.4 and cloning was carried out by transforming 
digested vector and PCR insert into strain G600 (as described in section 2.23.5). Five 
potential SSE2 clones were isolated and Figure 5.1 illustrates the results of BamH1 
digestion. BamH1 digestion should result in a large DNA fragment approximately 
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                    BamH1                                         2302 bp                                           BamH1 
                               ---------------------------------------------------------------------- 
 
pRS315                                                                                                                                        pRS315 
                                                                                          
                                                                                              
 <<--------------                                                  
 
 
                         
 
            kilobases        A            B           C           D         E            F             
                           
 
Figure 5.1. Diagnostic restriction digest of potential SSE2 clones. 
 
(i) pRS315-SSE2 construct with expected bp sizes after restriction digest with 
BamH1. BamH1 sites were included in the cloning primers before the SSE2 promoter 
and after the SSE2 stop codon. This should result in two linearised DNA bands of 
6018 bp (pRS315) and 2302 bp (SSE2). 
(ii) Agarose gel electrophoresis of five potential SSE2 plasmid clones. Each isolate 
was digested with restriction enzyme BamH1. 
Lane A: 1kb molecular weight marker. 
Lane B: BamH1 digestion of potential SSE2 clone 1A. Clone was negative as bands 
were approximately 3kb and 8kb. 
Lane C: BamH1 digestion of potential SSE2 clone 1C. Bands appeared positive as an 
SSE2 clone. Cloned SSE2 + promoter region = 2302 bp and pRS315 = 6018 bp. Clone 
1C was later sequenced and confirmed as an SSE2 clone. 
Lane D-F: BamH1 digestion of potential SSE2 clones 1E, 2A and 2E. Smaller bands 
appeared as a positive size for SSE2 but upper bands were too large to be confirmed 
as pRS315. 
 
10.0 - 
  
  6.0 - 
  
   
 
  3.0 - 
 
  2.0 - 
 
 
  1.0 - 
 
  0.5 - 
 
 
SSE2 
  PROMOTER 
 
                SSE2 (2082 bp) 
(i) pRS315-SSE2 construct digested with BamH1 enzyme 
(ii) Agarose gel electrophoresis of digested vectors 
Rest of plasmid = 6018 bp 
6018 bp 
 
 
 
2302 bp 
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6018 bp in size, representing pRS315, and a smaller band approximately 2302 bp 
representing SSE2 clone. Isolate 1C was later confirmed as an SSE2 clone by 
sequence analysis. The SSE2 gene was ready to be phenotypically analysed in CM02 
by plasmid shuffle. Figure 5.2 illustrates the construct of pRS315-SSE2 plasmid 
vector.      
 
                  
Figure 5.2. Plasmid construct of pRS315SSE2. 
 
 
5.1.2 A comparison of [PSI
+
] in CM02 + Sse1 and CM02 + Sse2 
              pRS315SSE2 and pRS315SSE1 were transformed into CM02. 5-FOA 
selection of transformants selected against pRS316SSE1. CM02 cells expressing 
pRS315SSE2 without SSE1 took 3-4 days to grow on 5-FOA at 30
o
C. Once the strains 
were made their initial [PSI
+
] phenotype was assessed by streaking onto YPD (Figure 
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5.3). Their [PSI
+
] phenotype was subjectively analysed by their red/white colour, as 
described in section 2.13. [PSI
+
] was further assessed by spotting Sse1 and Sse2 
strains onto medium with limiting adenine (SC) and medium with no adenine (SC - 
adenine). Sse2 appeared red and [psi
-
] on SC medium when expressed alone in CM02 
(Figure 5.4). As Sse2 failed to grow on SC - adenine it suggested that Sse2 cannot 
maintain [PSI
+
] propagation when expressed alone in CM02 (Figure 5.4).  
 
 
         
 
                                                 SSE2                             SSE1 
 
                                     
 
 
 
 
Figure 5.3. Assessment of [PSI
+
] in CM02 expressing Sse1 and Sse2. CM02 was 
transformed with pRS315SSE1 or pRS315SSE2 and incubated at 30
o
C for 2 days on 
SC - leucine medium. Transformants were replicated onto 5-FOA to select against 
pRS316SSE1. Yeast strains were streaked onto YPD medium and incubated for 2 days 
at 30
o
C and 2 days at room temperature. [PSI
+
]
 
was subjectively measured by the 
red/white hypothesis. 
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                                      SSE2                                         SSE1 
 
                                
 
 
                                
 
 
 
Figure 5.4. Assessment of [PSI
+
] in CM02 + Sse1 and CM02 + Sse2 by comparing 
growth on SC - adenine medium. CM02 was transformed with pRS315SSE1 or 
pRS315SSE2 and incubated at 30
o
C for 2 days on SC - leucine medium. 
Transformants were replicated onto 5-FOA to select against pRS316SSE1. Yeast were 
spotted onto SC and SC - adenine medium in 10 l dH2O and incubated for 2 days at 
30
o
C followed by 2 days at room temperature. CM02 + Sse2 failed to grow on 
medium lacking adenine indicating that it has no aggregated Sup35 and translation of 
ADE2 gene is being halted at the abberent stop codon. 
 
 
 
 
 
 
               To further assess Sse1 and Sse2 [PSI
+
] phenotypes a [psi
-
] 621 strain was 
mated with CM02 + Sse1 and CM02 + Sse2 and the diploids were selected on SD + 
adenine medium. [PSI
+
] is dominant so if any [PSI
+
] was present in the Sse2 strain 
then the diploids should have appeared white. Sse1 was white when mated with [psi
-
] 
621 which confirmed the presence of [PSI
+
]. However Sse2 appeared red when mated 
with 621 and the diploid failed to grow on SC – adenine suggesting again that Sse2 is 
completely [psi
-
] (Figure 5.5 and 5.6).  
 
SC  
SC - 
ADENINE 
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                               SSE1 X 621                                         SSE2 X 621 
                                               
                           SD + ADENINE                                SD + ADENINE 
 
 
Figure 5.5. Mating 621 [psi
-
] strain with Sse1 and Sse2 to create diploids. Yeast strain 
621 was cured on 3 mM GdnHCl and mated with CM02 + Sse1 or Sse2 on SD + 
adenine medium. [PSI
+
] is dominant and always propagated onto daughter cells. Sse1 
is [PSI
+
] as diploids appeared white. Sse2 is [psi
-
] as diploids appeared red. 
 
 
 
 
 
 
                                          SSE2 X 621        SSE1 X 621 
                                       
 
 
                                         SSE2 X 621          SSE1 X 621 
                                        
 
 
 
Figure 5.6. Diploid cells spotted onto YPD and SC - adenine to assess if [PSI
+
] is 
present. Diploid strains from Figure 5.5 were mixed with 10 l of dH2O and spotted 
onto YPD and SC - adenine. This reconfirmed that Sse1 is [PSI
+
] and Sse2 is [psi
-
]. 
 
 
YPD 
SC - 
ADENINE 
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5.1.3 A comparison of growth and thermostability in CM02 + Sse1 and CM02 + 
Sse2 
              CM02 was transformed with pRS315SSE1, pRS315SSE2 and pRS315. 
Transformants were replicated onto 5-FOA and each strain was monitored for growth 
at 30
o
C over 4 days. By day 1 Sse1 cells were growing well and there was no growth 
for either the negative control or for cells expressing Sse2. CM02 + Sse2 colonies 
appeared after 4 days at 30
o
C indicating that CM02 + Sse2 was slower to grow on 
medium with limiting adenine. Once the colonies were restreaked onto SC - leucine 
the strain grew as normal.  
              Growth curves were generated by monitoring CM02 + Sse1 and CM02 + 
Sse2 growth in liquid media over 8 hours. Both strains were incubated at 30
o
C and 
37
o
C and cell concentrations were monitored by OD600nm in a spectrophotometer. The 
growth curves illustrate that cells expressing Sse2 were slightly slower growing than 
cells expressing Sse1, at normal growth temperatures and at high temperatures (Figure 
5.7). The average cell doubling time at 37
o
C was 100 minutes for Sse1 and 132 
minutes for Sse2 (Table 5.1). Comparative growth analysis was performed on Sse1 
and Sse2 at 30
o
C, 37
o
C and 39
o
C (Figure 5.8) revealing that CM02 + Sse2 cells grow 
slowly even at 30
o
C. Sse2 cells were non-viable at 39
o
C and slow-growing at 37
o
C.  
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Figure 5.7. Growth curves for Sse1 and Sse2 at 30
o
C and 37
o
C. Cells were inoculated 
at OD600nm = 0.1 and grown at 30
o
C and 37
o
C shaking. OD600nm was assessed every 2 
hours for cell concentrations. T0 = inoculation timepoint and T4 = last OD reading 
after eight hours. Sse1 grew slightly better than Sse2 at 30
o
C and 37
o
C.   
 
 
 
(b) 37
o
C 
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                          Table 5.1. Cell generation time (GT) for Sse1 and Sse2. 
 
 
 
30
o
C average GT 
(minutes) 
 
37
o
C average GT 
(minutes) 
 
 
Sse1 
 
 
116 
 
 
100 
 
 
 
Sse2 
 
 
134 
 
132 
 
Sse1 grew well at both 30
o
C and 37
o
C and doubled slightly less than every two hours. 
Sse2 average doubling time took more than 2 hours and was a lot slower than Sse1.  
 
 
                            
                              
 
 
                              
                              
 
 
                             
                              
 
Figure 5.8. Temperature-sensitive analysis of CM02 + Sse1 and CM02 + Sse2. Yeast 
were serial diluted on YPD medium and incubated for 2 days at 30
o
C, 37
o
C and 39
o
C. 
Sse2 was non-viable at 39
o
C and slightly sensitive and slow-growing at 30
o
C and 
37
o
C. 
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5.2 Functional effects of introducing Sse1 prion-impairing mutations 
into Sse2 
              Sse1 and Sse2 sequence are 76% identical (Polier et al., 2010) (Figure 5.9). 
Twelve of the thirteen Sse1 mutants isolated in this study are located in residues 
which are conserved in Sse2. Sse1 residue E504 is not conserved in Sse2. It was 
hypothesised that one possibility why Sse2 cannot promote [PSI
+
] propagation is 
because it has this residue difference to Sse1. Mutation E504K was originally isolated 
in a screen for mutants which affect Sse1’s ability to maintain [PSI+]. By site-directed 
mutagenesis Sse2
Q504E 
mutant was created, making Sse2 more similar to Sse1. 
Sse2
Q504E
 mutant strain initially appeared slow-growing in CM02 sse1 sse2. When 
it was first transformed and replicated onto 5-FOA the colonies took a long time to 
grow (Figure 5.10). CM02 + Sse2
Q504E
 [PSI
+
] phenotype was analysed subjectively by 
colour on limiting adenine medium and was compared to WT Sse1 and WT Sse2 for  
its [PSI
+
] phenotype (Figure 5.11). It appeared that this mutation did improve the 
ability of Sse2 to promote [PSI
+
] propagation as it appeared pink in colour. It also 
displayed some growth on SC – adenine medium confirming its improved [PSI+] 
phenotype (not shown). When analysed for its affect on cellular thermostability the 
growth of mutant Sse2
Q504E
 was similar to WT Sse2 (Figure 5.12). 
                The effects caused by the mutation G616D on Sse2 were also assessed. In 
Sse1 this mutation disrupted the ability of Sse1 to propagate [PSI
+
] and disrupted 
cellular thermotolerance. The mutant Sse2
G616D
 was created by site-directed 
mutagenesis and it also appeared slow-growing in CM02 sse1 sse2 when first 
transformed into cells (Figure 5.10). When analysed on limiting adenine for its [PSI
+
] 
phenotype, mutant Sse2
G616D
 appeared similar to [psi
-
] WT Sse2 as it was red in 
colour (Figure 5.11). However, it did display severe thermosensitivity greater than 
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                   MSTPFGLDLGNNNSVLAVARNRGIDIVVNEVSNRSTPSVVGFGPKNRYLG 
                   |||||||||||||||||||||||||:||||||||||||:|||||:||||| 
   1 MSTPFGLDLGNNNSVLAVARNRGIDVVVNEVSNRSTPSLVGFGPRNRYLG 
 
      ETGKNKQTSNIKNTVANLKRIIGLDYHHPDFEQESKHFTSKLVELDDKKT 
|:||.|||||:||||.||||||||.:..|:|:.|:|.||||||:|.:.|. 
     51 ESGKTKQTSNVKNTVENLKRIIGLKFKDPEFDIENKFFTSKLVQLKNGKV 
 
  GAEVRFAGEKHVFSATQLAAMFIDKVKDTVKQDTKANITDVCIAVPPWYT 
|.||.|.|:.||||||||.||||||||.||:::||::|||||:|||.||: 
    101 GVEVEFGGKTHVFSATQLTAMFIDKVKHTVQEETKSSITDVCLAVPVWYS 
 
EEQRYNIADAARIAGLNPVRIVNDVTAAGVSYGIFKTDLPEGEEKPRIVA    
||||||||||||||||||||||||||||.||||:||.|||..||||||:. 
    151 EEQRYNIADAARIAGLNPVRIVNDVTAAAVSYGVFKNDLPGPEEKPRIIG 
 
FVDIGHSSYTCSIMAFKKGQLKVLGTACDKHFGGRDFDLAITEHFADEFK    
.||||||:||||||||:||::||||||.||||||||||.||||||||:|| 
    201 LVDIGHSTYTCSIMAFRKGEMKVLGTAYDKHFGGRDFDRAITEHFADQFK 
 
TKYKIDIRENPKAYNRILTAAEKLKKVLSANTNAPFSVESVMNDVDVSSQ 
.|||||||:|||||||||.|||||||||||||.|||||||||:|:||||| 
    251 DKYKIDIRKNPKAYNRILIAAEKLKKVLSANTTAPFSVESVMDDIDVSSQ 
 
LSREELEELVKPLLERVTEPVTKALAQAKLSAEEVDFVEIIGGTTRIPTL 
||||||||||:|||:|||.|:|.|||||||:..::|||||||||||||.| 
    301 LSREELEELVEPLLKRVTYPITNALAQAKLTVNDIDFVEIIGGTTRIPVL 
 
KQSISEAFGKPLSTTLNQDEAIAKGAAFICAIHSPTLRVRPFKFEDIHPY 
|:|||:.||||||:|||||||:|||||||||||||||||||||||||.|| 
    351 KKSISDVFGKPLSSTLNQDEAVAKGAAFICAIHSPTLRVRPFKFEDIDPY 
 
SVSYSWDKQVEDEDHMEVFPAGSSFPSTKLITLNRTGDFSMAASYTDITQ 
||||:|||||:|||.:|||||.||:||||||||:|||||||.|.||..:: 
    401 SVSYTWDKQVDDEDRLEVFPANSSYPSTKLITLHRTGDFSMKAVYTHPSK 
 
LPPNTPEQIANWEITGVQLPEGQDSVPVKLKLRCDPSGLHTIEEAYTIED 
||..|...||.|..|||::|:.||.:|||:||||||||||.||.|||.|| 
    451 LPKGTSTTIAKWSFTGVKVPKDQDFIPVKVKLRCDPSGLHIIENAYTTED 
 
IEVEEPIPLPEDAPEDAEQEFKKVTKTVKKDDLTIVAHTFGLDAKKLNEL 
|.|:||:|||||||||||.:||:||||:|||.|.:.|.||.|:..:||:| 
    501 ITVQEPVPLPEDAPEDAEPQFKEVTKTIKKDVLGMTAKTFALNPVELNDL 
 
IEKENEMLAQDKLVAETEDRKNTLEEYIYTLRGKLEEEYAPFASDAEKTK 
||||||:..|||||||||||||.|||||||||.||::||:.|||||||.| 
    551 IEKENELRNQDKLVAETEDRKNALEEYIYTLRAKLDDEYSDFASDAEKEK 
 
LQGMLNKAEEWLYDEGFDSIKAKYIAKYEELASLGNIIRGRYLAKEEEKK 
|:.||...|.|||.:|.||.|||||||||||||||||||||||||||||: 
    601 LKNMLATTENWLYGDGDDSTKAKYIAKYEELASLGNIIRGRYLAKEEEKR 
 
QAIRSKQEASQMAAMAEKLAAQRKAEAEKKEEKKDTEGDVDMD 
||:|:.||.|:|..:|||||.||:|.|...:...:.:.::|:| 
    661 QALRANQETSKMNDIAEKLAEQRRARAASDDSDDNNDENMDLD 
 
 
Figure 5.9. Comparison of Sse1 and Sse2 protein sequence. They are 76% identical. 
Sse1 is the top sequence and Sse2 is the bottom sequence. All Sse1 mutant residues 
are conserved in Sse2 with the exception of E504 (highlighted).  
Sse1 
 
Sse2 
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Figure 5.10. Growth of Sse2 mutants on 5-FOA after 3 days incubation at 30
o
C. Sse2 
and mutants were transformed into CM02 and incubated on SC - leucine medium for 
2 days at 30
o
C. Transformants were replicated onto 5-FOA, to select against 
pRS316SSE1, and incubated at 30
o
C for 2 days. Sse2 mutants struggled to grow and 
colonies did not appear until an additional 2 days at room temperature. 
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Q504E
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G616D
 
                                    
                                             
 
Figure 5.11. Sse2 mutant [PSI
+
] phenotypes on YPD medium. After initial 
transformation the mutants were restreaked onto SC - leucine medium followed by 
restreaking onto YPD medium. The mutants were spotted in 10 l dH2O onto YPD 
medium and incubated for 2 days at 30
o
C followed by 2 days at room temperature. 
Mutant Sse2
G616D 
appeared [psi
-
] and similar in colour to wild type Sse2. However 
mutant Sse2
Q504E
 had an improved [PSI
+
] appearance compared to wild type Sse2. 
 
Sse2
Q504E
 
Sse2
G616D
 
Sse2 
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WT Sse2, as it was non-viable at 37
o
C and slow-growing at 30
o
C (Figure 5.12). This 
residue appears to have conserved function in both Sse1 and Sse2 as it creates an 
unstable temperature-sensitive phenotype. 
 
 
                              30oC 
                                   
                                   
 
                                   37
o
C 
                                   
                                   
                               
                                   39
o
C 
                                   
                                   
                               
 
Figure 5.12. Comparative growth analysis of Sse2 mutants to assess temperature 
sensitivity. Sse2, Sse2
Q504E
 and Sse2
G616D
 were serial diluted onto YPD medium and 
incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Sse2 mutant Q504E grew similarly to 
wild type as it showed sensitivity to 30
o
C and 37
o
C and was non-viable at 39
o
C. 
However mutant G616D was very sensitive at 30
o
C and non-viable at 37
o
C and 39
o
C. 
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5.3 Initial investigation into Sse1 and Sse2 phosphorylation 
 
             In this section the role of protein kinases suggested to phosphorylate Sse1 
and Sse2 were investigated and the implications this phosphorylation has on growth 
and [PSI
+
] was assessed. The Phosphorylome Database is the source where this 
information was obtained (Ptacek et al., 2005) 
             Protein phosphorylation is a post-translational modification that is 
ubiquitous in eukaryotic cells (Rubinstein and Schmidt, 2007). Protein kinases 
account for approximately 2% of genes in the eukaryotic genome and they constitute 
one of the largest eukaryotic protein families (Manning et al., 2002). Protein 
phosphorylation regulates a plethora of cell signaling and biological processes 
(Rubinstein and Schmidt, 2007). Using proteome chip technology Ptacek et al. (2005) 
revealed that each yeast protein kinase they investigated recognised an average of 47 
substrates. The majority of these substrates (73%) were phosphorylated by less than 
three kinases indicating a high level of kinase-substrate specificity (Ptacek et al., 
2005). 
               Phosphorylation of proteins such as heat shock proteins could modulate their 
biological activity, cellular location and interaction with other proteins (Cohen, 2000). 
It has been shown that phosphorylation of Hsp90 impairs its ATPase activity and its 
ability to chaperone client proteins. Hsp90 phosphorylation has also been shown to be 
important for cell cycle regulation (Mollapour et al., 2010). Sse1 and Sse2 have 
important [PSI
+
] related functions and cell integrity functions that most likely rely on 
the location and interaction of both chaperones. In this section the implications that 
Sse1/Sse2 kinase protein deletions have on cellular growth and on [PSI
+
] phenotypes 
were investigated.  
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               Using proteome chip technology and mass spectrometry Ptacek et al. (2005) 
identified the substrates recognised by most protein kinases in yeast. As predicted by 
the Phosphorylome Database three kinases Akl1, Kin2 and Hsl1 phosphorylate either 
Sse1 or Sse2. Akl1 is a serine/threonine kinase involved in actin cytoskeleton 
organisation and is a member of the Ark kinase family of proteins (Cope et al., 1999; 
Henry et al., 2003). Akl is predicted to interact with and phosphorylate Sse1 (Ptacek 
et al., 2005). Kin2 is also a serine/threonine kinase involved in regulating cellular 
exocytosis (Elbert et al., 2005). Kin2 is structurally and functionally related to Kin1. 
They both belong to the Snf1 family of Ca
2+
/calmodulin-dependent kinase II group 
(CaMK) (Hanks et al., 1988; Lamb et al., 1991). Kin2 is predicted to phosphorylate 
both Sse1 and Sse2 (Ptacek et al., 2005). Hsl1 is a Nim1-related protein kinase that 
regulates cytokinesis at the yeast bud neck (Barral et al., 1999). Hsl1, along with 
Hsl7, targets and phosphorylates the protein Swe1 ultimately leading to Swe1 protein 
degradation (Mcmillan et al., 1999). Hsl1 has also been predicted to phosphorylate 
Sse2 (Ptacek et al., 2005). 
 
5.3.1 Deletion of protein kinases Akl1, Kin2 and Hsl1 in G600 
                Genes encoding AKL1, KIN2 and HSL1 were singularly knocked out in 
G600 using kanMX knockout constructs. This was performed using homologous 
recombination knockout techniques described in section 2.19. PCR products of 
knockout cassettes were obtained using Euroscarf genomic DNA and primers listed in 
Table 2.12.d. The PCR products were transformed into G600 a (AKL1) and G600 
HSL1 and KIN2) and transformants were selected on G418 medium. Six colonies 
per plate were selected and their DNA isolated for analysis. Potential akl1 knockouts 
were amplified with primers AKL1F/R resulting in four isolates (Lane D-G) 
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corresponding to the correct knockout size of 1989 bp (Figure 5.14). The other two 
isolates were WT AKL1 and an unknown product. The potential four knockouts were 
confirmed as akl1 knockouts using primers that anneal to the flanking regions of the 
knockout construct. This gel is of poor quality and is not included in the illustrated 
results. AKL1F with KAN01R resulted in a 353 bp DNA band and AKL1R with 
KAN02F resulted in a 742 bp band. 
 
 
(1) Wild type 
 
                      ------------------------------------------------------------------------ 
  
 
 
 
 
                                       
(2) akl1 
                                                                1989 bp 
                                        ------------------------------------------------ 
   
                                        353 bp                                                   742 bp  
                                        -------        -------------- 
 
 
 
Figure 5.13. Illustration shows the expected wild type AKL1 and akl1 PCR fragment 
sizes. (1) AKL1 wild type DNA coding sequence is 3327 bp. Primers AKL1F and 
AKL1R are located upstream and downstream of AKL1 coding sequence. PCR using 
these primers should result in a DNA band of approximately 3809 bp. (2) illustrates 
an akl1 knockout construct with kanMX gene replacing the coding sequence of AKL1. 
PCR using primers AKL1F and AKL1R should result in a band approximately 1989 
bp in size. Internal KAN01R and KAN02F primers used with external AKL1R and 
AKL1F primers should result in two bands of 353 bp and 742 bp. This confirms that 
AKL1 is replaced with kanMX. 
 
      5’      3’ 
        AKL1F 
        kanMX  
AKL1R 
   KAN01 
KAN02   AKL1F AKL1R 
   5’   3’         AKL11  
     AKL1F AKL1R 3809 bp 
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               kilobases          A       B        C       D      E       F      G 
                              
 
Figure 5.14. Diagnostic PCR for akl1 knockout strain.  
 
Lane A: 1kb DNA molecular marker. 
Lane B: Potential akl1 using primers AKL1F/R and DNA from isolate 1. DNA band 
did not correspond to the size of knockout construct. 
Lane C: Potential akl1 using primers AKL1F/R and DNA from isolate 2. DNA 
band did not correspond to the size of the knockout construct but to that of WT AKL1. 
Lane D-G: Potential akl1 using primers AKL1F/R and DNA from isolate 3-6. DNA 
bands did correspond to the size of knockout construct (1989 bp). All four isolates 
were later confirmed as akl1 by further diagnostic PCRs using internal KAN01 and 
KAN02 primers. 
 
 
 
            kin2 and hsl1 knockouts were performed at the same time using two different 
strains. The diagnostic PCR results for hsl1 are in Lane B-E in Figure 5.17 and 
confirm the isolation of a G600 hsl1 strain. The diagnostic PCR results for kin2 are 
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in Lane F-I also in Figure 5.17 and confirm the isolation of a G600 kin2 strain. 
Figures 5.15 and 5.16 annotate how these fragment sizes were obtained. 
 
 
(1) Wild type 
 
 
                      ------------------------------------------------------------------------------- 
  
 
 
 
 
 
 
                                       
(2) hsl1 
 
                                                                1995 bp 
                                        ------------------------------------------------ 
 
                                       331 bp                                                   770 bp  
                                        -----        --------------- 
 
 
 
 
Figure 5.15. Illustration shows the expected wild type HSL1 and hsl1 PCR fragment 
sizes. (1) HSL1 wild type DNA coding sequence is 4557 bp. Primers HSL1F and 
HSL1R are located upstream and downstream of HSL1 coding sequence. PCR using 
these primers should result in a DNA band of approximately 5045 bp. (2) illustrates a 
hsl1 knockout construct with kanMX gene replacing the coding sequence of HSL1. 
PCR using primers HSL1F and HSL1R should result in a band approximately 1995 bp 
in size. Internal KAN01R and KAN02F primers used with external HSL1R and 
HSL1F primers should result in two bands of 331 bp and 770 bp. This confirms that 
HSL1 is replaced with kanMX. 
 
      5’      3’          HSL1  
  HSL1F    HSL1R 5045 bp 
        5’      3’ 
   HSL1F 
         kanMX  
HSL1R 
   KAN01 
KAN02   HSL1F 
HSL1R 
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(1) Wild type 
 
                          ------------------------------------------------------------------------- 
  
 
 
 
 
   
 
 
                                     
(2) kin2 
                                                                2012 bp 
                                        ------------------------------------------------ 
 
                                       317 bp                                                   801 bp  
                                        -----        --------------- 
 
 
 
 
 
 
Figure 5.16. Illustration shows the expected wild type KIN2 and kin2 PCR fragment 
sizes. (1) KIN2 wild type DNA coding sequence is 3444 bp. Primers KIN2F and 
KIN2R are located upstream and downstream of KIN2 coding sequence. PCR using 
these primers should result in a DNA band of approximately 3949 bp. (2) illustrates a 
kin2 knockout construct with kanMX gene replacing the coding sequence of KIN2. 
PCR using primers KIN2F and KIN2R should result in a band approximately 2012 bp 
in size. Internal KAN01R and KAN02F primers used with external KIN2R and 
KIN2F primers should result in two bands of 317 bp and 801 bp. This confirms that 
KIN2 is replaced with kanMX. 
 
 
 
 
 
           5’      3’           KIN2  
  KIN2F    KIN2R  3949 bp 
      5’      3’ 
   KIN2F 
        kanMX  
KIN2R 
   KAN01 
KAN02   KIN2F 
KIN2R 
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Figure 5.17. Diagnostic PCR for hsl1 and kin2 knockout strains. 
 
Lane A: 1kb DNA molecular marker. 
Lane B: Potential hsl1 using primers HSL1F/R and DNA from isolate 1. DNA band 
corresponds to the size of hsl1 knockout construct (1995 bp).  
Lane C: Potential hsl1 using primers HSL1F/R and DNA from isolate 2. DNA band 
corresponds to the size of hsl1 knockout construct (1995 bp). 
Lane D: PCR product represents the left flanking region of hsl1 (331 bp). DNA was 
from isolate 1 and primers used were HSL1F and KAN01R.  
Lane E: PCR product represents the right flanking region of hsl1 (770 bp). DNA 
was from isolate 1 and primers used were HSL1R and KAN02F. 
Lane F: Potential kin2 using primers KIN2F/R and DNA from isolate 3. DNA band 
corresponds to the size of kin2 knockout construct (2012 bp). 
Lane G: Potential kin2 using primers KIN2F/R and DNA from isolate 5. DNA band 
corresponds to the size of kin2 knockout construct (2012 bp). 
Lane H: PCR product represents left flanking region of kin2 (317 bp). DNA was 
from isolate 3 and primers used were KIN2F and KAN01R. 
Lane I: PCR product represents right flanking region of kin2 (801 bp). DNA was 
from isolate 3 and primers used were KIN2R and KAN02F. 
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5.3.2 Analysis of the phenotypic effects caused by protein kinase deletion 
               Proteins need to interact with other biomolecules in order to execute their 
various biological functions (Ito et al., 2001). Deleting kinases which interact with 
and phosphorylate Sse proteins may lead to the disruption of Sse1/Sse2 function. As 
Sse proteins play a role in thermotolerance the effects that akl1, kin2 and hsl1 
deletions have on cellular thermostability were tested. As these kinases also interact 
with other proteins it would be difficult to conclude that any phenotypic changes are 
solely Sse related. Comparative growth analysis tests revealed that kin2 and hsl1 
grew relatively well at restrictive temperatures but akl1 was slightly sensitive and 
grew slower than the other knockout strains (Figure 5.18).  
            The effect that kinase knockouts have on cellular [PSI
+
] was also examined. 
Knockout strains were streaked onto YPD medium alongside G600 control and cells 
were incubated at 30
o
C for 2 days. [PSI
+
] phenotypes were subjectively measured on 
limiting adenine medium using the red/white colony colour. akl1 appeared to 
weaken [PSI
+
] in G600 whereas the other kinase knockouts seemed to have no effect 
on [PSI
+
] (Figure 5.19). From these tests it was concluded that akl1 appeared to be 
slightly [PSI
+
] weak and demonstrated slow growth. 
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                                  30 C 
                                  
                                   
 
                                  37 C 
                                  
                                   
 
                                   39 C 
                                  
                                   
 
 
Figure 5.18.  Comparative growth analysis of akl1, hsl1 and kin2 temperature 
sensitivity. Kinase knockout strains were serial diluted onto YPD medium and 
incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. akl1 was slightly slow-growing at 
37
o
C and 39
o
C. 
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                                    G600                                                           akl1 
                                       
 
 
hsl1                                                        kin2 
                              
                                      
 
Figure 5.19. [PSI
+
] phenotypes in kinase knockout strains. G600, akl1, hsl1 and 
kin2 were streaked onto YPD medium and incubated at 30
o
C for 2 days. akl1 
mutant showed a weak [PSI
+
] phenotype by its pink colony colour. 
 
 
 
5.3.3 Creating kinase double knockout mutants 
              Double knockout strains were created by mating G600 akl1 (Mat a) with 
either G600 kin2 or G600 hsl1 (both Mat ). As all three genes were knocked out 
with kanMX each strain was transformed with a different control plasmid as a 
selectable marker. akl1 was transformed with pRS315, kin2 with pRS316 and 
hsl1 with pRS423. Strains were mated on selective medium, incubated for 2 days at 
30
o
C and then replicated onto SD medium. Amino acids were added to the medium so 
that diploids would survive and haploids die (Figure 5.20). For example, akl1 hsl1 
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were replicated onto SD + adenine, tryptophan and uracil as haploid cells would not 
survive in the absence of leucine and histidine. Diploids were sporulated on 
sporulating medium with the addition of adenine, tryptophan and uracil or adenine, 
tryptophan and histidine.  
              Random spore analysis resulted in the isolation of red, white and pink 
colonies (Figure 5.21). Ten colonies were picked from each plate and DNA extracted 
for PCR analysis. Colony 5 from akl1 kin2 plate was confirmed as a double 
knockout by diagnostic PCR (Figure 5.22). Colony 7 from akl1 hsl1 plate was 
confirmed as a double knockout by diagnostic PCR (Figure 5.23). The absence of 
wild type kinase DNA bands from the diagnostic gels reconfirmed that the strains 
were sporulated correctly and that the mutants were haploid. PCR fragment sizes in 
Figures 5.22 and 5.23 can be annotated from Figures 5.13, 5.15 and 5.16 which 
illustrate how the various DNA bands were obtained. Interestingly both colonies 
confirmed as knockouts were white. 
 
akl1 kin2                                                    akl1 hsl1 
 
           
 
                         
 
Figure 5.20. Diploid strains were created by mating on selective media. 
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                      hsl1 akl1 (10
-3
)                                     kin2 akl1 (10
-3
) 
 
        
                            
                          
Figure 5.21. Random spore analysis of potential double knockout strains. Individual 
colonies represent a mixture of either haploid spores with potential to express the 
double knockout of interest or diploids which were unsuccessfully sporulated. 
Colonies appeared red, pink and white and at least one representative colony from 
each colour was picked for further analysis. 
                                   
 
 
 
 
5.3.4 Analysis of the temperature-sensitive effects of double kinase knockouts 
               It was speculated that perhaps the deletion of two Sse phosphorylating 
kinases would have a bigger impact on cell temperature sensitivity or cell viability. 
Mutant strains akl1 hsl1 and akl1 kin2 were analysed by comparative growth 
assays on YPD medium after 2 days incubation at 30
o
C, 37
o
C and 39
o
C. However, the 
double kinase knockout strains grew relatively well at these temperatures (Figure 
5.24). It was previously observed that akl1 struggled to grow and looked quite sick 
at 37
o
C and 39
o
C. However, it appeared to grow better in the presence of hsl1 and 
kin2 mutants. 
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Figure 5.22. Diagnostic PCR for double knockout strain akl1 kin2. 
Lane A: 1kb DNA molecular marker. 
Lane B: Potential akl1 using primers AKL1F/R and DNA isolate 5 for akl1 kin2. 
Product size was approximately 1989 bp which corresponds to kanMX knockout 
construct size. 
Lane C: Potential kin2 using primers KIN2F/R and DNA isolate 5 for akl1 kin2. 
Product size was approximately 2012 bp which corresponds to kanMX knockout 
construct size. 
Lane D: DNA isolate 5 amplified with primers AKL1R and KAN02F. PCR product 
was approximately 742 bp and reflects the right flanking region of akl1 knockout 
construct. 
Lane E: DNA isolate 5 amplified with primers AKL1F and KAN01R. PCR product 
was approximately 353 bp and reflects the left flanking region of akl1 knockout 
construct. 
Lane F: DNA isolate 5 amplified with primers KIN2R and KAN02F. PCR product 
was approximately 801 bp and reflects the right flanking region of kin2 knockout 
construct. 
Lane G: DNA isolate 5 amplified with primers KIN2F and KAN01R. PCR product 
was approximately 317 bp and reflects the left flanking region of kin2 knockout 
construct. 
   
     10.0 - 
   
  
   
       3.0 - 
  
       2.0 - 
   
  
 
       1.0 - 
 
   
       0.5 - 
 
 
 
2012 bp 
1989 bp 
 
 
801 bp 
742 bp 
 
353 bp 
317 bp 
 284 
 
                 Kilobases           A        B         C        D         E        F        G 
 
                               
 
Figure 5.23.   Diagnostic PCR for double knockout strain akl1 hsl1. 
Lane A: 1kb DNA molecular marker. 
Lane B: Potential akl1 using primers AKL1F/R and DNA isolate 7 for akl1 hsl1. 
Product size was approximately 1989 bp which corresponds to kanMX knockout 
construct size. 
Lane C: DNA isolate 7 amplified with primers AKL1F and KAN01R. PCR product 
was approximately 353 bp and reflects the left flanking region of akl1 knockout 
construct. 
Lane D: DNA isolate 7 amplified with primers AKL1R and KAN02F. PCR product 
was approximately 742 bp and reflects the right flanking region of akl1 knockout 
construct. 
Lane E: Potential hsl1 using primers HSL1F/R and DNA isolate 7 for akl1 hsl1. 
Product size was approximately 1995 bp which corresponds to kanMX knockout 
construct size. 
Lane F: DNA isolate 7 amplified with primers HSL1R and KAN02F. PCR product 
was approximately 770 bp and reflects the right flanking region of hsl1 knockout 
construct. 
Lane G: DNA isolate 7 amplified with primers HSL1F and KAN01R. PCR product 
was approximately 331 bp and reflects the left flanking region of hsl1 knockout 
construct. 
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Figure 5.24. Comparative growth analysis of the effects of protein kinase knockouts 
on strain G600. Double knockout strains were serial diluted onto YPD medium and 
incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Double knockout mutants were not ts at 
37
o
C or 39
o
C. 
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5.3.5 Analysis of [PSI
+
] in G600 protein kinase mutants 
             Single and double kinase mutants were spotted onto YPD medium alongside 
WT G600. The plates were incubated for 2 days at 30
o
C followed by 2 days at room 
temperature. All mutants appeared [PSI
+
]. akl1 appeared pink when streaked on 
YPD in Figure 5.19 however when spotted onto YPD it appeared only slightly [PSI
+
] 
weak (Figure 5.25). Interestingly, the addition of a second kinase mutation to 
G600 akl1 made the strain more [PSI
+
]. It appears that single and double deletions of 
kinases that phosphorylate Sse1 and Sse2 do not have a huge effect on [PSI
+
]. 
 
 
                 G600                        kin2                        akl1                        hsl1 
                            
                 
          
akl1 hsl1             akl1 kin2 
 
                                                 
 
 
Figure 5.25. [PSI
+
] phenotypic analysis in protein kinase mutant strains. All single 
and double knockout mutants were spotted onto YPD medium in 10 l of dH2O. The 
plates were incubated at 30
o
C for 2 days followed by 2 days at room temperature. All 
knockout strains were [PSI
+
]. akl1 appeared only slightly [PSI
+
] weak. 
 
 
 
 
               To further analyse [PSI
+
] in the kinase mutants each strain was spotted on 
SC - adenine medium (Figure 5.26). The plates were incubated at 30
o
C for 2 days 
followed by 2 days at room temperature. All mutants were expected to grow as they 
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all displayed a [PSI
+
] phenotype on YPD medium. However, single mutants kin2 
and hsl1 did not grow. The test was repeated again and the same phenotype 
appeared. Single mutant akl1 and double mutants akl1 kin2 and akl1 hsl1 all 
grew well on SC - adenine medium (Figure 5.26). These results were contradictory as 
kin2 and hsl1 displayed a [PSI
+
] phenotype on YPD but a [psi
-
] phenotype on SC - 
adenine.  
               Perhaps deleting kin2 and hsl1 impaired the adenine biosynthesis pathway 
somehow, and without supplemented adenine these mutants cannot grow. There is 
also the possibility that the mutants are actually [psi
-
] and they appear white on YPD 
because there is some sort of factor impairing the formation of the red pigment. There 
are possibly other conditions that a cell requires, other than the ade2 mutation, in 
order to produce the red pigment. Any genetic disruption to these processes could 
ultimately lead to a white phenotype. 
              The kinase mutants were streaked onto YPD + 3 mM GdnHCl agar and 
incubated at 30
o
C for 2 days followed by 2 days at room temperature. The only strains 
to cure were G600 WT and G600 akl1 (Figure 5.27). Perhaps the other mutants are 
successfully cured but the red pigment is not produced. There is also the possibility 
that these mutants are petite mutants and this may be the reason why they are white 
but Ade
-
. These results were quite unexpected and it is hard to make a conclusion as 
to exactly what is genetically/biochemically occurring. Possible future work is 
discussed in Chapter 6.  
              Preliminary results with single mutant hsl1 suggested that its genetic 
abnormality is dominant. hsl1 and akl1 were mated with [psi
-
] G620/G621 strains 
and the diploids were cured on 3 mM GdHCl. akl1 successfully cured but hsl1 
remained white. 
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akl1 hsl1             akl1 kin2 
                                                 
 
 
Figure 5.26. [PSI
+
] phenotypic analysis in kinase knockout strains. All knockout 
strains were spotted onto SC - adenine in 10 l of dH2O. The plates were incubated 
for 2 days at 30
o
C followed by 2 days at room temperature. Single kin2 and hsl1 
strains failed to grow on SC - adenine but grew with the addition of akl1 second 
deletion. This result was not expected as both mutants appeared [PSI
+
] on YPD 
medium, but failure to grow on medium without adenine is indicative of a [psi
-
] strain. 
 
 
 
                G600                        kin2              akl1                        hsl1                          
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Figure 5.27. Analysis of the curability of kinase mutants on 3 mM GdnHCl. G600 
WT and kinase mutants were streaked onto YPD + 3 mM GdnHCl and incubated at 
30
o
C for days. [PSI
+
] was analysed after the strains were left for 2 days at room 
temperature. The only mutant that successfully turned red (cured) was single mutant 
akl1. 
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5.4 Analysis of Sse1 and Sse2 phosphorylation sites 
             Protein phosphorylation is a universal mechanism which is essential for 
regulating cell behaviour in yeast and other eukaryotes. Protein kinases target their 
substrates by binding to short pieces of their linear protein sequence (Mok et al., 
2010). In this section the effects of altering these sites were examined and how this 
impacts the ability of Sse1 and Sse2 to propagate [PSI
+
] and maintain cellular 
integrity.  
 
5.4.1 Sse phosphorylation site location and the generation of mutations which 
alter these sites 
               The Sse serine residues which are phosphorylated in vivo by protein kinases 
were chosen to be analysed. Using the Phosphopep database the precise codons which 
the kinases are presumed to modify were identified. The phosphopep database has 
identified nearly 9,000 phosphorylation sites in the yeast proteome. Most sites in the 
database were identified from peptides which were separated by their isoelectric 
points and analysed using LTQ-FT and LTQ-Orbtitrap Mass Spectrometry 
instruments. Kinases phosphorylate these sites by adding a phosphate group onto the 
hydroxyl group of serine. These sites were S85 and S384 in Sse1 and S384, S679 and 
S682 in Sse2 (Figure 5.28). These sites were altered to alanine and glutamic acid 
residues. This was achieved by site-directed mutagenesis (Figure 5.29 and Figure 
5.31). The reason why alanine and glutamic acid were chosen is because alanine is 
refractory to phosphorylation and glutamic acid mimics phosphorylation 
(phosphomimetic) so they have opposing effects.  
                 The mutants were transformed into CM02 and selected on SC - leucine for 
2 days at 30
o
C. Transformants were replicated onto 5-FOA to select against 
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pRS316SSE1. Sse1 mutants grew well on this medium for 2 days (Figure 5.30) 
however the Sse2 mutants struggled to grow even after 4 days incubation (Figure 
5.32). Small colonies appeared after the plates were left at room temperature for 2 
days. These colonies were picked off and restreaked onto fresh SC - leucine where 
they all grew well.      
 
 
 
MSTPFGLDLGNNNSVLAVARNRGIDIVVNEVSNRSTPSVVGFGPKNRYLGETGKNKQTSN 
IKNTVANLKRIIGLDYHHPDFEQESKHFTSKLVELDDKKTGAEVRFAGEKHVFSATQLAA    
MFIDKVKDTVKQDTKANITDVCIAVPPWYTEEQRYNIADAARIAGLNPVRIVNDVTAAGV    
SYGIFKTDLPEGEEKPRIVAFVDIGHSSYTCSIMAFKKGQLKVLGTACDKHFGGRDFDLA 
ITEHFADEFKTKYKIDIRENPKAYNRILTAAEKLKKVLSANTNAPFSVESVMNDVDVSSQ   
LSREELEELVKPLLERVTEPVTKALAQAKLSAEEVDFVEIIGGTTRIPTLKQSISEAFGK   
PLSTTLNQDEAIAKGAAFICAIHSPTLRVRPFKFEDIHPYSVSYSWDKQVEDEDHMEVFP   
AGSSFPSTKLITLNRTGDFSMAASYTDITQLPPNTPEQIANWEITGVQLPEGQDSVPVKL    
KLRCDPSGLHTIEEAYTIEDIEVEEPIPLPEDAPEDAEQEFKKVTKTVKKDDLTIVAHTF   
GLDAKKLNELIEKENEMLAQDKLVAETEDRKNTLEEYIYTLRGKLEEEYAPFASDAEKTK 
LQGMLNKAEEWLYDEGFDSIKAKYIAKYEELASLGNIIRGRYLAKEEEKKQAIRSKQEAS 
QMAAMAEKLAAQRKAEAEKKEEKKDTEGDVDMD* 
 
 
 
 
MSTPFGLDLGNNNSVLAVARNRGIDVVVNEVSNRSTPSLVGFGPRNRYLGESGKTKQTSN 
VKNTVENLKRIIGLKFKDPEFDIENKFFTSKLVQLKNGKVGVEVEFGGKTHVFSATQLTA    
MFIDKVKHTVQEETKSSITDVCLAVPVWYSEEQRYNIADAARIAGLNPVRIVNDVTAAAV    
SYGVFKNDLPGPEEKPRIIGLVDIGHSTYTCSIMAFRKGEMKVLGTAYDKHFGGRDFDRA    
ITEHFADQFKDKYKIDIRKNPKAYNRILIAAEKLKKVLSANTTAPFSVESVMDDIDVSSQ    
LSREELEELVEPLLKRVTYPITNALAQAKLTVNDIDFVEIIGGTTRIPVLKKSISDVFGK    
PLSSTLNQDEAVAKGAAFICAIHSPTLRVRPFKFEDIDPYSVSYTWDKQVDDEDRLEVFP    
ANSSYPSTKLITLHRTGDFSMKAVYTHPSKLPKGTSTTIAKWSFTGVKVPKDQDFIPVKV    
KLRCDPSGLHIIENAYTTEDITVQEPVPLPEDAPEDAEPQFKEVTKTIKKDVLGMTAKTF    
ALNPVELNDLIEKENELRNQDKLVAETEDRKNALEEYIYTLRAKLDDEYSDFASDAEKEK    
LKNMLATTENWLYGDGDDSTKAKYIAKYEELASLGNIIRGRYLAKEEEKRQALRANQETS 
KMNDIAEKLAEQRRARAASDDSDDNNDENMDLD* 
 
 
 
Figure 5.28. Phosphorylation sites located on the Sse1 and Sse2 protein sequence. 
Sse1 is the top sequence and Sse2 is the bottom. Sites were confirmed using the 
Phosphopep database. All phosphorylation sites are serine residues. 
      
 
Sse1 
Sse2 
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      S85A 
      TTCGAGCAAGAAGCTAAGCACTTCACCTCTAAGTTGGTTGAATTGG 
      TTCGAGCAAGAATCTAAGCACTTCACCTCTAAGTTGGTTGAATTGG 
       
      S85E 
      TTCGAGCAAGAAGAAAAGCACTTCACCTCTAAGTTGGTTGAATTGG 
      TTCGAGCAAGAATCTAAGCACTTCACCTCTAAGTTGGTTGAATTGG 
       
      S384A 
      TTTATTTGCGCCATTCACGCTCCAACTCTAAGAGTTAGACCATTCAA 
      TTTATTTGCGCCATTCACTCTCCAACTCTAAGAGTTAGACCATTCAA 
       
      S384E 
      TTTATTTGCGCCATTCACGAACCAACTCTAAGAGTTAGACCATTCAA 
      TTTATTTGCGCCATTCACTCTCCAACTCTAAGAGTTAGACCATTCAA 
 
Figure 5.29. Location of SSE1 phosphorylation site mutants. Serine codons are 
highlighted and are in the top sequence. The mutants were generated by site-directed 
mutagenesis. This figure illustrates a select region of DNA sequence from SSE1 gene 
with the exact mutation on the bottom row. These codon mutations correspond to the 
particular amino acid site of phosphorylation. 
 
                              
                           
                                 
                            
                                 
                            
                                 
                            
                                 
 
Figure 5.30. Growth status of Sse1 phosphorylation mutants in CM02. CM02 was 
transformed with each mutant, selected on SC - leucine and incubated at 30
o
C for 2 
days. The plates were replicated onto 5-FOA, to select against pRS316SSE1, and 
incubated at 30
o
C for 2 days. Sse1 phosphorylation mutants could support growth.                 
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       S384A 
   CGCTTTCATATGTGCCATTCACGCTCCAACTTTAAGGGTCAGGCCG 
               
CGCTTTCATATGTGCCATTCACTCTCCAACTTTAAGGGTCAGGCCG 
        
 
       S384E 
      CGCTTTCATATGTGCCATTCACGAACCAACTTTAAGGGTCAGGCCG 
 
      CGCTTTCATATGTGCCATTCACTCTCCAACTTTAAGGGTCAGGCCG 
       
 
       S679A 
       ACGCGCTGCAGCTGATGATAGCGATGACAACAATGATGAAAACAT 
 
      ACGCGCTGCAAGTGATGATAGCGATGACAACAATGATGAAAACAT 
        
 
      S679E 
      ACGCGCTGCAGAAGATGATAGCGATGACAACAATGATGAAAACAT 
 
     ACGCGCTGCAAGTGATGATAGCGATGACAACAATGATGAAAACAT 
       
 
      S682A 
     AAGTGATGATGCCGATGACAACAATGATGAAAACATGGACCTTGA 
 
     AAGTGATGATAGCGATGACAACAATGATGAAAACATGGACCTTGA 
       
 
      S682E 
      AAGTGATGATGACGATGACAACAATGATGAAAACATGGACCTTGA 
 
     AAGTGATGATAGCGATGACAACAATGATGAAAACATGGACCTTGA 
       
 
 
 
Figure 5.31. Location of SSE2 phosphorylation site mutants. Serine codons are 
highlighted and are in the top sequence. Mutants were generated by site-directed 
mutagenesis. This figure illustrates a select region of DNA sequence from SSE2 gene 
with the exact mutation on the bottom rows. These codon mutations correspond to the 
particular amino acid site of phosphorylation. 
 
 
 
 
 
 293 
                                 
 
                                 
 
                                 
 
                                 
 
                                 
 
                                 
 
                                 
 
 
Figure 5.32. Growth status of Sse2 phosphorylation mutants in CM02. CM02 was 
transformed with each mutant, selected on SC - leucine and incubated at 30
o
C for 2 
days. The plates were replicated onto 5-FOA, to select against pRS316SSE1, and 
incubated at 30
o
C for 4 days. Sse2 phosphorylation mutants struggled to support 
growth even after 4 days incubation. The plates were left at room temperature for 2 
days and colonies were selected and restreaked onto fresh medium.                 
 
 
 
 
5.4.2 Investigation into the effects of phosphorylation site mutants on cellular 
thermostability 
               As Sse1 and Sse2 play a role in responding to thermal stress an objective 
was to test the effect the mutations have on the ability of Sse to maintain 
thermostability. CM02 with Sse1 and Sse2 phosphorylation site mutants were serial 
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Sse2
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diluted onto YPD and incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Sse1 mutants all 
grew at a similar rate to WT Sse1 at all temperatures (Figure 5.33).  
              Screening for temperature-sensitive mutants in Sse2 is slightly more difficult 
since WT Sse2 is slow-growing and non-viable at 39
o
C already. However, Sse2 
mutant S384E was temperature-sensitive and slow-growing at 30
o
C. In comparison 
S384A grew slightly better than WT Sse2 which showed growth at all temperatures 
(Figure 5.34). All other Sse2 mutants displayed similar growth to WT Sse2 (Figure 
5.35 and 5.36). S384E was also created in Sse1 but did not result in a temperature-
sensitive phenotype (Figure 5.33). 
 
 
5.4.3. Analysis of [PSI
+
] phenotypes in Sse1 and Sse2 phosphorylation site 
mutants 
               Sse1 mutants were streaked onto YPD and incubated at 30
o
C for 2 days. The 
mutants displayed a colour phenotype similar to WT Sse1 and were deemed as [PSI
+
] 
mutants (Figure 5.37). The mutants also cured efficiently on 3 mM GdnHCl which 
confirmed that nothing effected the ade2 red pigment development (Figure 5.38).  
               In comparison the Sse2 mutants were spotted onto YPD in 10 l of dH2O 
and they displayed varying degrees of [PSI
+
] (Figure 5.39). Mutants S384A and 
S682E appeared red [psi
-
] which was confirmed by their lack of growth on SC - 
adenine (Figure 5.40). However two mutants, S679E and S682A, appeared pink and 
[PSI
+
] was present in the cell as these mutants grew successfully on SC - adenine 
(Figure 5.40). However, all of the Sse2 mutants did appear to have slightly greater 
[PSI
+
] phenotypes than WT Sse2. 
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Figure 5.33. Comparative growth analysis of the temperature-sensitive effects caused 
by Sse1 phosphorylation site mutants. Sse1 mutants were serial diluted onto YPD 
medium and incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Mutants had no effect on 
the ability of Sse1 to maintain thermostability.  
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Figure 5.34. Comparative growth analysis of the temperature-sensitive effects caused 
by Sse2 phosphorylation site mutants. Sse2 mutants were serial diluted onto YPD 
medium and incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Mutant Sse2
S384E
 had an 
effect on Sse2 at temperatures as low as 30
o
C. In comparison mutant Sse2
S384A
 grew 
well and even slightly better than WT Sse2 at 39
o
C. WT Sse2 showed small amounts 
of growth at 39
o
C on this plate which is not reflected in the other plates in this test. 
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Figure 5.35. Comparative growth analysis of the temperature-sensitive effects caused 
by Sse2 phosphorylation site mutants. Sse2 mutants were serial diluted onto YPD 
medium and incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Phosphorylation site 
mutants Sse2
S679A
 and Sse2
S679E
 behaved similarly to WT Sse2 in that they were slow-
growing at 37
o
C and non-viable at 39
o
C. 
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Figure 5.36. Coimparative growth analysis of the temperature-sensitive effects caused 
by Sse2 phosphorylation site mutants. Sse2 mutants were serial diluted onto YPD 
medium and incubated at 30
o
C, 37
o
C and 39
o
C for 2 days. Phosphorylation site 
mutants Sse2
S682A
 and Sse2
S682E
 behaved similarly to WT Sse2 in that they were slow-
growing at 37
o
C and non-viable at 39
o
C. 
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Figure 5.37. [PSI
+
] phenotypic analysis of Sse1 phosphorylation mutants. Mutants 
were streaked onto YPD and incubated at 30
o
C for 2 days. Mutations to the 
phosphorylation sites of Sse1 appear to cause no disruption to [PSI
+
] propagation. 
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Figure 5.38. Analysis of Sse1 phosphorylation mutant curability on 3 mM GdnHCl. 
Mutants were streaked onto YPD + 3 mM GdnHCl and incubated at 30
o
C for 2 days. 
WT Sse1 and Sse1 mutants successfully cured on this medium. 
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Figure 5.39. Analysis of [PSI
+
] in Sse2 phosphorylation site mutants. CM02 + Sse1, 
Sse2 and Sse2 mutants were spotted onto YPD in 10 l dH2O. The plates were 
incubated at 30
o
C for 2 days and left at room temperature for 2 days prior to analysis. 
All Sse2 mutants appeared slightly more [PSI
+
] than WT Sse2, particularly Sse2
S679E 
and Sse2
S682A
.  
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Figure 5.40. Analysis of [PSI
+
] in Sse2 phosphorylation site mutants. CM02 + Sse1, 
Sse2 and Sse2 mutants were spotted onto SC - adenine in 10 l dH2O. The plates 
were incubated at 30
o
C for 2 days and left at room temperature for 2 days prior to 
analysis. Sse2 mutants S384A and S682E failed to grow like WT Sse2 control. 
Mutants S384E and S679A showed small amounts of growth and mutants S679E and 
S682A grew as well as WT Sse1. These results correspond with those in Figure 5.39 
in that certain Sse2 mutations make the strain more [PSI
+
]. 
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              Mutants S384E and S679A appeared dark pink on YPD and had a small 
amount of growth on SC - adenine. All mutants were mated with [psi
-
] strain G621 
resulting in mutants S384E, S679E and S682A demonstrating a dominant [PSI
+
] 
phenotype. The ability to isolate Sse2 mutants which improve the proteins ability to 
propagate [PSI
+
] alone is very interesting, particularly since these mutations affect 
kinases binding to Sse2. It appears that if you differentially phosphorylate Sse2 it can 
start to propagate [PSI
+
] again and could possibly be the reason why Sse2 cannot 
propagate [PSI
+
] in the first place. 
 
 
5.5 Chapter discussion 
             In Chapters 3 and 4 the focus was mainly on the role Sse1 plays in yeast 
prion propagation and cell integrity. In this Chapter Sse1 and Sse2 have been 
compared in their ability to provide the cell with Hsp110 functions when expressed as 
the sole Hsp110 isoform.   
             Cloning SSE2 enabled a comparative analysis of Sse1 and Sse2 phenotypes in 
CM02 to be carried out. SSE2 was successfully cloned into pRS315 under the control 
of its own promoter. This enabled the transformation of SSE2, alongside SSE1, into 
cells and shuffle out WT SSE1. Sse1 and Sse2 were first compared by assessing their 
ability to promote [PSI
+
] propagation. When spotted onto YPD Sse2 appeared [psi
-
] in 
comparison to Sse1. Sse2 also failed to grow on SC - adenine medium, indicative of a 
[psi
-
] strain. When Sse1 and Sse2 strains were mated with a [psi
-
] strain the Sse2 
diploids were red and failed to grow on SC - adenine, confirming again the hypothesis 
that Sse2 is incapable at propagating [PSI
+
]. As Sse2 is expressed at low levels under 
normal environmental conditions its low cellular presence may not be sufficient 
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enough to propagate [PSI
+
]. It has been shown that Sse2 is ~50% less efficient as Sse1 
at Ssa1 nucleotide exchange (Dragovic et al., 2006) and Polier et al. (2010) recently 
showed that Sse2 is capable of binding unfolded firefly luciferase but fails to stabilise 
it for Hsp70-mediated folding. Perhaps the limited expression of Sse2 protein at basal 
temperatures, its lack of holdase function and its insufficient NEF function inhibits its 
ability to maintain and propagate [PSI
+
].  
              As Sse1 and Sse2 have been recorded as having different expression levels at 
different temperatures (Mukai et al., 1993) the growth rates of cells expressing Sse1 
and Sse2 were compared in CM02. This was performed at 30
o
C and 37
o
C. Cells with 
WT Sse1 grew relatively fast at 30
o
C and 37
o
C with generation times of 116 and 100 
minutes respectively. It appears that heat stress caused the Sse1 strain to grow at a 
faster rate. In comparison, Sse2 had growth rates of 134 minutes at 30
o
C and 132 
minutes at 37
o
C so it was slower growing at both temperatures. This was not a 
surprising result as Sse2 expression is up-regulated at increased temperatures so no 
differences were observed between growth at 30
o
C and 37
o
C. Comparative growth 
analysis at 30
o
C, 37
o
C and 39
o
C confirmed this, as Sse2 was slow-growing at 30
o
C 
and 37
o
C and was completely non-viable at 39
o
C. These results concur with previous 
reports by Liu et al. (1999), Shaner et al. (2004) and Raviol et al. (2005). As Sse2 is a 
stress induced protein its expression is up-regulated by transcription factors such as 
Hsf1 and Msn2 (Wu and Li, 2008) at 37
o
C and not 30
o
C, perhaps this is why Sse2 
could grow similarly at both temperatures. It seems that Sse2 is either not expressed at 
a high enough level to cope with temperature stress or its structure disables it from 
making critical interactions necessary for normal cell growth. These findings agree 
with those made by Shaner et al. (2004) and Raviol et al. (2006).  
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                 Sse1 mutant E504K is located at the only amino acid residue not conserved 
in Sse2. E504K was previously isolated as an Sse1 mutant with a [PSI
+
] weak 
phenotype. It was theorised that if this residue is important for Sse1 to function in 
[PSI
+
] propagation then perhaps Sse2 could maintain [PSI
+
] if it expressed residue 
E504. Changing Sse2 Q504 to E504 resulted in cells that grew at a similar rate to WT 
Sse2 but expressed an enhanced [PSI
+
] phenotype (Figure 5.11). Therefore Sse2 
mutant Q504E has a specific affect on [PSI
+
] and does not enhance Sse2 growth 
indicating that Hsp110 residues are specific in their interactions and molecular 
functions. In Chapter 3 it could not be established exactly how this residue is 
important for Sse1 function and how the mutation disrupts the Sse1 structure. 
However, this residue is clearly important in [PSI
+
] propagation as its presence in 
Sse2 enhanced some function that led to an improved [PSI
+
] phenotype.  
               Mutant G616D was isolated in Sse1 as a [psi
-
] ts mutant and this residue is 
conserved in Sse2. The aim was to investigate whether this residue has conserved 
function in both Sse1 and Sse2. G616D was introduced into the Sse2 structure leading 
to a ts phenotype more extreme than that seen in WT Sse2. Sse2
G616D 
was slow- 
growing at 30
o
C and non-viable at 37
o
C (Figure 5.12). This residue appears to have 
conserved function in both Sse1 and Sse2. In Sse1 this mutant possibly disrupted 
Hsp70 binding and subsequent NEF function and its 30
o
C ts phenotype in Sse2 could 
also be due to a lack of NEF function.  
              Another area explored was how Sse phosphorylation affects [PSI
+
] 
propagation and thermostability. Surprisingly, single and double deletions of kinase 
proteins Akl1, Kin2 and Hsl1 did not appear to have a severe effect on cell growth or 
on [PSI
+
]. It soon became clear that the mutants had an unusual phenotype as all but 
akl1 failed to cure on 3 mM GdnHCl and mutants kin2 and hsl1 failed to grow on 
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SC – adenine when they appeared [PSI+] on limiting adenine. The adenine 
biosynthesis pathway is complicated and disruptions to it could ultimately affect a 
cells phenotype. There is the possibility that kin2 and hsl1 are [psi
-
] but failed to 
produce the red pigment associated with this phenotype. This would explain how the 
mutants grew as white cells on YPD, failed to grow on SC – adenine and failed to 
cure on GdnHCl. If this were the case then double mutants akl1 kin2 and 
akl1 hsl1 stabilised this [PSI
+
] disruption as they successfully grew on SC – 
adenine. But these double mutants also failed to cure on GdnHCl still indicating a 
problem with red pigment formation. There is also the possibility that they are [PSI
+
] 
mutants but failed to grow on SC – adenine as their mutation impairs the adenine 
biosynthesis pathway somehow, and without supplemented adenine these mutants 
cannot grow. There is something genetically complex occurring with these mutants 
and future work will need to be done in order to establish exactly what this is.                 
              In this Chapter the Sse1/Sse2 serine residues which are suggested as being 
phosphorylated in vivo by protein kinases were examined. The phosphopep database 
has identified five phosphorylation sites in Sse1 and Sse2 by mass spectrometry 
analysis. However, it is important to note that these phosphorylation sites have not yet 
been formally shown by 
32
P labeling in vivo. The residues were altered to alanine and 
glutamic acid residues by site-directed mutagenesis. The concept behind these amino 
acid substitutions was that alanine mutants would fail to be phosphorylated and 
glutamic acid mutants would mimic permanent phosphorylation. Sse1 
phosphorylation site mutants displayed no impairment to either temperature 
sensitivity or to [PSI
+
] phenotypes. In comparison, Sse2 phosphorylation site mutant 
S384E was slow-growing at 30
o
C and 37
o
C. This same mutation in Sse1 had no effect 
on cell growth. Sse2 mutant S384A enhanced cell growth at 37
o
C and 39
o
C. 
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Interestingly, mutants S384A and S384E are located at the same residue but resulted 
in two completely different phenotypes probably due to variations in protein 
phosphorylation. It appears that a lack of phosphorylation at S384 enhances the ability 
of Sse2 to withstand thermal stress and permanently activating phosphorylation 
(S384E) increases Sse2 temperature sensitivity. This is significant as it is not only the 
mutation that is having the effect on Sse2 but the resulting phenotype is dependent on 
the type of amino acid change occurring. As these two phenotypes were observed, 
there is an indication that posttranslational modification of Sse2 does have an impact 
on its function in thermotolerance. There is the possibility that this mutation may not 
just be disrupting kinase binding but also disrupting the Sse2 structure in a way that 
improves/disrupts its ability to withstand thermal stress. It also appears that Sse2 is 
more sensitive to these mutations than Sse1, in respect to thermostability, perhaps 
because Sse2 is already more sensitive to thermal stress than Sse1.  
                  Sse2 phosphorylation site mutants also resulted in improved [PSI
+
] 
propagation. Mutants S679E and S682A appeared pink on limiting adenine and grew 
well on medium lacking adenine. Most of the other Sse2 phosphorylating mutants did 
appear slightly more [PSI
+
] than WT Sse2 even if they did not fully grow on SC - 
adenine. Once again it appears that differentially phosphorylating Sse2 enhances its 
function, but this time it was enhancing [PSI
+
] propagation. Inhibiting and promoting 
phosphorylation of Sse2 did not result in a uniform patterned phenotype as some 
residues functioned better with phosphorylation and others without. There is the 
possibility that the mutations are altering the Sse2 structure in a way that enables Sse2 
to enhance [PSI
+
] propagation or a combination of structure and posttranslational 
modification.               
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               From this Chapter it can be concluded that Sse1 and Sse2 may be 
structurally similar but are different in their ability to propagate prions, in their 
response to thermal stress and in their response to mutation. Sse1 does play a more 
dominant role in the cell and mutations which make Sse2 more structurally similar to 
Sse1 do improve Sse2’s ability to promote [PSI+] propagation. It remains elusive as to 
how phosphorylation affects Sse1 and Sse2 function. Both the disruption and 
induction of phosphorylation appeared to have no impact on Sse1 functions. In 
comparison, certain phosphorylation site mutants affected Sse2 in a way that 
enhanced [PSI
+
] and also affected cell thermotolerance. Probably the most interesting 
mutant was located at S384 as it had opposing cellular effects dependent on whether it 
was phosphorylated or not.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER SIX 
DISCUSSION 
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6.1 General discussion 
              Previous work within the laboratory has revealed how molecular chaperones 
such as Hsp70 and Hsp104 have key roles in the maintenance and propagation of 
yeast prions. Such work has been supported by a plethora of research over the past 
decade which emphasises the significant role played by heat shock proteins in 
propagating yeast prions (Rikhvanov et al., 2007). Heat shock proteins are extensively 
characterised in Saccharomyces cerevisiae and the discovery that certain yeast 
proteins exhibit prion conformations has allowed scientists to uncover the nature of 
the relationship between prion and chaperone. Over the past few years evidence 
suggests that the molecular chaperone Hsp110 plays a critical role in yeast prion 
propagation (Fan et al., 2007; Kryndushkin and Wickner, 2007; Sadlish et al., 2008). 
As it has only been recently implicated in prion propagation we sought to determine 
the nature of the Hsp110 protein and how its expression affects yeast prion 
propagation, mainly through genetic analysis.  
 
6.1.1 The Sse1 mutants and their phenotypic consequences  
             The most important discovery made from this study was how a group of 
single Sse1 mutants could impair the ability of yeast to propagate both [PSI
+
] and 
[URE3] prions. Random mutagenesis screening resulted in the isolation of a group of 
thirteen Sse1 single mutants which displayed varying degrees of [PSI
+
] loss. This 
highlighted the importance of particular Sse1 amino acid residues and how their 
correct orientation ultimately affects how the protein exerts its prion promoting 
effects. These mutations were located across the SBD and NBD of Sse1 and not 
localised at one particular region. This emphasised how the whole Sse1 structure is 
important for its role in [PSI
+
] propagation. Mutants with the most severe loss of 
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[PSI
+
] were D236N, G342D, S440L and G616D. The [psi
-
] mutants were all predicted 
as disrupting ATP binding and Hsp70 binding, with some structural effects unclear 
from the 3D analysis. 
             This group of Sse1 mutants also affected the ability of [URE3] to propagate. 
The over-expression of Sse1 effectively cures [URE3] (Kryndushkin and Wickner, 
2007) but when the Sse1 mutants were over-expressed they could not suppress 
[URE3] to the same extent as WT Sse1. The mutants appeared to exert a dominant 
negative effect over the genomic WT copy of SSE1 with mutants G41D, D236N and 
G342D having the biggest effect. The fact that all mutants had a similar effect on 
[URE3] suggested that a number of Sse1 functions such as NEF activity, Hsp70 
interaction and interdomain interaction may all be necessary for Sse1’s curing effect 
on [URE3]. However it soon became clear, from structural data, that the mutants were 
potentially affecting a number of different Sse1 functions and interactions which 
highlighted the complicated nature in which Sse1 overproduction cures [URE3].        
            This work also highlighted how Sse1’s correct amino acid sequence is 
required to make the interactions it needs to carry out its prion promoting functions. 
The Sse1 mutants were successfully modeled on the Sse1 3D crystal structure. This 
molecular modeling helped to determine the potential structural implications of the 
new mutants. The mutations were suggested as causing disruption to amino acid 
charge, polarity and hydrophobicity and also disrupted interdomain interactions and 
possible Hsp70 interactions. The mutants with the most obvious structural disruptions 
were G342D and G343D, which were located at the ATP binding pocket and possibly 
cause disruption to ATP binding. Mutants T365I and E370K appeared to directly 
disrupt Hsp70 binding. Mutant E554K may also disrupt Hsp70 binding as it is located 
at the interface of an Hsp70 binding site but this mutation only produced a [PSI
+
] 
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weak phenotype. G41D and G616D may also disrupt Sse1-Hsp70 binding. It was 
unclear as to exactly how the other mutants were disrupting Sse1 structure and 
function but what was evident from the data obtained was that Hsp70 interaction, 
ATP binding and subsequent NEF activity are most likely the main functions that are 
necessary for prion propagation and are possibly being affected by these mutations. 
The fact that other mutants were isolated with no obvious disruption to Hsp70 or ATP 
binding suggested that Sse1 may play an independent role in prion propagation. These 
results led to the conclusion that Sse1 is a molecular chaperone that plays a major role 
in yeast prion propagation both indirectly through Hsp70 and possibly directly 
through interaction with [PSI
+
].   
 As well as the Sse1 mutants [PSI
+
]-related phenotypes, their cellular growth 
phenotypes were also assessed. As Sse1 and Sse2 are necessary for cellular growth 
and Sse1 deletion compromises the cells ability to withstand thermal stress (Mukai et 
al., 1993), it was aimed to establish whether any of the Sse1 mutants affected normal 
cellular homeostasis. Temperature sensitivity growth analysis in G600 background 
strain CM02 resulted in the mutants demonstrating various levels of sensitivity to 
37
o
C and 39
o
C. Most mutants were slow-growing at 39
o
C, which is possibly because 
the mutants disrupt Sse1 in a way that makes them sensitive to thermal aggregation, 
but mutants G342D and G616D were ts at 37
o
C. Mutant G616D was the most 
interesting mutant as it was non-viable in both CM02 and CM03 at 37
o
C, whereas the 
G342D ts phenotype was not reproduced in CM03. These results suggested that the 
mutants not only disrupt prion propagation but also normal cellular homeostasis, 
possibly through interfering with Sse1’s ability to bind and refold denatured proteins. 
These mutations could also potentially be indirectly disrupting the protein 
disaggregation system by interfering with the functionality of other molecular 
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chaperones such as Hsp104 or Hsp70. Or perhaps the particular mutations are 
disrupting a different function of Sse1 in maintaining cellular homeostasis. Results 
also suggested that Sse1 ts mutants such as G616D may be mutants of the PKA 
pathway. Sse1 is involved in maintaining the down-regulation of PKA signaling and 
G616D may disrupt Sse1’s normal function in this pathway and cause cell 
temperature sensitivity. 
              From the work presented in this thesis it can be concluded that Sse1 mutants 
G342D and G616D were possibly the most disruptive to the Sse1 structure and 
function and warrant further investigation. Table 6.1 summarises eight key mutants 
isolated in this study and what phenotypic effects they had on the cell. The key 
mutants were selected as the most [PSI
+
] weak mutants which also demonstrated other 
cellular impairments and protein structural effects. 
 
 
6.1.2 Hsp110 shares functional characteristics with yeast Fes1 protein and 
mammalian HSPH1 protein 
              Another aspect explored was whether proteins with similar functions could 
functionally compensate for Sse1 and Sse2. Initially in Chapter 3 it appeared that the 
NEF Fes1 and the human Hsp110 protein HSPH1 could not compensate for the 
combined loss of Sse1 and Sse2 in yeast. However, when repeated in a different 
background strain both Fes1 and HSPH1 could support growth in CM03 sse1 sse2. 
This highlighted the genetic background differences between BY4741 and G600. As 
BY4741 is widely used by other groups and G600 displayed other sensitivities it was 
confirmed that the yeast NEF Fes1 and a mammalian Hsp110 homolog HSPH1 could  
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Table 6.1. Overview of the key Sse1 mutations and their phenotypic 
consequences.  
 
 
MUTATION 
 
[PSI
+
] 
PHENOTYPE 
 
TEMPERATURE
-SENSITIVE (TS) 
GROWTH  
DISRUPT 
ABILITY OF 
SSE1 TO 
CURE 
[URE3]? 
 
STRUCTURAL 
EFFECTS 
 
 
G41D 
 
 
 
[psi
-
] 
COLOUR 
SCORE OF 8 
 
 
TS IN CM02 AT 
39
o
C 
 
 
YES 
 
POSSIBLE 
DISRUPTION TO 
HSP70 BINDING? 
 
 
G50D 
 
 
[psi
-
] 
COLOUR 
SCORE OF 8 
 
 
TS IN CM02 AT 
39
o
C 
 
 
YES 
UNKNOWN. 
POSSIBLE 
DISRUPTION TO 
HSP70:HSP110 
BINDING 
INTERFACE? 
 
 
D236N 
 
 
[psi
-
] 
COLOUR 
SCORE OF 10 
 
 
TS IN CM02 AT 
39
o
C 
 
YES. 
BIGGEST LOSS 
OF [URE3] 
CURING. 
 
 
UNKNOWN. 
POSSIBLY A LOSS 
OF ATP BINDING? 
 
 
G342D 
 
 
 
[psi
-
] 
COLOUR 
SCORE OF 10 
 
 
TS IN CM02 AT 
37
o
C AND 39
o
C 
 
 
YES 
 
 
DISRUPTS ATP 
BINDING 
 
 
T365I 
 
 
 
[psi
-
] 
COLOUR 
SCORE OF 7 
 
 
SLOW-GROWING 
IN CM02 AT 39
o
C 
 
 
YES 
 
 
DISRUPTS HSP70 
BINDING 
 
 
E370K 
 
 
 
[psi
-
] 
COLOUR 
SCORE OF 9 
 
 
TS IN CM02 AT 
39
o
C 
 
 
YES 
 
 
DISRUPTS ATP AND 
HSP70 BINDING 
 
 
S440L 
 
 
 
[psi
-
] 
COLOUR 
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provide growth when over-expressed, in a normally lethal, sse1 sse2 strain. Other 
groups such as Raviol et al. (2006b) and Sadlish et al. (2008) also confirmed that Fes1 
could functionally compensate for Hsp110 which also supported this theory. From 
these results it can be concluded that Sse1 shares enough conserved function with its 
mammalian counterpart thus allowing HSPH1 to compensate for the loss of yeast 
Hsp110. This highlighted how Hsp110 proteins may have conserved functions such as 
NEF activity and the ability to bind and interact with Hsp70. This result emphasised 
the relevance of studying molecular chaperones in yeast systems as they do share 
functional characteristics with their mammalian equivalents. The fact that yeast 
protein Fes1 compensated for Hsp110 deletion highlights the conserved nature of 
these proteins even though they are structurally dissimilar. This suggested that 
perhaps it is the increased NEF function provided by Fes1 that is enough to rescue the 
sse1 sse2 lethal phenotype. Or perhaps Fes1 provides another function similar to 
Sse1 that we are unaware of. Fes1 was also over-expressed in the Sse1 mutants to see 
if increased NEF activity could recover [PSI
+
]. The only mutant with an improved 
[PSI
+
] phenotype was G616D. This suggested that perhaps G616D may be the only 
mutant whose [psi
-
] phenotype is mainly due to a loss of NEF activity. 
 
6.1.3 Hsp110 may play a role in yeast cellular homeostasis and strain G600 has 
background sensitivity. 
             Another aim of this study was to establish why certain Sse1 mutants were 
temperature-sensitive and whether this had any link with the role of Sse1 in cellular 
signaling pathways. These experiments not only highlighted that Hsp110 may play a 
role in cell signaling pathways and in cellular morphology, but also resulted in the 
discovery that strain G600 and BY4741 are comparably different which may be 
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related to acquired mutations in G600. 37
o
C ts mutants G342D and G616D had 
osmoremedial temperature sensitivity suggesting a disruption to CWI signaling but 
tests on the mutants sensitivity to cell wall damaging agents resulted in a strain 
sensitivity problem. This led to the creation of a new BY4741 background sse1 sse2 
strain. The G616D mutant had a reproducible ts phenotype in CM03 however G342D 
only appeared slow-growing and not completely ts at 37
o
C, re-emphasising again the 
differences in strain backgrounds. At 37
o
C G616D failed to grow in the presence of 
constitutively activated members of the CWI signaling cascade, BCK1 and PKC1 and 
the mutants showed little difference in their ability to grow on the chemical medium 
when compared to wild type Sse1. These results suggested that the mutants disrupted 
something different to CWI signaling.  
              Sse1 has been linked with protein kinase A (PKA) signaling and it has been 
shown that the temperature-sensitive effects of sse1 can be alleviated by reducing 
PKA signaling (Trott et al., 2005). This prompted the analysis of whether or not 
decreasing PKA activity could restore G342D and G616D temperature sensitivity in 
both CM02 and CM03. PKA activity is decreased by growth on non-fermentable 
carbon sources. When the mutants were grown on YP-glycerol they grew as well as 
WT Sse1 at 30
o
C and 37
o
C, in both CM02 and CM03. Trott et al. (2005) suggested 
that Sse1 may be a negative regulator of PKA so it is possible that the Sse1 ts mutants 
are not functioning properly as negative regulators of this pathway and thus 
demonstrate ts phenotypes on glucose medium at 37
o
C because PKA is over-
activated. These results were promising and could potentially establish why mutants 
G342D and G616D have a slow-growing or non-viable phenotype at increased 
temperatures. G616D could be located at a point in the Sse1 structure critical for 
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Sse1’s role in regulating PKA signaling. This result was suggestive of a PKA 
signaling problem and warrants further investigation. 
               As discussed before, CM02 and CM03 demonstrated comparable growth and 
sensitivity differences. They were different in their ability to complement Hsp110 
deletion with Fes1 and HSPH1 and they also displayed temperature-sensitive 
differences when expressing mutant G342D. CM02 and CM03 also showed 
comparable differences in sensitivity to cell wall damaging agents, when expressing 
WT Sse1. This evidence taken together confirmed the belief that CM02 has a 
background strain weakness making it particularly sensitive. However this 
characteristic was not observed in the PKA signaling tests as CM02 grew a lot better 
than CM03 on non-fermentable carbon medium. Another difference observed in the 
strains was their response to the expression of the Sse1 mutant Q458* but this may 
have been due to a difference in the level of nonsense suppression between the strains. 
A number of factors could contribute to increased readthrough in CM02 including the 
presence of the nonsense suppressor mutant SUQ5. When a truncated version of 
Q458* was created it could not support growth in either of the strains which 
confirmed that the stop codon mutant could possibly be subjected to increased 
readthrough in CM02. 
              Substantial differences observed between G600 and BY4741 background 
sensitivity prompted a genomic analysis of G600 to be carried out. This revealed that 
G600 contains 6,500 SNPs equating to approximately 1,500 non-synonymous amino 
acid changes. Amino acid changes were identified in a number of proteins that could 
potentially impact Sse1/Sse2 function and strain sensitivity. Changes were identified 
in proteins which phosphorylate Sse1 and Sse2, in the CWI signaling counterpart 
Pkc1 and in the PKA signaling protein Ira2. A number of ORFs had altered stop 
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codons, leading to protein elongation at the C-terminus, which could affect G600 
molecular and cellular processes. Inactivating stop codon mutations (ISCMs) were 
also identified which could contribute to G600 sensitivity if the protein affected is 
necessary for cell signaling processes. Gene YBR074W encodes a vacuolar 
proteolytic enzyme and contained a 653 amino acid truncation in G600. Interestingly, 
when expressed on plasmid DNA, YBRO74W did improve G600 [psi
-
] strain growth 
on SDS and congo red, suggesting that insufficient translation of YBRO74W may 
affect the strain sensitivity to chemical stress. An overall increased sensitivity of G600 
[psi
-
] cells compared to [PSI
+
] cells on chemical medium was also observed, 
suggesting that some of G600 sensitivity may rely on cellular levels of [PSI
+
]. These 
results were indicative that ISCMs in G600 may be the reason why it is a sensitive 
strain and [psi
-
] strains may be more sensitive because of the increased functional 
Sup35 promoting translation termination at these ISCMs. This theory warrants further 
investigation which is discussed in section 6.3. 
                Sse1 may interact with the transcription factor SBF (Swi4-Swi6) in a way 
that supports cell growth and proliferation (Shaner et al., 2008). Swi6 is also involved 
in CWI signaling (Madden et al., 1997). The effect Swi6 deletion has on the cell, in 
the presence of Sse1 and Sse2 mutants, was tested in strain CM03. Comparative 
growth analysis revealed that deleting Swi6 has a major impact on sse1 cells at all 
temperatures but had little effect on sse2 cells even at 39
o
C. Four Sse1 mutants were 
also tested in the presence of swi6. They were all non-viable at 39
o
C and slow- 
growing at other temperatures but did not exhibit as severe of an effect as 
sse1 swi6. These results suggested that it is the combined loss of Sse1 and Swi6 that 
is having the negative effect on cell thermostability as sse1 grows relatively well at 
30
o
C and sse2 swi6 also grows well. These results were similar to those produced 
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by Shaner et al. (2008). Somehow the combined loss of function of Sse1 and Swi6 has 
a major impact on cell thermostability, either through CWI signaling or some other 
process. Normal cell morphology was also disrupted in swi6 sse1, swi6 sse2 and 
swi6 sse1 sse2 + sse1 mutants. They had a large, amorphous and elongated 
structure with some mutants exhibiting more severe effects than others. sse1, sse2 
delete strains and sse1 mutants were tested alone and expressed normal circular 
budding cell morphology. Despite Shaner et al. (2008) stating that swi6 alone 
disrupts cell morphology no obvious physical changes were observed in 
BY4741 swi6. From these results it was concluded that the combined effect of swi6 
and sse1/sse2 mutations has a huge impact on cell structure resulting in disrupted cell 
size and shape. It is possible that Sse1 NEF function may contribute to cell shape and 
morphology as complete loss of NEF ( sse1) and possible NEF mutant T365I had the 
most severe affect on cell structure and shape, in the presence of swi6.  
 
 
6.1.4. Sse1 and Sse2 proteins may have comparable differences in their roles in 
[PSI
+
] propagation and cellular homeostasis 
              The comparative functional differences between SSE1 and SSE2 were 
analysed as little is known about these. Firstly, the abilities of Sse1 and Sse2 to 
provide cell growth and to promote [PSI
+
] were compared.  SSE2 expressed alone in 
CM02 was incapable of maintaining [PSI
+
] but in comparison SSE1 expressed alone 
had a [PSI
+
] phenotype, indicative of the major functional difference between these 
two homologous proteins. Although they are structurally similar and are both 
divergent members of the Hsp70 superfamily, Sse1 was more potent in its ability to 
propagate [PSI
+
]. Perhaps because SSE2 has low expression levels or low nucleotide 
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exchange function it is less able to function in yeast prion propagation. When 
comparing growth rates SSE2 generation time was slower than SSE1 at 30
o
C and 
37
o
C. There was little difference in generation time in SSE2 cells when grown at 
either 30
o
C or 37
o
C which was reflected in the subsequent comparative growth 
analysis. SSE2 was ts at 39
o
C but slow-growing at both 30
o
C and 37
o
C. It could be 
that Sse2 is less able to function as a ‘holdase’ of denatured proteins when the cell is 
exposed to increased temperatures. This could be why sse1 cells are more 
thermosensitive, as Sse2 is incapable at functioning in the protein disaggregation 
response to cellular stress (Shaner et al., 2004; Raviol et al., 2006). These results 
highlighted the importance of Sse1 and how it is the most important Hsp110 isoform 
in [PSI
+
] propagation and in cell stress responses. 
               It was proposed that as Sse1 and Sse2 are 76% identical (Polier et al., 2010) 
it may be the small differences which make Sse2 incapable of promoting [PSI
+
] 
propagation. The only Sse1 mutant location which was not conserved in Sse2 was 
E504. As this residue is important for Sse1 to function in [PSI
+
] propagation it was 
theorised that Sse2 may also function better if it expressed E504 rather than Q504. 
Tests showed that Sse2
Q504E 
had an improved [PSI
+
] phenotype compared to WT Sse2 
but failed to provide Sse2 with better thermostability. This result suggested that 
Hsp110 proteins differ in their function between [PSI
+
] propagation and 
thermostability as recovery of one phenotype did not result in recovery of the other. 
Residue G616 is conserved between Sse1 and Sse2 and to test if they have conserved 
function the G616D mutation was introduced into the Sse2 structure. The Sse2
G616D
 
mutant remained [psi
-
] but also exhibited a ts phenotype much worse than WT Sse2. It 
was concluded from these results that Sse1 and Sse2 do share conservation in their 
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function but possibly if Sse2 was more structurally similar to Sse1 it may be better 
able to promote [PSI
+
] propagation.  
               Another enigmatic area explored was the effects phosphorylation has on the 
ability of Hsp110 to carry out its functions. Single and double deletions of the kinases 
proteins Akl1, Kin2 and Hsl1 had no major impact on [PSI
+
] or on cell 
thermostability. Problems were encountered when it was discovered that single kin2 
and hsl1 mutants failed to grow on SC – adenine medium even though they appeared 
[PSI
+
] and single and double kin2 and hsl1 mutants failed to cure on GdnHCl. A 
number of potential possibilities as to why these unexpected phenotypes have 
appeared has been considered and will be further discussed in section 6.3. 
             The Sse1/Sse2 sites where phosphates bind to were identified using the 
Phosphopep database. These sites were altered in two ways, one that mimics 
constitutively active phosphorylation (E) or another which inhibits phosphorylation 
(A) completely. Sse1 phosphorylation site mutants displayed no effects on either 
temperature sensitivity or on [PSI
+
]. In comparison, Sse2 phosphorylation site 
mutants did affect growth at restrictive temperatures. Mutant S384E was more ts than 
WT Sse2, therefore enhancing phosphorylation at this residue negatively affected 
temperature sensitivity. In comparison mutant S384A had enhanced growth at 
restrictive temperatures and it was resistant to phosphorylation. This characteristic 
appears unique to Sse2 as the same mutants were induced in Sse1 but did not have an 
effect. Most of the Sse2 phosphorylation site mutants also resulted in improved [PSI
+
] 
propagation. The mutants appeared pink on limiting adenine and demonstrated 
full/partial growth on medium lacking adenine. Once again Sse2 mutants have a 
divergence in function as ones that improve growth and thermostability (S384A) did 
not exhibit the greatest improvement in [PSI
+
] propagation. It appears from these 
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results that differentially phosphosphorylating Sse2 affects its ability to promote 
[PSI
+
] propagation and withstand thermal stress.  However there did not seem to be 
any preference for phosphorylation activation or deactivation as a combination of the 
mutants demonstrated the altered phenotypes. This work highlighted another 
difference between Sse1 and Sse2, as Sse2 seemed more sensitive to altering 
phosphorylation. It can only be presumed that the phenotypic results from these 
experiments were a result of posttranslational modification by protein 
phosphorylation. It is also possible that these mutations are causing structural 
alterations to the Sse2 protein that interfere with other interactions or functions that 
are not related to phosphorylation. The impact of phosphorylation on Sse2 needs to be 
further investigated. 
 
                
6.2 A hypothesis for the role of Hsp110 in prion propagation 
           Previous work published by other groups has proven Hsp110 as a prion 
promoting chaperone (Fan et al., 2007; Sadlish et al., 2008). Other work also suggests 
that Sse1 plays an important role in cell signaling functions (Shaner et al., 2008). The 
work demonstrated in this thesis furthers our understanding of the role played by 
Hsp110 in yeast prion propagation and in cellular homeostasis. It is proposed that 
Sse1 plays an integral role in [PSI
+
] and [URE3] propagation by interacting with 
Hsp70 at critical points necessary to drive nucleotide exchange. It is this nucleotide 
exchange that allows Hsp70 to bind and release prion aggregates and subsequently 
allows them pass onto daughter cells. ATP binding is also important for Sse1 to 
functionally interact with Hsp70 as mutations which disrupted ATP binding led to a 
loss of [PSI
+
]. Mutational and structural analysis also led to the conclusion that Sse1 
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may play an Hsp70-independent role in prion propagation as certain mutants 
displayed [PSI
+
] weak phenotypes but were not located at amino acid positions 
believed to be important for NEF function. Sse1 could functionally interact with 
[PSI
+
] protein aggregates in a way that aids its folding and propagation and certain 
amino acid residues could be critical for this interaction. It is also proposed that Sse1 
is important for cellular tolerance to heat stress possibly by the up-regulation of Sse1 
expression during times of stress and aiding in the protein disaggregation system. 
Sse1 may also play a role in PKA signaling and may function alongside Hsp90 in 
maintaining cellular homeostasis and signaling through a number of cascades. Sse1 
may also function alongside SBF transcription factors in the maintenance of cell 
shape and morphology. Together Sse1 and Sse2 are critical for cell survival but it is 
Sse1 that plays a more important role than Sse2 in prion propagation. Figure 6.1 
illustrates the proposed functions played by Sse1 in prion propagation and in other 
cellular processes. 
 
            The results from this study can also be utilised to help further our 
understanding of the role played by Hsp110 in mammalian prion propagation. Yeast 
and mammalian Hsp110 both function as NEFs for Hsp70 (Dragovic et al., 2006) and 
in mammals HSPH1 may aid in prion propagation by providing this essential 
function. The fact that yeast Sse1 may have prion-related functions separate from its 
NEF function also implies the possibility that mammalian HSPH1 may also interact 
with PrP
sc 
intermediates in a way that promotes its stability and progression. 
Understanding the mechanisms by which Sse1 functions in yeast prion propagation 
could help to determine the nature of the relationship between mammalian HSPH1 
and prion disease. 
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Figure 6.1. The proposed functions of Sse1 in yeast.  
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6.3 Future work 
            While the importance of Hsp110 as a molecular chaperone has been 
demonstrated mainly by genetic means there remains much scope for studying the 
nature of Hsp110 and the Hsp110 mutants by biochemical analysis. Purification of the 
Sse1 and Sse2 mutant proteins would allow us to test what effects the mutations are 
having on the ability of Sse1/Sse2 to hydrolyse ATP and function as NEFs. This 
would give a greater insight into the direct impact these mutations are having on the 
Sse1/Sse2 structure and subsequent functions. Sse1 mutants of particular interest 
would be ones implicated as disrupting NEF activity or ATPase activity. Sse2 mutant 
Q504E is interesting as it improved the ability of Sse2 to maintain [PSI
+
] propagation. 
Purifying this protein, along with WT Sse2, would allow the rate of ATPase activity 
or nucleotide exchange to be measured and would determine if there is any 
improvement in the mutant versus WT.  
               The temperature-sensitive Sse1 mutant G616D was osmoremedial on 1 M 
sorbitol but tests failed to confirm any sensitivity to cell wall damaging medium in 
this mutant. Osmoremedial mutants often signify a disruption to the cell wall or cell 
organelles making the cell ‘leaky’. By biochemical analysis this mutant strain could 
be tested to see if it is suffering from cytoplasm leakage and if so what the nature of 
the contents is. Mutant G616D was also recovered on non-fermentable glycerol 
indicating that it may be disrupting the ability of Sse1 to negatively regulate PKA 
signaling. Testing PKA activity in G616D mutant could help establish this theory. 
Ira2 protein is involved in PKA signaling and this protein was identified as having a 
non-synonymous change in G600. The IRA2 gene could be incorporated into CM02 to 
see if this has an impact on growth. This mutation could be responsible for why 
G342D was ts in CM02 but not CM03. 
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               The sensitivity of G600 to cell wall damaging agents was slightly improved 
when gene YBR074W was expressed. Other genes identified with nonsense mutations 
such as YNL106C could be transformed into G600 and tested alone and with 
YBR074W for improved growth on cell wall perturbing medium. If these genes are 
severely truncated in G600 then they could be responsible for disrupting cell 
homeostasis in G600. 
              Insight into the role of phosphorylation in chaperone function led to some 
interesting results. It appears that differentially phosphorylating Sse2 may impact its 
ability to maintain [PSI
+
] and its thermostability. Future work could involve looking 
at these phosphorylation sites in more detail and perhaps performing some 
biochemical analysis on Sse2 when in a phosphorylated and non-phosphorylated state. 
This could be done by GFP tagging the Sse2 protein mutants and looking at 
differences in cellular location when in a phosphorylated and non-phosphorylated 
state. The mutants could also be measured for their rate of ATP hydrolysis using an 
ATPase assay. This would indicate if phosphorylation has any impact on the ability of 
Sse2 to exchange ATP in the peptide binding cycle. 
              Problems were encountered with kinase knockout strains. Due to time 
constraints no conclusion was made as to how they were affecting the cell. There are a 
number of things that could be explored such as whether disrupting these genes has an 
indirect effect on the adenine biosynthesis pathway, thus resulting in cells dying on 
SC – adenine. Are the mutants disrupting the pathway responsible for formation of the 
red pigment? It appears that hsl1 inability to cure on GdnHCl may be a dominant 
genetic defect as mating this mutant with a cured strain resulted in white colonies that 
were still unable to cure. These diploids could be sporulated to see if the colony 
colour segregates normally and also repeat the test for kin2. From preliminary results 
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it appears that hsl1 and kin2 may be [psi
-
] but somehow failing to produce the red 
pigment. This mutation could be introduced into a different strain such as 74D to see 
if the same phenotype occurs or whether it is a strain specific defect. 
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